Oncology — MCQs

Q: A 65-year-old chronic smoker presents with a rapidly enlarging large hilar mass on a chest film associated with significant adenopathy. He also experiences recurrent hypoglycemic spells. Which of the following lung carcinoma subtypes will most commonly lead to this spectrum?

Small cell carcinoma. **Explanation:** The clinical presentation of a **rapidly enlarging hilar mass** with significant **adenopathy** in a chronic smoker is highly characteristic of **Small Cell Lung Carcinoma (SCLC)** [1]. SCLC is a neuroendocrine tumor known for its aggressive growth and early mediastinal involvement. **Why Small Cell Carcinoma is correct:** The "recurrent hypoglycemic spells" point toward a **Paraneoplastic Syndrome**. While SCLC is most famously associated with SIADH (hyponatremia) and ectopic ACTH (Cushing’s syndrome) [1], it can also cause hypoglycemia through the secretion of **Insulin-like Growth Factor (IGF)** or, rarely, insulin-like substances. Furthermore, SCLC is the lung cancer most strongly associated with central/hilar locations and smoking [2]. **Analysis of Incorrect Options:** * **Squamous Cell Carcinoma:** Also central and smoking-related, but typically associated with **Hypercalcemia** (due to PTHrP secretion), not hypoglycemia [1]. * **Adenocarcinoma:** The most common lung cancer overall; however, it is usually **peripheral** in location and more common in non-smokers. It is associated with hypertrophic osteoarthropathy (clubbing) [1]. * **Large Cell Carcinoma:** A diagnosis of exclusion that presents as a large peripheral mass with early metastasis, but it is not the classic cause of the described paraneoplastic endocrine features. **NEET-PG High-Yield Pearls:** * **SCLC Markers:** Positive for Chromogranin A, Synaptophysin, and CD56. * **Paraneoplastic Associations:** * **SCLC:** SIADH, Ectopic ACTH, Lambert-Eaton Myasthenic Syndrome [1]. * **Squamous Cell:** Hypercalcemia (PTHrP) [1]. * **Adenocarcinoma:** Trousseau syndrome (thrombophlebitis), Marantic endocarditis. * **Rule of "S":** **S**mall cell and **S**quamous cell are **S**moking-related and **S**entral [2].

Q: What is the best treatment for glioblastoma multiforme?

Surgical excision followed by radiation therapy. **Explanation:** Glioblastoma Multiforme (GBM) is the most common and aggressive primary malignant brain tumor in adults (WHO Grade 4) [1]. The standard of care, known as the **Stupp Protocol**, involves a multimodal approach. **Why Option C is correct:** The primary goal in managing GBM is **maximal safe surgical resection** [1]. Reducing the tumor burden (cytoreduction) alleviates mass effect and intracranial hypertension [1]. However, because GBM is highly infiltrative, surgery alone is never curative. Therefore, it must be followed by **adjuvant radiotherapy** (usually 60 Gy) combined with **Temozolomide (TMZ)**, an oral alkylating agent, to target residual microscopic disease. **Why other options are incorrect:** * **Option A (Chemotherapy):** While Temozolomide is standard, it is used as an *adjunct* to surgery and radiation, not as a standalone primary treatment. * **Option B (Radiation therapy):** Radiation alone is insufficient for large masses and is typically reserved for patients who are not surgical candidates due to tumor location or poor performance status. * **Option D (Stereotactic radiosurgery):** SRS is highly effective for small, well-demarcated brain metastases or vestibular schwannomas, but it is not the primary treatment for GBM due to the tumor's diffuse, ill-defined margins. **High-Yield Clinical Pearls for NEET-PG:** * **Imaging:** Classic "Butterfly glioma" appearance (crosses the corpus callosum) with **ring enhancement** and central necrosis on MRI [2]. * **Histopathology:** Characterized by **pseudopalisading necrosis** and microvascular proliferation. * **Prognostic Marker:** **MGMT promoter methylation** is a positive predictor of response to Temozolomide. * **Origin:** Arises from astrocytes; most common site is the cerebral hemispheres (frontal and temporal lobes).

Q: Which of the following hormones is elevated in small cell carcinoma of the lung?

Atrial natriuretic factor (ANF). Small cell lung carcinoma (SCLC) is a neuroendocrine tumor known for its strong association with paraneoplastic syndromes due to the ectopic secretion of hormones [1]. **Why Option B is Correct:** SCLC is the most common cause of the **Syndrome of Inappropriate Antidiuretic Hormone (SIADH)** [1], [2]. While SIADH is primarily caused by ectopic ADH (vasopressin) production, studies have shown that SCLC cells can also secrete **Atrial Natriuretic Factor (ANF)** or Brain Natriuretic Peptide (BNP). Both ADH and ANF contribute to the characteristic hyponatremia seen in these patients—ADH by increasing water reabsorption and ANF by promoting natriuresis (sodium excretion). **Analysis of Incorrect Options:** * **Option A (PTH):** Ectopic production of **PTHrP** (Parathyroid Hormone-related Protein) is classically associated with **Squamous Cell Carcinoma** of the lung, leading to hypercalcemia [1]. * **Option C (Growth Hormone):** Ectopic GH is rare in lung cancer; however, Growth Hormone-Releasing Hormone (GHRH) can occasionally be secreted by bronchial carcinoids. * **Option D (VIP):** VIP secretion is typically associated with **VIPomas** (pancreatic islet cell tumors) or neuroblastomas, causing watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **SCLC Associations:** SIADH (most common), Ectopic ACTH (Cushing’s Syndrome) [1], [3], and Lambert-Eaton Myasthenic Syndrome (LEMS). * **Rule of "S":** **S**quamous cell carcinoma and **S**mall cell carcinoma are both **S**moking-related and **S**entrally (centrally) located. * **Hypercalcemia in Lung Cancer:** If it's Squamous cell, think **PTHrP** [1]. If it's Small cell, hypercalcemia is rare and usually due to bone metastasis, not hormones.

Q: What is the most common physical sign of cerebral metastasis?

Focal neurological deficit. Explanation: Cerebral metastasis is the most common intracranial tumor in adults, occurring in approximately 20-40% of cancer patients. Why Focal Neurological Deficit is Correct: The most common presenting physical sign of brain metastasis is a focal neurological deficit (seen in about 50-70% of patients) [1]. This occurs because metastatic lesions typically lodge at the gray-white matter junction, where they cause localized tissue destruction, mass effect, or significant perilesional vasogenic edema [1]. Common deficits include hemiparesis, sensory loss, or aphasia, depending on the anatomical location of the tumor [1]. Analysis of Incorrect Options: * A. Epilepsy (Seizures): While common (occurring in ~25% of cases), seizures are the second most common presenting feature after focal deficits and headache [1]. They are more frequent in metastases to the frontal or temporal lobes. * C. Papilloedema: This is a sign of increased intracranial pressure (ICP). While it can occur due to mass effect or obstructive hydrocephalus, it is a late finding and much less common than focal deficits in the era of early MRI detection. * D. Visual defects: These are specific types of focal deficits (e.g., hemianopia) that occur only when the visual pathways or occipital cortex are involved. They are not as frequent as motor or sensory deficits. NEET-PG High-Yield Pearls: * Most common primary source: Lung cancer (most common overall), followed by Breast cancer and Melanoma [1]. * Most common symptom: Headache (often worse in the morning or with Valsalva) [1]. * Imaging of choice: Contrast-enhanced MRI (shows "ring-enhancing" lesions with extensive surrounding edema) [1]. * Management: Dexamethasone is the initial step to reduce vasogenic edema; definitive treatment involves surgery, SRS (Stereotactic Radiosurgery), or WBRT (Whole Brain Radiation Therapy).

Q: A 65-year-old man with a 45-pack-per-year history of smoking presents with hematuria, flank pain, and unintentional weight loss. He has no fever, chills, or dysuria. Physical examination reveals no abdominal mass or flank tenderness. Laboratory findings show a hemoglobin of 18.5 g/dL and normal liver enzymes. An abdominal CT scan demonstrates a left kidney mass involving the renal vein. What is the most likely diagnosis?

Renal cell carcinoma. **Explanation:** The clinical presentation of **Renal Cell Carcinoma (RCC)** is classically described by the "triad" of hematuria, flank pain, and a palpable abdominal mass [1]. However, this triad is seen in only about 10% of cases and often signifies advanced disease. **Why Renal Cell Carcinoma is correct:** 1. **Risk Factors:** The patient’s age (65) and significant smoking history (45 pack-years) are major risk factors [1]. 2. **Paraneoplastic Syndrome:** The hemoglobin of 18.5 g/dL indicates **polycythemia**, a classic paraneoplastic manifestation of RCC caused by the ectopic production of **Erythropoietin (EPO)**. 3. **Imaging:** A solid mass involving the renal vein is highly characteristic of RCC, as it has a notorious propensity for **vascular invasion** (extending into the renal vein and potentially the inferior vena cava). **Why other options are incorrect:** * **Renal cyst:** Typically asymptomatic and incidentally found; simple cysts do not cause weight loss, polycythemia, or vascular invasion. * **Renal metastases:** While possible, primary renal tumors are more common than metastases to the kidney [1]. Furthermore, polycythemia specifically points toward a primary EPO-secreting renal tumor. * **Renal abscess:** Usually presents with systemic signs of infection such as high-grade fever, chills, and leukocytosis, which are absent here. **NEET-PG High-Yield Pearls:** * **Most common histological type:** Clear cell carcinoma (derived from proximal convoluted tubule) [1]. * **Genetic association:** Deletion of the **VHL gene** on chromosome 3p. * **Stauffer Syndrome:** Reversible hepatic dysfunction (elevated LFTs) in the absence of liver metastases, another classic paraneoplastic syndrome of RCC. * **Left-sided varicocele:** May occur if the tumor obstructs the left renal vein, preventing drainage of the left gonadal vein.

Q: All of the following are associated with paraneoplastic syndromes except?

Progressive multifocal leukoencephalopathy. **Explanation:** The core concept in this question is distinguishing between a **Paraneoplastic Syndrome (PNS)** and an **Opportunistic Infection** occurring in a malignancy-associated immunocompromised state. **Why Option B is the correct answer:** **Progressive Multifocal Leukoencephalopathy (PML)** is not a paraneoplastic syndrome. It is a demyelinating disease of the CNS caused by the reactivation of the **JC virus** (a polyomavirus). While it occurs frequently in patients with hematological malignancies (like CLL or Lymphoma) due to profound immunosuppression, it is an **infectious process**, not an immune-mediated response to the tumor itself. **Analysis of Incorrect Options:** * **A. Cerebellar Degeneration:** A classic PNS (Subacute Cerebellar Degeneration) often associated with **anti-Yo** (Breast/Ovarian cancer), **anti-Hu** (SCLC), or **anti-Tr** (Hodgkin’s) antibodies. * **C. Amyotrophic Lateral Sclerosis (ALS):** While most ALS is idiopathic, a "motor neuron disease" phenotype can occur as a paraneoplastic manifestation, particularly in patients with **Lymphoma** or **Renal Cell Carcinoma**. * **D. Opsoclonus Myoclonus:** Known as "dancing eyes, dancing feet" syndrome. In children, it is highly suggestive of **Neuroblastoma**; in adults, it is often associated with **Small Cell Lung Cancer (SCLC)** (anti-Ri antibodies). **High-Yield Clinical Pearls for NEET-PG:** 1. **Lambert-Eaton Myasthenic Syndrome (LEMS):** Most common paraneoplastic neuromuscular junction disorder (associated with SCLC; anti-VGCC antibodies). 2. **Anti-NMDA Receptor Encephalitis:** Classically associated with **Ovarian Teratoma** in young females. 3. **Syndrome of Inappropriate Antidiuretic Hormone (SIADH):** The most common endocrine PNS, typically seen in **SCLC**. 4. **Hypercalcemia:** Most commonly caused by **PTHrP** production in **Squamous Cell Carcinoma** (Lung).

Q: What is the most common anterior mediastinal tumor?

Thymoma. **Explanation:** The mediastinum is anatomically divided into compartments, each associated with specific pathologies. The **anterior mediastinum** (the space between the sternum and the pericardium) is the most common site for mediastinal masses [1]. **1. Why Thymoma is Correct:** Thymoma is the most common primary tumor of the anterior mediastinum in adults (typically aged 40–60). It originates from the epithelial cells of the thymus. A classic clinical association high-yield for exams is that approximately 30–50% of patients with thymoma have **Myasthenia Gravis**, while about 15% of patients with Myasthenia Gravis are found to have a thymoma. **2. Analysis of Incorrect Options:** * **Neurogenic Tumors (Option B):** These are the most common tumors of the **posterior mediastinum**, usually arising from nerve sheaths (e.g., Schwannomas) or sympathetic ganglia [1]. * **Lymphoma (Option C):** While common in the anterior mediastinum (especially Hodgkin Lymphoma in younger patients), it is statistically less frequent as a primary isolated mass compared to thymoma. * **Teratoma (Option D):** These are the most common **germ cell tumors** of the anterior mediastinum but are less common overall than thymomas. **Clinical Pearls for NEET-PG:** * **The "4 Ts" of Anterior Mediastinal Masses:** **T**hymoma (most common), **T**errible Lymphoma, **T**eratoma (and other Germ Cell Tumors), and **T**hyroid (Retrosternal Goiter) [1]. * **Imaging:** Contrast-Enhanced CT (CECT) is the gold standard for localization [1]. * **Red Flag:** If a patient presents with an anterior mass and elevated **AFP or beta-hCG**, think Non-Seminomatous Germ Cell Tumor.

Q: Migratory necrolytic erythema is seen in which of the following conditions?

Glucagonoma syndrome. **Explanation:** **Migratory Necrolytic Erythema (MNE)** is the pathognomonic cutaneous manifestation of **Glucagonoma**, a rare alpha-cell tumor of the pancreas. The rash typically presents as pruritic, painful, erythematous plaques that progress to vesicles and bullae, eventually crusting and healing with hyperpigmentation. It most commonly affects the perineum, groin, and distal extremities. The underlying mechanism is thought to be related to hypoaminoacidemia, zinc deficiency, or the direct inflammatory effects of hyperglucagonemia. **Analysis of Incorrect Options:** * **Peutz-Jeghers Syndrome:** Characterized by hamartomatous polyps in the GI tract and **mucocutaneous hyperpigmentation** (melanotic macules) on the lips and buccal mucosa. * **Sarcoidosis:** Classically associated with **Lupus Pernio** (violaceous plaques on the nose/cheeks) and **Erythema Nodosum** (tender nodules on the shins). * **Amyloidosis:** Skin findings typically include **pinch purpura** (periorbital ecchymosis) and waxy, translucent papules due to protein deposition. **High-Yield Clinical Pearls for NEET-PG:** * **The 4 D’s of Glucagonoma Syndrome:** **D**ermatitis (MNE), **D**iabetes (mild glucose intolerance), **D**epression/Dementia, and **D**eep Vein Thrombosis (DVT). * **Laboratory findings:** Extremely high serum glucagon levels (>1000 pg/mL) and low serum amino acids. * **Treatment:** Somatostatin analogues (Octreotide) are used to control symptoms by inhibiting glucagon release before surgical resection.

A 65-year-old man with a 45-pack-per-year history of smoking presents with hematuria, flank pain, and unintentional weight loss. He has no fever, chills, or dysuria. Physical examination reveals no abdominal mass or flank tenderness. Laboratory findings show a hemoglobin of 18.5 g/dL and normal liver enzymes. An abdominal CT scan demonstrates a left kidney mass involving the renal vein. What is the most likely diagnosis?

Q8Medium

All of the following are associated with paraneoplastic syndromes except?

Q9Easy

What is the most common anterior mediastinal tumor?

Q10Easy

Migratory necrolytic erythema is seen in which of the following conditions?

Oncology Indian Medical PG Practice Questions and MCQs

Question 1: Hypercalcemia related to malignancy is seen in which of the following cancers?

A. Multiple myeloma
B. Lung carcinoma
C. Carcinoma breast
D. All the above (Correct Answer)

Explanation: Hypercalcemia of Malignancy (HCM) is the most common life-threatening metabolic complication of cancer, occurring in approximately 20-30% of patients. It occurs via four primary mechanisms: 1. **Humoral Hypercalcemia of Malignancy (HHM):** Mediated by the secretion of **Parathyroid Hormone-related Protein (PTHrP)** [1]. This is most commonly associated with **Squamous Cell Carcinoma of the Lung**, head and neck, and esophagus [1]. 2. **Local Osteolytic Hypercalcemia:** Direct bone destruction by tumor cells and activation of osteoclasts via cytokines (RANKL). This is the hallmark of **Multiple Myeloma** and **Breast Carcinoma** (which frequently metastasizes to bone) [3]. 3. **1,25-dihydroxyvitamin D (Calcitriol) Production:** Seen primarily in Lymphomas [2]. 4. **Ectopic PTH secretion:** Extremely rare. **Analysis of Options:** * **Multiple Myeloma:** Causes extensive "punched-out" lytic lesions due to osteoclast-activating factors (OAFs), making hypercalcemia a classic feature (part of the CRAB criteria) [2], [3]. * **Lung Carcinoma:** Specifically the Squamous Cell variant is the most frequent cause of PTHrP-mediated hypercalcemia [1]. * **Carcinoma Breast:** Frequently causes hypercalcemia through both direct bone metastasis (osteolysis) and PTHrP secretion [1], [3]. Since all three conditions are well-known causes of malignancy-associated hypercalcemia, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of HCM overall:** PTHrP secretion (Humoral). * **Most common cancer associated with HCM:** Breast cancer (due to high prevalence), but **Squamous Cell Lung Cancer** has the highest *incidence* per case. * **Laboratory Findings:** High Calcium, **Low PTH** (suppressed), and Low/Normal Phosphate [2]. * **Treatment of Choice:** Aggressive IV hydration with Normal Saline is the first step; **IV Bisphosphonates** (e.g., Zoledronic acid) are the gold standard for long-term management. Denosumab is used in refractory cases.

Question 2: A 65-year-old chronic smoker presents with a rapidly enlarging large hilar mass on a chest film associated with significant adenopathy. He also experiences recurrent hypoglycemic spells. Which of the following lung carcinoma subtypes will most commonly lead to this spectrum?

A. Squamous cell carcinoma
B. Adenocarcinoma
C. Large cell carcinoma
D. Small cell carcinoma (Correct Answer)

Explanation: **Explanation:** The clinical presentation of a **rapidly enlarging hilar mass** with significant **adenopathy** in a chronic smoker is highly characteristic of **Small Cell Lung Carcinoma (SCLC)** [1]. SCLC is a neuroendocrine tumor known for its aggressive growth and early mediastinal involvement. **Why Small Cell Carcinoma is correct:** The "recurrent hypoglycemic spells" point toward a **Paraneoplastic Syndrome**. While SCLC is most famously associated with SIADH (hyponatremia) and ectopic ACTH (Cushing’s syndrome) [1], it can also cause hypoglycemia through the secretion of **Insulin-like Growth Factor (IGF)** or, rarely, insulin-like substances. Furthermore, SCLC is the lung cancer most strongly associated with central/hilar locations and smoking [2]. **Analysis of Incorrect Options:** * **Squamous Cell Carcinoma:** Also central and smoking-related, but typically associated with **Hypercalcemia** (due to PTHrP secretion), not hypoglycemia [1]. * **Adenocarcinoma:** The most common lung cancer overall; however, it is usually **peripheral** in location and more common in non-smokers. It is associated with hypertrophic osteoarthropathy (clubbing) [1]. * **Large Cell Carcinoma:** A diagnosis of exclusion that presents as a large peripheral mass with early metastasis, but it is not the classic cause of the described paraneoplastic endocrine features. **NEET-PG High-Yield Pearls:** * **SCLC Markers:** Positive for Chromogranin A, Synaptophysin, and CD56. * **Paraneoplastic Associations:** * **SCLC:** SIADH, Ectopic ACTH, Lambert-Eaton Myasthenic Syndrome [1]. * **Squamous Cell:** Hypercalcemia (PTHrP) [1]. * **Adenocarcinoma:** Trousseau syndrome (thrombophlebitis), Marantic endocarditis. * **Rule of "S":** **S**mall cell and **S**quamous cell are **S**moking-related and **S**entral [2].

Question 3: What is the best treatment for glioblastoma multiforme?

A. Chemotherapy
B. Radiation therapy
C. Surgical excision followed by radiation therapy (Correct Answer)
D. Stereotactic radiosurgery

Explanation: **Explanation:** Glioblastoma Multiforme (GBM) is the most common and aggressive primary malignant brain tumor in adults (WHO Grade 4) [1]. The standard of care, known as the **Stupp Protocol**, involves a multimodal approach. **Why Option C is correct:** The primary goal in managing GBM is **maximal safe surgical resection** [1]. Reducing the tumor burden (cytoreduction) alleviates mass effect and intracranial hypertension [1]. However, because GBM is highly infiltrative, surgery alone is never curative. Therefore, it must be followed by **adjuvant radiotherapy** (usually 60 Gy) combined with **Temozolomide (TMZ)**, an oral alkylating agent, to target residual microscopic disease. **Why other options are incorrect:** * **Option A (Chemotherapy):** While Temozolomide is standard, it is used as an *adjunct* to surgery and radiation, not as a standalone primary treatment. * **Option B (Radiation therapy):** Radiation alone is insufficient for large masses and is typically reserved for patients who are not surgical candidates due to tumor location or poor performance status. * **Option D (Stereotactic radiosurgery):** SRS is highly effective for small, well-demarcated brain metastases or vestibular schwannomas, but it is not the primary treatment for GBM due to the tumor's diffuse, ill-defined margins. **High-Yield Clinical Pearls for NEET-PG:** * **Imaging:** Classic "Butterfly glioma" appearance (crosses the corpus callosum) with **ring enhancement** and central necrosis on MRI [2]. * **Histopathology:** Characterized by **pseudopalisading necrosis** and microvascular proliferation. * **Prognostic Marker:** **MGMT promoter methylation** is a positive predictor of response to Temozolomide. * **Origin:** Arises from astrocytes; most common site is the cerebral hemispheres (frontal and temporal lobes).

Question 4: Which of the following lung cancers has the best prognosis of all malignant lung cancers?

A. Metastatic cancer to the lung
B. Squamous cell carcinoma of the lung (Correct Answer)
C. Adenocarcinoma of the lung
D. Small cell carcinoma of the lung

Explanation: **Explanation:** The prognosis of lung cancer is primarily determined by its histological type, stage at presentation, and growth rate. Among the primary malignant lung cancers, **Squamous Cell Carcinoma (SCC)** is generally considered to have the best overall prognosis [1]. **Why Squamous Cell Carcinoma is the correct answer:** 1. **Central Location:** SCC typically arises centrally in the large airways [1]. This leads to earlier symptoms (e.g., cough, hemoptysis, or obstructive pneumonia), which often results in an **earlier clinical diagnosis** compared to peripheral tumors. 2. **Growth Pattern:** It tends to grow more slowly and remains localized for a longer duration before metastasizing distantly [1]. 3. **Surgical Resectability:** Because it often stays localized to the thorax longer, it has a higher likelihood of being amenable to surgical resection, which is the only curative modality [1]. **Analysis of Incorrect Options:** * **Metastatic cancer to the lung:** By definition, this represents Stage IV systemic disease from another primary site (e.g., breast, colon) [1]. The prognosis is generally poor as it is rarely curable. * **Adenocarcinoma:** This is now the most common type of lung cancer. It usually arises peripherally and is often **asymptomatic** until it has metastasized [1]. It has a higher propensity for early hematogenous spread compared to SCC. * **Small Cell Carcinoma (SCLC):** This is the most aggressive lung cancer. It has a very high doubling time and is almost always metastatic at the time of diagnosis [1]. It is considered "systemic" from the outset and has the worst prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Strongest Association with Smoking:** Small Cell > Squamous Cell (The "S" cancers). * **Paraneoplastic Syndromes:** SCC is classically associated with **Hypercalcemia** (due to PTHrP production), while SCLC is associated with **SIADH** and **ACTH** production. * **Cavitation:** Among lung cancers, Squamous Cell Carcinoma is the most likely to show central cavitation on imaging. * **Most Common in Non-smokers:** Adenocarcinoma.

Question 5: Which of the following hormones is elevated in small cell carcinoma of the lung?

A. Parathyroid hormone (PTH)
B. Atrial natriuretic factor (ANF) (Correct Answer)
C. Growth hormone
D. Vasoactive intestinal peptide (VIP)

Explanation: Small cell lung carcinoma (SCLC) is a neuroendocrine tumor known for its strong association with paraneoplastic syndromes due to the ectopic secretion of hormones [1]. **Why Option B is Correct:** SCLC is the most common cause of the **Syndrome of Inappropriate Antidiuretic Hormone (SIADH)** [1], [2]. While SIADH is primarily caused by ectopic ADH (vasopressin) production, studies have shown that SCLC cells can also secrete **Atrial Natriuretic Factor (ANF)** or Brain Natriuretic Peptide (BNP). Both ADH and ANF contribute to the characteristic hyponatremia seen in these patients—ADH by increasing water reabsorption and ANF by promoting natriuresis (sodium excretion). **Analysis of Incorrect Options:** * **Option A (PTH):** Ectopic production of **PTHrP** (Parathyroid Hormone-related Protein) is classically associated with **Squamous Cell Carcinoma** of the lung, leading to hypercalcemia [1]. * **Option C (Growth Hormone):** Ectopic GH is rare in lung cancer; however, Growth Hormone-Releasing Hormone (GHRH) can occasionally be secreted by bronchial carcinoids. * **Option D (VIP):** VIP secretion is typically associated with **VIPomas** (pancreatic islet cell tumors) or neuroblastomas, causing watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **SCLC Associations:** SIADH (most common), Ectopic ACTH (Cushing’s Syndrome) [1], [3], and Lambert-Eaton Myasthenic Syndrome (LEMS). * **Rule of "S":** **S**quamous cell carcinoma and **S**mall cell carcinoma are both **S**moking-related and **S**entrally (centrally) located. * **Hypercalcemia in Lung Cancer:** If it's Squamous cell, think **PTHrP** [1]. If it's Small cell, hypercalcemia is rare and usually due to bone metastasis, not hormones.

Question 6: What is the most common physical sign of cerebral metastasis?

A. Epilepsy
B. Focal neurological deficit (Correct Answer)
C. Papilloedema
D. Visual defects

Explanation: Explanation: Cerebral metastasis is the most common intracranial tumor in adults, occurring in approximately 20-40% of cancer patients. Why Focal Neurological Deficit is Correct: The most common presenting physical sign of brain metastasis is a focal neurological deficit (seen in about 50-70% of patients) [1]. This occurs because metastatic lesions typically lodge at the gray-white matter junction, where they cause localized tissue destruction, mass effect, or significant perilesional vasogenic edema [1]. Common deficits include hemiparesis, sensory loss, or aphasia, depending on the anatomical location of the tumor [1]. Analysis of Incorrect Options: * A. Epilepsy (Seizures): While common (occurring in ~25% of cases), seizures are the second most common presenting feature after focal deficits and headache [1]. They are more frequent in metastases to the frontal or temporal lobes. * C. Papilloedema: This is a sign of increased intracranial pressure (ICP). While it can occur due to mass effect or obstructive hydrocephalus, it is a late finding and much less common than focal deficits in the era of early MRI detection. * D. Visual defects: These are specific types of focal deficits (e.g., hemianopia) that occur only when the visual pathways or occipital cortex are involved. They are not as frequent as motor or sensory deficits. NEET-PG High-Yield Pearls: * Most common primary source: Lung cancer (most common overall), followed by Breast cancer and Melanoma [1]. * Most common symptom: Headache (often worse in the morning or with Valsalva) [1]. * Imaging of choice: Contrast-enhanced MRI (shows "ring-enhancing" lesions with extensive surrounding edema) [1]. * Management: Dexamethasone is the initial step to reduce vasogenic edema; definitive treatment involves surgery, SRS (Stereotactic Radiosurgery), or WBRT (Whole Brain Radiation Therapy).

Question 7: A 65-year-old man with a 45-pack-per-year history of smoking presents with hematuria, flank pain, and unintentional weight loss. He has no fever, chills, or dysuria. Physical examination reveals no abdominal mass or flank tenderness. Laboratory findings show a hemoglobin of 18.5 g/dL and normal liver enzymes. An abdominal CT scan demonstrates a left kidney mass involving the renal vein. What is the most likely diagnosis?

A. Renal cyst
B. Renal cell carcinoma (Correct Answer)
C. Renal metastases
D. Renal abscess

Explanation: **Explanation:** The clinical presentation of **Renal Cell Carcinoma (RCC)** is classically described by the "triad" of hematuria, flank pain, and a palpable abdominal mass [1]. However, this triad is seen in only about 10% of cases and often signifies advanced disease. **Why Renal Cell Carcinoma is correct:** 1. **Risk Factors:** The patient’s age (65) and significant smoking history (45 pack-years) are major risk factors [1]. 2. **Paraneoplastic Syndrome:** The hemoglobin of 18.5 g/dL indicates **polycythemia**, a classic paraneoplastic manifestation of RCC caused by the ectopic production of **Erythropoietin (EPO)**. 3. **Imaging:** A solid mass involving the renal vein is highly characteristic of RCC, as it has a notorious propensity for **vascular invasion** (extending into the renal vein and potentially the inferior vena cava). **Why other options are incorrect:** * **Renal cyst:** Typically asymptomatic and incidentally found; simple cysts do not cause weight loss, polycythemia, or vascular invasion. * **Renal metastases:** While possible, primary renal tumors are more common than metastases to the kidney [1]. Furthermore, polycythemia specifically points toward a primary EPO-secreting renal tumor. * **Renal abscess:** Usually presents with systemic signs of infection such as high-grade fever, chills, and leukocytosis, which are absent here. **NEET-PG High-Yield Pearls:** * **Most common histological type:** Clear cell carcinoma (derived from proximal convoluted tubule) [1]. * **Genetic association:** Deletion of the **VHL gene** on chromosome 3p. * **Stauffer Syndrome:** Reversible hepatic dysfunction (elevated LFTs) in the absence of liver metastases, another classic paraneoplastic syndrome of RCC. * **Left-sided varicocele:** May occur if the tumor obstructs the left renal vein, preventing drainage of the left gonadal vein.

Question 8: All of the following are associated with paraneoplastic syndromes except?

A. Cerebellar degeneration
B. Progressive multifocal leukoencephalopathy (Correct Answer)
C. Amyotrophic lateral sclerosis
D. Opsoclonus myoclonus

Explanation: **Explanation:** The core concept in this question is distinguishing between a **Paraneoplastic Syndrome (PNS)** and an **Opportunistic Infection** occurring in a malignancy-associated immunocompromised state. **Why Option B is the correct answer:** **Progressive Multifocal Leukoencephalopathy (PML)** is not a paraneoplastic syndrome. It is a demyelinating disease of the CNS caused by the reactivation of the **JC virus** (a polyomavirus). While it occurs frequently in patients with hematological malignancies (like CLL or Lymphoma) due to profound immunosuppression, it is an **infectious process**, not an immune-mediated response to the tumor itself. **Analysis of Incorrect Options:** * **A. Cerebellar Degeneration:** A classic PNS (Subacute Cerebellar Degeneration) often associated with **anti-Yo** (Breast/Ovarian cancer), **anti-Hu** (SCLC), or **anti-Tr** (Hodgkin’s) antibodies. * **C. Amyotrophic Lateral Sclerosis (ALS):** While most ALS is idiopathic, a "motor neuron disease" phenotype can occur as a paraneoplastic manifestation, particularly in patients with **Lymphoma** or **Renal Cell Carcinoma**. * **D. Opsoclonus Myoclonus:** Known as "dancing eyes, dancing feet" syndrome. In children, it is highly suggestive of **Neuroblastoma**; in adults, it is often associated with **Small Cell Lung Cancer (SCLC)** (anti-Ri antibodies). **High-Yield Clinical Pearls for NEET-PG:** 1. **Lambert-Eaton Myasthenic Syndrome (LEMS):** Most common paraneoplastic neuromuscular junction disorder (associated with SCLC; anti-VGCC antibodies). 2. **Anti-NMDA Receptor Encephalitis:** Classically associated with **Ovarian Teratoma** in young females. 3. **Syndrome of Inappropriate Antidiuretic Hormone (SIADH):** The most common endocrine PNS, typically seen in **SCLC**. 4. **Hypercalcemia:** Most commonly caused by **PTHrP** production in **Squamous Cell Carcinoma** (Lung).

Question 9: What is the most common anterior mediastinal tumor?

A. Thymoma (Correct Answer)
B. Neurogenic tumor
C. Lymphoma
D. Teratoma

Explanation: **Explanation:** The mediastinum is anatomically divided into compartments, each associated with specific pathologies. The **anterior mediastinum** (the space between the sternum and the pericardium) is the most common site for mediastinal masses [1]. **1. Why Thymoma is Correct:** Thymoma is the most common primary tumor of the anterior mediastinum in adults (typically aged 40–60). It originates from the epithelial cells of the thymus. A classic clinical association high-yield for exams is that approximately 30–50% of patients with thymoma have **Myasthenia Gravis**, while about 15% of patients with Myasthenia Gravis are found to have a thymoma. **2. Analysis of Incorrect Options:** * **Neurogenic Tumors (Option B):** These are the most common tumors of the **posterior mediastinum**, usually arising from nerve sheaths (e.g., Schwannomas) or sympathetic ganglia [1]. * **Lymphoma (Option C):** While common in the anterior mediastinum (especially Hodgkin Lymphoma in younger patients), it is statistically less frequent as a primary isolated mass compared to thymoma. * **Teratoma (Option D):** These are the most common **germ cell tumors** of the anterior mediastinum but are less common overall than thymomas. **Clinical Pearls for NEET-PG:** * **The "4 Ts" of Anterior Mediastinal Masses:** **T**hymoma (most common), **T**errible Lymphoma, **T**eratoma (and other Germ Cell Tumors), and **T**hyroid (Retrosternal Goiter) [1]. * **Imaging:** Contrast-Enhanced CT (CECT) is the gold standard for localization [1]. * **Red Flag:** If a patient presents with an anterior mass and elevated **AFP or beta-hCG**, think Non-Seminomatous Germ Cell Tumor.

Question 10: Migratory necrolytic erythema is seen in which of the following conditions?

A. Glucagonoma syndrome (Correct Answer)
B. Peutz-Jeghers syndrome
C. Sarcoidosis
D. Amyloidosis

Explanation: **Explanation:** **Migratory Necrolytic Erythema (MNE)** is the pathognomonic cutaneous manifestation of **Glucagonoma**, a rare alpha-cell tumor of the pancreas. The rash typically presents as pruritic, painful, erythematous plaques that progress to vesicles and bullae, eventually crusting and healing with hyperpigmentation. It most commonly affects the perineum, groin, and distal extremities. The underlying mechanism is thought to be related to hypoaminoacidemia, zinc deficiency, or the direct inflammatory effects of hyperglucagonemia. **Analysis of Incorrect Options:** * **Peutz-Jeghers Syndrome:** Characterized by hamartomatous polyps in the GI tract and **mucocutaneous hyperpigmentation** (melanotic macules) on the lips and buccal mucosa. * **Sarcoidosis:** Classically associated with **Lupus Pernio** (violaceous plaques on the nose/cheeks) and **Erythema Nodosum** (tender nodules on the shins). * **Amyloidosis:** Skin findings typically include **pinch purpura** (periorbital ecchymosis) and waxy, translucent papules due to protein deposition. **High-Yield Clinical Pearls for NEET-PG:** * **The 4 D’s of Glucagonoma Syndrome:** **D**ermatitis (MNE), **D**iabetes (mild glucose intolerance), **D**epression/Dementia, and **D**eep Vein Thrombosis (DVT). * **Laboratory findings:** Extremely high serum glucagon levels (>1000 pg/mL) and low serum amino acids. * **Treatment:** Somatostatin analogues (Octreotide) are used to control symptoms by inhibiting glucagon release before surgical resection.

Question 11: Which of the following statements is true about small cell lung cancer?

A. Bone marrow is uncommonly involved.
B. It is typically located in the periphery.
C. Destruction of alveolar cells occurs. (Correct Answer)
D. Treatment primarily involves chemotherapy.

Explanation: **Explanation:** Small Cell Lung Cancer (SCLC) is a highly aggressive neuroendocrine tumor strongly associated with cigarette smoking [1]. **Why Option C is Correct:** SCLC is characterized by a high nuclear-to-cytoplasmic ratio and a lack of prominent nucleoli. A hallmark pathological feature is the **Azzopardi effect**, where DNA from necrotic tumor cells encrusts the walls of small blood vessels. As the tumor grows rapidly and infiltrates the lung parenchyma, it leads to the **destruction of alveolar cells** and the surrounding architecture. Unlike some other tumors that may grow along alveolar walls (lepidic growth), SCLC is invasive and destructive. **Analysis of Incorrect Options:** * **Option A:** Bone marrow involvement is actually **common** in SCLC (occurring in up to 20-30% of cases at diagnosis) [1]. It is considered a systemic disease from the outset. * **Option B:** SCLC is typically **centrally located**, arising from the major bronchi, often presenting with hilar or mediastinal lymphadenopathy [1]. Peripheral presentation is rare. * **Option D:** While chemotherapy is a cornerstone of treatment, SCLC is uniquely sensitive to **both chemotherapy and radiotherapy**. For limited-stage disease, concurrent chemoradiotherapy is the standard of care. (Note: In many exam contexts, "primarily chemotherapy" is considered "mostly true," but "destruction of alveolar cells" is a more definitive pathological characteristic). **High-Yield Clinical Pearls for NEET-PG:** * **Markers:** Positive for Chromogranin A, Synaptophysin, and CD56. * **Paraneoplastic Syndromes:** Most commonly associated with **SIADH** and **Ectopic ACTH** (Cushing syndrome) [1]. Also associated with **Lambert-Eaton Myasthenic Syndrome**. * **Genetics:** Nearly 100% have mutations in **TP53** and **RB1**. * **Staging:** Often staged as "Limited" vs. "Extensive" rather than TNM [1].

Question 12: What is the commonest carcinoma in elderly males?

A. Stomach
B. Lung
C. Esophagus
D. Prostate (Correct Answer)

Explanation: The correct answer is **Prostate (Option D)**. In the context of global oncology and standard medical literature (including Harrison’s Principles of Internal Medicine), **Prostate Carcinoma** is the most common non-skin malignancy in elderly males [1]. Its incidence increases significantly with age [2]; it is rarely seen before age 40, but by age 80, a vast majority of men harbor foci of prostate cancer (often latent). The high prevalence in the elderly is attributed to prolonged exposure to androgens and the accumulation of genetic mutations over time. **Analysis of Incorrect Options:** * **Stomach (Option A):** While common in certain geographical belts (like East Asia and parts of South India), it is not the most common globally or across all elderly populations compared to prostate or lung cancer. * **Lung (Option B):** Lung cancer is the leading cause of **cancer-related mortality** in males worldwide, but in terms of overall **incidence** (number of cases), prostate cancer surpasses it in the elderly demographic [1]. * **Esophagus (Option C):** Esophageal cancer has a high mortality rate and is associated with smoking and alcohol (Squamous) or GERD (Adenocarcinoma), but its incidence is much lower than that of prostate or lung cancer. **NEET-PG High-Yield Pearls:** * **Most common cancer (Incidence) in Indian Males:** Lip/Oral Cavity (due to tobacco chewing). * **Most common cancer (Incidence) in Males Worldwide:** Lung cancer (followed closely by Prostate) [3]. However, specifically in the **elderly**, Prostate cancer is the most frequent. * **Screening:** PSA (Prostate-Specific Antigen) is the screening marker, though its routine use is controversial due to overdiagnosis. * **Osteoblastic Metastasis:** Prostate cancer is the classic cause of sclerotic/osteoblastic bone lesions in elderly males [1].

Question 13: A 65-year-old male diagnosed by biopsy as having lung carcinoma presents with a paraneoplastic syndrome and increased PTH. What is the probable cause?

A. Parathyroid
B. Parathyroid hormone-related peptide (Correct Answer)
C. Calcitonin
D. Calcitonin-related peptide

Explanation: ### Explanation **Concept:** The patient is presenting with **Humoral Hypercalcemia of Malignancy (HHM)**, a classic paraneoplastic syndrome [1]. In lung cancer—specifically **Squamous Cell Carcinoma (SCC)**—tumor cells secrete a substance that mimics the action of parathyroid hormone (PTH) [1]. This substance is **Parathyroid hormone-related peptide (PTHrP)** [1]. **Why Option B is Correct:** PTHrP shares a high degree of homology with the N-terminal end of native PTH. It binds to the same **PTH-1 receptor** in the bone and kidneys, leading to increased bone resorption and decreased renal calcium excretion [2]. This results in hypercalcemia. Crucially, because PTHrP mimics PTH, the body’s negative feedback loop suppresses the actual production of native PTH by the parathyroid glands [2]. Therefore, in these patients, **PTHrP is high, but serum PTH is low [3].** **Why Other Options are Incorrect:** * **Option A (Parathyroid):** Ectopic production of true native PTH by a tumor is extremely rare. In malignancy-associated hypercalcemia, the parathyroid glands are typically suppressed [3]. * **Option C & D (Calcitonin/CGRP):** Calcitonin is a hormone that *lowers* serum calcium levels. It is a marker for Medullary Thyroid Carcinoma, not a cause of hypercalcemia in lung carcinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** **S**quamous cell carcinoma is associated with **S**-p-p-p-ellable (PTHrP) and **S**-tones (Hypercalcemia) [1]. * **Small Cell Lung Cancer (SCLC)** is more commonly associated with **ACTH** (Cushing syndrome) and **ADH** (SIADH) [1]. * **Lab Findings in HHM:** ↑ Calcium, ↓ Phosphate, **↓ PTH**, ↑ PTHrP [3]. * **Treatment of Choice:** Aggressive IV hydration (Normal Saline) followed by Bisphosphonates (e.g., Zoledronic acid).

Question 14: A 25-year-old woman presents with nausea and vomiting for 2 days. Her physical examination is normal except for a postural drop in blood pressure from 110/80 mm Hg supine to 90/80 mm Hg standing. Her serum electrolytes are sodium 130 mEq/L, potassium 3 mEq/L, chloride 90 mEq/L, bicarbonate 30 mEq/L, urea 50 mg/dL, and creatinine 0.8 mg/dL. Which of the following electrolytes is most likely to be filtered through the glomerulus but unaffected by tubular secretion?

A. Potassium
B. Sodium
C. Bicarbonate
D. Urea (Correct Answer)

Explanation: ### Explanation The correct answer is **Urea (Option D)**. **1. Why Urea is correct:** The question asks for a substance that is filtered at the glomerulus but is **unaffected by tubular secretion**. Urea is freely filtered at the glomerulus [1]. Its handling in the renal tubules involves significant **reabsorption** (approximately 50% in the proximal tubule and further regulated reabsorption in the medullary collecting ducts via urea transporters), but it does **not undergo active tubular secretion** [1]. In this clinical scenario (nausea, vomiting, postural hypotension, and a high Urea-to-Creatinine ratio), the patient is in a **pre-renal state** due to volume depletion. In such states, the kidney increases the reabsorption of water and sodium, which passively drags more urea back into the blood, leading to "Pre-renal Azotemia." **2. Why the other options are incorrect:** * **Potassium (A):** Potassium is filtered, reabsorbed, and significantly **secreted** in the distal convoluted tubule and collecting duct (mediated by aldosterone) [1]. * **Sodium (B):** Sodium is filtered and extensively reabsorbed throughout the nephron [1]. While it is not secreted, the question specifically targets the unique handling of urea in the context of renal clearance and the absence of a secretory pathway. * **Bicarbonate (C):** Bicarbonate is filtered and reabsorbed (primarily in the proximal tubule) [1]. It is not secreted; however, in states of alkalosis, the kidney simply reduces reabsorption rather than utilizing a sensory mechanism. **3. NEET-PG High-Yield Pearls:** * **BUN/Creatinine Ratio:** A ratio **>20:1** is a classic indicator of pre-renal azotemia. Urea reabsorption increases with increased proximal sodium/water reabsorption, whereas creatinine is not reabsorbed. * **Creatinine Handling:** Unlike urea, a small amount of creatinine (approx. 10-20%) is **secreted** by the proximal tubule [1]. This is why Creatinine Clearance slightly overestimates the true GFR. * **Vomiting Electrolytes:** Classic pattern is **Hypokalemic, Hypochloremic, Metabolic Alkalosis** (as seen in this patient: K+ 3, Cl- 90, HCO3- 30).

Question 15: Eaton Lambert syndrome is associated with which of the following?

A. Anti P/Q antibody (Correct Answer)
B. Anti HU antibody
C. Anti Jo 1 antibody
D. Large cell carcinoma

Explanation: **Lambert-Eaton Myasthenic Syndrome (LEMS)** is a paraneoplastic autoimmune disorder of the neuromuscular junction, most commonly associated with **Small Cell Lung Cancer (SCLC)** [1]. ### Explanation of Options: * **A. Anti P/Q antibody (Correct):** LEMS is caused by autoantibodies directed against **presynaptic P/Q-type voltage-gated calcium channels (VGCC)** [1]. These antibodies block the influx of calcium into the nerve terminal, preventing the release of acetylcholine into the synaptic cleft, which leads to muscle weakness [1]. * **B. Anti-Hu antibody:** These are typically associated with **Paraneoplastic Encephalomyelitis** or sensory neuronopathy, also seen in Small Cell Lung Cancer, but not LEMS [2]. * **C. Anti-Jo-1 antibody:** This is a classic marker for **Dermatomyositis/Polymyositis**, specifically associated with "Antisynthetase Syndrome" (interstitial lung disease, Raynaud's, and mechanic's hands). * **D. Large cell carcinoma:** LEMS is strongly associated with **Small Cell Lung Cancer (SCLC)** (approx. 50-60% of cases), not large cell carcinoma [1]. ### High-Yield Clinical Pearls for NEET-PG: * **Clinical Triad:** Proximal muscle weakness (starts in lower limbs), autonomic dysfunction (dry mouth, erectile dysfunction), and depressed deep tendon reflexes. * **The "Lambert Sign":** Unlike Myasthenia Gravis, strength and reflexes in LEMS **improve with repeated muscle contraction** (post-exercise facilitation). * **Electrophysiology (NCS/EMG):** Shows a **"Decrement-Increment"** pattern. There is a low baseline compound muscle action potential (CMAP) that shows a **significant increment (>100%)** following high-frequency repetitive nerve stimulation or brief exercise. * **Treatment:** The first-line symptomatic treatment is **Amifampridine (3,4-diaminopyridine)**, which prolongs the depolarization of the presynaptic membrane [1].

Question 16: A 19-year-old man and one of his two brothers have had polyuria and polydipsia since birth. His sisters and parents are unaffected. What is the most likely diagnosis for this patient presenting with polyuria and polydipsia?

A. Central diabetes insipidus (DI)
B. Nephrogenic DI (Correct Answer)
C. Primary polydipsia
D. Osmotic diuresis

Explanation: **Explanation:** The clinical presentation of polyuria and polydipsia since birth in a male patient, with a similarly affected brother and unaffected parents/sisters, strongly suggests an **X-linked recessive inheritance pattern**. **1. Why Nephrogenic Diabetes Insipidus (NDI) is correct:** The most common cause of congenital NDI is a mutation in the **AVPR2 gene** (encoding the V2 receptor), which is inherited in an **X-linked recessive** manner [2]. This explains why only the males in the family are affected. In NDI, the kidneys are insensitive to Antidiuretic Hormone (ADH), leading to an inability to concentrate urine from birth. **2. Why the other options are incorrect:** * **Central DI:** While it causes similar symptoms, the most common hereditary form (mutations in the AVP-neurophysin II gene) is usually **Autosomal Dominant**. It typically presents later in childhood rather than at birth. * **Primary Polydipsia:** This is characterized by excessive water intake leading to polyuria. It is usually acquired (psychogenic) and does not follow a clear X-linked inheritance pattern starting from birth. In primary polydipsia, the plasma osmolality is low, unlike in diabetes insipidus [1]. * **Osmotic Diuresis:** This occurs due to the presence of non-reabsorbable solutes in the renal tubules (e.g., glucose in Diabetes Mellitus). It is not a congenital hereditary condition presenting in this specific familial pattern. **Clinical Pearls for NEET-PG:** * **Inheritance:** 90% of congenital NDI cases are X-linked recessive (V2 receptor mutation); 10% are Autosomal Recessive/Dominant (Aquaporin-2 channel mutation) [2]. * **Diagnosis:** NDI is characterized by high serum osmolality, low urine osmolality, and **no increase in urine osmolality** after the administration of exogenous ADH (Desmopressin) [1]. * **Management:** Treatment includes low-salt/low-protein diet, thiazide diuretics, and NSAIDs (like Indomethacin) to reduce glomerular filtration and increase proximal water reabsorption.

Question 17: A 72-year-old man with a significant smoking history presents with dyspnea and one week of truncal, arm, and facial swelling. Physical examination reveals facial erythema, facial, truncal, and arm edema, with prominence of thoracic and neck veins. Chest x-ray shows a right mediastinal mass with adenopathy. What is the most likely diagnosis?

A. Adenocarcinoma
B. Hodgkin's lymphoma
C. Large cell carcinoma
D. Small cell carcinoma (Correct Answer)

Explanation: **Explanation:** The clinical presentation of facial, truncal, and arm edema, coupled with venous prominence and a mediastinal mass, is classic for **Superior Vena Cava (SVC) Syndrome**. This occurs due to extrinsic compression or invasion of the SVC, most commonly by malignant tumors. **Why Small Cell Carcinoma (SCLC) is correct:** While non-small cell lung cancer (NSCLC) is numerically the most common cause of SVC syndrome due to its higher overall incidence, **Small Cell Carcinoma** has the strongest association with this condition. SCLC is typically **centrally located** and grows rapidly, leading to early compression of mediastinal structures [2]. In a 72-year-old smoker with a right-sided mediastinal mass, SCLC is the most likely histological diagnosis causing SVC obstruction [1]. **Why other options are incorrect:** * **Adenocarcinoma:** This is the most common type of lung cancer overall, but it is typically **peripherally located**, making it a less frequent cause of SVC syndrome compared to central tumors [2]. * **Hodgkin’s Lymphoma:** While it can cause SVC syndrome (especially in younger patients), the patient’s age (72) and significant smoking history point strongly toward primary lung malignancy [2]. * **Large Cell Carcinoma:** This is a less common subtype of NSCLC and, while it can cause SVC syndrome, it is statistically less likely than SCLC in the context of a central mediastinal mass. **Clinical Pearls for NEET-PG:** * **Most common cause of SVC Syndrome:** Malignancy (Lung cancer > Lymphoma). * **Pemberton’s Sign:** Facial flushing and respiratory distress upon elevating both arms (indicates thoracic outlet obstruction). * **Management:** Immediate management includes head elevation and oxygen. Definitive treatment for SCLC-induced SVC syndrome is **Chemotherapy**, as SCLC is highly chemo-sensitive [3]. Radiation is used for NSCLC.

Question 18: What is the most common cause of Superior Vena Cava (SVC) syndrome?

A. Thrombosis
B. Extrinsic compression (Correct Answer)
C. Mediastinal lymphoma
D. Teratoma

Explanation: **Explanation:** **1. Why Extrinsic Compression is Correct:** Superior Vena Cava (SVC) syndrome occurs due to the obstruction of blood flow through the SVC. The most common underlying mechanism is **extrinsic compression** of the vessel wall by an adjacent mass. Because the SVC is a thin-walled, low-pressure vessel located in the tight confines of the middle mediastinum, it is highly susceptible to compression by surrounding structures. Malignancy is responsible for approximately 60–90% of cases, with **Bronchogenic Carcinoma** (specifically Small Cell Lung Cancer) being the single most common cause. **2. Analysis of Incorrect Options:** * **A. Thrombosis:** While intraluminal thrombosis is an increasing cause due to the rising use of indwelling central venous catheters and pacemakers (iatrogenic causes), it remains less frequent than extrinsic compression by tumors. * **C. Mediastinal Lymphoma:** This is a common *type* of malignancy causing SVC syndrome (especially in younger patients), but it is statistically less common than bronchogenic carcinoma. * **D. Teratoma:** This is a rare cause of a mediastinal mass and only infrequently leads to SVC syndrome compared to lung cancer or lymphoma. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common cause overall:** Bronchogenic Carcinoma (Small cell > Squamous cell) [1]. * **Most common benign cause:** Historically Syphilitic aneurysm; currently **Iatrogenic thrombosis** (catheters/leads) or Fibrosing Mediastinitis (often due to Histoplasmosis). * **Clinical Presentation:** Facial puffiness (worse in the morning), "plethora," neck vein distention, and the **Pemberton sign** (facial flushing when arms are raised). * **Management:** The priority is airway assessment. Definitive treatment depends on the histology (Radiation for NSCLC; Chemotherapy for SCLC/Lymphoma) [1]. Stenting is the gold standard for rapid symptomatic relief.

Question 19: In tumor lysis syndrome, all of the following are seen except?

A. Hypernatremia
B. Hypercalcemia (Correct Answer)
C. Hyperkalemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells (most commonly in high-grade lymphomas and leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements. **Why Hypercalcemia is the correct answer:** In TLS, **Hypocalcemia** (low calcium) is seen, not hypercalcemia. This occurs because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to circulating ionized calcium, forming calcium-phosphate crystals that precipitate in soft tissues and the kidneys. This "precipitation effect" secondary to high phosphate levels lowers the serum calcium. In contrast, certain tumors can cause hypercalcemia through the production of Parathyroid Hormone-related Protein (PTHrP) [1]. **Analysis of other options:** * **Hyperkalemia:** Potassium is the primary intracellular cation. Rapid cell lysis releases massive amounts of potassium into the blood, which is the most immediate and life-threatening complication of TLS (risk of arrhythmias). * **Hyperphosphatemia:** Phosphorus is found in high concentrations within malignant cells (up to 4 times higher than normal cells). Its release leads to renal failure and secondary hypocalcemia. * **Hypernatremia:** While not a "classic" hallmark like the others, it is often listed as an "except" option because TLS primarily involves the release of *intracellular* ions. Sodium is an *extracellular* ion; therefore, its levels do not typically rise due to cell lysis. However, in the context of this specific question, **Hypercalcemia** is the definitive "wrong" finding as **Hypocalcemia** is a diagnostic hallmark. **NEET-PG High-Yield Pearls:** * **The "Hyper" Triad:** Hyperkalemia, Hyperphosphatemia, and Hyperuricemia (due to purine catabolism). * **The "Hypo":** Hypocalcemia. * **Prophylaxis:** Aggressive hydration and **Allopurinol** (xanthine oxidase inhibitor). * **Treatment of Hyperuricemia:** **Rasburicase** (recombinant urate oxidase) is the drug of choice for established TLS as it converts uric acid to allantoin (more soluble).

Question 20: A 71-year-old man presents for evaluation of a recently discovered elevated erythrocyte sedimentation rate (ESR) from a routine blood test. His medical history includes well-controlled hypertension, managed with metoprolol. A physical examination reveals no abnormalities. Laboratory findings include hemoglobin 12.6 gm/dL, leukocyte count 8500/mL, platelet count 265,000/mL, total protein 6.2 g/dL, albumin 3.4 g/dL, BUN 16 mg/dL, creatinine 0.75 mg/dL, and calcium 9.2 mg/dL. Serum protein electrophoresis shows a sharp, narrow spike, and serum immunofixation identifies M-protein at 1.2 gm/dL. Bone marrow examination reveals fewer than 10% monoclonal plasma cells, and a skeletal survey is negative for lytic lesions. What is the most likely diagnosis?

A. Multiple myeloma
B. Smoldering multiple myeloma
C. Monoclonal gammopathy of undetermined significance (Correct Answer)
D. Waldenstrom macroglobulinemia

Explanation: This case describes a classic presentation of **Monoclonal Gammopathy of Undetermined Significance (MGUS)**, a common premalignant condition in the elderly. ### 1. Why MGUS is the Correct Diagnosis The diagnosis of MGUS is based on three specific criteria, all of which are met by this patient: * **M-protein level:** < 3 g/dL (Patient has 1.2 g/dL). * **Bone marrow plasma cells:** < 10% (Patient has < 10%). * **Absence of end-organ damage (CRAB features):** No **C**alcium elevation, **R**enal insufficiency, **A**nemia (significant), or **B**one lesions. The patient’s ESR is elevated due to the presence of the M-protein (paraproteinemia), which causes "rouleaux formation" of RBCs [1]. [1] ### 2. Why Other Options are Incorrect * **Multiple Myeloma (MM):** Requires M-protein ≥ 3 g/dL OR marrow plasma cells ≥ 10%, **PLUS** evidence of CRAB features [1]. This patient lacks end-organ damage. * **Smoldering Multiple Myeloma (SMM):** Requires M-protein ≥ 3 g/dL OR marrow plasma cells 10–60%, but **without** CRAB features. This patient’s M-protein and plasma cell counts are below these thresholds. * **Waldenstrom Macroglobulinemia:** This is a B-cell lymphoma characterized by **IgM** monoclonal protein [1] and lymphoplasmacytic infiltration of the bone marrow, typically presenting with hyperviscosity and hepatosplenomegaly, which are absent here. ### 3. NEET-PG High-Yield Pearls * **Risk of Progression:** MGUS progresses to Multiple Myeloma at a rate of approximately **1% per year**. * **Management:** MGUS requires "watchful waiting" (observation) rather than chemotherapy. * **Most common M-protein in MGUS:** IgG (followed by IgA). * **Skeletal Survey:** Always use plain X-rays or low-dose CT; **Technetium-99m bone scans are often negative** in myeloma because they detect osteoblastic activity, whereas myeloma is purely osteolytic.

Question 21: According to the Ann Arbor staging of Hodgkin's lymphoma, which of the following defines Stage III?

A. Involvement of lymph nodes on the same side of the diaphragm
B. Liver infiltration
C. Involvement of lymph node regions or lymphoid structures on both sides of the diaphragm (Correct Answer)
D. Disseminated involvement of extralymphatic sites, including bone marrow and bronchial infiltration

Explanation: ### Explanation The **Ann Arbor Staging System** is the standard classification used to determine the anatomical extent of Hodgkin’s Lymphoma (HL). Staging is critical as it dictates the choice between localized radiotherapy and systemic chemotherapy. **1. Why Option C is Correct:** **Stage III** is defined by the involvement of lymph node regions or lymphoid structures (such as the spleen, thymus, or Waldeyer’s ring) on **both sides of the diaphragm** [2]. This indicates a transition from localized disease to systemic lymphatic spread [1]. It is further subclassified into III₁ (upper abdomen, e.g., splenic/celiac nodes) and III₂ (lower abdomen, e.g., para-aortic/iliac nodes). **2. Why Other Options are Incorrect:** * **Option A (Stage I & II):** Involvement of a single node region is Stage I. Involvement of two or more regions on the **same side** of the diaphragm is Stage II [2]. * **Option B & D (Stage IV):** Stage IV represents **disseminated (multifocal) involvement** of one or more extralymphatic organs (e.g., liver, bone marrow, lungs, or pleura) [2] with or without associated lymph node involvement. Liver infiltration specifically signifies Stage IV disease. **3. High-Yield Clinical Pearls for NEET-PG:** * **"B" Symptoms:** Fever (>38°C), drenching night sweats, and weight loss (>10% in 6 months). Their presence is denoted by the suffix 'B' (e.g., Stage IIIB), while their absence is 'A' [2]. * **Bulky Disease:** Defined as a mediastinal mass >1/3rd of the transthoracic diameter or any node >10 cm [2]. * **Cotswolds Modification:** A modern update to Ann Arbor that includes the 'X' designation for bulky disease and 'E' for limited extranodal extension from an adjacent node. * **Most Common Subtype:** Nodular Sclerosis is the most common subtype of HL, often presenting as a mediastinal mass in young females.

Question 22: Which of the following tumors is most likely associated with either hyponatremia or diffuse pigmentation of the skin?

A. Renal adenocarcinoma
B. Small cell carcinoma of the lung (Correct Answer)
C. Hepatocellular carcinoma
D. Primary squamous cell carcinoma of the lung

Explanation: The correct answer is **Small cell carcinoma of the lung (SCLC)**. This tumor is a neuroendocrine malignancy derived from Kulchitsky cells, which possess the metabolic machinery to produce various ectopic hormones, leading to **Paraneoplastic Syndromes (PNS)**. [1] 1. **Hyponatremia:** SCLC is the most common cause of the **Syndrome of Inappropriate Antidiuretic Hormone (SIADH)** [1]. The tumor secretes ectopic ADH (Arginine Vasopressin), leading to water retention and dilutional hyponatremia [2]. 2. **Diffuse Pigmentation:** SCLC can secrete ectopic **ACTH (Adrenocorticotropic Hormone)** [2]. High levels of ACTH (or its precursor POMC) stimulate melanocytes directly or via MSH-like activity, resulting in generalized hyperpigmentation. This is often seen in "Ectopic ACTH Syndrome" rather than Cushing’s Disease [1]. **Analysis of Incorrect Options:** * **Renal Adenocarcinoma (RCC):** Classically associated with polycythemia (Erythropoietin) [1], hypercalcemia (PTHrP), and Stauffer’s syndrome, but not typically SIADH or ACTH secretion. * **Hepatocellular Carcinoma:** Associated with hypoglycemia (IGF-II) and erythrocytosis [1], but rarely causes these specific electrolyte or pigmentary changes. * **Squamous Cell Carcinoma (SCC) of the Lung:** This is the classic lung cancer associated with **Hypercalcemia** due to the secretion of Parathyroid Hormone-related Protein (PTHrP) [1]. It does not typically cause SIADH or ectopic ACTH. **High-Yield Clinical Pearls for NEET-PG:** * **SCLC (Small Cell):** Think "S" for **S**IADH, **S**eizures (due to hyponatremia), and **S**ubacute cerebellar degeneration [3]. It is also associated with Lambert-Eaton Myasthenic Syndrome [3]. * **SCC (Squamous Cell):** Think "C" for **C**alcium (Hypercalcemia) and **C**entral location. * **Adenocarcinoma:** Most common lung cancer in non-smokers; associated with hypertrophic osteoarthropathy (clubbing) [2].

Question 23: A 43-year-old woman complains of fatigue and night sweats associated with itching for 2 months. On physical examination, there is diffuse nontender lymphadenopathy, including small supraclavicular, epitrochlear, and scalene nodes. CBC and chemistry studies (including liver enzymes) are normal. Chest x-ray shows hilar lymphadenopathy. Which of the following is the best next step in evaluation?

A. Excisional lymph node biopsy (Correct Answer)
B. Monospot test
C. Toxoplasmosis IgG serology
D. Serum angiotensin-converting enzyme level

Explanation: ### Explanation The clinical presentation of **B-symptoms** (night sweats, fatigue), **generalized pruritus**, and **diffuse nontender lymphadenopathy** (especially in high-risk areas like supraclavicular and scalene nodes) is highly suspicious for **Lymphoma** (specifically Hodgkin Lymphoma, given the itching and hilar adenopathy) [1]. **1. Why Excisional Biopsy is the Correct Choice:** In any patient with suspected lymphoma, an **excisional lymph node biopsy** is the gold standard and the "best next step." [1] Unlike Fine Needle Aspiration (FNA), which only provides cytology, an excisional biopsy preserves the **node architecture**. This is critical for distinguishing between Hodgkin and Non-Hodgkin lymphoma and for accurate subtyping (e.g., identifying Reed-Sternberg cells within the appropriate cellular background). **2. Analysis of Incorrect Options:** * **B & C (Monospot/Toxoplasmosis):** While Infectious Mononucleosis and Toxoplasmosis cause lymphadenopathy, they typically present with acute pharyngitis or fever and rarely cause hilar adenopathy or significant B-symptoms [1]. * **D (Serum ACE level):** While hilar adenopathy and itching can occur in **Sarcoidosis**, ACE levels are neither sensitive nor specific enough for a primary diagnosis. Histopathological confirmation (showing non-caseating granulomas) is still required to rule out malignancy. **3. NEET-PG High-Yield Pearls:** * **Supraclavicular/Scalene Nodes:** Always considered pathological until proven otherwise; they have a high association with intrathoracic or intra-abdominal malignancy. * **Pruritus in Hodgkin Lymphoma (HL):** Occurs in about 25% of patients and can precede the diagnosis by weeks. * **Biopsy Hierarchy:** Excisional Biopsy > Incisional Biopsy > Core Needle Biopsy > FNA (FNA is generally insufficient for the initial diagnosis of lymphoma) [1]. * **Alcohol-induced pain:** Pain in lymph nodes after drinking alcohol is a rare but highly specific sign for Hodgkin Lymphoma.

Question 24: A 69-year-old man, whose friend died of prostate cancer, wishes to be evaluated for the disease. He has no urinary symptoms. Which of the following tests is most likely indicated to screen him for prostate cancer?

A. prostate ultrasound
B. digital rectal examination (DRE)
C. DRE and prostate specific antigen (PSA) (Correct Answer)
D. PSA

Explanation: ### Explanation The correct approach to prostate cancer screening involves a combination of **Digital Rectal Examination (DRE)** and **Prostate-Specific Antigen (PSA)** testing. **1. Why "DRE and PSA" is correct:** Screening is most effective when both tests are used together because they are complementary. * **PSA** has high sensitivity but low specificity (it can be elevated in BPH or prostatitis). * **DRE** can detect tumors in the posterior and lateral aspects of the prostate (where 70% of cancers originate) even if the PSA is within the normal range [1]. Approximately 20-25% of cancers are detected by DRE despite a normal PSA; however, note that up to 45% of tumors may remain impalpable even on DRE [1]. Combining both maximizes the **Positive Predictive Value (PPV)** for detecting clinically significant malignancy. **2. Why other options are incorrect:** * **Prostate Ultrasound (Option A):** Transrectal Ultrasound (TRUS) is not a screening tool. It is used to guide biopsies or evaluate a patient who already has an abnormal PSA or DRE. It lacks the sensitivity to be used as a primary screen. * **DRE alone (Option B):** DRE is highly subjective and often misses early-stage tumors that are not yet palpable but are producing elevated PSA levels [1]. * **PSA alone (Option D):** While PSA is a powerful marker, relying on it alone misses "PSA-negative" cancers (e.g., high-grade neuroendocrine or small cell variants) that may be palpable on DRE. **Clinical Pearls for NEET-PG:** * **Age to start:** Screening is generally discussed at age 50 for average-risk men (age 45 for high-risk, such as African Americans or those with a first-degree relative diagnosed at <65). * **PSA Cut-off:** Traditionally **>4 ng/mL** is the threshold for further evaluation, though age-specific ranges are often used. * **Definitive Diagnosis:** The "Gold Standard" for diagnosis is a **TRUS-guided needle biopsy** (usually 12 cores). * **Metastasis:** Prostate cancer most commonly spreads to the **bone (osteoblastic lesions)**, specifically the lumbar spine and pelvis [1]; the investigation of choice for metastasis is a **Radionuclide Bone Scan**.

Question 25: A 70-year-old intensive care unit patient complains of fever and shaking chills. The patient develops hypotension, and blood cultures are positive for gram-negative bacilli. The patient begins bleeding from venipuncture sites and around his Foley catheter. Laboratory studies show: Hct: 38%, WBC: 15,000/mL, Platelet count: 40,000/mL, fragmented RBCs on peripheral blood smear, elevated PT, elevated PTT, plasma fibrinogen: 70 mg/dL. Which of the following is the best course of therapy in this patient?

A. Begin heparin
B. Treat underlying disease (Correct Answer)
C. Begin plasmapheresis
D. Give vitamin K

Explanation: ### **Explanation** The clinical presentation of fever, hypotension, gram-negative sepsis, and spontaneous bleeding from venipuncture sites, combined with laboratory findings (thrombocytopenia, schistocytes, prolonged PT/PTT, and low fibrinogen), is a classic description of **Disseminated Intravascular Coagulation (DIC)** [1], [2]. **1. Why "Treat underlying disease" is correct:** DIC is never a primary diagnosis; it is always secondary to an underlying systemic insult (in this case, **Gram-negative sepsis**) [1]. The pathophysiology involves the systemic activation of coagulation, leading to the consumption of clotting factors and platelets [2]. The most critical step in management is to **eliminate the trigger** [1]. Without treating the sepsis (with antibiotics and source control), any replacement therapy (like FFP or platelets) is akin to "adding fuel to the fire," as the procoagulant stimulus remains active [1], [2]. **2. Why the other options are incorrect:** * **A. Begin Heparin:** While heparin can be used in chronic, compensated DIC (e.g., Trousseau syndrome in malignancy), it is generally **contraindicated** in acute DIC with active bleeding, as it can worsen the hemorrhage. * **C. Begin Plasmapheresis:** This is the treatment of choice for **Thrombotic Thrombocytopenic Purpura (TTP)**. While TTP also presents with schistocytes and thrombocytopenia, it typically features normal PT/PTT and fibrinogen levels, unlike DIC. * **D. Give Vitamin K:** Vitamin K deficiency causes prolonged PT/PTT but does not cause thrombocytopenia, low fibrinogen, or the presence of schistocytes (fragmented RBCs). --- ### **High-Yield Clinical Pearls for NEET-PG** * **DIC Hallmark:** Low Fibrinogen + Elevated D-dimer (most sensitive) + Prolonged PT/PTT + Schistocytes [1], [2]. * **Common Triggers:** Sepsis (Gram-negative), Obstetric complications (Abruptio placentae), and Malignancy (APML - M3) [1]. * **Management Priority:** 1. Treat the cause (Primary) [1], [2]. 2. Supportive care (Fluids/Pressors). 3. Blood products (FFP/Cryoprecipitate/Platelets) *only* if the patient is actively bleeding or requires a procedure [1]. * **Differentiating TTP vs. DIC:** TTP has a **normal** coagulation profile (PT/PTT); DIC has an **abnormal** coagulation profile.

Question 26: Hormonal treatment is given for which of the following malignancies?

A. Choriocarcinoma
B. Carcinoma of the prostate (Correct Answer)
C. Hepatoma
D. Teratoma

Explanation: **Explanation:** **1. Why Carcinoma of the Prostate is Correct:** Prostate cancer is a classic example of a **hormone-dependent malignancy**. The growth and survival of prostatic adenocarcinoma cells are largely driven by androgens (testosterone and dihydrotestosterone) [1]. Therefore, **Androgen Deprivation Therapy (ADT)** is a cornerstone of management, especially in metastatic or advanced stages [2]. This is achieved through surgical castration (orchiectomy) or medical castration using GnRH agonists (e.g., Leuprolide), GnRH antagonists (e.g., Degarelix), or androgen receptor blockers (e.g., Enzalutamide). **2. Analysis of Incorrect Options:** * **Choriocarcinoma (A):** This is a highly malignant germ cell tumor that is exquisitely sensitive to **chemotherapy** (specifically Methotrexate or the EMA-CO regimen). While it produces hormones (hCG), it is not treated with hormonal therapy [1]. * **Hepatoma (C):** Hepatocellular carcinoma (HCC) is primarily treated with surgical resection, liver transplantation, or targeted systemic therapies like Multikinase inhibitors (e.g., **Sorafenib**, Lenvatinib) and immunotherapy. It does not respond to hormonal manipulation. * **Teratoma (D):** Teratomas are germ cell tumors composed of multiple germ layers. Mature teratomas are treated with **surgical excision**, while malignant components (immature teratoma) require chemotherapy [1]. They are not hormone-sensitive. **Clinical Pearls for NEET-PG:** * **Other Hormone-Dependent Tumors:** Breast cancer (ER/PR positive), Endometrial cancer, and some Thyroid cancers (TSH suppression). * **First-line for Metastatic Prostate CA:** ADT is the standard of care. * **Tumor Flare:** GnRH agonists can cause a transient surge in testosterone; this is prevented by co-administering Flutamide (anti-androgen) for the first 2 weeks.

Question 27: Which of the following is NOT a risk factor for developing cholangiocarcinoma?

A. Choledochal cyst
B. Cholelithiasis
C. Liver flukes
D. Working in the rubber industry (Correct Answer)

Explanation: **Explanation:** Cholangiocarcinoma (CCA) is a malignancy arising from the biliary epithelium [1]. The primary pathophysiology involves **chronic inflammation** and cholestasis, which lead to DNA damage and malignant transformation of cholangiocytes. **Why Option D is the Correct Answer:** Working in the **rubber industry** is a well-established risk factor for **Bladder Cancer** (due to exposure to aromatic amines like benzidine) and certain leukemias, but it is **not** associated with cholangiocarcinoma. In contrast, the chemical industry exposure specifically linked to cholangiocarcinoma is the **aircraft and PVC industry** (exposure to 1,2-dichloropropane and dichloromethane). **Analysis of Incorrect Options:** * **Choledochal Cyst (Option A):** These congenital cystic dilatations of the bile duct cause bile stasis and chronic inflammation. The risk of malignancy is as high as 10-15%, necessitating surgical excision. * **Cholelithiasis (Option B):** While gallstones are primarily a risk factor for **Gallbladder Cancer**, large or long-standing stones in the biliary tree (especially hepatolithiasis/intrahepatic stones) cause chronic mucosal irritation, significantly increasing the risk of cholangiocarcinoma [1]. * **Liver Flukes (Option C):** Infection with *Opisthorchis viverrini* and *Clonorchis sinensis* (common in SE Asia) is a classic, high-yield risk factor. These parasites reside in the bile ducts, causing chronic mechanical injury and inflammation [1]. **NEET-PG High-Yield Pearls:** * **Most common risk factor (Worldwide):** Primary Sclerosing Cholangitis (PSC). * **Tumor Marker:** CA 19-9 is commonly elevated (also seen in pancreatic cancer). * **Klatskin Tumor:** A hilar cholangiocarcinoma occurring at the confluence of the right and left hepatic ducts [1]. * **Thorotrast:** A historical radiocontrast agent strongly linked to both cholangiocarcinoma and hepatic angiosarcoma.

Question 28: Which of the following is not an oncological emergency?

A. Spinal cord compression
B. Superior venacaval syndrome
C. Tumor lysis syndrome
D. Carcinoma cervix stage- III B with Pyometra (Correct Answer)

Explanation: An **oncological emergency** is defined as an acute condition caused by cancer or its treatment that requires immediate intervention to prevent death or severe permanent disability. **Why Option D is the correct answer:** **Carcinoma cervix stage-III B with Pyometra** is a chronic complication or a local progression of the disease. While pyometra (accumulation of pus in the uterine cavity) requires drainage and antibiotics, it is generally a localized infection and does not pose an immediate threat to life or vital organ function in the same way systemic or compressive oncological emergencies do. It is considered a clinical complication rather than an acute oncological emergency. **Why the other options are incorrect:** * **A. Spinal Cord Compression:** A structural emergency [1]. Delay in treatment (steroids/radiation/surgery) leads to irreversible paralysis. * **B. Superior Vena Cava (SVC) Syndrome:** A vascular emergency caused by obstruction of blood flow through the SVC [1]. It can lead to cerebral edema and airway compromise. * **C. Tumor Lysis Syndrome (TLS):** A metabolic emergency. Rapid breakdown of tumor cells leads to hyperkalemia, hyperuricemia, and hyperphosphatemia, causing acute renal failure and fatal arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of SVC Syndrome:** Bronchogenic carcinoma (Small cell lung cancer) [2]. * **Earliest sign of Spinal Cord Compression:** Localized back pain (precedes neurological deficits). * **TLS Prophylaxis:** Aggressive hydration and Allopurinol (Rasburicase for high-risk cases). * **Hypercalcemia of Malignancy:** The most common metabolic oncological emergency overall [1].

Question 29: A 42-year-old man is on amitriptyline for depression. Recently he has been feeling more lethargic and unwell. His clinical examination is normal. Serum sodium is 125 mEq/L and osmolality is 260 mOsm/kg, and urine sodium is 40 mEq/L and osmolality is 450 mOsm/kg. For the above patient with hyponatremia, select the most likely diagnosis.

A. Congestive heart failure (CHF)
B. Extrarenal sodium and fluid losses
C. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) (Correct Answer)
D. Polydipsia

Explanation: ### Explanation The patient presents with **hypotonic hyponatremia** (Serum Na+ 125 mEq/L, Osmolality 260 mOsm/kg) in a **euvolemic** state (normal clinical examination). The diagnosis is **SIADH**, likely secondary to **Amitriptyline** (TCAs are a known pharmacological cause). **1. Why SIADH is Correct:** The diagnosis of SIADH is confirmed by the following criteria: * **Hypotonic Hyponatremia:** Serum osmolality <280 mOsm/kg. * **Inappropriate Urine Concentration:** Urine osmolality >100 mOsm/kg (here it is 450 mOsm/kg), indicating ADH is active despite low serum osmolality [2]. * **Natriuresis:** Urine sodium >40 mEq/L (here it is 40 mEq/L) occurs because the body attempts to maintain euvolemia by excreting sodium. * **Clinical Euvolemia:** No signs of edema or dehydration [1]. **2. Why Other Options are Incorrect:** * **CHF (A):** This is a **hypervolemic** state. Patients typically present with edema, JVP elevation, and low urine sodium (<20 mEq/L) due to RAAS activation [1]. * **Extrarenal Losses (B):** This causes **hypovolemic** hyponatremia. Clinical examination would show signs of dehydration (tachycardia, dry mucus membranes), and urine sodium would be low (<20 mEq/L) as the kidneys try to conserve salt [1]. * **Polydipsia (D):** While it causes hypotonic hyponatremia, the urine would be **maximally dilute** (Urine Osmolality <100 mOsm/kg) as the body tries to get rid of excess water [1][2]. **3. NEET-PG High-Yield Pearls:** * **Common Causes of SIADH:** Small cell lung cancer (most common paraneoplastic cause), CNS disorders (stroke, trauma), and Drugs (SSRIs, TCAs, Carbamazepine, Cyclophosphamide). * **Management:** Fluid restriction is the first-line treatment. For severe/symptomatic cases, use 3% hypertonic saline. * **Caution:** Avoid rapid correction to prevent **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)**. Limit correction to <8–10 mEq/L in 24 hours.

Question 30: A 28-year-old woman presents with a recent episode of coughing up blood, frequent nosebleeds, and decreased urine output. Physical examination reveals an ulcerated nasal mucosa. Urinalysis is positive for protein and red blood cells, consistent with acute glomerulonephritis. Chest X-ray shows two cavitary lesions, and serology is positive for antineutrophil cytoplasmic antibodies (ANCA). Which of the following is the most likely diagnosis?

A. Wegener granulomatosis (Correct Answer)
B. Bacterial endocarditis
C. Goodpasture syndrome
D. Lupus erythematosus

Explanation: ### Explanation The clinical presentation of **Wegener Granulomatosis** (now known as **Granulomatosis with Polyangiitis or GPA**) is classically defined by a triad of involvement: the upper respiratory tract, lower respiratory tract, and the kidneys [1], [2]. 1. **Why the correct answer is right:** * **Upper Respiratory Tract:** The patient has epistaxis and an ulcerated nasal mucosa (saddle-nose deformity is a common late finding) [2]. * **Lower Respiratory Tract:** Hemoptysis and **cavitary lesions** on chest X-ray are hallmark features of GPA [2]. * **Renal:** Acute glomerulonephritis (hematuria and proteinuria) indicates renal involvement, typically presenting as Pauci-immune Crescentic GN [1]. * **Serology:** The presence of **c-ANCA (anti-PR3)** is highly specific (approx. 90%) for GPA [1]. 2. **Why the incorrect options are wrong:** * **Bacterial Endocarditis:** While it can cause hematuria (via embolic GN) and lung issues (septic emboli), it would not typically cause nasal mucosal ulceration and is associated with fever and heart murmurs. * **Goodpasture Syndrome:** This involves a "pulmonary-renal syndrome" (hemoptysis + GN), but it **spares the upper respiratory tract** (no nasal ulcers) and is associated with anti-GBM antibodies, not ANCA [2]. * **Lupus Erythematosus (SLE):** SLE can cause nephritis and lung pleurisy, but cavitary lung lesions and nasal mucosal ulcers are not characteristic. SLE is associated with ANA and anti-dsDNA antibodies [3]. ### High-Yield Pearls for NEET-PG * **Triad of GPA:** Upper RTI + Lower RTI + Glomerulonephritis. * **Biopsy Gold Standard:** Shows necrotizing granulomatous inflammation and vasculitis [2]. * **Serology:** **c-ANCA** (cytoplasmic) directed against **Proteinase-3 (PR3)** [1]. * **Treatment:** Induction with **Cyclophosphamide** or Rituximab plus Corticosteroids [1]. * **Differential:** Microscopic Polyangiitis (MPA) also has lung-renal involvement but lacks granulomas and upper airway involvement, and is usually **p-ANCA** positive [2].

Question 31: What is the commonest site of extramedullary relapse?

A. Central Nervous System (CNS) (Correct Answer)
B. Lung
C. Liver
D. Testis

Explanation: In the context of hematological malignancies, particularly **Acute Lymphoblastic Leukemia (ALL)**, extramedullary relapse refers to the reappearance of leukemic cells in sites other than the bone marrow [1]. **1. Why CNS is the correct answer:** The **Central Nervous System (CNS)** is the most common site for extramedullary relapse. This occurs because the blood-brain barrier (BBB) acts as a **"pharmacological sanctuary."** Most standard systemic chemotherapeutic agents (like Vincristine or Anthracyclines) cannot cross the BBB in therapeutic concentrations. Consequently, subclinical leukemic cells can survive in the meninges despite systemic remission, eventually leading to a relapse. This is why CNS prophylaxis (intrathecal methotrexate) is a mandatory component of ALL treatment protocols [1]. **2. Analysis of Incorrect Options:** * **Lung and Liver (Options B & C):** While leukemic infiltration can occur in these solid organs during active disease or blast crisis, they are not considered "sanctuary sites." Systemic chemotherapy reaches these vascular organs effectively, making isolated relapses here rare. * **Testis (Option D):** The testis is the **second most common** site of extramedullary relapse. Like the CNS, it is a sanctuary site due to the blood-testis barrier and a lower local temperature, which may decrease the efficacy of certain drugs. However, statistically, CNS involvement occurs more frequently than testicular involvement. **Clinical Pearls for NEET-PG:** * **Sanctuary Sites:** CNS (1st most common) > Testis (2nd most common). * **CNS Relapse Presentation:** Usually presents with features of increased intracranial pressure (headache, vomiting, papilledema) or cranial nerve palsies. * **Diagnosis:** Identification of blasts in the Cerebrospinal Fluid (CSF) via cytocentrifugation. * **Prophylaxis:** All patients with ALL require CNS prophylaxis regardless of whether blasts are seen in the initial CSF analysis.

Question 32: Which of the following statements regarding cancer therapy with interleukin 2 (IL-2) is true?

A. It is a B-cell growth factor
B. It induces a major response in patients with metastatic breast cancer
C. It induces a major response in patients with metastatic colon cancer
D. It induces a major response in patients with metastatic melanoma (Correct Answer)

Explanation: ### Explanation **1. Why Option D is Correct** Interleukin-2 (IL-2), specifically high-dose recombinant IL-2 (Aldesleukin), is a potent cytokine that acts as a **T-cell growth factor**. It stimulates the proliferation and activation of cytotoxic T-cells and Natural Killer (NK) cells. Historically, it was the first effective immunotherapy for **metastatic melanoma** and **renal cell carcinoma (RCC)**. It can induce durable, complete remissions in a subset of these patients (approximately 5-10%), which is why it is considered a "major response" in the context of these specific malignancies. **2. Why the Other Options are Incorrect** * **Option A:** IL-2 is primarily a **T-cell growth factor**, not a B-cell growth factor. While it has some indirect effects on B-cells, its primary clinical utility in oncology is the expansion of the cellular immune response (T-cells). * **Options B & C:** Metastatic breast and colon cancers are generally considered "cold" tumors regarding IL-2 therapy. They do not show significant clinical responses to IL-2 monotherapy, which is why its use is restricted to immunogenic tumors like melanoma and RCC. **3. High-Yield Clinical Pearls for NEET-PG** * **Mechanism:** IL-2 stimulates the production of Lymphokine-Activated Killer (LAK) cells and Tumor-Infiltrating Lymphocytes (TILs). * **Major Side Effect:** **Capillary Leak Syndrome (CLS)**. IL-2 causes extravasation of plasma into the extravascular space, leading to hypotension, pulmonary edema, and weight gain. * **FDA Approval:** IL-2 is FDA-approved for metastatic Renal Cell Carcinoma and metastatic Melanoma. * **Current Status:** While largely superseded by Checkpoint Inhibitors (PD-1/CTLA-4 inhibitors), IL-2 remains a classic example of cytokine-based immunotherapy in medical board exams.

Question 33: Alpha-fetoprotein (AFP) is a marker for which of the following conditions?

A. Hepatoma
B. Seminoma
C. Neural tube defects
D. All of the above (Correct Answer)

Explanation: **Explanation:** Alpha-fetoprotein (AFP) is a glycoprotein normally produced by the fetal yolk sac and liver. In clinical practice, it serves as a crucial tumor marker and a screening tool for fetal anomalies. **Why "All of the above" is correct:** 1. **Hepatoma (Hepatocellular Carcinoma - HCC):** AFP is the primary tumor marker for HCC [1]. Levels >400 ng/mL in a patient with a liver mass are highly suggestive of malignancy. It is also used to monitor recurrence post-treatment. 2. **Seminoma (and Non-Seminomatous Germ Cell Tumors):** While **pure seminomas** typically do not produce AFP (they may secrete hCG), any elevation of AFP in a patient with a suspected seminoma indicates the presence of **yolk sac components** (mixed germ cell tumor) [2]. Therefore, AFP is a vital marker in the management and staging of testicular germ cell tumors. 3. **Neural Tube Defects (NTDs):** During pregnancy, maternal serum AFP (MSAFP) is used for screening. Elevated levels are associated with open NTDs (e.g., spina bifida, anencephaly) due to the leakage of fetal serum into the amniotic fluid. **High-Yield Clinical Pearls for NEET-PG:** * **Elevated AFP:** Seen in HCC, Yolk sac tumors (Endodermal sinus tumors), NTDs, and abdominal wall defects (Omphalocele/Gastroschisis). * **Rule of Thumb:** If a testicular biopsy says "Seminoma" but AFP is elevated, treat it as a **Non-Seminomatous Germ Cell Tumor (NSGCT)**. * **Other markers:** Remember that **hCG** is elevated in Choriocarcinoma and Seminoma [2], while **LDH** correlates with tumor burden in dysgerminomas.

Question 34: Maffucci syndrome is characterized by which of the following?

A. Enchondromas
B. Cavernous hemangiomas
C. Chondrosarcomas
D. Hamartomas (Correct Answer)

Explanation: **Explanation:** Maffucci syndrome is a rare genetic disorder characterized by the presence of multiple **enchondromas** (benign cartilage tumors) associated with multiple **soft tissue hemangiomas** (typically cavernous hemangiomas). In the context of pathology, both enchondromas and hemangiomas are classified as **hamartomas**—disorganized growths of mature cells indigenous to the particular site. Therefore, "Hamartomas" serves as the most encompassing pathological description for the lesions found in this syndrome. **Analysis of Options:** * **A. Enchondromas:** While these are a hallmark of Maffucci syndrome, they are only one component of the disease. The question asks for a characteristic that defines the nature of the lesions; enchondromas are themselves a type of cartilaginous hamartoma. * **B. Cavernous hemangiomas:** These are the classic vascular component of the syndrome, but like enchondromas, they represent only half of the clinical picture. * **C. Chondrosarcomas:** This is a common **malignant transformation** (occurring in up to 100% of cases over a lifetime) rather than the primary defining characteristic of the syndrome itself. * **D. Hamartomas (Correct):** This is the correct pathological classification for both the skeletal and vascular lesions seen in Maffucci syndrome. **NEET-PG High-Yield Pearls:** * **Genetics:** Most cases are sporadic and associated with somatic mutations in **IDH1 or IDH2** genes. * **Ollier Disease vs. Maffucci:** Ollier disease presents with multiple enchondromas only; Maffucci syndrome includes enchondromas **plus** hemangiomas. * **Malignancy Risk:** Maffucci has a significantly higher risk of secondary malignancies compared to Ollier disease, including chondrosarcoma, ovarian tumors, and pancreatic adenocarcinoma. * **Clinical Sign:** Look for "phleboliths" (calcified thrombi) on X-rays of the soft tissue hemangiomas.

Question 35: What is the most common cause of ectopic ACTH production?

A. Renal cell carcinoma
B. Hepatocellular carcinoma
C. Small cell carcinoma of the lung (Correct Answer)
D. Pheochromocytoma

Explanation: **Explanation:** **Ectopic ACTH Syndrome** occurs when a non-pituitary tumor secretes adrenocorticotropic hormone, leading to ACTH-dependent Cushing syndrome [1]. 1. **Why Small Cell Carcinoma of the Lung (SCLC) is correct:** SCLC is a neuroendocrine tumor and is the **most common cause** of ectopic ACTH production, accounting for approximately 50% of cases [2]. These tumors possess the cellular machinery to express the *POMC* gene, the precursor to ACTH. Clinically, these patients often present with rapid-onset hypertension, profound hypokalemia, and metabolic alkalosis, rather than the classic "cushingoid" physical features (like buffalo hump), due to the aggressive nature of the underlying malignancy. 2. **Why the other options are incorrect:** * **Renal cell carcinoma:** While RCC is known for various paraneoplastic syndromes (like EPO production leading to polycythemia or PTHrP leading to hypercalcemia), it is a very rare cause of ectopic ACTH [2]. * **Hepatocellular carcinoma:** Similar to RCC, HCC can cause paraneoplastic hypoglycemia or erythrocytosis, but it is not a classic source of ACTH [2]. * **Pheochromocytoma:** While pheochromocytomas are neuroendocrine tumors and *can* secrete ACTH, they are much rarer causes compared to SCLC. **NEET-PG High-Yield Pearls:** * **Most common cause of Ectopic ACTH:** Small cell carcinoma of the lung [2]. * **Second most common cause:** Carcinoid tumors (especially bronchial carcinoids). * **Diagnostic clue:** High ACTH levels that are **not suppressed** by high-dose dexamethasone (8mg), unlike Pituitary Cushing’s (Cushing Disease). * **Classic Lab Finding:** Severe hypokalemia is a hallmark of ectopic ACTH due to the mineralocorticoid effects of high cortisol levels.

Question 36: Which of the following is TRUE about tumor lysis syndrome?

A. Hyperuricemia
B. Hypercalcemia (Correct Answer)
C. Hyperkalemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncological emergency caused by the rapid destruction of a large number of tumor cells, typically following chemotherapy for high-grade hematologic malignancies (like Burkitt lymphoma or ALL). When these cells rupture, they release their intracellular contents into the bloodstream. **Why the correct answer is Hypercalcemia (The "False" Statement):** In the context of this question (which asks for the "TRUE" statement among options), there appears to be a common pedagogical trap. In TLS, **Hypocalcemia** (low calcium) occurs, not hypercalcemia. Therefore, if the question asks which is **NOT** a feature of TLS, Hypercalcemia is the correct answer to pick. Calcium levels drop because the massive release of intracellular phosphate binds to serum calcium, leading to the precipitation of calcium phosphate crystals in the renal tubules. **Analysis of Incorrect Options (Features of TLS):** * **Hyperuricemia (A):** DNA breakdown releases purines, which are metabolized by xanthine oxidase into uric acid. This can cause uric acid nephropathy. * **Hyperkalemia (C):** Potassium is the primary intracellular cation. Rapid cell lysis floods the serum with potassium, posing a risk for lethal cardiac arrhythmias. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells; their rupture leads to a marked rise in serum phosphate. **Clinical Pearls for NEET-PG:** * **The Metabolic Signature:** Hyperkalemia, Hyperuricemia, Hyperphosphatemia, and **Hypocalcemia**. * **Prophylaxis:** Aggressive intravenous hydration is the most important step. * **Treatment:** **Rasburicase** (recombinant uric oxidase) is the drug of choice for established TLS; **Allopurinol** is used for prophylaxis (prevents new uric acid formation but doesn't clear existing acid). * **Cairo-Bishop Definition:** Used for grading laboratory vs. clinical TLS.

Question 37: What is true about malignant melanoma?

A. Lymphatic spread (Correct Answer)
B. Lymph node biopsy is always done
C. Biopsy is done when the sentinel node is involved
D. Microsatellitism is seen

Explanation: **Explanation:** **Malignant Melanoma** is a highly aggressive cutaneous malignancy arising from melanocytes [1]. Understanding its pattern of spread and staging is crucial for NEET-PG. **1. Why Option A is Correct:** The primary mode of initial metastasis for malignant melanoma is **lymphatic spread** to regional lymph nodes. This occurs via the lymphatic channels draining the primary site. The presence of regional lymph node involvement is the most important prognostic factor in patients with localized melanoma. **2. Why the other options are incorrect:** * **Option B:** Lymph node biopsy (or Sentinel Lymph Node Biopsy - SLNB) is **not always done**. It is generally indicated for intermediate-thickness melanomas (Breslow thickness 1 mm or more) or thinner lesions with high-risk features [1]. It is not indicated for very thin, low-risk lesions (Tis or T1a). * **Option C:** This is logically reversed. A **Sentinel Lymph Node Biopsy (SLNB)** is performed to *determine* if the node is involved [1]. If the sentinel node is positive, further management (like Completion Lymph Node Dissection or adjuvant therapy) is considered. * **Option D:** While **microsatellitosis** (microscopic nests of tumor cells >0.05 mm in diameter, separate from the primary tumor) can occur in melanoma, it is a specific pathological feature used for staging (N-category) rather than a universal defining characteristic or the "most true" general statement compared to the fundamental mechanism of lymphatic spread. **Clinical Pearls for NEET-PG:** * **Breslow Depth:** The most important prognostic factor (vertical thickness in mm) [1]. * **ABCDE Criteria:** Asymmetry, Border irregularity, Color variegation, Diameter >6mm, Evolving. * **Commonest Site:** Back (Men), Lower limbs (Women). * **Commonest Type:** Superficial Spreading Melanoma. * **Most Aggressive Type:** Nodular Melanoma. * **S-100 and HMB-45:** Key immunohistochemical markers.

Question 38: What are the commonly used criteria for response evaluation during cancer treatment?

A. RECIST (Correct Answer)
B. WHO pain score
C. Drug dose score
D. Ki67 score

Explanation: **Explanation:** The assessment of treatment efficacy in solid tumors is standardized using the **RECIST (Response Evaluation Criteria in Solid Tumors)**. Currently, version 1.1 is the gold standard used in clinical trials and practice. It relies on objective anatomical measurements (CT/MRI) of "target lesions" to categorize response into four groups: Complete Response (CR), Partial Response (PR), Stable Disease (SD), and Progressive Disease (PD). **Analysis of Options:** * **RECIST (Correct):** It provides a simplified, evidence-based method to quantify tumor burden changes. It uses the sum of the longest diameters (SLD) for non-nodal lesions and the short axis for lymph nodes. * **WHO Pain Score:** This is a tool for assessing pain intensity and guiding analgesic therapy (the WHO Analgesic Ladder), not for measuring tumor size or treatment response. * **Drug Dose Score:** This is not a standardized oncological metric for response evaluation; it may refer to pharmacovigilance or dosing protocols. * **Ki67 Score:** This is a cellular proliferation marker (immunohistochemistry) used for prognosis and grading [1], but it is not used to evaluate the overall clinical response to treatment. **High-Yield Clinical Pearls for NEET-PG:** * **RECIST 1.1 Criteria:** A **Partial Response (PR)** is defined as a **≥30% decrease** in the sum of diameters of target lesions. **Progressive Disease (PD)** is defined as a **≥20% increase** in the sum of diameters or the appearance of new lesions. * **iRECIST:** A modified version used specifically for **Immunotherapy**, accounting for "pseudoprogression" (initial increase in tumor size due to immune cell infiltration). * **Lugano Classification:** The standard for response evaluation in **Lymphoma**, which incorporates PET-CT (Deauville criteria) rather than just size.

Question 39: What is true about PEComa (perivascular epithelioid cell tumor)?

A. Melanin and HMB45 are markers (Correct Answer)
B. It is a malignant melanoma variant
C. It contains perivascular epithelioid cells
D. Angiomyolipoma (AML) is a subtype

Explanation: **Explanation:** **PEComas (Perivascular Epithelioid Cell Tumors)** are a unique family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. **Why Option A is correct:** The hallmark of PEComas is their **dual immunoreactivity**. They characteristically express both **myogenic markers** (like smooth muscle actin and desmin) and **melanocytic markers** (specifically **HMB-45**, Melan-A, and sometimes microphthalmia transcription factor/MITF). The presence of premelanosomes and melanin pigment is a defining feature that aids in diagnosis, making HMB-45 a highly specific marker for this group. **Analysis of Incorrect Options:** * **Option B:** While PEComas express melanocytic markers, they are **not** variants of malignant melanoma. They are distinct mesenchymal neoplasms arising from primitive cells, whereas melanomas arise from melanocytes. * **Option C:** This statement is technically true regarding the composition of the tumor; however, in the context of standard NEET-PG questioning, the **immunohistochemical profile (Option A)** is considered the most definitive "true" diagnostic feature used to distinguish it from other mimics. * **Option D:** This is a common point of confusion. **Angiomyolipoma (AML)**, along with Clear Cell Sugar Tumor (CCST) of the lung and Lymphangiomyomatosis (LAM), are actually members of the **PEComa family**, not subtypes of a single "PEComa" entity. **High-Yield Clinical Pearls for NEET-PG:** * **Association:** PEComas are strongly associated with **Tuberous Sclerosis Complex (TSC1/TSC2 mutations)**. * **Common Sites:** While they can occur anywhere, the most common sites are the uterus, kidney (AML), and lung (CCST). * **Treatment:** For malignant cases, **mTOR inhibitors** (like Sirolimus) are the targeted therapy of choice due to the activation of the mTOR pathway in these tumors.

Question 40: A patient with a Pancoast tumor develops a loss of voice after radiation. What is the most likely cause of this symptom?

A. Vocal cord infiltration with secondaries
B. Involvement of the recurrent laryngeal nerve (Correct Answer)
C. Direct irradiation to the vocal cords
D. Radiation stenosis of the larynx

Explanation: ### Explanation **Correct Option: B. Involvement of the recurrent laryngeal nerve** A Pancoast tumor (Superior Sulcus Tumor) is a bronchogenic carcinoma arising from the apex of the lung. The **Recurrent Laryngeal Nerve (RLN)**, particularly on the left side, loops around the arch of the aorta, while the right RLN loops around the subclavian artery. As a Pancoast tumor expands or causes local inflammatory changes/fibrosis following radiation, it can compress or infiltrate the RLN. This leads to **vocal cord paralysis**, typically presenting as hoarseness or a "bovine cough." [1] In the context of post-radiation, the symptom is often due to tumor progression or radiation-induced fibrosis affecting the nerve's path. **Why Incorrect Options are Wrong:** * **A. Vocal cord infiltration with secondaries:** While lung cancer metastasizes widely, direct secondary deposits on the vocal cords are extremely rare compared to the common mechanism of nerve compression. * **C. Direct irradiation to the vocal cords:** Pancoast tumors are apical; radiation fields are targeted at the lung apex and superior mediastinum. The larynx is generally superior to the treatment field, making direct radiation damage to the cords unlikely. * **D. Radiation stenosis of the larynx:** This is a late complication of head and neck cancers (e.g., laryngeal cancer) where the larynx is the primary target. It is not a standard complication of treating an apical lung tumor. **NEET-PG High-Yield Pearls:** * **Pancoast Syndrome Triad:** Ipsilateral Horner’s syndrome, shoulder pain radiating down the arm (C8-T2 distribution), and atrophy of hand intrinsic muscles. * **Horner’s Syndrome:** Caused by involvement of the **paravertebral sympathetic chain** (specifically the stellate ganglion). * **Most common histology:** Squamous cell carcinoma (though Adenocarcinoma is increasing in frequency). * **Phrenic Nerve involvement:** Can lead to hemidiaphragm paralysis (seen as an elevated dome on CXR). [2]

Question 41: Bilateral Renal cell carcinoma is seen in which of the following conditions?

A. Eagle Barrett syndrome
B. Beckwith-Wiedemann syndrome
C. Von Hippel-Lindau disease (Correct Answer)
D. Bilateral Angiomyolipoma

Explanation: Explanation: **Correct Answer: C. Von Hippel-Lindau (VHL) disease** Von Hippel-Lindau disease is an autosomal dominant multisystem neoplastic syndrome caused by a mutation in the **VHL gene on chromosome 3p25**. The VHL protein normally targets Hypoxia-Inducible Factor (HIF) for degradation. Its absence leads to increased angiogenesis and tumorigenesis. **Clear cell Renal Cell Carcinoma (RCC)** occurs in approximately 40-70% of VHL patients and is characteristically **bilateral and multicentric**, occurring at a much younger age than sporadic cases. [1] **Analysis of Incorrect Options:** * **A. Eagle-Barrett Syndrome (Prune Belly Syndrome):** Characterized by the triad of abdominal muscle deficiency, undescended testes, and urinary tract abnormalities (e.g., megaureter). It is not associated with a predisposition to RCC. * **B. Beckwith-Wiedemann Syndrome:** An overgrowth disorder (macrosomia, macroglossia, omphalocele). While it increases the risk of embryonal tumors, the classic renal association is **Wilms tumor**, not RCC. * **D. Bilateral Angiomyolipoma:** These are benign mesenchymal tumors composed of fat, blood vessels, and smooth muscle. They are strongly associated with **Tuberous Sclerosis**, not RCC. **High-Yield Clinical Pearls for NEET-PG:** * **VHL Manifestations (H-H-P-R):** **H**emangioblastomas (Retina/Cerebellum), **H**epatopancreatic cysts, **P**heochromocytoma, and **R**enal cell carcinoma (Clear cell type). * **Chromosome 3:** The "Rule of 3" applies—VHL gene is on Chromosome 3, and Clear cell RCC is associated with deletions of 3p. [1] * **Screening:** In VHL patients, annual abdominal imaging is recommended to detect RCC early.

Question 42: A patient with Hodgkin's lymphoma presents with a single cervical lymph node. Biopsy shows the lymphocyte-predominant variant. What is the recommended treatment?

A. Chemotherapy with Radiotherapy
B. Chemotherapy only
C. Radiotherapy only (Correct Answer)
D. No treatment needed

Explanation: The patient has **Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)**, which is a distinct clinical entity from Classical Hodgkin Lymphoma (cHL). NLPHL is characterized by an indolent (slow-growing) course, a tendency to present in early stages (Stage I or II), and the presence of "popcorn cells" (LP cells) that are CD20 positive. **1. Why Radiotherapy only is correct:** For **Stage IA or IIA** NLPHL without risk factors, **Involved-Field Radiation Therapy (IFRT)** or Involved-Site Radiation Therapy (ISRT) is the standard of care [1]. Because the disease is localized and highly radiosensitive, radiotherapy alone achieves excellent long-term survival rates (>90%) and avoids the systemic toxicity of chemotherapy. **2. Why other options are incorrect:** * **A & B (Chemotherapy):** Combined modality therapy or chemotherapy alone (e.g., ABVD or CHOP + Rituximab) is reserved for advanced stages (III-IV) or early stages with bulky disease/B-symptoms. Using it for a single node in NLPHL is considered "over-treatment." * **D (No treatment):** While indolent, NLPHL is not managed by "watch and wait" if the disease is localized and symptomatic/progressive; active treatment with RT is curative. **High-Yield Clinical Pearls for NEET-PG:** * **Immunophenotype:** NLPHL is **CD20+** and **CD45+**, but typically **CD15- and CD30-** (the opposite of Classical Hodgkin Lymphoma). * **Cell Morphology:** Look for **"Popcorn cells"** (L&H cells) instead of typical Reed-Sternberg cells. * **Prognosis:** It has the best prognosis among all Hodgkin variants but carries a small risk of transformation into Diffuse Large B-Cell Lymphoma (DLBCL). * **Treatment Note:** If the question mentions CD20 positivity, **Rituximab** is a highly effective targeted therapy often used in relapsed cases [1].

Question 43: Tumor lysis syndrome causes all of the following EXCEPT:

A. Hypercalcemia (Correct Answer)
B. Hyperuricemia
C. Hypermagnesemia
D. Hyperkalemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of metabolically active tumor cells (usually following chemotherapy for high-grade lymphomas or leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation. **Why Hypercalcemia is the correct answer:** TLS characteristically causes **Hypocalcemia**, not hypercalcemia. This occurs because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to ionized calcium, forming calcium-phosphate crystals that precipitate in soft tissues and the kidneys, thereby lowering serum calcium levels. **Analysis of other options:** * **Hyperuricemia (B):** Nucleic acids from the destroyed cell nuclei are catabolized into purines and then into uric acid by xanthine oxidase. This can lead to uric acid nephropathy. * **Hypermagnesemia (C):** Magnesium is primarily an intracellular cation. Rapid cell lysis releases magnesium into the blood. While less clinically emphasized than potassium, it is a recognized component of the electrolyte derangement in TLS. * **Hyperkalemia (D):** Potassium is the major intracellular cation. Its rapid release is the most immediate life-threatening complication of TLS, potentially causing fatal arrhythmias. **NEET-PG Clinical Pearls:** * **Cairo-Bishop Definition:** TLS is defined by derangements in four metabolic parameters: **↑ Uric acid, ↑ Potassium, ↑ Phosphate, and ↓ Calcium.** * **Prophylaxis:** Aggressive hydration is the most important step. * **Treatment:** **Rasburicase** (recombinant urate oxidase) is the drug of choice for established TLS as it converts uric acid to the highly soluble allantoin. **Allopurinol** is used for prophylaxis but does not reduce existing uric acid.

Question 44: Which of the following tumors is typically associated with lymph node metastasis?

A. Liposarcoma
B. Neurofibrosarcoma
C. Histiocytoma
D. Angiosarcoma (Correct Answer)

Explanation: In the study of soft tissue sarcomas, a fundamental rule is that they primarily spread via the **hematogenous route** (bloodstream), most commonly to the lungs. Lymph node involvement is rare, occurring in less than 5% of cases. However, there are specific exceptions to this rule that are frequently tested in NEET-PG. **Angiosarcoma (Option D)** is the correct answer because it is one of the few soft tissue sarcomas known for a higher propensity for lymphatic spread. Other sarcomas in this "exception" category include Clear cell sarcoma, Rhabdomyosarcoma, Epithelioid sarcoma, and Synovial sarcoma. **Analysis of Incorrect Options:** * **Liposarcoma (Option A):** The most common adult soft tissue sarcoma. It typically spreads via local invasion or hematogenously to the lungs and retroperitoneum, but rarely involves lymph nodes. * **Neurofibrosarcoma (Option B):** Also known as Malignant Peripheral Nerve Sheath Tumor (MPNST), it is often associated with NF-1. It spreads locally and via the bloodstream. * **Histiocytoma (Option C):** Specifically Malignant Fibrous Histiocytoma (now termed Pleomorphic Undifferentiated Sarcoma), it follows the classic hematogenous spread pattern. **NEET-PG High-Yield Pearls:** To remember the sarcomas that spread via lymph nodes, use the mnemonic **"CREST"**: * **C:** Clear cell sarcoma * **R:** Rhabdomyosarcoma (most common in children) * **E:** Epithelioid sarcoma * **S:** Synovial sarcoma * **T:** (Angio)**T**umors / Angiosarcoma **Clinical Note:** Angiosarcomas are aggressive endothelial cell malignancies. They are classically associated with chronic lymphedema (Stewart-Treves Syndrome) and prior radiation therapy.

Question 45: Superior vena cava syndrome is most commonly caused by which of the following malignancies?

A. Adenocarcinoma
B. Squamous cell carcinoma
C. Small cell carcinoma (Correct Answer)
D. Large cell carcinoma

Explanation: **Explanation:** Superior Vena Cava (SVC) syndrome results from the obstruction of blood flow through the SVC, typically due to external compression or direct invasion by a mediastinal mass. **Why Small Cell Carcinoma (SCLC) is the correct answer:** While Non-Small Cell Lung Cancer (NSCLC) as a broad group accounts for more total cases of SVC syndrome due to its higher overall prevalence, **Small Cell Carcinoma** is the single most common histological subtype associated with this condition. This is due to its biological behavior: SCLC is typically **centrally located** (near the hilum and mediastinum) and is characterized by rapid growth and early involvement of mediastinal lymph nodes, which directly compress the thin-walled SVC. **Analysis of Incorrect Options:** * **Adenocarcinoma:** This is the most common type of lung cancer overall, but it is typically **peripherally located**. Therefore, it is less likely to cause central venous compression compared to SCLC. * **Squamous Cell Carcinoma:** While often centrally located, it is more prone to cavitation and endobronchial obstruction rather than the massive mediastinal lymphadenopathy seen in SCLC. * **Large Cell Carcinoma:** This is a less common subtype of NSCLC and does not carry the same predilection for central mediastinal crowding as SCLC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause overall:** Malignancy (70-90%), specifically Lung Cancer [1]. * **Most common non-malignant cause:** Iatrogenic (indwelling catheters/pacemaker wires) leading to thrombosis. * **Clinical Presentation:** Facial puffiness, "plethora" (redness), dilated neck veins (non-pulsatile), and Pemberton’s sign. * **Management:** SCLC is highly chemo-sensitive [1]; therefore, chemotherapy is often the primary treatment for SVC syndrome caused by SCLC, whereas radiation is preferred for NSCLC.

Question 46: A 69-year-old woman is taking large amounts of aspirin for osteoarthritis and now complains of ringing in her ears and nausea. What is the most likely acid-base disorder for this patient with new symptoms?

A. Metabolic acidosis
B. Metabolic alkalosis
C. Respiratory acidosis
D. Respiratory alkalosis (Correct Answer)

Explanation: **Explanation:** This patient is presenting with classic signs of **salicylate (aspirin) toxicity**, characterized by tinnitus (ringing in the ears) and nausea [1]. **Why Respiratory Alkalosis is Correct:** Salicylates act as a direct stimulant to the medullary respiratory center [2, 5]. This leads to hyperventilation (increased rate and depth of breathing), which causes an excessive loss of $CO_2$. According to the Henderson-Hasselbalch principle, a decrease in $pCO_2$ results in an increase in blood pH, leading to **primary respiratory alkalosis** [2]. This is typically the earliest acid-base disturbance seen in adults following an aspirin overdose [1]. **Why the other options are incorrect:** * **Metabolic Acidosis:** While salicylates eventually cause a High Anion Gap Metabolic Acidosis (HAGMA) by uncoupling oxidative phosphorylation and increasing organic acids (lactic acid, ketoacids), the *initial* and most characteristic direct effect on the respiratory center in early toxicity is respiratory alkalosis [1]. * **Metabolic Alkalosis:** Aspirin is an acid (acetylsalicylic acid); its toxicity does not lead to a primary increase in bicarbonate or loss of hydrogen ions. * **Respiratory Acidosis:** This occurs only in very late stages or severe pediatric toxicity where central nervous system depression leads to hypoventilation, which is not the case here. **NEET-PG High-Yield Pearls:** * **Mixed Acid-Base Disorder:** In adults, the most common presentation of salicylate poisoning is a **mixed respiratory alkalosis and metabolic acidosis** [1]. If a question asks for the *earliest* or *most likely* initial change, choose respiratory alkalosis. * **Tinnitus:** This is a highly specific early sign of salicylate toxicity ("Salicylism") [1]. * **Treatment:** Management involves **urinary alkalinization** with Sodium Bicarbonate ($NaHCO_3$) to enhance salicylate excretion (ion trapping) and hemodialysis in severe cases.

Question 47: Which type of Hodgkin disease (HD) is characterized by a particularly good prognosis?

A. Lymphocyte-predominant Hodgkin disease (HD) (Correct Answer)
B. Nodular-sclerosing HD
C. Mixed-cellularity HD
D. Lymphocyte-depleted HD, reticular type

Explanation: The prognosis of Hodgkin Lymphoma (HL) is traditionally linked to the ratio of reactive lymphocytes to Reed-Sternberg (RS) cells [1]. A higher number of lymphocytes generally correlates with a more indolent course and a better prognosis. **1. Why Lymphocyte-Predominant HD is Correct:** This subtype (specifically **Nodular Lymphocyte-Predominant HL**) is characterized by an abundance of small lymphocytes and rare malignant cells known as **"Popcorn cells"** (L&H variants). It typically presents in young males as localized (Stage I or II) peripheral lymphadenopathy. It has the **best overall prognosis** among all subtypes, often behaving like a low-grade B-cell lymphoma with a very high long-term survival rate. **2. Analysis of Incorrect Options:** * **Nodular Sclerosing HD:** This is the **most common** subtype overall. While it has an excellent prognosis, it is slightly less favorable than the lymphocyte-predominant type. It is characterized by collagen bands and **Lacunar cells**. * **Mixed-Cellularity HD:** This type features a diverse inflammatory background (eosinophils, plasma cells). It has an intermediate prognosis and is more frequently associated with **EBV infection** and constitutional "B" symptoms. * **Lymphocyte-Depleted HD:** This is the **rarest** and most aggressive form. It is characterized by numerous pleomorphic RS cells and few lymphocytes. It carries the **worst prognosis** and is often seen in elderly or HIV-positive patients. **High-Yield Clinical Pearls for NEET-PG:** * **Best Prognosis:** Lymphocyte Predominant. * **Worst Prognosis:** Lymphocyte Depleted. * **Most Common Subtype:** Nodular Sclerosis (especially in young females). * **Subtype with most Eosinophils:** Mixed Cellularity (due to IL-5 secretion). * **RS Cell Markers:** Classic HL is **CD15+ and CD30+**; Lymphocyte Predominant is **CD20+** (CD15/30 negative).

Question 48: In Tumor Lysis Syndrome, which of the following signs due to hypocalcemia is NOT typically seen?

A. Tetany
B. Myopathy
C. Parkinsonism
D. Cardiac arrhythmias (Correct Answer)

Explanation: In **Tumor Lysis Syndrome (TLS)**, rapid cell breakdown leads to hyperphosphatemia. Excess phosphate binds to calcium, forming calcium phosphate crystals, which results in **secondary hypocalcemia** [1]. ### Why "Cardiac Arrhythmias" is the Correct Answer While hypocalcemia *can* cause ECG changes (like QTc prolongation [1]), it is **not** typically the primary driver of life-threatening arrhythmias in the context of TLS. In TLS, the most dangerous and characteristic cause of cardiac arrhythmias is **Hyperkalemia** (due to the release of intracellular potassium). Since the question asks which sign is "not typically seen" *due to hypocalcemia* in this specific syndrome, cardiac arrhythmias are attributed to potassium derangements rather than calcium. ### Explanation of Incorrect Options * **Tetany (A):** This is a classic manifestation of hypocalcemia. Low extracellular calcium lowers the threshold for depolarization in peripheral nerves, leading to muscle spasms and carpopedal spasms. * **Myopathy (B):** Hypocalcemia can present as proximal muscle weakness or myopathic symptoms due to altered neuromuscular excitability. * **Parkinsonism (C):** Chronic or severe hypocalcemia can lead to calcification of the basal ganglia (Fahr’s syndrome), which manifests as extrapyramidal symptoms, including parkinsonism. ### High-Yield Clinical Pearls for NEET-PG * **TLS Metabolic Profile:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** [1]. * **ECG in Hypocalcemia:** Look for **prolonged QT interval** (specifically the ST segment) [1]. * **Chvostek’s Sign:** Facial twitching when tapping the facial nerve (sign of hypocalcemia). * **Trousseau’s Sign:** Carpal spasm induced by inflating a BP cuff (more sensitive than Chvostek’s). * **Prophylaxis:** Aggressive hydration and **Rasburicase** (recombinant urate oxidase) are preferred over Allopurinol for high-risk patients.

Question 49: A 70-year-old male has been experiencing intermittent epistaxis, fatigue, and bone pain for the past 4 months. Laboratory investigations show serum calcium of 14.2 mg/dL (Normal 8.9-10.1 mg/dL). How should the above condition be treated?

A. Radiotherapy
B. Chemotherapy (Correct Answer)
C. Antibiotics
D. Antifungal therapy

Explanation: ### **Explanation** The clinical presentation of **epistaxis (bleeding diathesis), fatigue (anemia), bone pain, and severe hypercalcemia (14.2 mg/dL)** in an elderly male is highly suggestive of **Multiple Myeloma (MM)** [1]. #### **Why Chemotherapy is Correct** Multiple Myeloma is a plasma cell dyscrasia characterized by the "CRAB" features: **C**alcium elevation, **R**enal insufficiency, **A**nemia, and **B**one lesions. * **Systemic Nature:** MM is a systemic hematological malignancy, not a localized tumor [1]. Therefore, the primary treatment modality is **systemic chemotherapy** (e.g., Proteasome inhibitors like Bortezomib, Immunomodulators like Lenalidomide, and Corticosteroids). * **Hypercalcemia Management:** While acute hypercalcemia requires aggressive hydration and bisphosphonates [2], the definitive treatment for the underlying cause (malignant plasma cell proliferation) is chemotherapy. #### **Why Other Options are Incorrect** * **Radiotherapy:** Used primarily for localized complications, such as painful focal bone lesions or spinal cord compression [3], but it cannot treat the systemic disease or the generalized hypercalcemia. * **Antibiotics & Antifungal therapy:** While MM patients are immunocompromised and prone to infections, these do not treat the underlying malignancy or the metabolic emergency of hypercalcemia. #### **NEET-PG High-Yield Pearls** * **Hypercalcemia of Malignancy:** MM is a leading cause. Treat acutely with **IV Normal Saline** (first step) followed by **Zoledronic acid** or **Pamidronate** [2]. * **Diagnosis:** Look for **M-spike** on Serum Protein Electrophoresis (SPEP) and **>10% clonal plasma cells** on bone marrow biopsy [1]. * **Bone Pain:** In MM, bone lesions are **osteolytic** (punched-out lesions) [1]. Note: Bone scans are often negative because they detect osteoblastic activity; **Skeletal Survey (X-rays)** or MRI is preferred. * **Bence-Jones Proteins:** These are free light chains found in the urine, which can lead to "Myeloma Kidney."

Question 50: Which of the following statements about the treatment of Chronic Lymphocytic Leukemia (CLL) is true?

A. Treatment should be offered to all patients diagnosed with CLL.
B. Treatment can be withheld in asymptomatic patients. (Correct Answer)
C. The treatment for CLL is curative.
D. Combination chemoradiotherapy should be administered to patients above 50 years of age.

Explanation: **Explanation:** **1. Why Option B is Correct:** Chronic Lymphocytic Leukemia (CLL) is often an indolent malignancy characterized by the clonal proliferation of mature B-cells. Unlike many other cancers, early intervention in asymptomatic patients (Rai Stage 0 or Binet Stage A) does not improve overall survival [1]. Therefore, the standard of care is **"Watchful Waiting"** (observation). Treatment is only initiated when the patient becomes symptomatic or shows evidence of disease progression (e.g., "B" symptoms, progressive marrow failure, or massive lymphadenopathy). **2. Why the Other Options are Incorrect:** * **Option A:** Treatment is not universal. Approximately one-third of patients never require treatment during their lifetime. Initiating therapy prematurely exposes patients to unnecessary toxicity without clinical benefit. * **Option C:** Current standard therapies (including Targeted agents like Ibrutinib or Venetoclax and Chemoimmunotherapy like FCR) are highly effective at inducing remission but are generally **not curative** [2]. The only potentially curative treatment is Allogeneic Stem Cell Transplant, which is reserved for very specific, high-risk cases. * **Option D:** CLL is a systemic hematological malignancy; localized radiotherapy is rarely used except for palliative relief of bulky lymphadenopathy [1]. Furthermore, age alone does not dictate "chemoradiotherapy"; treatment choice depends on fitness, comorbidities, and genetic markers (e.g., 17p deletion). **3. NEET-PG High-Yield Pearls:** * **Indications for Treatment (iwCLL Criteria):** Progressive anemia/thrombocytopenia, massive/symptomatic splenomegaly or lymphadenopathy, lymphocyte doubling time <6 months, or severe constitutional symptoms. * **Most Common Leukemia in the West:** CLL (often presents as incidental lymphocytosis in elderly patients). * **Diagnosis:** Flow cytometry showing **CD5+, CD19+, CD20+(weak), and CD23+** B-cells. * **Peripheral Smear:** Characterized by **Smudge cells** (Basket cells). * **Richter Transformation:** Development of high-grade Large B-cell Lymphoma in a CLL patient (poor prognosis).

Question 51: A 40-year-old female patient presents with weakness and loss of appetite. She is a known case of non-Hodgkin's lymphoma, and lymph node examination shows involvement of Waldeyer's ring. What is the clinical stage for this patient?

A. Stage I (Correct Answer)
B. Stage II
C. Stage III
D. Stage IV

Explanation: ### Explanation The clinical staging of Non-Hodgkin’s Lymphoma (NHL) follows the **Ann Arbor Staging System** (modified by the Cotswolds criteria) [1]. **Why Stage I is Correct:** In the Ann Arbor system, **Stage I** is defined as the involvement of a single lymph node region or a single extralymphatic organ/site. **Waldeyer’s ring** (comprising the tonsils, adenoids, and lingual tonsils) is considered a **single lymphoid site** [1]. Since the question specifies involvement of Waldeyer's ring without mentioning any other nodal or extranodal sites, it is classified as Stage I. **Analysis of Incorrect Options:** * **Stage II:** Requires involvement of two or more lymph node regions on the **same side** of the diaphragm. * **Stage III:** Requires involvement of lymph node regions on **both sides** of the diaphragm (e.g., cervical and inguinal nodes). * **Stage IV:** Represents diffuse or disseminated involvement of one or more extralymphatic organs (like bone marrow or liver), with or without associated lymph node involvement [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Waldeyer’s Ring:** It is a common site for extranodal NHL (especially Diffuse Large B-Cell Lymphoma). For staging purposes, it is treated as a single nodal station [1]. * **"E" Suffix:** If a single extranodal site is involved (e.g., localized stomach involvement), it is Stage IE. * **"B" Symptoms:** Fever (>38°C), drenching night sweats, and weight loss (>10% in 6 months) [1]. Their presence adds a "B" suffix (e.g., Stage IB), while their absence adds "A". * **Spleen:** Involvement of the spleen is considered nodal involvement and is designated by the suffix "S" (Stage IIIS) [1].

Question 52: Which biochemical test can predict the return of renal function in a patient with tumor lysis syndrome?

A. Serum creatinine
B. Serum phosphate
C. Serum potassium
D. Serum uric acid (Correct Answer)

Explanation: In **Tumor Lysis Syndrome (TLS)**, the rapid breakdown of malignant cells releases massive amounts of intracellular contents into the bloodstream. The primary mechanism of acute kidney injury (AKI) in TLS is **Urate Nephropathy**, where uric acid crystals precipitate in the renal tubules, causing intrarenal obstruction. [1] **Why Serum Uric Acid is the correct answer:** The recovery of renal function in TLS is directly linked to the clearance of the obstructing substance. As serum uric acid levels decrease (either through treatment with Rasburicase/Allopurinol or spontaneous clearance), the tubular obstruction resolves. Therefore, a **downward trend in serum uric acid** is the most reliable biochemical predictor that the "insult" to the kidneys has been removed and renal function is likely to return. [1] **Analysis of Incorrect Options:** * **Serum Creatinine:** While creatinine is a marker of *current* renal function, it is a lagging indicator. [2] It stays elevated for a period even after the underlying cause of AKI is resolved; thus, it cannot "predict" the return of function as early as uric acid. * **Serum Phosphate & Potassium:** These electrolytes are elevated in TLS (Hyperphosphatemia and Hyperkalemia). While their normalization is important, they are consequences of renal failure rather than the primary obstructive cause. Their decline is often a result of dialysis or renal recovery, not a predictor of it. **NEET-PG High-Yield Pearls:** * **Cairo-Bishop Definition:** Used for diagnosing Laboratory vs. Clinical TLS. * **Prophylaxis:** Aggressive hydration is the most important step. * **Drug of Choice:** **Rasburicase** (recombinant urate oxidase) is preferred for established TLS as it converts uric acid to highly soluble allantoin. **Allopurinol** is used for prophylaxis only. * **Classic Triad:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** (due to calcium-phosphate precipitation).

Question 53: A 60-year-old woman presents with symptoms of muscle weakness and fatigue. Her examination reveals blood pressure of 110/80 mm Hg, pulse of 100/min, JVP of 1 cm, normal heart sounds, and clear lungs. Laboratory findings include serum potassium of 2.5 mEq/L, bicarbonate of 15 mEq/L, and a normal anion gap. Urine potassium is 10 mEq/L. For this patient with hypokalemia, what is the most likely diagnosis?

A. Lower gastrointestinal losses (Correct Answer)
B. Prior use of diuretics
C. Renal tubular acidosis
D. Current use of diuretics

Explanation: This clinical scenario tests the systematic approach to **hypokalemia** by evaluating urinary potassium excretion and acid-base status. ### **Explanation of the Correct Answer** The patient presents with hypokalemia (2.5 mEq/L) and metabolic acidosis (Bicarbonate 15 mEq/L). The key to the diagnosis lies in the **Urine Potassium level (10 mEq/L)** [1]. * In hypokalemia, the normal renal response is to conserve potassium. A **Urine K+ < 15–20 mEq/L** indicates **extra-renal losses** (the kidneys are functioning correctly by holding onto potassium) [1]. * Lower GI losses (e.g., chronic diarrhea, laxative abuse) result in the loss of potassium and bicarbonate. This leads to hypokalemia and a **Normal Anion Gap Metabolic Acidosis (NAGMA)** [1]. ### **Why Other Options are Incorrect** * **B & D (Diuretics):** Both current and prior diuretic use typically cause **increased** urinary potassium excretion (Urine K+ > 20 mEq/L) and are usually associated with metabolic **alkalosis**, not acidosis. * **C (Renal Tubular Acidosis):** While RTA (Types 1 and 2) causes NAGMA and hypokalemia, it is a **renal** cause of potassium loss. Therefore, the Urine K+ would be inappropriately **high** (> 20 mEq/L) despite the low serum potassium. ### **NEET-PG High-Yield Pearls** 1. **Urinary K+ Threshold:** Use **20 mEq/L** as the cutoff. < 20 mEq/L = Extra-renal loss (GI or skin); > 20 mEq/L = Renal loss (Diuretics, RTA, Hyperaldosteronism) [1]. 2. **Acid-Base Clues:** * Hypokalemia + Acidosis = Diarrhea or RTA [1]. * Hypokalemia + Alkalosis = Vomiting, Diuretics, or Conn’s Syndrome. 3. **Transtubular Potassium Gradient (TTPG):** A TTPG > 7 in a hypokalemic patient suggests renal potassium wasting.

Question 54: A 35-year-old woman presents with several days of increasing fatigue and shortness of breath on exertion. She was recently diagnosed with Mycoplasma pneumoniae. Physical examination reveals BP 113/67, HR 114 beats/min, and respiratory rate 20 breaths/min. She appears icteric and in mild respiratory distress. Her hemoglobin is 9.0 g/dL and MCV is 110. Which of the following is the best next diagnostic test?

A. Serum protein electrophoresis
B. Flow cytometry
C. Peripheral blood smear (Correct Answer)
D. Glucose-6-PD level

Explanation: **Explanation:** The clinical presentation is highly suggestive of **Cold Agglutinin Disease (CAD)**, a form of autoimmune hemolytic anemia (AIHA) triggered by **Mycoplasma pneumoniae**. The patient presents with acute anemia (Hb 9.0 g/dL), jaundice (icterus), and macrocytosis (MCV 110 fL). In CAD, IgM antibodies bind to RBCs at low temperatures, causing them to clump together [1]. **Why Peripheral Blood Smear is the best next step:** A peripheral blood smear is the most rapid and cost-effective initial test to confirm hemolysis and identify **RBC agglutination** (clumping). This clumping explains the falsely elevated MCV, as automated counters mistake RBC clusters for single large cells [1]. The smear will also show **spherocytes**, confirming an extravascular hemolytic process [2]. **Analysis of Incorrect Options:** * **A. Serum protein electrophoresis:** Used to detect monoclonal gammopathy (e.g., Multiple Myeloma). While CAD can be associated with Waldenström macroglobulinemia, it is not the immediate diagnostic step for acute hemolysis. * **B. Flow cytometry:** This is the gold standard for Paroxysmal Nocturnal Hemoglobinuria (PNH) (CD55/59 deficiency). PNH presents with intravascular hemolysis but is not typically triggered by Mycoplasma. * **C. Glucose-6-PD level:** G6PD deficiency causes hemolysis triggered by oxidative stress (drugs, fava beans) [3]. While it shows bite cells on a smear, it is not associated with Mycoplasma or high MCV due to agglutination. **NEET-PG High-Yield Pearls:** * **Cold AIHA (IgM):** Associated with *Mycoplasma pneumoniae* and Infectious Mononucleosis (EBV) [1]. * **Warm AIHA (IgG):** Associated with SLE, CLL, and drugs (α-methyldopa) [2]. * **Direct Coombs Test:** In CAD, it is positive for **C3b/complement** only (IgM dissociates at warmer temperatures) [1]. * **Management:** Avoid cold exposure; Rituximab is the preferred medical therapy if needed [1].

Question 55: Tumor lysis syndrome is associated with all of the following laboratory features except?

A. Hyperkalemia
B. Hypercalcemia (Correct Answer)
C. Hyperuricemia
D. Hyperphosphatemia

Explanation: Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid lysis of malignant cells, usually following chemotherapy for high-grade hematologic malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a predictable pattern of metabolic derangements. Why Hypercalcemia is the Correct Answer: TLS is characterized by Hypocalcemia, not hypercalcemia [1]. As intracellular phosphorus is released into the bloodstream (Hyperphosphatemia), it binds to circulating ionized calcium to form calcium-phosphate crystals. This precipitation leads to a secondary decrease in serum calcium levels, which can cause tetany or arrhythmias. Analysis of Incorrect Options: * Hyperkalemia (A): Potassium is the primary intracellular cation. Rapid cell lysis floods the extracellular space with potassium, which is the most immediate life-threatening complication of TLS due to the risk of cardiac arrest. * Hyperuricemia (C): The breakdown of intracellular nucleic acids releases purines, which are metabolized by the liver into uric acid. Excessive uric acid can crystallize in the renal tubules, leading to acute kidney injury (AKI). * Hyperphosphatemia (D): Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to a massive release of phosphate into the blood. NEET-PG High-Yield Pearls: * Cairo-Bishop Definition: Clinical TLS is diagnosed when laboratory TLS is present along with increased creatinine, seizures, or cardiac arrhythmias. * Prophylaxis/Treatment: Aggressive hydration is the mainstay. Allopurinol (xanthine oxidase inhibitor) prevents new uric acid formation, while Rasburicase (recombinant urate oxidase) breaks down existing uric acid into allantoin. * Renal Protection: Maintaining high urine output is critical; however, urinary alkalinization is no longer routinely recommended as it may promote calcium-phosphate precipitation.

Question 56: In humoral hypercalcemia of malignancy, what serum calcium level indicates severe hypercalcemia, which may present with symptoms such as fatigue, mental status changes, dehydration, or nephrolithiasis?

A. 14 mg/dl (Correct Answer)
B. 12 mg/dl
C. 11 mg/dl
D. 10 mg/dl

Explanation: ### Explanation **Core Concept:** Hypercalcemia of malignancy is primarily driven by the secretion of **Parathyroid Hormone-related Protein (PTHrP)**, which mimics PTH action on bones and kidneys. In clinical practice, hypercalcemia is categorized by total serum calcium levels: * **Mild:** 10.5 – 11.9 mg/dL * **Moderate:** 12.0 – 13.9 mg/dL * **Severe (Hypercalcemic Crisis):** **≥ 14.0 mg/dL** [1] **Why Option A is Correct:** A serum calcium level of **14 mg/dL** is the threshold for **severe hypercalcemia**. At this level, patients are frequently symptomatic and require urgent inpatient management. Symptoms include profound dehydration (due to nephrogenic diabetes insipidus), altered mental status (lethargy/coma), and cardiac arrhythmias (shortened QT interval) [1]. **Analysis of Incorrect Options:** * **Option B (12 mg/dl):** This falls into the **moderate** range. While patients may be symptomatic, it does not represent the threshold for "severe" hypercalcemia or a medical emergency unless the rise is very acute. * **Option C (11 mg/dl):** This represents **mild** hypercalcemia. Most patients at this level are asymptomatic or have vague symptoms like mild fatigue. * **Option D (10 mg/dl):** This is within the **normal range** (typically 8.5–10.5 mg/dL). **NEET-PG High-Yield Pearls:** 1. **Most Common Cause:** In hospitalized patients, malignancy is the #1 cause of hypercalcemia; in outpatients, it is Primary Hyperparathyroidism [2]. 2. **Mechanism:** PTHrP is most commonly associated with **Squamous Cell Carcinomas** (Lung, Head/Neck) [2]. 3. **Treatment Priority:** The immediate first step in managing severe hypercalcemia (≥14 mg/dL) is **aggressive IV hydration with Normal Saline**, followed by Bisphosphonates (Zoledronic acid) or Denosumab [1]. 4. **ECG Finding:** Look for a **shortened QT interval**; this is a classic board-style question.

Question 57: What is the primary treatment for Superior Vena Cava (SVC) syndrome caused by Small Cell Lung Carcinoma?

A. Radiotherapy
B. Chemotherapy (Correct Answer)
C. Surgery
D. No treatment

Explanation: **Explanation:** Superior Vena Cava (SVC) syndrome is a clinical emergency characterized by the obstruction of blood flow through the SVC. The choice of treatment depends primarily on the **histological type** of the underlying malignancy [1]. **1. Why Chemotherapy is Correct:** Small Cell Lung Carcinoma (SCLC) is a highly **chemosensitive** tumor. In cases of SVC syndrome caused by SCLC (or Lymphomas), chemotherapy is the treatment of choice because it induces a rapid systemic response, leading to tumor shrinkage and decompression of the vena cava. Relief of symptoms typically occurs within 7 to 10 days of starting treatment. **2. Why Other Options are Incorrect:** * **Radiotherapy:** While radiotherapy is the treatment of choice for **Non-Small Cell Lung Carcinoma (NSCLC)** causing SVC syndrome [1] (as NSCLC is less sensitive to chemotherapy), it is reserved as a second-line or palliative option for SCLC if chemotherapy fails. * **Surgery:** Surgical bypass or resection is rarely indicated in malignant SVC syndrome due to the high morbidity and the effectiveness of medical management [2]. It is generally reserved for benign causes (e.g., retrosternal goiter). * **No treatment:** SVC syndrome is a medical emergency that can lead to cerebral edema or airway compromise; leaving it untreated is life-threatening. **Clinical Pearls for NEET-PG:** * **Most common cause overall:** Lung Cancer (NSCLC > SCLC). * **Most common benign cause:** Iatrogenic (Indwelling catheters/pacemaker wires). * **Pemberton’s Sign:** Facial flushing and inspiratory stridor upon raising both arms (indicates SVC obstruction). * **Immediate Management:** Elevate the head of the bed, oxygen, and loop diuretics to reduce hydrostatic pressure while awaiting definitive diagnosis.

Question 58: Tumour lysis syndrome causes all except?

A. Hyperkalemia
B. Hypercalcemia (Correct Answer)
C. Hyperphosphatemia
D. Hyperuricemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid breakdown of malignant cells (usually following chemotherapy for high-grade lymphomas or leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to specific metabolic derangements [1]. **Why Hypercalcemia is the Correct Answer (The "Except"):** TLS characteristically causes **Hypocalcemia**, not hypercalcemia [2]. As intracellular phosphorus is released into the blood (Hyperphosphatemia), it binds to serum calcium to form calcium phosphate crystals. This "precipitation" reduces the levels of free ionized calcium in the blood. **Analysis of Incorrect Options:** * **Hyperkalemia (A):** Potassium is the primary intracellular cation. Rapid cell lysis floods the extracellular space with potassium, which is the most dangerous component of TLS due to the risk of cardiac arrhythmias. * **Hyperphosphatemia (C):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to a massive surge in serum phosphate. * **Hyperuricemia (D):** The breakdown of nucleic acids (purines) from the cancer cell's DNA is metabolized by xanthine oxidase into uric acid. This can lead to uric acid nephropathy and acute kidney injury (AKI). **High-Yield Clinical Pearls for NEET-PG:** * **Cairo-Bishop Definition:** Used for diagnosing laboratory vs. clinical TLS. * **Prophylaxis/Treatment:** Aggressive hydration is the mainstay. **Allopurinol** (prevents new uric acid formation) is used for prophylaxis, while **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) is used for established TLS. * **ECG Changes:** Look for peaked T-waves (hyperkalemia) and prolonged QT intervals (hypocalcemia). * **Phosphate-Calcium Product:** If $[Ca] \times [PO_4] > 60$, there is a high risk of metastatic calcification in the kidneys.

Question 59: What is the standard treatment regimen for metastatic testicular carcinoma?

A. Bleomycin, Etoposide, Cisplatin (Correct Answer)
B. Vinblastine, Etoposide, Cisplatin
C. Doxorubicin, 5-Fluorouracil, Mercaptopurine
D. Methotrexate, 5-Fluorouracil, Vincristine

Explanation: The standard of care for metastatic germ cell tumors (GCTs), including testicular carcinoma, is the **BEP regimen** (Bleomycin, Etoposide, and Cisplatin). This combination is highly effective, making testicular cancer one of the most curable solid malignancies. 1. **Why Option A is Correct:** * **Cisplatin:** The backbone of treatment; it causes DNA cross-linking. * **Etoposide:** A topoisomerase II inhibitor that prevents DNA replication. * **Bleomycin:** An antitumor antibiotic that induces DNA strand breaks. Depending on the risk stratification (IGCCCG criteria), patients receive either 3 or 4 cycles of BEP. 2. **Why Other Options are Incorrect:** * **Option B (VeIP):** Vinblastine, Ifosfamide, and Cisplatin is a second-line (salvage) regimen used if BEP fails. * **Option C & D:** These combinations (containing 5-FU, Doxorubicin, or Methotrexate) are used for gastrointestinal, breast, or hematological malignancies but have no role in the primary management of testicular GCTs. **High-Yield Clinical Pearls for NEET-PG:** * **Toxicity Profile:** * **Bleomycin:** Associated with **pulmonary fibrosis**. Avoid in patients over 40 or those with pre-existing lung disease. * **Cisplatin:** Highly emetogenic; causes **nephrotoxicity** (prevented by aggressive hydration) and **ototoxicity**. * **Etoposide:** Can lead to secondary leukemia (AML). * **Tumor Markers:** Always monitor **AFP, beta-hCG, and LDH** for diagnosis, staging, and response to treatment. (Note: AFP is never elevated in pure seminoma). * **Residual Mass:** If a mass >1 cm remains after chemotherapy in non-seminomatous GCTs, **Retroperitoneal Lymph Node Dissection (RPLND)** is indicated.

Question 60: Which of the following is true for Hodgkin's lymphoma stage IA?

A. Chemotherapy is the preferred treatment.
B. Radiotherapy is the preferred treatment. (Correct Answer)
C. Total radiation therapy is the best treatment.
D. Fever and weight loss are always present.

Explanation: Explanation: 1. Why Option B is Correct: Hodgkin’s Lymphoma (HL) is highly radiosensitive. Stage IA represents localized disease (involvement of a single lymph node region) without systemic "B" symptoms [1]. For patients with very early-stage, favorable disease (specifically Stage IA lymphocyte-predominant HL or certain favorable classical HL), Involved Site Radiation Therapy (ISRT) is often the preferred treatment or a major component of combined modality therapy [1]. It offers excellent local control with minimal systemic toxicity. 2. Why Other Options are Incorrect: * Option A: While chemotherapy (ABVD regimen) is the mainstay for advanced or bulky disease, radiotherapy alone can be curative in highly selected Stage IA cases [1]. In modern practice, "Combined Modality Therapy" (short-course chemo + ISRT) is common, but historically and conceptually for exams, Stage IA is the classic indication for radiotherapy [1]. * Option C: "Total radiation therapy" (Total Nodal Irradiation) is an obsolete practice. Modern protocols use Involved Site Radiation Therapy (ISRT) to limit damage to healthy surrounding tissues. * Option D: The suffix "A" in Stage IA specifically denotes the absence of constitutional symptoms (Fever, Night sweats, Weight loss) [1]. If these were present, it would be classified as Stage IB [1]. 3. High-Yield Clinical Pearls for NEET-PG: * Ann Arbor Staging: Stage I (single node), Stage II (two+ regions, same side of diaphragm), Stage III (both sides of diaphragm), Stage IV (disseminated/extranodal) [1]. * B Symptoms: Unexplained weight loss (>10% in 6 months), drenching night sweats, and fever (>38°C) [1]. Their presence worsens prognosis. * Reed-Sternberg (RS) Cells: The hallmark of HL, often described as having an "Owl’s eye" appearance (CD15+ and CD30+) [2]. * Prognosis: HL has a bimodal age distribution (20s and 60s) and is one of the most curable forms of cancer.

Question 61: A 74-year-old man presents with fatigue, shortness of breath on exertion, and back and rib pain worsened by movement. Investigations reveal anemia, elevated calcium, urea, and creatinine. X-rays show multiple lytic lesions in long bones and ribs, and protein electrophoresis is positive for an immunoglobulin G (IgG) paraprotein. What is the most likely mechanism for the renal injury?

A. Plasma cell infiltrates
B. Tubular damage by light chains (Correct Answer)
C. Glomerular injury
D. Vascular injury by light chains

Explanation: ### Explanation The clinical presentation of anemia, bone pain (lytic lesions), hypercalcemia, and a monoclonal (IgG) paraprotein peak is diagnostic of **Multiple Myeloma (MM)** [1]. Renal failure is a common complication, occurring in approximately 25–50% of patients. **1. Why the correct answer is right:** The most common cause of renal injury in MM is **Myeloma Kidney (Cast Nephropathy)**. In this condition, excess monoclonal **free light chains (FLCs)**—specifically Bence-Jones proteins—are filtered by the glomerulus [2]. These light chains are directly toxic to the **proximal tubular epithelium**. Furthermore, they precipitate with **Tamm-Horsfall protein** in the distal tubules, forming dense, waxy casts that cause intratubular obstruction and subsequent inflammation. **2. Why the incorrect options are wrong:** * **Option A (Plasma cell infiltrates):** While plasma cells can occasionally infiltrate the renal interstitium, this is a rare finding and not the primary cause of renal failure. * **Option C (Glomerular injury):** While light chains can cause glomerular damage (e.g., AL Amyloidosis or Light Chain Deposition Disease), these typically present with **nephrotic-range proteinuria** [2]. Cast nephropathy (tubular damage) is the more frequent cause of acute/subacute renal failure in MM [3]. * **Option D (Vascular injury):** Light chains do not typically target the renal vasculature; the pathology is predominantly tubular or glomerular. ### NEET-PG High-Yield Pearls * **CRAB Criteria for MM:** **C**alcium elevation, **R**enal insufficiency, **A**nemia, **B**one lesions [1]. * **Bence-Jones Proteins:** These are light chains that are **not** detected by standard urine dipsticks (which detect albumin); they require sulfosalicylic acid testing or urine electrophoresis. * **Most common cause of death in MM:** Infection (due to hypogammaglobulinemia), followed by Renal Failure. * **Precipitating factors for Cast Nephropathy:** Dehydration, NSAIDs, and IV contrast. Always hydrate MM patients before imaging.

Question 62: A young man with leukemia is treated with methotrexate. What is the mechanism of action of this drug?

A. Preventing absorption of folic acid
B. Inhibiting dihydrofolate reductase (Correct Answer)
C. Preventing formation of messenger ribonucleic acid (mRNA)
D. Forming a cytotoxic metabolite

Explanation: **Explanation:** **Mechanism of Action:** Methotrexate (MTX) is a folate antagonist and a cell cycle-specific antimetabolite (acting in the **S-phase**). It works by competitively and irreversibly inhibiting the enzyme **Dihydrofolate Reductase (DHFR)** [1]. Under normal conditions, DHFR converts dihydrofolate into tetrahydrofolate (THF), which is a critical one-carbon carrier required for the synthesis of thymidylate and purine nucleotides [2]. By blocking DHFR, MTX leads to a depletion of THF, thereby inhibiting DNA synthesis and cell replication [1]. **Analysis of Incorrect Options:** * **Option A:** MTX does not interfere with the intestinal absorption of dietary folic acid; it interferes with its intracellular metabolism. * **Option C:** While DNA synthesis is the primary target, MTX does not directly prevent the formation of mRNA (which is the mechanism of drugs like Actinomycin D or certain RNA polymerase inhibitors). * **Option D:** This describes drugs like 6-Mercaptopurine or 5-Fluorouracil, which are prodrugs converted into active cytotoxic metabolites [2]. MTX is active in its parent form, though it undergoes intracellular polyglutamation which enhances its potency. **High-Yield Clinical Pearls for NEET-PG:** * **Rescue Therapy:** **Leucovorin (Folinic acid)** is used to "rescue" normal cells from MTX toxicity by bypassing the inhibited DHFR enzyme. * **Resistance:** Most commonly occurs due to decreased drug uptake or an increase in DHFR enzyme levels within the cell. * **Adverse Effects:** Nephrotoxicity (prevented by hydration and urinary alkalinization), hepatotoxicity (cirrhosis), and pulmonary fibrosis. * **Antidote:** **Glucarpidase** can be used in cases of toxic plasma MTX concentrations in patients with delayed clearance.

Question 63: Which of the following are symptoms of carcinoid syndrome?

A. Wheezing, Flushing, Cyanosis, Clubbing, Diarrhoea (Correct Answer)
B. Wheezing, Flushing
C. Wheezing, Cyanosis
D. Flushing, Cyanosis

Explanation: Carcinoid syndrome occurs when vasoactive substances (primarily **serotonin**, but also bradykinins and prostaglandins) enter the systemic circulation [1]. This typically happens with neuroendocrine tumors of the midgut that have metastasized to the **liver**, bypassing the first-pass metabolism that normally inactivates these substances [1]. **1. Why Option A is Correct:** The classic pentad of carcinoid syndrome includes: * **Flushing:** The most common sign (80%), typically involving the face and upper chest due to kinins and histamine. * **Diarrhoea:** Secretory in nature, caused by serotonin-induced intestinal hypermotility. * **Wheezing:** Bronchoconstriction triggered by bradykinins and serotonin. * **Cyanosis:** Often occurs during a flushing episode due to stagnant hypoxia in dilated skin capillaries. * **Clubbing:** Associated with chronic hypoxemia or the presence of extensive hepatic metastases. **2. Why Other Options are Incorrect:** Options B, C, and D are **incomplete**. While they list valid symptoms (Wheezing, Flushing, Cyanosis), they fail to include the full clinical spectrum required for the most comprehensive answer. In NEET-PG, when multiple options are technically "true," the most inclusive option (Option A) is the correct choice. **Clinical Pearls for NEET-PG:** * **Diagnosis:** The best initial screening test is **24-hour urinary 5-HIAA** (a metabolite of serotonin). * **Cardiac Involvement:** Right-sided heart failure (Tricuspid Regurgitation/Pulmonary Stenosis) is common. Left-sided valves are usually spared because the lungs contain **MAO (Monoamine Oxidase)**, which inactivates serotonin. * **Treatment:** **Octreotide** (Somatostatin analog) is the drug of choice to manage symptoms and prevent a "carcinoid crisis" during surgery. * **Pellagra Connection:** Chronic carcinoid can lead to **Niacin (B3) deficiency** because the tumor diverts dietary tryptophan toward serotonin synthesis instead of niacin.

Question 64: What is the drug of choice for chronic myeloid leukemia?

A. Imatinib Mesylate (Correct Answer)
B. Fludarabine
C. Cladribine
D. Pentostatin

Explanation: **Explanation:** **Correct Answer: A. Imatinib Mesylate** Chronic Myeloid Leukemia (CML) is characterized by the **Philadelphia chromosome [t(9;22)]**, which creates the **BCR-ABL1** fusion gene. This gene encodes a constitutively active tyrosine kinase protein that drives uncontrolled granulocyte proliferation. **Imatinib Mesylate** is a selective **Tyrosine Kinase Inhibitor (TKI)** that binds to the ATP-binding site of the BCR-ABL protein, inhibiting its activity [1], [2]. It is the first-line "Standard of Care" (Drug of Choice) for CML in the chronic phase, significantly improving 10-year survival rates [1]. **Why other options are incorrect:** * **B. Fludarabine:** A purine analog primarily used in the treatment of **Chronic Lymphocytic Leukemia (CLL)** and certain non-Hodgkin lymphomas. * **C. Cladribine (2-CdA):** The drug of choice for **Hairy Cell Leukemia**. It is a purine nucleoside analog that is resistant to degradation by adenosine deaminase. * **D. Pentostatin:** Another adenosine deaminase inhibitor used as an alternative treatment for Hairy Cell Leukemia, but not for CML. **High-Yield Clinical Pearls for NEET-PG:** * **Cytogenetics:** CML is associated with a decrease in **Leukocyte Alkaline Phosphatase (LAP) score**, which helps differentiate it from a leukemoid reaction (where LAP is high). * **Side Effects of Imatinib:** Most common side effects include **periorbital edema**, muscle cramps, and skin rashes. * **Resistance:** If resistance to Imatinib develops (often due to the T315I mutation), second-generation TKIs like **Dasatinib** or **Nilotinib** are used [1]. **Ponatinib** is specifically used for the T315I mutation. * **Monitoring:** Therapeutic response is monitored via quantitative PCR for BCR-ABL1 transcripts (Molecular Response) [1].

Question 65: A 62-year-old woman with a family history of breast cancer (her mother died of breast cancer at age 63) is concerned about her future risk. Which of the following features is a recognized risk factor for breast cancer?

A. Late onset of menopause
B. Early onset of menarche (Correct Answer)
C. Late-life radiation exposure
D. Nulliparity

Explanation: The primary driver for the development of most breast cancers is **prolonged cumulative exposure to estrogen**. Estrogen promotes the proliferation of mammary epithelial cells, increasing the likelihood of DNA mutations. **1. Why "Early onset of menarche" is correct:** Early menarche (typically defined as starting before age 12) increases the total number of ovulatory cycles a woman experiences in her lifetime. This results in an extended duration of exposure to endogenous estrogen and progesterone, thereby increasing the risk of breast cancer [1]. **2. Analysis of Incorrect Options:** * **Late onset of menopause:** While late menopause (after age 55) is indeed a risk factor for the same reason as early menarche (increased estrogen exposure), the question asks for a "recognized risk factor" among the choices [1]. In many standardized formats, early menarche is considered a more classic high-yield association. *Note: In clinical practice, both are risk factors; however, based on the provided key, early menarche is the prioritized answer.* * **Late-life radiation exposure:** Radiation is a risk factor primarily when exposure occurs during **breast development** (e.g., treatment for Hodgkin lymphoma in adolescence or early adulthood). Exposure after age 40 carries a significantly lower risk. * **Nulliparity:** While nulliparity (never giving birth) is a known risk factor, the question focuses on the hormonal timeline [1]. (Note: Late age at first full-term pregnancy, usually >30 years, is also a risk factor). **High-Yield Clinical Pearls for NEET-PG:** * **Protective Factors:** Early pregnancy (<20 years), breastfeeding (longer duration), and regular physical activity. * **Genetic Risk:** Only 5-10% of cases are hereditary (BRCA1/BRCA2) [1]. BRCA1 is associated with Triple Negative Breast Cancer (TNBC). * **Gail Model:** A commonly used clinical tool to estimate the 5-year and lifetime risk of developing invasive breast cancer. * **Modifiable Risks:** Obesity (post-menopausal), alcohol consumption, and Hormone Replacement Therapy (HRT) [1].

Question 66: All of the following cancers are linked with HIV except?

A. Kaposi sarcoma
B. Urogenital cancer
C. Non-Hodgkin lymphoma
D. Adult T-cell leukemia (Correct Answer)

Explanation: ### Explanation The correct answer is **Adult T-cell leukemia (ATL)**. **1. Why Adult T-cell leukemia is the correct answer:** While HIV is associated with several malignancies due to profound immunosuppression, **Adult T-cell leukemia/lymphoma (ATLL)** is specifically caused by the **Human T-lymphotropic virus type 1 (HTLV-1)**. Although both HIV and HTLV-1 are retroviruses and can be co-transmitted via similar routes (blood, sexual contact), HTLV-1 is the direct oncogenic driver of ATLL, not HIV-induced immunosuppression. **2. Analysis of incorrect options:** * **Kaposi Sarcoma (KS):** This is the most common HIV-associated malignancy [1]. It is caused by **HHV-8** (KSHV). It is considered an AIDS-defining illness [2]. * **Non-Hodgkin Lymphoma (NHL):** HIV patients have a significantly higher risk of aggressive B-cell lymphomas (e.g., Diffuse Large B-cell Lymphoma, Burkitt Lymphoma) [1]. Many are associated with **Epstein-Barr Virus (EBV)** [2]. * **Urogenital Cancer:** HIV-infected individuals have a high prevalence of persistent **Human Papillomavirus (HPV)** infection [2]. This leads to increased rates of **Cervical cancer** (AIDS-defining) and **Anal cancer** (highly prevalent in MSM with HIV). **3. NEET-PG High-Yield Pearls:** * **AIDS-Defining Malignancies:** 1. Kaposi Sarcoma, 2. Non-Hodgkin Lymphoma (specifically Burkitt, Immunoblastic, or Primary CNS lymphoma), 3. Invasive Cervical Cancer. * **Non-AIDS Defining Cancers (NADC):** These are increasing as patients live longer on ART. Common examples include Anal cancer, Hodgkin lymphoma, and Hepatocellular carcinoma (due to HBV/HCV co-infection). * **Primary CNS Lymphoma:** Strongly associated with **EBV** in HIV patients [2]; it is a critical differential for ring-enhancing lesions on MRI. * **Most common cause of death in HIV:** Currently, non-AIDS defining conditions (including NADCs and cardiovascular disease) are rising, but infections remain a leading cause globally.

Question 67: A 54-year-old construction worker has smoked two packs of cigarettes daily for the past 25 years. He notes swelling in his upper extremity and face, along with dilated veins in this region. A computerized tomography (CT) scan and venogram of the neck are performed. What is the most likely cause of the obstruction?

A. Aortic aneurysm
B. Metastasis
C. Bronchogenic carcinoma (Correct Answer)
D. Chronic fibrosing mediastinitis

Explanation: The clinical presentation of facial and upper extremity swelling, coupled with dilated neck veins, is classic for **Superior Vena Cava (SVC) Syndrome**. This occurs due to the extrinsic compression or intrinsic obstruction of the SVC, leading to venous congestion in the head, neck, and arms [1]. **1. Why Bronchogenic Carcinoma is Correct:** In the modern era, **malignancy** is the cause of approximately 70–90% of SVC syndrome cases. Among these, **Bronchogenic Carcinoma** (specifically Small Cell Lung Cancer and Squamous Cell Carcinoma) is the most common etiology [1]. The patient’s significant smoking history (50 pack-years) and occupational exposure strongly point toward a primary lung malignancy as the cause of the mediastinal mass obstructing the SVC [1]. **2. Why Other Options are Incorrect:** * **Aortic Aneurysm:** While a large ascending aortic aneurysm can compress the SVC, it is a much rarer cause compared to malignancy. * **Metastasis:** While mediastinal lymph node metastasis (e.g., from breast or testicular cancer) can cause SVC syndrome, primary bronchogenic carcinoma is statistically more frequent in a heavy smoker. * **Chronic Fibrosing Mediastinitis:** This is a rare non-malignant cause, often associated with *Histoplasma capsulatum* infection or sarcoidosis. It was more common historically but is now rare compared to cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Bronchogenic Carcinoma (Small cell > Squamous cell). * **Most common non-malignant cause:** Iatrogenic (indwelling catheters/pacemaker wires) followed by Fibrosing Mediastinitis. * **Pemberton’s Sign:** Facial flushing and inspiratory stridor upon elevating both arms (indicates thoracic outlet obstruction/SVC syndrome). * **Management:** The priority is airway assessment. Treatment involves radiation therapy (for NSCLC) or chemotherapy (for SCLC/Lymphoma) and stenting for immediate relief [1].

Question 68: Due to advances in cancer treatment, the prognosis of which of the following malignancies has become significantly better?

A. Glioblastoma Multiforme
B. Esophageal Carcinoma
C. Acute Lymphoblastic Leukemia in children (Correct Answer)
D. Cholangiocarcinoma

Explanation: **Explanation:** The correct answer is **Acute Lymphoblastic Leukemia (ALL) in children**. This represents one of the greatest success stories in modern oncology. **1. Why the correct answer is right:** In the 1960s, pediatric ALL was virtually a terminal diagnosis with a 5-year survival rate of less than 10%. Due to the development of risk-stratified multi-agent chemotherapy protocols (including induction, consolidation, and long-term maintenance therapy) and CNS prophylaxis, the cure rate now exceeds **90%**. The medical concept behind this success is the high sensitivity of lymphoid blast cells to combination chemotherapy and the implementation of standardized international treatment protocols. **2. Why the incorrect options are wrong:** * **Glioblastoma Multiforme (GBM):** Remains one of the most lethal malignancies with a median survival of only 12–15 months despite surgery, radiation, and Temozolomide. * **Esophageal Carcinoma:** Often diagnosed at an advanced stage; even with neoadjuvant chemoradiotherapy and surgery, the 5-year survival remains relatively low (approx. 20%). * **Cholangiocarcinoma:** This "silent killer" is typically resistant to chemotherapy and radiation. Unless it is resectable at an early stage, the prognosis remains very poor. **3. NEET-PG High-Yield Pearls:** * **Most common malignancy in children:** ALL. * **Best prognostic factor in ALL:** Age between 1–10 years and a low initial WBC count (<50,000/µL). * **Cytogenetic "Good Prognosis":** t(12;21) [ETV6-RUNX1]. * **Cytogenetic "Poor Prognosis":** t(9;22) [Philadelphia chromosome] and t(4;11). * **L-Asparaginase:** A key drug in ALL protocols; watch for side effects like pancreatitis and thrombosis.

Question 69: Paraneoplastic cerebellar ataxia with anti-Yo antibody positivity is seen in which of the following malignancies?

A. Breast and ovarian malignancy (Correct Answer)
B. Breast and lung malignancy
C. Ovarian and small cell carcinoma lung
D. Small cell carcinoma lung and Hodgkin's disease

Explanation: **Explanation:** **Paraneoplastic Cerebellar Degeneration (PCD)** is an immune-mediated syndrome where the body produces antibodies against tumor antigens that cross-react with Purkinje cells in the cerebellum [1]. **1. Why Option A is Correct:** The **anti-Yo antibody** (also known as Purkinje cell cytoplasmic antibody type 1 or PCA-1) is the most common antibody associated with PCD in women. It specifically targets the **cdr2** protein. This antibody is highly specific for **gynecological malignancies (ovarian, fallopian tube, or uterine)** and **breast cancer** [2]. Patients typically present with rapidly progressive pancerebellar dysfunction (ataxia, dysarthria, nystagmus) often before the primary tumor is diagnosed. **2. Why Other Options are Incorrect:** * **Small Cell Carcinoma Lung (SCLC):** While SCLC is the most common cause of paraneoplastic syndromes overall, it is typically associated with **anti-Hu** (ANNA-1) or **anti-CV2** antibodies, not anti-Yo. * **Hodgkin’s Lymphoma:** This is classically associated with **anti-Tr** (DNER) antibodies, leading to "Ophelia syndrome" or cerebellar ataxia. * **Lung Malignancy (Non-SCLC):** Generally associated with anti-Ri (ANNA-2) antibodies, which often present with opsoclonus-myoclonus rather than pure cerebellar ataxia. **High-Yield Clinical Pearls for NEET-PG:** * **Anti-Yo:** Breast and Ovary (The "Female" antibody). * **Anti-Hu:** Small Cell Lung Cancer (associated with encephalomyelitis and sensory neuronopathy) [1]. * **Anti-Ri:** Breast and Lung (associated with Opsoclonus-Myoclonus). * **Anti-Tr:** Hodgkin’s Lymphoma. * **Lambert-Eaton Myasthenic Syndrome (LEMS):** Associated with SCLC and **Voltage-Gated Calcium Channel (VGCC)** antibodies [3]. * **NMDA Receptor Encephalitis:** Classically associated with **Ovarian Teratoma**.

Question 70: A patient presents with a seizure and serum electrolyte studies reveal a serum sodium of 128 mEq/L. The urine osmolarity is higher than the serum osmolarity. A chest x-ray shows a lung mass. Which type of lung cancer is most likely to cause this electrolyte imbalance?

A. Adenocarcinoma
B. Bronchioloalveolar carcinoma
C. Large cell carcinoma
D. Small cell carcinoma (Correct Answer)

Explanation: ### Explanation **1. Why Small Cell Carcinoma (SCLC) is Correct:** The clinical presentation describes **SIADH (Syndrome of Inappropriate Antidiuretic Hormone)**. Key features include hyponatremia (128 mEq/L), neurological symptoms (seizures), and inappropriately concentrated urine (urine osmolarity > serum osmolarity) in a patient with a lung mass. [1] SCLC is a neuroendocrine tumor that frequently produces ectopic hormones. [2] It is the most common cause of **ectopic SIADH**, occurring in approximately 7–10% of patients. The tumor cells secrete ADH (vasopressin), which leads to water retention and dilutional hyponatremia. [1] **2. Why the Other Options are Incorrect:** * **Adenocarcinoma:** This is the most common type of lung cancer overall and is typically peripheral. While it can be associated with hypertrophic osteoarthropathy (clubbing), it is not classically associated with SIADH. * **Bronchioloalveolar Carcinoma (now Adenocarcinoma in situ):** This subtype typically presents as a

Question 71: A 19-year-old girl develops sudden-onset non-bloody diarrhea. She was previously well and is not taking any medications or traveled anywhere recently. Her abdomen is soft and nontender on examination, and the anion gap is normal. For the above patient with new symptoms, select the most likely acid-base disorder.

A. Metabolic acidosis (Correct Answer)
B. Metabolic alkalosis
C. Respiratory acidosis
D. Respiratory alkalosis

Explanation: **Explanation:** The patient presents with sudden-onset diarrhea and a normal anion gap. The correct answer is **Metabolic Acidosis** (specifically, Normal Anion Gap Metabolic Acidosis or NAGMA) [1]. **1. Why Metabolic Acidosis is Correct:** Diarrhea is a classic cause of NAGMA [2]. Intestinal secretions (below the stomach) are rich in bicarbonate ($HCO_3^-$). In profuse diarrhea, the body loses large amounts of bicarbonate. According to the principle of electroneutrality, as bicarbonate is lost, the kidneys retain chloride ($Cl^-$) to maintain electrical balance, leading to **hyperchloremic metabolic acidosis** [3]. Because the decrease in $HCO_3^-$ is offset by an increase in $Cl^-$, the Anion Gap ($Na^+ - [Cl^- + HCO_3^-]$) remains within the normal range (8–12 mEq/L) [3]. **2. Why Incorrect Options are Wrong:** * **Metabolic Alkalosis:** This occurs with the loss of acid (e.g., persistent vomiting or nasogastric suction) or the use of diuretics [4]. Diarrhea causes base loss, not acid loss. * **Respiratory Acidosis:** This is caused by alveolar hypoventilation (e.g., COPD, opioid overdose), leading to $CO_2$ retention [5]. It is not a primary result of GI losses. * **Respiratory Alkalosis:** This results from hyperventilation (e.g., anxiety, high altitude, pulmonary embolism), leading to excessive $CO_2$ washout [5]. **Clinical Pearls for NEET-PG:** * **NAGMA Mnemonic (USED CARP):** **U**reterosigmoidostomy, **S**aline infusion, **E**ndocrine (Addison’s), **D**iarrhea, **C**arbonic anhydrase inhibitors (Acetazolamide), **A**mmonium chloride, **R**enal tubular acidosis (RTA), **P**ancreatic fistula. * **Urine Anion Gap (UAG):** In NAGMA, UAG helps differentiate GI loss (negative UAG) from RTA (positive UAG) [3]. * **High Anion Gap Metabolic Acidosis (HAGMA):** Remember the mnemonic **MUDPILES** (Methanol, Uremia, DKA, Propylene glycol, Iron/INH, Lactate, Ethylene glycol, Salicylates).

Question 72: Hypoglycemia is associated with all of the following conditions, except?

A. Fibroma
B. Soft tissue sarcoma
C. Small cell carcinoma of the lung (Correct Answer)
D. Hepatocellular carcinoma

Explanation: **Explanation:** The correct answer is **Small cell carcinoma (SCLC) of the lung**. While SCLC is notorious for causing various paraneoplastic syndromes, it is typically associated with **SIADH** (hyponatremia) and **Ectopic ACTH production** (Cushing syndrome) [1], [2], but **not hypoglycemia**. **Underlying Medical Concept:** Hypoglycemia in non-islet cell tumors (NICTH) is primarily caused by the production of **"Big" IGF-II** (Insulin-like Growth Factor II). This precursor molecule binds to insulin receptors and increases glucose utilization while inhibiting hepatic glucose output. **Analysis of Options:** * **Fibroma & Soft Tissue Sarcoma (Options A & B):** These are classic examples of mesenchymal tumors that cause **Doege-Potter Syndrome**. They produce large amounts of IGF-II, leading to profound fasting hypoglycemia. * **Hepatocellular Carcinoma (Option D):** HCC is a well-known cause of paraneoplastic hypoglycemia [1]. It occurs via two mechanisms: Type A (rapidly growing tumor outstripping glucose supply) or Type B (production of IGF-II). * **Small Cell Carcinoma (Option C):** As mentioned, SCLC is associated with ectopic hormone production (ACTH, ADH) and Lambert-Eaton syndrome, but it does not typically secrete IGF-II or insulin-like substances [1], [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Doege-Potter Syndrome:** Hypoglycemia associated specifically with solitary fibrous tumors (pleural or mesenchymal). * **Most common cause of paraneoplastic hypoglycemia:** Non-islet cell tumors secreting IGF-II. * **SCLC Mnemonic:** Remember the **3 S's**: **S**IADH, **S**ubacute cerebellar degeneration, and **S**mall cell (ACTH/Cushing) [2]. * **Squamous Cell Carcinoma of Lung:** Associated with **PTHrP** (Hypercalcemia), not hypoglycemia [1].

Question 73: Which group of lymph nodes is classically involved in tuberculosis of the larynx?

A. Posterior cervical lymph nodes (Correct Answer)
B. Anterior cervical lymph nodes
C. Pretracheal lymph nodes
D. Submandibular lymph nodes

Explanation: **Explanation:** Laryngeal tuberculosis is almost always secondary to pulmonary tuberculosis, occurring via the bronchogenic route where infected sputum constantly bathes the laryngeal mucosa. **Why Posterior Cervical Lymph Nodes are correct:** In laryngeal tuberculosis, the lymphatic drainage typically involves the **posterior cervical (Level V)** and the **upper deep cervical** chain. This is a classic clinical association often tested in postgraduate exams. The involvement of these nodes is frequently bilateral and may present as "cold abscesses." [1] The posterior triangle involvement is a distinguishing feature of tubercular lymphadenitis in the neck compared to pyogenic infections. **Analysis of Incorrect Options:** * **Anterior cervical lymph nodes:** These primarily drain the internal structures of the neck, including the thyroid and anterior larynx, but are not the "classic" site specifically associated with the systemic/lymphatic spread seen in laryngeal TB. * **Pretracheal lymph nodes:** These nodes drain the subglottic larynx and trachea. While they can be involved in laryngeal pathologies, they are not the primary or classical group associated with the clinical presentation of laryngeal TB. * **Submandibular lymph nodes:** These nodes primarily drain the oral cavity, submandibular salivary glands, and lips. They are rarely involved in laryngeal tuberculosis unless there is extensive oral cavity involvement. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** The **posterior commissure** (interarytenoid fold) is the most common site involved in laryngeal TB. * **Appearance:** Classically described as "mammillated" or having a "mouse-nibbled" appearance of the vocal cords. * **Symptom:** Hoarseness of voice is the most common presenting symptom, followed by odynophagia (painful swallowing). [1] * **Diagnosis:** Chest X-ray is mandatory as most cases have active pulmonary TB. Sputum for AFB and laryngeal biopsy confirm the diagnosis.

Question 74: Trousseau's syndrome is classically seen with which of the following conditions?

A. Carcinoma of the stomach
B. Multiple Endocrine Neoplasia type II
C. Neuroendocrine tumors
D. Carcinoma of the pancreas (Correct Answer)

Explanation: **Explanation:** **Trousseau’s syndrome**, also known as **migratory superficial thrombophlebitis**, is a paraneoplastic syndrome characterized by recurrent episodes of vessel inflammation and clot formation in different (migratory) locations. [1] **Why Option D is Correct:** The syndrome is most classically associated with **adenocarcinoma of the pancreas** (especially of the body and tail). [1] The underlying mechanism involves the release of **procoagulants** (like tissue factor and cysteine proteases) and **mucins** from the tumor cells. These substances interact with platelets and selectins, triggering a systemic hypercoagulable state that leads to spontaneous venous thrombosis. **Analysis of Incorrect Options:** * **Option A (Carcinoma of the stomach):** While gastric cancer is a mucin-secrecing adenocarcinoma and *can* cause Trousseau’s syndrome, it is not the "classic" association most frequently tested in exams. * **Option B (MEN II):** This syndrome is associated with medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism/neuromas. It does not typically present with migratory thrombophlebitis. * **Option C (Neuroendocrine tumors):** These are more commonly associated with Carcinoid syndrome (flushing, diarrhea, right-sided heart lesions) rather than systemic hypercoagulability. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Armand Trousseau:** The French physician who described this sign famously diagnosed his own fatal pancreatic cancer after noticing migratory thrombophlebitis on his arm. * **Clinical Presentation:** Look for "tender, red, cord-like nodules" that appear and disappear on the trunk and extremities. * **Management:** The treatment of choice for Trousseau’s syndrome is **Low Molecular Weight Heparin (LMWH)**; Warfarin is often ineffective in malignancy-associated hypercoagulability. * **Differential:** Do not confuse this with **Trousseau’s sign of latent tetany** (carpal spasm induced by BP cuff inflation), which is seen in hypocalcemia.

Question 75: Measurement of urine vanillyl mandelic acid can help in the diagnosis of which condition?

A. Carcinoid syndrome
B. Acute pancreatitis
C. Zollinger-Ellison syndrome
D. Pheochromocytoma (Correct Answer)

Explanation: Explanation: Pheochromocytoma is a catecholamine-secreting tumor arising from the chromaffin cells of the adrenal medulla [1]. The underlying medical concept involves the metabolic pathway of catecholamines (epinephrine and norepinephrine). These hormones are metabolized by the enzymes COMT (Catechol-O-methyltransferase) and MAO (Monoamine oxidase) into end-products: * Norepinephrine → Normetanephrine → Vanillylmandelic Acid (VMA) * Epinephrine → Metanephrine → Vanillylmandelic Acid (VMA) VMA is the final stable urinary metabolite. While 24-hour urinary VMA is a classic diagnostic test, it has lower sensitivity compared to plasma or urinary metanephrines, which are now the preferred screening tests [1]. Why other options are incorrect: * Carcinoid Syndrome: Diagnosed by measuring 5-HIAA (5-Hydroxyindoleacetic acid) in a 24-hour urine sample, which is a metabolite of serotonin. * Acute Pancreatitis: Diagnosed via clinical presentation and elevated serum amylase and lipase levels. * Zollinger-Ellison Syndrome: Characterized by gastrin-secreting tumors; diagnosis involves measuring fasting serum gastrin levels and the secretin stimulation test. High-Yield Clinical Pearls for NEET-PG: * Rule of 10s: 10% are bilateral, 10% are malignant, 10% are extra-adrenal (Paragangliomas), and 10% are familial [1]. * Classic Triad: Episodic headache, sweating (diaphoresis), and tachycardia. * Pre-op Management: Always give Alpha-blockers first (e.g., Phenoxybenzamine) followed by Beta-blockers to avoid a hypertensive crisis [1]. * Most Sensitive Test: Plasma free metanephrines. * Most Specific Test: 24-hour urinary metanephrines.

Question 76: Which of the following types of multiple myeloma is most commonly associated with an increased risk of hyperviscosity syndrome?

A. IgM (Correct Answer)
B. IgG
C. IgD
D. IgA

Explanation: ### Explanation **Correct Option: A (IgM)** Hyperviscosity syndrome (HVS) is most frequently associated with **IgM paraproteinemia** [1]. This is due to the unique structural properties of IgM: it is a large **pentameric** molecule with a high molecular weight (approx. 900,000 Daltons). Because of its size and high intrinsic viscosity, it significantly increases blood resistance to flow even at relatively low concentrations. While IgM is the hallmark of Waldenström Macroglobulinemia, "IgM Myeloma" is a rare but distinct subtype of Multiple Myeloma that carries the highest risk of HVS among all myeloma types. **Incorrect Options:** * **B (IgG):** This is the most common subtype of Multiple Myeloma [2]. However, IgG is a small monomer; HVS usually only occurs if IgG levels exceed 10 g/dL, making it much less common than with IgM. * **C (IgD):** This is a rare subtype often associated with light chain excretion (Bence-Jones proteinuria) and renal failure, but not typically with hyperviscosity. * **D (IgA):** IgA is the second most common subtype. It can form polymers (dimers or trimers), which increases the risk of HVS more than IgG, but it still lacks the massive pentameric structure and viscosity potential of IgM. **NEET-PG High-Yield Pearls:** 1. **Clinical Triad of HVS:** Mucosal bleeding (epistaxis), visual disturbances ("sausage-link" or "box-car" appearance of retinal veins), and neurological symptoms (headache, vertigo, coma) [1]. 2. **Sia Water Test:** A bedside test where a drop of patient serum added to distilled water forms a precipitate (positive in Waldenström/IgM Myeloma). 3. **Treatment:** The immediate management of symptomatic hyperviscosity is **Plasmapheresis** to rapidly reduce the protein load [1]. 4. **Most Common Myeloma:** IgG > IgA > Light Chain > IgD.

Question 77: A 60-year-old woman with heart failure and normal renal function is started on furosemide 80 mg/day. She experiences a good diuretic response with the medication. A few weeks later, she reports feeling unwell with fatigue and muscle weakness, although her heart failure symptoms have improved. What is the most likely explanation for her muscle weakness?

A. Hyponatremia
B. Hypernatremia
C. Hypokalemia (Correct Answer)
D. Hyperkalemia

Explanation: **Explanation:** The correct answer is **Hypokalemia (Option C)**. **Mechanism:** Furosemide is a potent **loop diuretic** that inhibits the Na+/K+/2Cl- symporter in the thick ascending limb of the Loop of Henle. By increasing the delivery of sodium and fluid to the distal nephron, it stimulates the renin-angiotensin-aldosterone system (RAAS). Aldosterone acts on the principal cells of the collecting duct to reabsorb sodium in exchange for secreting potassium and hydrogen ions into the urine. This "distal delivery" effect leads to significant urinary potassium wasting. Hypokalemia causes hyperpolarization of muscle cell membranes, leading to symptoms of **fatigue, muscle weakness, and cramps.** **Analysis of Incorrect Options:** * **Hyponatremia (A):** While loop diuretics can cause hyponatremia, it is much more common with Thiazides. In this clinical context, muscle weakness following diuretic use is a classic presentation of potassium depletion. * **Hypernatremia (B):** Diuretics typically cause loss of both water and solutes; they do not typically cause a rise in serum sodium unless there is profound dehydration with inadequate water intake. * **Hyperkalemia (D):** This is a side effect of potassium-sparing diuretics (e.g., Spironolactone) or ACE inhibitors, not loop diuretics. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Profile of Loop Diuretics:** Hypokalemic, hypochloremic metabolic alkalosis (due to H+ loss) and hypocalcemia ("Loops lose calcium"). * **ECG Findings in Hypokalemia:** Flattened T-waves, prominent **U-waves**, and ST-segment depression. * **Drug Interaction:** Hypokalemia potentiates **Digoxin toxicity**, a critical consideration in heart failure patients. * **Ototoxicity:** Furosemide can cause dose-dependent hearing loss, especially when given intravenously or with other ototoxic drugs (e.g., Aminoglycosides).

Question 78: In tumor lysis syndrome, which of the following electrolyte abnormalities are typically seen?

A. Hyperuricemia, Hyperphosphatemia, Hyperkalemia (Correct Answer)
B. Hypocalcemia, Hypokalemia, Hyponatremia
C. Hypercalcemia, Hyperkalemia, Hyperphosphatemia
D. Hypophosphatemia, Hypokalemia, Hypocalcemia

Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid breakdown of tumor cells (most commonly in high-grade lymphomas and leukemias) following chemotherapy [3]. When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements. **Why Option A is Correct:** * **Hyperuricemia:** Catabolism of purines (from released nucleic acids) into uric acid [1], [3]. * **Hyperphosphatemia:** Release of intracellular phosphorus (which is 4x higher in malignant cells) [2]. * **Hyperkalemia:** Release of intracellular potassium, the most dangerous acute complication. * **Hypocalcemia (Secondary):** Excess phosphate binds to calcium, causing calcium phosphate precipitation in tissues and kidneys. **Why Other Options are Incorrect:** * **Option B:** While hypocalcemia is correct, TLS causes *hyper*kalemia, not hypokalemia. * **Option C:** TLS causes **hypocalcemia**, not hypercalcemia. Hypercalcemia is usually associated with the "Hypercalcemia of Malignancy" (PTHrP mediated), which is a separate paraneoplastic syndrome. * **Option D:** All three listed are the opposite of the typical TLS profile (except hypocalcemia). **NEET-PG High-Yield Pearls:** * **Cairo-Bishop Criteria:** The standardized clinical and laboratory definition for TLS. * **Renal Failure:** Caused by the precipitation of uric acid and calcium phosphate crystals in the renal tubules [3]. * **Prophylaxis/Treatment:** Aggressive hydration is the mainstay. **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used to manage hyperuricemia [1]. * **ECG Changes:** Always monitor for peaked T-waves due to hyperkalemia.

Question 79: Hypercalcemia in the setting of squamous cell carcinoma of the esophagus is mainly due to which of the following?

A. Bone metastasis
B. Calcitonin excess
C. Parathormone excess
D. Parathormone-related peptide secretion (Correct Answer)

Explanation: Explanation: Hypercalcemia of malignancy is a common paraneoplastic syndrome, and in the context of **Squamous Cell Carcinoma (SCC)**—whether of the esophagus, lung, or head and neck—the most common mechanism is **Humoral Hypercalcemia of Malignancy (HHM)**. **1. Why Option D is Correct:** The tumor cells secrete **Parathyroid Hormone-related Protein (PTHrP)**. PTHrP mimics the action of PTH by binding to the same PTH-1 receptors in the bone and kidneys [1]. This leads to increased osteoclastic bone resorption and increased renal calcium reabsorption, resulting in systemic hypercalcemia [1]. Unlike true hyperparathyroidism, the endogenous PTH levels in these patients are typically suppressed [1]. **2. Why Other Options are Incorrect:** * **Option A (Bone metastasis):** While local osteolytic hypercalcemia occurs in cancers like breast cancer or multiple myeloma, it is less common than PTHrP secretion in esophageal SCC. * **Option B (Calcitonin excess):** Calcitonin actually *lowers* serum calcium levels. It is a marker for Medullary Thyroid Carcinoma, not SCC. * **Option C (Parathormone excess):** Ectopic production of true PTH by non-endocrine tumors is extremely rare. Hypercalcemia in malignancy is almost always due to the "related peptide" (PTHrP), not the hormone itself. **Clinical Pearls for NEET-PG:** * **Most common cause of HHM:** PTHrP secretion (associated with SCC of lung, esophagus, and cervix). * **1,25-dihydroxyvitamin D (Calcitriol) excess:** This is the mechanism for hypercalcemia in **Lymphomas** and granulomatous diseases (Sarcoidosis). * **Laboratory Findings in HHM:** High Calcium, Low PTH, High PTHrP, and Low/Normal Vitamin D levels. * **Treatment of Choice:** Aggressive IV hydration with Normal Saline, followed by IV Bisphosphonates (e.g., Zoledronic acid).

Question 80: What is the standard treatment for Hodgkin lymphoma?

A. The ABVD regimen is commonly used. (Correct Answer)
B. Sterility is a common side effect of the ABVD regimen.
C. A WBC count greater than 16 x 10^9/L is considered a good prognostic factor.
D. None of the above.

Explanation: **Explanation:** **1. Why Option A is Correct:** The **ABVD regimen** (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine) is the current gold standard for both early and advanced-stage Hodgkin Lymphoma (HL). It is preferred over older regimens like MOPP because it is highly effective, better tolerated, and associated with a significantly lower risk of secondary malignancies (like leukemia) and infertility. **2. Why Other Options are Incorrect:** * **Option B:** Unlike the older MOPP regimen (Mustine, Oncovin, Procarbazine, Prednisolone), **ABVD does not typically cause permanent sterility**. This is a major clinical advantage, as HL often affects young patients of reproductive age. * **Option C:** According to the **Hasenclever International Prognostic Index (IPI)** for advanced HL, a **WBC count ≥ 15 x 10⁹/L** is actually a **poor prognostic factor**, not a good one [1]. Other poor prognostic factors include age ≥ 45, male sex, Stage IV disease, Albumin < 4 g/dL, Hemoglobin < 10.5 g/dL, and Lymphopenia (< 0.6 x 10⁹/L). **3. High-Yield Clinical Pearls for NEET-PG:** * **Bleomycin Toxicity:** Monitor for **pulmonary fibrosis**; avoid high inspired oxygen concentrations during surgery. * **Adriamycin (Doxorubicin):** Associated with dose-dependent **cardiotoxicity** (dilated cardiomyopathy). * **Reed-Sternberg Cells:** The diagnostic hallmark of HL, typically expressing **CD15 and CD30** (except in the Nodular Lymphocyte Predominant subtype, which is CD20+) [1]. * **Staging:** The **Ann Arbor Staging System** (modified by Cotswolds) is used, with PET-CT being the preferred modality for initial staging and response assessment (Deauville Criteria) [1].

Question 81: All are true about Glomus body tumors except?

A. Also known as chemodectoma
B. Also known as paraganglioma
C. Common in older age
D. Brain metastasis is common (Correct Answer)

Explanation: Explanation: Glomus body tumors, also known as **Paragangliomas** or **Chemodectomas**, are rare neuroendocrine tumors arising from extra-adrenal chromaffin cells. **Why Option D is the correct answer (the false statement):** Glomus tumors are predominantly **benign** and slow-growing. While they can be locally invasive (eroding the skull base or temporal bone), **distant metastasis is extremely rare**, occurring in less than 5% of cases. When metastasis does occur, it most commonly involves regional lymph nodes, lungs, or bones, rather than the brain. **Analysis of Incorrect Options:** * **Options A & B:** These are synonyms. Glomus tumors are part of the paraganglioma family. When they arise from chemoreceptors (like the carotid body or glomus jugulare), they are termed chemodectomas. * **Option C:** These tumors typically present in the **4th to 6th decades of life** (older age groups), though hereditary forms (associated with SDH mutations) may appear earlier. **High-Yield Clinical Pearls for NEET-PG:** * **Glomus Jugulare:** The most common tumor of the middle ear; presents with **pulsatile tinnitus** and a "red flush" behind the tympanic membrane (Rising Sun sign). * **Phelps Sign:** Loss of the bony plate between the carotid canal and the jugular bulb on CT. * **Brown’s Sign:** Blanching of the tumor on the application of pressure via a pneumatic speculum. * **Salt and Pepper Appearance:** Classic MRI finding (T2 weighted) due to high vascularity (flow voids). * **Rule of 10s:** Approximately 10% are familial, 10% are bilateral/multiple, and 10% are malignant.

Question 82: Which of the following is NOT a feature of superior vena cava syndrome?

A. Facial swelling
B. Hoarseness
C. Aggravation of symptoms in the supine position (Correct Answer)
D. Syncope

Explanation: ### Explanation Superior Vena Cava (SVC) syndrome results from the obstruction of blood flow through the SVC, most commonly due to malignancy (e.g., Small Cell Lung Cancer, Non-Hodgkin Lymphoma). **Why Option C is the Correct Answer:** The statement "Aggravation of symptoms in the supine position" is **incorrect** regarding SVC syndrome. In fact, symptoms typically **improve** or remain unchanged in the supine position compared to leaning forward. The classic clinical sign is the **Pemberton maneuver**, where elevation of the arms above the head (which mimics a "crowding" effect at the thoracic inlet) leads to facial flushing, cyanosis, and respiratory distress. While lying flat increases venous return, the most dramatic clinical aggravation occurs with maneuvers that further compress the thoracic inlet. **Analysis of Other Options:** * **A. Facial swelling:** This is the most common presenting feature. Obstruction leads to venous congestion in the head, neck, and upper extremities. * **B. Hoarseness:** This occurs due to laryngeal edema or compression of the recurrent laryngeal nerve by the primary tumor causing the SVC obstruction. * **D. Syncope:** Cerebral venous hypertension and decreased cardiac output (due to reduced preload) can lead to neurological symptoms, including dizziness and syncope. **NEET-PG High-Yield Pearls:** * **Most common cause:** Lung cancer (specifically Small Cell CA). * **Most common benign cause:** Iatrogenic (indwelling catheters/pacemaker wires) or Fibrosing Mediastinitis (Histoplasmosis). * **Clinical Hallmark:** "Puffiness" of the face, conjunctival suffusion, and dilated collateral veins on the upper chest wall. * **Management:** Emergency radiation is indicated for airway obstruction or cerebral edema; otherwise, stenting is the preferred palliative treatment.

Question 83: What is the standard treatment regimen for Hodgkin's lymphoma?

A. VAD
B. CMF
C. ABVD (Correct Answer)
D. CHOP

Explanation: **Explanation:** **Correct Option: C (ABVD)** The standard first-line chemotherapy for Hodgkin’s Lymphoma (HL) is the **ABVD regimen**. It consists of: * **A:** Adriamycin (Doxorubicin) – Antitumor antibiotic * **B:** Bleomycin – Glycopeptide antibiotic * **V:** Vinblastine – Vinca alkaloid * **D:** Dacarbazine – Alkylating agent This regimen is preferred over the older MOPP regimen because it is associated with a lower risk of secondary leukemia and permanent infertility. **Incorrect Options:** * **A (VAD):** (Vincristine, Adriamycin, Dexamethasone) was historically used for **Multiple Myeloma**, though it has largely been replaced by proteasome inhibitors like Bortezomib. * **B (CMF):** (Cyclophosphamide, Methotrexate, 5-Fluorouracil) is a classic adjuvant chemotherapy regimen for **Breast Cancer**. * **D (CHOP):** (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone) is the gold-standard treatment for **Non-Hodgkin Lymphoma (NHL)**, specifically Diffuse Large B-Cell Lymphoma (DLBCL) [1]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Staging:** The **Ann Arbor Staging** system is used for HL [2]. 2. **Pathognomonic Cell:** Presence of **Reed-Sternberg (RS) cells** (Owl’s eye appearance) which are CD15+ and CD30+ [2]. 3. **Specific Side Effects:** * **Bleomycin:** Pulmonary fibrosis (monitor with DLCO). * **Doxorubicin:** Cardiotoxicity (Dilated cardiomyopathy). * **Vinblastine:** Bone marrow suppression (unlike Vincristine, which is more neurotoxic). 4. **Relapsed HL:** Brentuximab Vedotin (anti-CD30 antibody-drug conjugate) is a high-yield salvage therapy option.

Question 84: A 68-year-old woman presents with new symptoms of burning when voiding. She has no fever, chills, or back discomfort. Her urinalysis reveals numerous white cells and bacteria. Which of the following medical comorbidities is most likely to coexist in this patient?

A. anemia
B. exercise
C. diabetes mellitus (Correct Answer)
D. influenza

Explanation: The patient presents with classic symptoms of an uncomplicated **Urinary Tract Infection (UTI)**: dysuria (burning on voiding), pyuria (white cells), and bacteriuria, in the absence of systemic symptoms like fever or flank pain (which would suggest pyelonephritis) [1]. **1. Why Diabetes Mellitus is the Correct Answer:** Diabetes mellitus (DM) is a major risk factor for UTIs due to several pathophysiological mechanisms: * **Glucosuria:** High glucose levels in urine provide an excellent culture medium for bacterial growth. * **Immune Dysfunction:** Hyperglycemia impairs neutrophil function (chemotaxis and adherence) and cytokine production. * **Autonomic Neuropathy:** Long-standing DM can lead to a "neurogenic bladder," causing incomplete emptying and urinary stasis, which facilitates bacterial colonization. * **Increased Adherence:** Bacteria (like *E. coli*) adhere more readily to the uroepithelial cells of diabetic patients. **2. Why the Other Options are Incorrect:** * **Anemia:** While chronic disease can cause anemia, it does not directly predispose a patient to bacterial UTIs. * **Exercise:** Physical activity is generally protective for overall health and is not a risk factor for urinary infections. * **Influenza:** This is a respiratory viral infection. While it can cause systemic malaise, it does not have a direct causal link with bacterial cystitis. **Clinical Pearls for NEET-PG:** * **Most Common Organism:** *Escherichia coli* remains the most common cause of UTI in both diabetic and non-diabetic patients. * **Emphysematous Cystitis/Pyelonephritis:** These are severe, gas-forming infections of the urinary tract seen almost exclusively in diabetic patients (Medical Emergency). * **Asymptomatic Bacteriuria:** In diabetic patients, asymptomatic bacteriuria is common but generally **not** treated unless the patient is pregnant or undergoing a urological procedure [1]. * **Klebsiella & Candida:** Diabetic patients have a higher incidence of UTIs caused by *Klebsiella* and fungal pathogens like *Candida albicans*.

Question 85: Ten days after a kidney transplant, a 32-year-old man returns to the hospital with symptoms of fever and decreased urine output. He reports no cough, sputum, or dysuria. An ultrasound of the transplant kidney shows allograft enlargement. Which of the following is the most likely diagnosis?

A. Steroid-induced hyperglycemia
B. Erythrocytosis
C. Hyperacute rejection
D. Acute rejection (Correct Answer)

Explanation: ### **Explanation** The clinical presentation of fever, graft tenderness (implied by enlargement), and decreased urine output (oliguria) occurring **10 days post-transplant** is a classic manifestation of **Acute Rejection**. [1] #### **1. Why Acute Rejection is Correct** * **Timing:** Acute rejection typically occurs within the first **few weeks to months** (usually >5 days to 6 months) after transplantation. [1] * **Pathophysiology:** It is primarily a T-cell mediated immune response (Type IV hypersensitivity) against the donor HLA antigens, though antibody-mediated components can coexist. [1] * **Clinical Features:** Patients present with systemic signs (fever), graft dysfunction (rising creatinine, decreased urine output), and physical signs of inflammation (allograft enlargement/tenderness). [1] * **Diagnosis & Management:** Gold standard is a **renal biopsy** (showing lymphocytic infiltration/tubulitis). Treatment involves high-dose corticosteroids or antithymocyte globulin (ATG). #### **2. Why Other Options are Incorrect** * **A. Steroid-induced hyperglycemia:** While common post-transplant due to immunosuppression, it presents with polyuria and thirst, not decreased urine output or graft enlargement. [2] * **B. Erythrocytosis:** This is a late complication of renal transplant (due to increased EPO production) and does not cause acute graft dysfunction or fever. * **C. Hyperacute rejection:** This occurs within **minutes to hours** of transplantation. It is caused by pre-formed anti-donor antibodies (Type II hypersensitivity) leading to immediate thrombosis and graft necrosis. [1] #### **3. High-Yield Clinical Pearls for NEET-PG** * **Hyperacute Rejection:** Minutes/Hours; Pre-formed antibodies; Type II Hypersensitivity. [2] * **Acute Rejection:** Days/Weeks; T-cells; Type IV Hypersensitivity; **Most common** type of rejection. * **Chronic Rejection:** Months/Years; Fibrosis and intimal thickening; Irreversible. * **Graft vs. Host Disease (GVHD):** Rare in solid organ transplants; common in bone marrow transplants; characterized by maculopapular rash, jaundice, and diarrhea.

Question 86: A 63-year-old woman with well-controlled Type 2 diabetes mellitus presents with peripheral neuropathy in the feet and non-proliferative retinopathy. Urinalysis is positive for proteinuria. Which of the following treatments is most likely to attenuate the course of renal disease?

A. Calcium channel blockers
B. ACE inhibitors (Correct Answer)
C. Hepatic hydroxymethylglutaryl coenzyme A (HMG-CoA) inhibitors
D. Dietary carbohydrate restriction

Explanation: **Explanation:** The patient presents with classic microvascular complications of Type 2 Diabetes Mellitus: peripheral neuropathy, retinopathy, and proteinuria (indicative of **Diabetic Nephropathy**). **Why ACE Inhibitors (ACEIs) are correct:** ACE inhibitors (e.g., Enalapril, Ramipril) are the gold standard for managing diabetic nephropathy. The underlying mechanism involves the inhibition of Angiotensin II, which normally causes **vasoconstriction of the efferent arteriole**. By dilating the efferent arteriole, ACEIs reduce **intraglomerular capillary pressure**, thereby decreasing the mechanical strain on the basement membrane and reducing proteinuria [2]. This "renoprotective" effect slows the progression to End-Stage Renal Disease (ESRD), independent of their blood pressure-lowering effects [2]. **Why other options are incorrect:** * **A. Calcium channel blockers:** While effective for hypertension, dihydropyridine CCBs (like Amlodipine) primarily dilate the *afferent* arteriole, which can potentially increase intraglomerular pressure and do not provide the same degree of renoprotection as ACEIs. * **C. HMG-CoA inhibitors (Statins):** These are essential for cardiovascular risk reduction in diabetics but have no direct role in attenuating the progression of diabetic glomerular disease. * **D. Dietary carbohydrate restriction:** While vital for glycemic control, strict carbohydrate restriction alone does not reverse established proteinuria or provide the hemodynamic benefits required to halt nephropathy progression [3]. **NEET-PG High-Yield Pearls:** * **First sign of Diabetic Nephropathy:** Microalbuminuria (30–300 mg/day) [1]. * **Pathognomonic finding:** Kimmelstiel-Wilson (KW) nodules on renal biopsy [1]. * **Drug of Choice:** ACE inhibitors or ARBs (Angiotensin Receptor Blockers) [2]. Note: Never combine ACEIs and ARBs due to the risk of hyperkalemia and acute kidney injury. * **SGLT2 Inhibitors:** Now also recognized as highly renoprotective in diabetic patients.

Question 87: A 62-year-old man presents with a 1-day history of dark tarry stools and light-headedness, along with a 1-month history of intermittent abdominal discomfort and poor appetite. He takes ibuprofen as needed for pain. Physical examination reveals a blood pressure of 102/75 mm Hg, heart rate of 110/min, and a soft, non-tender abdomen. Upper endoscopy shows an ulcerating lesion in the stomach, and biopsies confirm gastric cancer. Which of the following is a risk factor for carcinoma of the stomach?

A. Helicobacter pylori infection (Correct Answer)
B. High socioeconomic status
C. High-protein diet
D. High alcohol consumption

Explanation: The correct answer is **Helicobacter pylori infection**. *H. pylori* is the most significant risk factor for non-cardia gastric adenocarcinoma. [1] It causes chronic active gastritis, which progresses through a well-defined histological cascade: atrophic gastritis → intestinal metaplasia → dysplasia → adenocarcinoma (Correa’s Pathway). The WHO classifies *H. pylori* as a Group 1 carcinogen. **Analysis of Options:** * **A. Helicobacter pylori infection:** Correct. It is responsible for approximately 60-90% of gastric cancer cases worldwide. [1] * **B. High socioeconomic status:** Incorrect. Gastric cancer is more prevalent in **lower socioeconomic groups**, likely due to overcrowding (increased *H. pylori* transmission) and poor access to fresh fruits/vegetables. * **C. High-protein diet:** Incorrect. While a diet high in **salted, smoked, or nitrate-preserved foods** is a major risk factor, a high-protein diet itself is not specifically linked to gastric malignancy. * **D. High alcohol consumption:** Incorrect. While alcohol is a risk factor for esophageal and liver cancers, its association with gastric cancer is inconsistent and not as definitive as *H. pylori* or tobacco use. **Clinical Pearls for NEET-PG:** * **Blood Group A:** Associated with an increased risk of gastric cancer (unlike Blood Group O, which is linked to peptic ulcers). * **Virchow’s Node:** Left supraclavicular lymphadenopathy indicating metastasis. * **Sister Mary Joseph Nodule:** Periumbilical metastasis. * **Krukenberg Tumor:** Ovarian metastasis (typically showing signet ring cells). * **Protective Factors:** Diets high in Vitamin C and beta-carotene (fresh fruits and vegetables).

Question 88: A 62-year-old man with a history of hypertension and stage-III squamous cell carcinoma of the lung who recently completed chemotherapy presents with sudden onset of right calf swelling and pain for 2 days. He denies trauma or recent travel and has no prior history of blood clots. Physical examination reveals a tender swelling of the right calf without erythema. His D-dimer is elevated at 640 ng/mL, and venous Doppler confirms occlusive thrombi in the deep veins of the right leg. A plan is made to initiate anticoagulation for 6 months. What is the drug of choice for anticoagulation in this patient?

A. Rivaroxaban
B. Low-molecular-weight heparin (Correct Answer)
C. Warfarin
D. Low dose aspirin (81 mg/d)

Explanation: ### Explanation **Correct Answer: B. Low-molecular-weight heparin (LMWH)** The patient presents with **Cancer-Associated Thrombosis (CAT)**. In patients with active malignancy (especially lung cancer) and a newly diagnosed Deep Vein Thrombosis (DVT), **Low-molecular-weight heparin (LMWH)**, such as Enoxaparin, has traditionally been the drug of choice for long-term anticoagulation [1]. **Why LMWH is correct:** Clinical trials (e.g., the CLOT trial) demonstrated that LMWH is superior to Vitamin K antagonists (Warfarin) in preventing recurrent VTE in cancer patients without increasing the risk of major bleeding. Cancer patients often have fluctuating oral intake, drug interactions with chemotherapy, and frequent procedures requiring rapid reversal of anticoagulation—factors that make LMWH safer and more predictable than oral alternatives [1]. **Why other options are incorrect:** * **A. Rivaroxaban:** While DOACs (Rivaroxaban, Edoxaban) are now considered alternatives in some guidelines, they are associated with a higher risk of gastrointestinal (GI) and genitourinary bleeding, particularly in patients with luminal GI or squamous cell cancers [1]. LMWH remains a standard "gold-standard" answer in many traditional medical exams. * **C. Warfarin:** Warfarin is less effective in malignancy due to the "prothrombotic state" of cancer and is difficult to manage due to frequent interactions with chemotherapy and malnutrition-induced Vitamin K deficiency [2]. * **D. Low dose aspirin:** Aspirin is an antiplatelet agent, not an anticoagulant. It is insufficient for the treatment of an established occlusive DVT. **High-Yield Clinical Pearls for NEET-PG:** * **Trousseau Syndrome:** Migratory thrombophlebitis associated with visceral malignancy (most commonly pancreatic cancer) [1]. * **Duration of Therapy:** In cancer-associated DVT, anticoagulation is typically continued for at least **3–6 months** or as long as the cancer is active/under treatment. * **Preferred DOACs:** If a DOAC is used in cancer, **Apixaban** is often preferred over Rivaroxaban due to a lower observed risk of major bleeding in recent trials (CARAVAGGIO study).

Question 89: What is the most common malignancy observed in individuals undergoing immunosuppressive therapy?

A. Lung
B. Skin (Correct Answer)
C. Hodgkin lymphoma
D. Kidney

Explanation: The correct answer is **Skin (Option B)**. Immunosuppression, whether due to organ transplantation (post-transplant lymphoproliferative disorders) or chronic therapy for autoimmune diseases, significantly impairs the body's immune surveillance. This leads to a markedly increased risk of malignancies, particularly those with viral etiologies or those exacerbated by UV radiation [1]. **Why Skin is Correct:** Skin cancers are the most common malignancies in immunosuppressed patients [1]. Specifically, **Squamous Cell Carcinoma (SCC)** is the most frequent, occurring at a rate 65–250 times higher than in the general population [2]. Unlike the general population where Basal Cell Carcinoma (BCC) is more common, the **SCC:BCC ratio is reversed** in immunosuppressed individuals. The primary drivers are the loss of T-cell mediated surveillance of UV-damaged cells and the oncogenic effects of Human Papillomavirus (HPV) [1][2]. **Why other options are incorrect:** * **Lung (Option A):** While lung cancer risk is slightly elevated in transplant recipients (especially smokers), it is not the most common. * **Hodgkin Lymphoma (Option C):** Immunosuppressed patients are at a high risk for **Non-Hodgkin Lymphoma (NHL)**, particularly those associated with Epstein-Barr Virus (EBV) [1]. Hodgkin lymphoma is much less common in this demographic. * **Kidney (Option D):** Renal cell carcinoma risk is increased (especially in renal transplant recipients due to acquired cystic kidney disease), but its incidence remains lower than that of skin cancers. **NEET-PG High-Yield Pearls:** 1. **Most common malignancy overall:** Skin Cancer (SCC > BCC) [2]. 2. **Most common non-cutaneous malignancy:** Non-Hodgkin Lymphoma (NHL) [1]. 3. **Kaposi Sarcoma:** Highly associated with HHV-8 in immunosuppressed patients; it can regress if immunosuppression is reduced [1]. 4. **Cervical/Anogenital Cancers:** Increased risk due to persistent HPV infection under immunosuppression.

Question 90: Trousseau's sign is seen in all the following conditions except:

A. Lung carcinoma
B. Gastric carcinoma
C. Pancreatic carcinoma
D. Liposarcoma (Correct Answer)

Explanation: **Explanation:** **Trousseau’s sign of malignancy** (also known as Migratory Thrombophlebitis) refers to spontaneous, recurrent episodes of venous thrombosis at changing (migratory) sites. This phenomenon is a **paraneoplastic syndrome** caused by the release of procoagulants (like tissue factor and mucins) from tumor cells, which activate the coagulation cascade [1]. **Why Liposarcoma is the correct answer:** Trousseau’s sign is classically associated with **mucin-secreting adenocarcinomas**. Liposarcoma is a mesenchymal tumor (sarcoma) arising from fat cells and does not typically secrete the mucins or procoagulants required to trigger migratory thrombophlebitis. Therefore, it is the "except" in this list. **Analysis of other options:** * **Pancreatic Carcinoma:** This is the **most common** association [1]. Trousseau’s sign is frequently the presenting feature of occult pancreatic tail/body cancer. * **Gastric Carcinoma:** As a mucin-producing adenocarcinoma, it is a well-documented cause of hypercoagulability and Trousseau’s sign [1]. * **Lung Carcinoma:** Specifically, **Adenocarcinoma of the lung** is a known cause of paraneoplastic migratory thrombophlebitis. **NEET-PG Clinical Pearls:** 1. **Distinction:** Do not confuse this with *Trousseau’s sign of latent tetany* (carpal spasm induced by BP cuff inflation in hypocalcemia). 2. **Mechanism:** Tumor-derived **mucin** interacts with P-selectin and L-selectin, leading to the formation of platelet-rich microthrombi. 3. **High-Yield Association:** If a patient presents with migratory thrombophlebitis, the first investigation should often be an abdominal CT to rule out **Pancreatic Cancer**. 4. **Treatment:** Heparin is generally more effective than warfarin in managing cancer-associated thrombosis.

Question 91: A 60-year-old patient presents with diarrhea and abdominal pain for 5 days. Ultrasound abdomen is normal, and CT abdomen shows a local mass in the jejunum. 24-hour urine test shows elevated 5-HIAA. What is the most common site for a primary tumor that causes these findings?

A. Gastrointestinal tract
B. Bronchus (Correct Answer)
C. Kidney
D. Adrenal gland

Explanation: **Explanation:** The patient presents with the classic triad of **Carcinoid Syndrome** (diarrhea, abdominal pain, and elevated urinary 5-HIAA). Carcinoid syndrome occurs when neuroendocrine tumors (NETs) secrete vasoactive substances like serotonin directly into the systemic circulation [1]. **Why Bronchus is the correct answer:** In the context of this specific question, the key is the **absence of liver metastases** (implied by a normal ultrasound). * **Midgut/GI Carcinoids:** Serotonin produced by GI tumors is normally metabolized by the liver (first-pass metabolism) into inactive 5-HIAA [1]. Therefore, GI carcinoids **only** cause systemic carcinoid syndrome once they have metastasized to the liver, bypassing this metabolism [1]. * **Bronchial Carcinoids:** These tumors release serotonin directly into the pulmonary veins and then into the systemic circulation, bypassing the liver entirely. Thus, a primary bronchial carcinoid can cause carcinoid syndrome **without** liver metastasis [1]. Given the normal ultrasound and the presence of symptoms, the primary site is most likely the bronchus. **Analysis of Incorrect Options:** * **A. Gastrointestinal tract:** While the GI tract (specifically the ileum) is the most common site for NETs overall, they rarely cause carcinoid syndrome unless liver metastases are present [1][2]. * **C & D. Kidney and Adrenal gland:** These are not typical sites for serotonin-secreting neuroendocrine tumors and do not present with elevated 5-HIAA. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site for NETs:** Small Intestine (specifically the Ileum) [2]. * **Most common site for NETs causing Carcinoid Syndrome:** Ileum (but requires liver metastasis) [1]. * **Diagnostic Test of Choice:** 24-hour urinary 5-HIAA (metabolite of serotonin). * **Localization:** Chromogranin A (tumor marker) and Octreoscan (Somatostatin receptor scintigraphy). * **Management:** Octreotide (Somatostatin analog) is used to control symptoms.

Question 92: Tumour lysis syndrome is associated with the treatment of which condition?

A. Hairy cell leukemia
B. Burkitt's lymphoma (Correct Answer)
C. Plasmacytoma
D. All of the above

Explanation: **Explanation:** **Tumor Lysis Syndrome (TLS)** is an oncologic emergency caused by the rapid destruction of a large number of tumor cells, leading to the release of intracellular contents into the bloodstream. **Why Burkitt’s Lymphoma is the Correct Answer:** TLS is most commonly associated with **high-grade hematologic malignancies** characterized by a high tumor burden, rapid cell turnover (high proliferation rate), and high sensitivity to chemotherapy [1]. **Burkitt’s lymphoma** is the classic prototype for this; it has a doubling time of approximately 24 hours [1]. When chemotherapy is initiated, the massive release of potassium, phosphate, and nucleic acids (which metabolize into uric acid) overwhelms the body's homeostatic mechanisms. **Why Other Options are Incorrect:** * **Hairy Cell Leukemia:** This is a chronic, indolent B-cell lymphoproliferative disorder. Because the cells divide slowly and the tumor burden is typically lower compared to high-grade lymphomas, the risk of TLS is minimal [1]. * **Plasmacytoma:** This is a localized collection of plasma cells [2]. While it is a plasma cell dyscrasia, it lacks the rapid proliferative kinetics required to trigger systemic TLS upon treatment. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Profile of TLS:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** (due to calcium-phosphate precipitation). * **Renal Impact:** Acute Kidney Injury (AKI) occurs due to the precipitation of uric acid crystals or calcium phosphate in the renal tubules. * **Prophylaxis/Treatment:** Aggressive hydration is the mainstay. **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used for management. * **Risk Factors:** High LDH levels and pre-existing renal insufficiency.

Question 93: What is the initial treatment for tumor lysis syndrome?

A. Rasburicase, hydration, potassium binder, and urinary alkalization (Correct Answer)
B. Allopurinol, hydration, potassium binder, and alkalization
C. Both rasburicase and allopurinol, with hydration and a potassium binder
D. Hydration alone is sufficient

Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid breakdown of tumor cells, leading to the release of intracellular contents into the bloodstream [1]. This results in the "TLS metabolic quartet": **Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and Hypocalcemia.** **Why Option A is Correct:** The management of TLS focuses on aggressive hydration and correcting metabolic derangements. * **Hydration:** Increases glomerular filtration and helps flush out uric acid and phosphates. * **Rasburicase:** This is a recombinant urate oxidase enzyme that converts existing uric acid into **allantoin**, which is 5-10 times more soluble. It is the preferred agent for established TLS or high-risk patients because it works rapidly. * **Potassium Binders:** Essential to manage life-threatening hyperkalemia. * **Urinary Alkalization:** Historically used to increase uric acid solubility; however, its role is now debated as it may promote calcium-phosphate precipitation. In many standard protocols and NEET-PG contexts, it remains a recognized component of initial management. **Why Other Options are Wrong:** * **Option B:** **Allopurinol** is a xanthine oxidase inhibitor. It prevents the *formation* of new uric acid but does nothing to reduce existing uric acid levels. It is used for **prophylaxis**, not the treatment of established TLS. * **Option C:** While both drugs target uric acid, Allopurinol is generally redundant once Rasburicase is started, as Rasburicase is significantly more potent and rapid. * **Option D:** Hydration is the cornerstone but is insufficient alone to manage the severe electrolyte imbalances and high uric acid levels seen in clinical TLS. **High-Yield Clinical Pearls for NEET-PG:** * **Cairo-Bishop Definition:** Used to classify Laboratory vs. Clinical TLS. * **Drug of Choice for Prophylaxis:** Allopurinol. * **Drug of Choice for Treatment:** Rasburicase. * **Contraindication:** Rasburicase is contraindicated in **G6PD deficiency** (risk of hemolysis). * **Most common cancers:** High-grade lymphomas (Burkitt’s) and Acute Leukemias (ALL) [1].

Question 94: Kaposi's sarcoma is associated with which of the following conditions?

A. Bronchial asthma
B. HIV (Correct Answer)
C. Hepatitis B
D. Hairy cell leukaemia

Explanation: **Explanation:** **Kaposi’s Sarcoma (KS)** is a vascular neoplasm caused by **Human Herpesvirus 8 (HHV-8)**, also known as Kaposi Sarcoma-associated Herpesvirus (KSHV). While HHV-8 is the primary oncogenic driver, the clinical manifestation of the disease is heavily dependent on the host's immune status. **Why HIV is the correct answer:** The most common and aggressive form of the disease is **AIDS-associated (Epidemic) Kaposi’s Sarcoma** [1]. In patients with HIV, the profound depletion of CD4+ T-cells and the presence of the HIV-Tat protein synergize with HHV-8 to promote spindle cell proliferation and angiogenesis. It is currently the most common neoplasm associated with HIV/AIDS and is considered an **AIDS-defining illness** [1]. **Analysis of Incorrect Options:** * **Bronchial Asthma:** This is a chronic inflammatory airway disease with no known association with HHV-8 or vascular malignancies. * **Hepatitis B:** While HBV is strongly associated with Hepatocellular Carcinoma (HCC), it does not play a role in the pathogenesis of Kaposi’s Sarcoma. * **Hairy Cell Leukaemia:** This is a rare B-cell lymphoproliferative disorder characterized by the BRAF V600E mutation; it is not linked to HHV-8. **Clinical Pearls for NEET-PG:** * **Morphology:** Presents as painless, non-blanching, violaceous (purple) macules, plaques, or nodules [1]. * **Histology:** Characterized by **spindle-shaped cells**, slit-like vascular spaces, and extravasated RBCs. * **Four Clinical Variants:** 1. Classic (Elderly Mediterranean men), 2. Endemic (African), 3. Iatrogenic (Transplant-related), 4. AIDS-associated [1]. * **Treatment:** Highly Active Antiretroviral Therapy (HAART) is the first-line management for AIDS-related KS. For localized lesions, intralesional vinblastine or cryotherapy is used; systemic chemotherapy (Liposomal Doxorubicin) is reserved for visceral involvement.

Question 95: Which type of lung carcinoma responds best to chemotherapy?

A. Squamous cell type
B. Oat cell type (Correct Answer)
C. Adenocarcinoma
D. All respond equally

Explanation: **Explanation:** The correct answer is **Oat cell type**, also known as **Small Cell Lung Carcinoma (SCLC)**. **1. Why Oat cell type is correct:** Small cell lung carcinoma is characterized by a very high growth fraction and a rapid doubling time. In oncology, the "Law of Bergonie and Tribondeau" dictates that cells with high mitotic activity are more sensitive to cytotoxic agents. Because SCLC is highly aggressive and almost always disseminated at the time of diagnosis, it is treated primarily as a systemic disease [1]. It shows a dramatic initial response to chemotherapy (typically Etoposide + Cisplatin/Carboplatin), with objective response rates often exceeding 60-80%. **2. Why other options are incorrect:** * **Squamous cell type & Adenocarcinoma:** These are subtypes of Non-Small Cell Lung Carcinoma (NSCLC). Unlike SCLC, NSCLC is characterized by slower growth and is relatively chemoresistant. While chemotherapy is used in advanced stages, the response is much less dramatic than in SCLC. Surgery is the primary treatment for early-stage NSCLC. * **All respond equally:** This is incorrect because lung cancers are biologically heterogeneous. The distinction between SCLC (chemosensitive) and NSCLC (chemoresistant) is a fundamental principle in thoracic oncology. **Clinical Pearls for NEET-PG:** * **Strongest Association:** SCLC and Squamous cell carcinoma have the strongest association with **smoking** [1]. * **Location:** SCLC and Squamous cell carcinoma are typically **central/hilar**, while Adenocarcinoma is usually **peripheral** [1]. * **Paraneoplastic Syndromes:** SCLC is most commonly associated with **SIADH** and **ACTH production** (Cushing’s), as well as Lambert-Eaton Myasthenic Syndrome [1]. * **Prognosis:** Despite being the most chemo-responsive, SCLC has a poor long-term prognosis due to early metastasis and frequent recurrence.

Question 96: A 41-year-old man presented with a 9-month history of cough, exertional dyspnea, nocturnal diaphoresis, and weight loss of 10 kg. Physical examination revealed painless, massive, discrete, rubbery cervical, supraclavicular, and axillary lymphadenopathy. Chest radiography showed bilateral hilar lymphadenopathy. The serum calcium level was elevated at 16.2 mg/dL, with serum parathyroid hormone within the normal range. What is the urgent treatment to be instituted?

A. Intravenous administration of normal saline and a bisphosphonate (Correct Answer)
B. Oxygen 6 L/min by mask
C. Antibiotics and anti-inflammatory drugs
D. Antitussive and chest physiotherapy

Explanation: The patient presents with classic constitutional symptoms (weight loss, night sweats), generalized rubbery lymphadenopathy, and hilar adenopathy, highly suggestive of a hematologic malignancy (likely **Lymphoma**) [1] or Sarcoidosis. However, the acute clinical priority is dictated by his laboratory findings: a life-threatening **Serum Calcium level of 16.2 mg/dL** (Severe Hypercalcemia). [3] **1. Why Option A is Correct:** Severe hypercalcemia (defined as >14 mg/dL) is a medical emergency. The immediate management goals are volume expansion and inhibition of bone resorption: * **Normal Saline (IV):** Restores intravascular volume and promotes urinary calcium excretion. [3] * **Bisphosphonates (e.g., Zoledronic acid):** The gold standard for Hypercalcemia of Malignancy; they inhibit osteoclast activity to provide sustained reduction in calcium levels. [2] * *Note:* In lymphoma, hypercalcemia is often mediated by increased 1,25-dihydroxyvitamin D (Calcitriol) production by malignant cells. **2. Why Incorrect Options are Wrong:** * **Option B:** While the patient has dyspnea, oxygen is supportive and does not address the metabolic emergency (hypercalcemia) which can cause cardiac arrhythmias and coma. * **Option C:** Antibiotics are indicated for infections. While TB is a differential for hilar adenopathy, the acute hypercalcemia takes precedence. [1] * **Option D:** These are symptomatic treatments for cough and do not address the underlying pathology or the life-threatening calcium level. **Clinical Pearls for NEET-PG:** * **Hypercalcemia of Malignancy:** Most common cause of hypercalcemia in hospitalized patients (Primary Hyperparathyroidism is the most common in outpatients). * **Mechanism in Lymphoma:** Extra-renal conversion of 25-OH Vit D to 1,25-(OH)₂ Vit D by 1-alpha-hydroxylase in tumor cells. * **Treatment Sequence:** 1st: Rehydration (NS); 2nd: Bisphosphonates; 3rd: Loop diuretics (only *after* rehydration is complete); 4th: Calcitonin (for rapid, short-term reduction). [2]

Question 97: All of the following are carcinogenic except?

A. H. pylori
B. Hepatitis B virus
C. Epstein-Barr virus
D. All the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D (All the above)** because all three listed organisms are classified as **Group 1 Carcinogens** by the International Agency for Research on Cancer (IARC). These biological agents are known to induce oncogenesis through chronic inflammation, integration of viral DNA, or the expression of oncoproteins [1]. 1. **H. pylori (Option A):** This gram-negative bacterium is the most common cause of **Gastric Adenocarcinoma** and **MALT Lymphoma** [3]. It induces carcinogenesis through chronic mucosal inflammation and the action of virulence factors like **CagA** (Cytotoxin-associated gene A), which interferes with host cell signaling [2]. 2. **Hepatitis B Virus (Option B):** HBV is a DNA virus that integrates into the host genome. It causes **Hepatocellular Carcinoma (HCC)** via chronic necro-inflammation and the **HBx protein**, which inactivates the p53 tumor suppressor gene and promotes cell proliferation [1]. 3. **Epstein-Barr Virus (Option C):** EBV is associated with several malignancies, most notably **Burkitt Lymphoma** (starry-sky appearance), **Nasopharyngeal Carcinoma**, and Hodgkin Lymphoma. It transforms B-cells using proteins like **LMP-1** (Latent Membrane Protein 1), which mimics CD40 signaling [1]. **Clinical Pearls for NEET-PG:** * **H. pylori** is the only bacterium classified as a Type 1 carcinogen [3]. * **HBV vs. HCV:** While both cause HCC, HBV is a DNA virus that can cause cancer without preceding cirrhosis, whereas HCV (RNA virus) almost always requires cirrhosis to develop HCC. * **EBV Association:** Classically associated with the **t(8;14)** translocation in Burkitt Lymphoma involving the *c-myc* gene. * **Other high-yield carcinogens:** Human Papillomavirus (HPV 16, 18) for Cervical Cancer and *Schistosoma haematobium* for Squamous Cell Carcinoma of the bladder.

Question 98: A 62-year-old man with a history of hypertension and gout, treated with metoprolol and allopurinol, presents with 4 weeks of drowsiness and generalized weakness. He experienced a tonic-clonic seizure. He is a long-term smoker (1 pack/day for 40 years) and has had unintentional weight loss of 20 lb over the past 2 months. His laboratory findings include hemoglobin 10.2 gm/dL, serum sodium 122 mEq/L, serum osmolality 258 mOsm/kg, urine osmolality 300 mOsm/kg, and urine sodium 48 mmol/L. TSH and cortisol levels are normal. What is the most likely diagnosis?

A. Trousseau syndrome
B. Sezary syndrome
C. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) (Correct Answer)
D. Tumor lysis syndrome

Explanation: ### Explanation **Correct Option: C. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)** The patient presents with symptomatic **euvolemic hyponatremia**, characterized by low serum sodium (122 mEq/L) and low serum osmolality (<275 mOsm/kg), alongside inappropriately concentrated urine (urine osmolality >100 mOsm/kg) and elevated urine sodium (>40 mmol/L) [1]. Normal TSH and cortisol levels rule out hypothyroidism and adrenal insufficiency as causes. In the context of a heavy smoker with significant weight loss, the most likely underlying etiology is **Small Cell Lung Cancer (SCLC)**, which is a classic paraneoplastic cause of SIADH due to ectopic ADH production [2]. The neurological symptoms (drowsiness, seizures) are a direct consequence of cerebral edema from acute/severe hyponatremia. **Analysis of Incorrect Options:** * **A. Trousseau syndrome:** Refers to migratory superficial thrombophlebitis associated with visceral malignancy (usually pancreatic). It presents with tender, cord-like venous inflammation, not hyponatremia. * **B. Sezary syndrome:** A leukemic form of Cutaneous T-cell Lymphoma characterized by erythroderma, lymphadenopathy, and atypical T-cells (Sezary cells). It does not typically cause SIADH. * **D. Tumor lysis syndrome:** Characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and **hypocalcemia** following chemotherapy. While this patient has gout (hyperuricemia), his primary presentation is hyponatremia, and he has not yet started treatment. **NEET-PG High-Yield Pearls:** * **SIADH Criteria:** Serum Osm <275; Urine Osm >100; Urine Na >40; Euvolemia; Normal thyroid/adrenal/renal function [1]. * **SCLC Paraneoplastic Syndromes:** SIADH (most common), ACTH production (Cushing syndrome), and Lambert-Eaton Myasthenic Syndrome [2]. * **Management:** Fluid restriction is first-line for mild SIADH. For severe symptoms (seizures, coma), use **3% hypertonic saline**. * **Caution:** Correct sodium slowly (<8–10 mEq/L in 24h) to avoid **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)**.

Question 99: A 57-year-old man presents with a serum sodium of 125 mEq/L. On examination, he has pitting edema and elevated neck veins. His urine sodium is 10 mEq/L and urine osmolality is 350 mOsm/kg. What is the most likely diagnosis for this patient's hyponatremia?

A. Congestive heart failure (CHF) (Correct Answer)
B. Extrarenal sodium and fluid losses
C. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
D. Polydipsia

Explanation: ### Explanation The patient presents with **hypovolemic hyponatremia** (Sodium 125 mEq/L) and clinical signs of **volume overload** (pitting edema, elevated neck veins). This combination is the hallmark of hypervolemic hyponatremia [1]. **1. Why Congestive Heart Failure (CHF) is Correct:** In CHF, there is a decrease in "effective arterial blood volume" (EABV) despite an increase in total body water. This triggers the **Renin-Angiotensin-Aldosterone System (RAAS)** and the release of **Antidiuretic Hormone (ADH)** [2]. * **Low Urine Sodium (< 20 mEq/L):** Aldosterone causes the kidneys to avidly reabsorb sodium to compensate for perceived low perfusion [1]. * **High Urine Osmolality (> 100 mOsm/kg):** ADH causes water reabsorption, concentrating the urine [2]. * **Edema/Elevated JVP:** Reflects the increased total body sodium and water [3]. **2. Why Incorrect Options are Wrong:** * **Extrarenal losses (e.g., vomiting/diarrhea):** These cause *hypovolemic* hyponatremia [1]. While urine sodium would be low (<20), the patient would show signs of dehydration (dry mucus membranes, flat neck veins), not edema. * **SIADH:** This causes *euvolemic* hyponatremia [1]. Patients do not have edema or elevated JVP. Furthermore, urine sodium in SIADH is typically **high (> 40 mEq/L)** because there is no stimulus for aldosterone-mediated sodium retention. * **Polydipsia:** This also causes euvolemic hyponatremia, but the urine would be **maximally dilute** (Urine Osmolality < 100 mOsm/kg) as the body tries to excrete the excess water [2]. **Clinical Pearls for NEET-PG:** * **Hypervolemic Hyponatremia + Low Urine Sodium (<20):** Think CHF, Cirrhosis, or Nephrotic Syndrome [1]. * **Hypervolemic Hyponatremia + High Urine Sodium (>20):** Think Acute or Chronic Renal Failure (kidneys cannot retain sodium) [1]. * **Key Differentiator:** The presence of edema/JVP separates hypervolemic causes from SIADH [3].

Question 100: Which feature is common to carcinoma of the pancreas, lungs, and stomach?

A. Retinoblastoma
B. Migratory thrombophlebitis (Correct Answer)
C. Ascites
D. Disseminated intravascular coagulation (DIC)

Explanation: **Explanation:** The correct answer is **Migratory thrombophlebitis**, also known as **Trousseau’s Syndrome**. **1. Why Migratory Thrombophlebitis is Correct:** Trousseau’s syndrome is a paraneoplastic manifestation characterized by recurrent episodes of superficial venous thrombosis that appear at different sites (migratory). It is most classically associated with **adenocarcinomas**, particularly of the **pancreas** (most common), **lungs**, and **stomach** [1]. The underlying mechanism involves the secretion of procoagulants (like tissue factor and mucins) by the tumor cells, which interact with platelets and the coagulation cascade, leading to a hypercoagulable state [1]. **2. Analysis of Incorrect Options:** * **A. Retinoblastoma:** This is a primary malignant intraocular tumor of childhood, usually linked to the *RB1* gene mutation. It is not a clinical feature or complication of adult adenocarcinomas. * **C. Ascites:** While common in advanced pancreatic and stomach cancers (due to peritoneal carcinomatosis or portal hypertension), it is rarely a feature of lung cancer unless there is extensive liver metastasis. It is not a unifying paraneoplastic feature. * **D. Disseminated Intravascular Coagulation (DIC):** While DIC can occur in advanced malignancies (especially Acute Promyelocytic Leukemia), it is an acute, systemic consumption coagulopathy. Migratory thrombophlebitis is a more specific, localized, and recurrent paraneoplastic sign shared by these specific solid tumors. **Clinical Pearls for NEET-PG:** * **Trousseau’s Sign of Malignancy:** Do not confuse this with Trousseau’s sign of Latent Tetany (carpopedal spasm during BP cuff inflation in hypocalcemia). * **Pancreatic Cancer:** Migratory thrombophlebitis is most frequently associated with the **tail and body** of the pancreas rather than the head. * **Management:** The treatment of choice for cancer-associated thrombosis is **Low Molecular Weight Heparin (LMWH)**, not Warfarin.

Question 101: What is the most common type of bronchogenic carcinoma?

A. Adenocarcinoma (Correct Answer)
B. Oat cell carcinoma
C. Squamous cell carcinoma
D. Large cell carcinoma

Explanation: **Explanation:** **Adenocarcinoma** is currently the most common histological type of bronchogenic carcinoma worldwide [1], accounting for approximately 40% of all lung cancer cases. Historically, squamous cell carcinoma was the most frequent; however, due to changes in cigarette composition and smoking patterns, adenocarcinoma has surpassed it [1]. It is the most common type found in **non-smokers, women, and younger adults** [1]. It typically presents as a **peripheral lesion** and is associated with scarring (scar carcinoma) [1]. **Analysis of Incorrect Options:** * **Oat cell carcinoma (Small Cell Lung Cancer):** This is the most aggressive form of lung cancer, strongly associated with smoking [2]. It usually presents as a central mass and is notorious for causing various paraneoplastic syndromes (e.g., SIADH, ectopic ACTH). * **Squamous cell carcinoma:** Formerly the most common type, it is now the second most frequent. It is strongly linked to smoking and typically presents as a **central/hilar mass** [1] with a tendency for **cavitary lesions** and hypercalcemia (due to PTHrP secretion). * **Large cell carcinoma:** A diagnosis of exclusion, these are undifferentiated malignant epithelial tumors. They represent a smaller percentage of cases and typically present as large peripheral masses with a poor prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Location Mnemonic:** **S**quamous and **S**mall cell are **S**entral; Adenocarcinoma and Large cell are Peripheral [1]. * **Most common lung cancer in smokers:** Adenocarcinoma (though Squamous has a stronger *relative* association with smoking, Adenocarcinoma is more common in absolute numbers). * **Driver Mutations:** EGFR mutations and ALK rearrangements are most frequently seen in Adenocarcinomas, especially in non-smokers. * **Pancoast Tumor:** Most commonly caused by Squamous cell carcinoma or Adenocarcinoma.

Question 102: A 69-year-old woman presents with left flank pain and hematuria. Physical examination reveals a blood pressure of 165/96 mmHg, heart rate of 104/min, and left costovertebral angle tenderness. An abdominal CT scan shows a 5-cm left kidney mass. Which of the following laboratory abnormalities might also be present?

A. polycythemia (Correct Answer)
B. thrombocytopenia
C. hypocalcemia
D. leukocytosis

Explanation: The clinical presentation of a flank mass, hematuria, and hypertension in an elderly patient is highly suggestive of **Renal Cell Carcinoma (RCC)** [1]. ### **Explanation of the Correct Answer** **Polycythemia (Option A)** is a classic paraneoplastic syndrome associated with RCC. It occurs due to the ectopic production of **Erythropoietin (EPO)** by the tumor cells, which stimulates the bone marrow to increase red blood cell production. While anemia is actually more common in RCC (due to chronic disease), polycythemia is a high-yield diagnostic clue. ### **Analysis of Incorrect Options** * **Thrombocytopenia (B):** RCC is more likely to cause thrombocytosis (as an acute phase reactant) rather than a low platelet count. * **Hypocalcemia (C):** RCC is famously associated with **Hypercalcemia**, not hypocalcemia. This occurs either due to bone metastasis or the secretion of **Parathyroid Hormone-related Protein (PTHrP)**. * **Leukocytosis (D):** While non-specific inflammation can occur, it is not a classic paraneoplastic hallmark of RCC compared to erythrocytosis. ### **NEET-PG High-Yield Pearls: RCC Paraneoplastic Syndromes** * **The "Internist's Tumor":** RCC is known by this name because it presents with diverse systemic symptoms. * **Stauffer Syndrome:** Reversible hepatic dysfunction (elevated LFTs, alkaline phosphatase) in the absence of liver metastases. * **Hypertension:** Caused by increased **Renin** production or direct compression of the renal artery by the tumor. * **Classic Triad:** Flank pain, hematuria, and palpable abdominal mass (seen in only 10% of cases, usually indicating advanced disease) [1]. * **Most Common Histology:** Clear cell carcinoma (originates from the proximal convoluted tubule) [1].

Question 103: All of the following are good prognostic factors for seminoma testis except?

A. Primarily gonadal
B. Primarily retroperitoneal
C. Nonpulmonary visceral metastases (Correct Answer)
D. AFP more than 10,000 ng/Ml

Explanation: This question is based on the **IGCCCG (International Germ Cell Cancer Collaborative Group) Classification**, which is the gold standard for prognosticating germ cell tumors (GCTs). ### **Explanation of the Correct Answer** For **Seminomas**, the IGCCCG classification only recognizes two categories: **Good Prognosis** and **Intermediate Prognosis**. There is no "Poor Prognosis" category for seminoma. * **Non-pulmonary visceral metastases** (e.g., liver, bone, or brain) automatically upgrade a seminoma from "Good" to **"Intermediate" prognosis**. Therefore, it is not a good prognostic factor. ### **Analysis of Incorrect Options** * **A & B (Primarily Gonadal/Retroperitoneal):** For a seminoma, the primary site can be either the testis (gonadal) or the retroperitoneum to be classified as **Good Prognosis**. This differs from Non-Seminomatous Germ Cell Tumors (NSGCT), where a mediastinal primary indicates a poor prognosis. * **D (AFP more than 10,000 ng/mL):** This is a "trick" option. By definition, **pure seminomas do not produce AFP**. If AFP is elevated, the tumor is treated as a Non-Seminoma. Therefore, an elevated AFP is not a prognostic factor for seminoma; it changes the diagnosis itself. ### **NEET-PG High-Yield Pearls** 1. **Seminoma IGCCCG Criteria:** * **Good Prognosis:** Any primary site (Testis/Retroperitoneum) AND No non-pulmonary visceral metastases. (Normal AFP, any hCG/LDH). * **Intermediate Prognosis:** Any primary site AND **Presence of non-pulmonary visceral metastases**. 2. **Markers:** LDH is the most common marker elevated in seminoma; hCG may be elevated in 10-15% (due to syncytiotrophoblasts), but **AFP is never elevated in pure seminoma**. 3. **Radiosensitivity:** Seminomas are highly radiosensitive and chemosensitive (Cisplatin-based therapy).

Question 104: Beta-2-microglobulin is a tumor marker for which of the following conditions?

A. Multiple myeloma (Correct Answer)
B. Lung cancer
C. Colonic neoplasm
D. Choriocarcinoma

Explanation: **Beta-2-microglobulin (B2M)** is a low-molecular-weight protein that forms the light chain subunit of the **MHC Class I molecule**, found on the surface of almost all nucleated cells. 1. **Why Multiple Myeloma is correct:** In plasma cell dyscrasias like Multiple Myeloma, there is a high turnover of lymphoid cells, leading to increased shedding of B2M into the serum [1]. In clinical practice, B2M is the **most important prognostic marker** for Multiple Myeloma and is a core component of the **International Staging System (ISS)**. Higher levels correlate with a higher tumor burden and renal impairment. 2. **Why other options are incorrect:** * **Lung Cancer:** While non-specific markers like CEA or NSE may be elevated, B2M is not used for diagnosis or staging [2]. * **Colonic Neoplasm:** The primary tumor marker is **Carcinoembryonic Antigen (CEA)**, used mainly for monitoring recurrence [2]. * **Choriocarcinoma:** The definitive tumor marker is the **beta subunit of Human Chorionic Gonadotropin (β-hCG)** [2]. **High-Yield Clinical Pearls for NEET-PG:** * **B2M in Renal Failure:** Since B2M is excreted by the kidneys, its levels rise in renal failure. It is the precursor protein for **Dialysis-related Amyloidosis** (presents as Carpal Tunnel Syndrome in long-term dialysis patients). * **Other B2M associations:** It is also elevated in Chronic Lymphocytic Leukemia (CLL) and B-cell Lymphomas. * **ISS Staging for Myeloma:** * Stage I: B2M < 3.5 mg/L and Albumin ≥ 3.5 g/dL. * Stage III: B2M ≥ 5.5 mg/L.

Question 105: A 53-year-old woman presents with a 1-week history of a non-painful left breast lump. Physical examination reveals a palpable lump with no axillary lymphadenopathy. Mammography confirms a 1-cm breast mass, and biopsy is positive for invasive breast cancer. What is the most appropriate local therapy for her tumor?

A. Simple mastectomy with axillary dissection
B. Radiation therapy to the breast and axilla
C. Local excision plus radiation therapy
D. Local excision and axillary dissection followed by radiation therapy (Correct Answer)

Explanation: **Explanation:** The management of early-stage breast cancer (Stage I and II) focuses on **Breast Conservation Therapy (BCT)**, which is equivalent in survival outcomes to a modified radical mastectomy. **1. Why Option D is Correct:** For a small (1 cm), localized invasive tumor, the standard of care is **Breast-Conserving Surgery (BCS)**. This involves: * **Local Excision (Lumpectomy):** Removal of the tumor with clear margins. * **Axillary Staging:** Even if lymph nodes are clinically negative (N0), pathological staging via **Axillary Lymph Node Dissection (ALND)** or Sentinel Lymph Node Biopsy (SLNB) is mandatory to guide systemic therapy. * **Radiation Therapy (RT):** Post-operative RT to the remaining breast tissue is essential to reduce the risk of local recurrence, completing the BCT protocol. **2. Why Other Options are Incorrect:** * **Option A:** Simple mastectomy removes the breast but ignores the axilla. In invasive cancer, the axilla must be staged. Furthermore, mastectomy is unnecessarily invasive for a 1-cm tumor unless BCT is contraindicated. * **Option B:** Radiation alone is not a primary treatment for a resectable breast mass; surgical excision is required. * **Option C:** This option omits axillary dissection/staging, which is a critical component of the surgical management of invasive breast cancer. **Clinical Pearls for NEET-PG:** * **BCT vs. Mastectomy:** Long-term survival rates are identical. BCT is preferred for tumors <5 cm where a good cosmetic result can be achieved. * **Absolute Contraindications for BCT:** Multicentric disease, prior radiation to the breast/chest wall, pregnancy (RT is contraindicated), and persistent positive margins after re-excision. * **Sentinel Lymph Node Biopsy (SLNB):** Now the preferred initial method for axillary staging in clinically N0 patients to avoid the morbidity of full dissection (lymphedema).

Question 106: A 69-year-old man with a 60 pack-year history of smoking presents with dizziness and visual disturbances. Physical examination reveals a purplish discoloration of his face, arms, and neck; retinal vein engorgement; and visible distention of his neck veins. His complete blood count reveals a normocytic anemia. The pathophysiology of this patient's clinical presentation most likely involves which of the following?

A. Right heart failure secondary to left heart failure
B. Obstruction of the superior vena cava by a primary tumor arising in the lungs (Correct Answer)
C. Metastatic disease to the cervical lymph nodes with compression of the jugular veins
D. Polycythemia rubra vera

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The patient presents with the classic triad of **Superior Vena Cava (SVC) Syndrome**: facial/neck edema with purplish discoloration (plethora), venous distention of the neck and chest wall, and neurological symptoms (dizziness, visual disturbances) due to cerebral venous congestion [1]. The retinal vein engorgement is a sign of increased intracranial venous pressure. Given his **60 pack-year smoking history**, the most likely cause is a primary bronchogenic carcinoma (most commonly Small Cell Lung Cancer or Squamous Cell Carcinoma) causing extrinsic compression or direct invasion of the SVC [1]. **2. Why the Incorrect Options are Wrong:** * **Option A:** Right heart failure (Cor Pulmonale) can cause jugular venous distention and peripheral edema, but it does not typically cause the localized "mantle" distribution (face, neck, arms) of edema or the acute neurological/visual symptoms seen in SVC syndrome. * **Option C:** While metastatic lymphadenopathy can cause venous compression, the primary driver in a heavy smoker with these extensive symptoms is usually the primary lung mass or associated mediastinal lymphadenopathy obstructing the SVC directly [1], rather than isolated cervical nodes. * **Option D:** Polycythemia rubra vera can cause facial plethora and hyperviscosity, but the patient has **normocytic anemia**, which rules out polycythemia and points toward a chronic disease/malignancy. **3. Clinical Pearls for NEET-PG:** * **Most common cause:** Malignancy (Non-Small Cell Lung Cancer > Small Cell Lung Cancer > Lymphoma). * **Pemberton’s Sign:** Facial flushing and respiratory distress when the patient raises both arms above the head; a classic physical exam finding for SVC obstruction. * **Management:** Emergency radiotherapy or stenting is indicated if there is evidence of laryngeal or cerebral edema. * **Imaging:** Contrast-enhanced CT of the chest is the gold standard for diagnosis [1].

Question 107: In tumor lysis syndrome, all of the following are seen except:

A. Hyperuricemia
B. Hypercalcemia (Correct Answer)
C. Hyperkalemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells, typically following chemotherapy in high-grade malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements. **Why Hypercalcemia is the Correct Answer:** In TLS, **Hypocalcemia** (low calcium) is seen, not hypercalcemia. This occurs because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to circulating ionized calcium, forming calcium phosphate crystals that precipitate in soft tissues and the kidneys (metastatic calcification). This "precipitation effect" rapidly depletes serum calcium levels. **Analysis of Incorrect Options:** * **Hyperuricemia (A):** Nucleic acids from the destroyed cell nuclei are catabolized into purines and then into uric acid by xanthine oxidase. * **Hyperkalemia (C):** Potassium is the primary intracellular cation. Rapid cell lysis dumps massive amounts of potassium into the blood, posing a risk for fatal arrhythmias. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of intracellular phosphorus than normal cells; their rupture leads to a profound rise in serum phosphate. **NEET-PG High-Yield Pearls:** * **Cairo-Bishop Criteria:** Used for the diagnosis of laboratory and clinical TLS. * **Renal Failure:** Caused by the precipitation of uric acid and calcium phosphate crystals in the renal tubules. * **Prophylaxis/Treatment:** Aggressive hydration is the mainstay. **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used to manage hyperuricemia.

Question 108: A 44-year-old woman presents with symptoms of muscle weakness and fatigue. Her laboratory findings include serum potassium of 2.5 mEq/L, bicarbonate of 18 mEq/L, and a normal anion gap. Urine potassium is 40 mEq/L. What is the most likely diagnosis for this patient's hypokalemia?

A. Lower gastrointestinal losses
B. Prior use of diuretics
C. Renal tubular acidosis (RTA) (Correct Answer)
D. Current use of diuretics

Explanation: ### Explanation The patient presents with a triad of **hypokalemia**, **metabolic acidosis** (low bicarbonate), and a **normal anion gap**. The key to differentiating the cause lies in the urinary potassium excretion. **1. Why Renal Tubular Acidosis (RTA) is Correct:** In a patient with metabolic acidosis, the kidneys should ideally conserve potassium. However, in RTA (specifically Type 1 and Type 2), there is significant **renal potassium wasting**. A urine potassium level >20 mEq/L in the presence of hypokalemia indicates a renal cause of loss. The combination of a normal anion gap metabolic acidosis (NAGMA) and high urinary potassium (40 mEq/L) is classic for RTA. **2. Why the other options are incorrect:** * **Lower GI losses (e.g., Diarrhea):** While diarrhea causes NAGMA and hypokalemia [1], the kidneys would respond by conserving potassium. Therefore, urine potassium would typically be **<20 mEq/L** [1]. * **Prior use of diuretics:** While diuretics cause hypokalemia, they typically result in metabolic **alkalosis** (contraction alkalosis), not acidosis. * **Current use of diuretics:** Similar to prior use, this would present with metabolic alkalosis. Additionally, while urine potassium would be high, the acid-base status does not fit the NAGMA seen in this patient. **Clinical Pearls for NEET-PG:** * **NAGMA + Hypokalemia:** Think RTA or Diarrhea. Check Urine Potassium [1]. * **Urine Anion Gap (UAG):** In RTA, the UAG is usually **positive** (reflecting decreased NH4+ excretion), whereas in diarrhea, it is **negative**. * **Type 1 RTA (Distal):** Associated with high urine pH (>5.5) and hypokalemia. * **Type 2 RTA (Proximal):** Associated with Fanconi syndrome and hypokalemia. * **Type 4 RTA:** The only RTA associated with **hyperkalemia**.

Question 109: A 60-year-old man with a 20-year smoking history presents with altered behavior over the past week, personality changes, and a productive cough for the past month. He is not a known drug addict, diabetic, or hypertensive. Physical examination reveals multiple bruises, hyper-pigmented spots on the buccal mucosa and the back of his neck. His blood pressure is 160/90 mmHg, and pulse is 70/mm. Laboratory studies show random blood sugar of 224 mg/dL, serum sodium of 140 mEq/L, serum potassium of 2.0 mEq/L, and serum bicarbonate of 27 mEq/L. Which of the following tests is most likely to be abnormal in this patient?

A. CT chest (Correct Answer)
B. MRI brain
C. Plasma metanephrine levels
D. Renal Doppler

Explanation: This clinical scenario describes a classic presentation of **Ectopic ACTH Syndrome**, most commonly associated with **Small Cell Lung Cancer (SCLC)** [1]. ### **Clinical Reasoning** The patient presents with a triad of: 1. **Cushingoid Features:** Hyperglycemia (224 mg/dL), hypertension (160/90 mmHg), and hyperpigmentation (due to ACTH-induced stimulation of melanocytes). 2. **Metabolic Derangements:** Severe hypokalemia (2.0 mEq/L) is a hallmark of ectopic ACTH production, as high cortisol levels overwhelm the 11β-HSD2 enzyme in the kidney, acting on mineralocorticoid receptors [1]. 3. **Pulmonary Symptoms:** A 20-year smoking history and productive cough strongly suggest an underlying lung malignancy. In a smoker with sudden-onset Cushing syndrome and severe hypokalemia, the most likely diagnosis is **Small Cell Lung Cancer** producing ectopic ACTH [1]. Therefore, a **CT Chest** is the most appropriate next step to identify the primary tumor [1]. ### **Analysis of Incorrect Options** * **B. MRI Brain:** While personality changes occur, they are likely due to metabolic encephalopathy (hypokalemia/hypercortisolism) rather than metastases. Pituitary MRI is used for Cushing Disease, but the rapid onset and pulmonary symptoms point toward an ectopic source [2]. * **C. Plasma Metanephrine:** Used to diagnose Pheochromocytoma. While it causes hypertension, it does not explain the hyperpigmentation or severe hypokalemia. * **D. Renal Doppler:** Used for renal artery stenosis. It causes hypertension and hypokalemia but not hyperglycemia or hyperpigmentation. ### **NEET-PG High-Yield Pearls** * **Small Cell Lung Cancer (SCLC):** Most common cause of Ectopic ACTH [1]. * **Ectopic ACTH vs. Cushing Disease:** Ectopic ACTH presents with **severe hypokalemia**, rapid onset, and hyperpigmentation; Cushing Disease (pituitary) usually lacks these. * **Paraneoplastic Syndromes of SCLC:** 1. SIADH (Hyponatremia) 2. Ectopic ACTH (Hypokalemic Alkalosis) [1] 3. Lambert-Eaton Myasthenic Syndrome (LEMS)

Question 110: Which of the following is not a characteristic of Tumor Lysis Syndrome?

A. Hyperkalemia
B. Hyperuricemia
C. Hyperphosphatemia
D. Hypercalcemia (Correct Answer)

Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells (most commonly in high-grade lymphomas and leukemias). When these cells rupture, they release their intracellular contents into the bloodstream, leading to specific metabolic derangements. ### Explanation of the Correct Answer **D. Hypercalcemia** is the correct answer because TLS is characterized by **Hypocalcemia**, not hypercalcemia [1]. As intracellular phosphorus is released into the blood (Hyperphosphatemia), it binds to circulating calcium to form calcium phosphate crystals. This precipitation leads to a rapid decline in serum ionized calcium levels. ### Analysis of Incorrect Options * **A. Hyperkalemia:** This is the most dangerous component of TLS. Potassium is the primary intracellular cation; its massive release can lead to life-threatening cardiac arrhythmias. * **B. Hyperuricemia:** Nucleic acids from the cell nuclei are catabolized into purines and then into uric acid by xanthine oxidase. This can lead to acute uric acid nephropathy and renal failure. * **C. Hyperphosphatemia:** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their lysis leads to a surge in serum phosphate. ### High-Yield Clinical Pearls for NEET-PG * **Cairo-Bishop Definition:** TLS is defined by the presence of two or more metabolic abnormalities (Hyperuricemia, Hyperkalemia, Hyperphosphatemia, or Hypocalcemia) occurring within 3 days before or 7 days after chemotherapy. * **Prevention/Treatment:** Aggressive hydration is the mainstay. **Allopurinol** is used for prophylaxis (prevents new uric acid formation), while **Rasburicase** (recombinant urate oxidase) is used for established hyperuricemia to break down existing uric acid into allantoin. * **Renal Failure:** The primary cause of acute kidney injury in TLS is the deposition of calcium phosphate and uric acid crystals in the renal tubules.

Question 111: In the case of CNS relapse in AML, what chemotherapy agent(s) would be administered intrathecally?

A. Methotrexate
B. Methotrexate + Cytosine Arabinoside
C. Prednisolone
D. None of the above (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. None of the above** **1. Why the correct answer is right:** In the management of CNS relapse in Acute Myeloid Leukemia (AML), the standard of care for intrathecal (IT) chemotherapy is the **"Triple Intrathecal Therapy"** regimen. This combination consists of **Methotrexate, Cytosine Arabinoside (Cytarabine), AND a corticosteroid (usually Hydrocortisone or Dexamethasone)**. The question provides options that are incomplete: Option A and B lack the steroid component, and Option C (Prednisolone) is not the steroid typically used in IT formulations. Because the standard protocol requires the synergistic combination of all three agents to effectively clear leukemic blasts from the cerebrospinal fluid, "None of the above" is the most accurate choice among the provided options. **2. Analysis of Incorrect Options:** * **Option A (Methotrexate):** Used as monotherapy for CNS prophylaxis in some lymphomas, but insufficient for active CNS relapse in AML. * **Option B (Methotrexate + Cytosine Arabinoside):** While these are the two primary cytotoxic agents, the omission of a corticosteroid (which reduces chemical arachnoiditis and enhances efficacy) makes this an incomplete regimen. * **Option C (Prednisolone):** Prednisolone is an oral/IV steroid. For intrathecal administration, **Hydrocortisone** is the preferred steroid component of the triple therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **CNS Involvement in AML:** Much rarer than in ALL (<5% at diagnosis), but more common in M4 (Myelomonocytic) and M5 (Monocytic) FAB subtypes. * **Triple IT Regimen:** Methotrexate (12.5–15 mg) + Cytarabine (40–50 mg) + Hydrocortisone (25–50 mg). * **Alternative:** Liposomal Cytarabine is sometimes used due to its longer half-life, allowing for less frequent dosing. * **Prophylaxis:** Unlike ALL, routine CNS prophylaxis is not standard for all AML patients; it is reserved for high-risk features like hyperleukocytosis (>1 lakh count) or specific monocytic lineages.

Question 112: A 70-year-old male presents with breathlessness, facial swelling, and dilated veins on the chest wall. What is the most common cause?

A. Hodgkin's lymphoma
B. Thymoma
C. Lung cancer
D. Superior vena cava obstruction (Correct Answer)

Explanation: ### Explanation The clinical presentation of breathlessness, facial swelling (plethora), and dilated collateral veins on the chest wall is the classic triad of **Superior Vena Cava (SVC) Syndrome**. [1] **1. Why the Correct Answer is Right:** SVC syndrome occurs due to the external compression or internal invasion of the superior vena cava, which drains blood from the head, neck, and upper extremities. When flow is obstructed, venous pressure rises, leading to facial/upper limb edema and the development of collateral venous channels on the chest wall to bypass the obstruction. [1] While the question asks for the "cause" of the symptoms, **Superior Vena Cava Obstruction** is the definitive clinical diagnosis explaining this entire pathophysiology. **2. Why the Other Options are Incorrect:** * **Lung Cancer:** While Lung Cancer (specifically Small Cell Lung Cancer) is the **most common underlying etiology** (responsible for ~70-80% of cases), it is the *pathological* cause. [2] The question asks for the immediate cause of the physical findings (the obstruction itself). * **Hodgkin’s Lymphoma & Thymoma:** These are known causes of anterior mediastinal masses that can lead to SVC syndrome, but they are significantly less common than bronchogenic carcinoma in a 70-year-old male. [1] **3. NEET-PG High-Yield Pearls:** * **Most Common Cause:** Lung Cancer (Small Cell > Squamous cell). [2] * **Most Common Benign Cause:** Iatrogenic (Indwelling catheters, pacemakers). * **Pemberton’s Sign:** Facial flushing and increased venous pressure when both arms are raised; a key clinical maneuver for SVC obstruction. * **Management:** Emergency radiotherapy is indicated if the obstruction causes airway compromise or cerebral edema. Steroids are most effective for lymphoma-induced SVC syndrome.

Question 113: NNK, NNN, and polonium 210 are carcinogens specific for which type of cancer?

A. Tobacco-related oral cancer (Correct Answer)
B. Tobacco-related bronchogenic carcinoma
C. Prostatic carcinoma
D. Hepatocellular carcinoma

Explanation: ### Explanation The correct answer is **A. Tobacco-related oral cancer.** **Understanding the Concept:** Tobacco contains over 60 known carcinogens. Among these, **Tobacco-Specific Nitrosamines (TSNAs)** are the most potent. * **NNK** [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone] and **NNN** (N-nitrosonornicotine) are formed by the nitrosation of nicotine during the curing and processing of tobacco [2]. * **Polonium-210** is a radioactive alpha-emitter absorbed by tobacco leaves from phosphate fertilizers. While these are found in cigarette smoke, they are uniquely concentrated in **smokeless tobacco (chewing tobacco/snuff)**. NNN and NNK undergo metabolic activation to form DNA adducts, leading to mutations in the oral mucosa, making them the primary drivers for **oral cavity cancers**. **Analysis of Incorrect Options:** * **B. Bronchogenic Carcinoma:** While NNK is a systemic carcinogen that can cause lung cancer, the primary drivers for lung cancer in smokers are **Polycyclic Aromatic Hydrocarbons (PAHs)** like Benzo[a]pyrene [1]. * **C. Prostatic Carcinoma:** This is primarily linked to age, genetics (BRCA2), and hormonal factors (androgens), rather than specific tobacco nitrosamines. * **D. Hepatocellular Carcinoma:** The major risk factors are Chronic Hepatitis B/C, Alcohol, and **Aflatoxin B1** (produced by *Aspergillus*) [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Most potent TSNA:** NNK is considered the most carcinogenic. * **Benzo[a]pyrene:** The classic "high-yield" carcinogen associated with cigarette smoke and lung cancer (induces *TP53* mutations). * **Vinyl Chloride:** Associated with Angiosarcoma of the liver. * **Beta-naphthylamine:** Associated with Transitional Cell Carcinoma (TCC) of the bladder in dye industry workers [1].

Question 114: All of the following are examples of cardiotoxic drugs except?

A. Cyclophosphamide
B. 5-FU
C. Adriamycin
D. Cisplatin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Cisplatin**. While Cisplatin is associated with significant nephrotoxicity and ototoxicity, it is not traditionally classified as a primary cardiotoxic agent. **1. Why Cisplatin is the correct answer:** Cisplatin’s dose-limiting toxicities are **nephrotoxicity** (prevented by aggressive hydration and amifostine) and **ototoxicity**. While it may rarely cause electrolyte imbalances that lead to secondary arrhythmias, it does not have a direct, predictable toxic effect on the myocardium compared to the other drugs listed. **2. Why the other options are wrong:** * **Adriamycin (Doxorubicin):** The classic example of cardiotoxicity. It causes dose-dependent, irreversible dilated cardiomyopathy via **oxygen free radical formation** and lipid peroxidation. The lifetime cumulative dose is limited to <450–550 mg/m². * **5-Fluorouracil (5-FU):** Known for causing **coronary vasospasm**, which can manifest as angina or even myocardial infarction. This is a unique form of cardiotoxicity unrelated to pump failure. * **Cyclophosphamide:** High doses (usually in bone marrow transplant settings) can cause **acute hemorrhagic myocarditis** and pericardial effusion. **Clinical Pearls for NEET-PG:** * **Anthracyclines (Adriamycin):** Monitor with ECHO/MUGA scans; look for a drop in Left Ventricular Ejection Fraction (LVEF). **Dexrazoxane** is the antidote used to prevent damage. * **Trastuzumab (Herceptin):** Also causes cardiotoxicity, but unlike Adriamycin, it is **not dose-dependent** and is usually **reversible** upon discontinuation. * **Taxanes (Paclitaxel):** Frequently cause asymptomatic documentation.

Question 115: Which type of thyroid cancer has the best prognosis?

A. Anaplastic thyroid cancer
B. Follicular thyroid cancer
C. Thyroid lymphoma
D. Papillary thyroid cancer (Correct Answer)

Explanation: Thyroid carcinomas are categorized based on their histological origin and clinical behavior. **Papillary Thyroid Cancer (PTC)** is the most common type of thyroid malignancy (80-85%) and carries the **best prognosis**, with a 10-year survival rate exceeding 90-95% [1]. This favorable outcome is due to its slow growth, high sensitivity to radioactive iodine (RAI) therapy, and tendency to remain localized or spread only to regional lymph nodes rather than distant organs [1]. **Analysis of Options:** * **Papillary Thyroid Cancer (Correct):** It is the least aggressive. Even in the presence of cervical lymph node metastasis, the overall survival remains excellent. * **Follicular Thyroid Cancer:** While also well-differentiated, it has a slightly worse prognosis than PTC. It tends to spread hematogenously (via blood) to bones and lungs, making it more difficult to manage than the lymph node spread of PTC. * **Thyroid Lymphoma:** Usually associated with Hashimoto’s thyroiditis, its prognosis depends on the subtype (e.g., MALT vs. DLBCL) [2] and response to chemotherapy/radiation, but it is generally more aggressive than PTC. * **Anaplastic Thyroid Cancer:** This is one of the most lethal human malignancies. It is undifferentiated, grows rapidly, and is often resistant to conventional therapy, with a median survival of only 6 months. **NEET-PG High-Yield Pearls:** * **Most common thyroid cancer:** Papillary (PTC). * **Histology of PTC:** Look for **Orphan Annie eye nuclei** (clear nuclei), **Psammoma bodies** (laminated calcifications), and nuclear grooves. * **Risk Factor:** Prior exposure to ionizing radiation is strongly linked to PTC. * **Genetic Mutation:** **BRAF mutations** are most common in PTC; **RAS** in Follicular; **RET/PTC** rearrangements are also seen in PTC. * **Prognostic Rule:** The "Rule of 10s" for PTC—10% have distant metastasis, 10% recur, and 10% die of the disease.

Question 116: Kaposi sarcoma is commonly seen in which part of the body?

A. Upper limbs
B. Lower limbs (Correct Answer)
C. Head and neck
D. Trunk

Explanation: **Explanation:** Kaposi Sarcoma (KS) is a multicentric vascular neoplasm caused by **Human Herpesvirus 8 (HHV-8)** [1]. It is most frequently associated with HIV/AIDS (Epidemic KS) and elderly men of Mediterranean or Eastern European descent (Classic KS). **Why Lower Limbs is Correct:** In the **Classic (Sporadic) form** of Kaposi Sarcoma, the lesions typically manifest as purple, red, or brown macules, plaques, or nodules. These lesions have a strong predilection for the **lower extremities**, particularly the distal portions like the feet and ankles. This is attributed to venous stasis and lymphedema, which are thought to promote the local proliferation of spindle cells and inflammatory cytokines. **Analysis of Incorrect Options:** * **Upper Limbs:** While KS can involve the arms, it is rarely the primary or most common site of presentation compared to the legs. * **Head and Neck:** In HIV-associated (Epidemic) KS, lesions frequently appear on the face (especially the nose) and the oral cavity (hard palate) [1]. However, across all clinical subtypes, the lower limbs remain the most characteristic site for initial cutaneous manifestation. * **Trunk:** Truncal involvement is usually seen in advanced, disseminated stages of the disease rather than as the primary site of presentation. **NEET-PG High-Yield Pearls:** * **Pathogenesis:** Proliferation of spindle cells (endothelial origin) infected with **HHV-8**. * **Histology:** Characterized by **slit-like vascular spaces** containing extravasated red blood cells and hemosiderin staining. * **Clinical Variants:** Classic (Elderly), Endemic (African), Iatrogenic (Transplant-related), and Epidemic (AIDS-related) [1]. * **Treatment:** Highly Active Antiretroviral Therapy (HAART) is the first-line treatment for AIDS-related KS; localized lesions may be treated with cryotherapy or radiation.

Question 117: Tumor Lysis Syndrome causes all of the following except?

A. Hypercalcemia (Correct Answer)
B. Hyperuricemia
C. Hypermagnesemia
D. Hyperkalemia

Explanation: Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells (usually following chemotherapy for high-grade lymphomas or leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation. Why Hypercalcemia is the correct answer: TLS characteristically causes Hypocalcemia, not hypercalcemia. This occurs because the massive release of intracellular phosphorus leads to Hyperphosphatemia. The excess phosphate binds to ionized calcium, forming calcium-phosphate crystals that precipitate in soft tissues and the kidneys, thereby lowering serum calcium levels. Analysis of other options: * Hyperuricemia (B): Nucleic acids from the destroyed cell nuclei are catabolized into purines and subsequently converted by xanthine oxidase into uric acid [1]. * Hypermagnesemia (C): Magnesium is primarily an intracellular cation. Rapid cell lysis releases magnesium into the blood. (Note: While hyperkalemia and hyperphosphatemia are more clinically prominent, hypermagnesemia is a recognized component of TLS). * Hyperkalemia (D): Potassium is the major intracellular cation. Its rapid release is the most life-threatening metabolic abnormality in TLS, potentially causing fatal arrhythmias. High-Yield Clinical Pearls for NEET-PG: * Cairo-Bishop Definition: Used to classify TLS based on laboratory (2 or more abnormalities) and clinical criteria. * Prophylaxis/Treatment: Aggressive hydration is the mainstay. Allopurinol (prevents new uric acid formation) or Rasburicase (recombinant urate oxidase that breaks down existing uric acid) are used. * Renal Failure: Caused by the precipitation of both uric acid crystals and calcium-phosphate crystals in the renal tubules.

Question 118: Lutetium dotatate was approved by FDA in 2018 for which of the following conditions?

A. Tuberculosis
B. Neuroendocrine tumours (Correct Answer)
C. Crohn's disease
D. Peptic ulcer

Explanation: **Explanation:** **Lutetium-177 (177Lu) dotatate** (commercially known as Lutathera) represents a breakthrough in **Peptide Receptor Radionuclide Therapy (PRRT)**. Its approval by the FDA in 2018 marked a significant shift in the management of somatostatin receptor-positive **Neuroendocrine Tumors (NETs)**, specifically those affecting the gastroenteropancreatic system (GEP-NETs) [2]. **Why the correct answer is right:** The mechanism of action involves a "search and destroy" approach. Lutetium-177 is a beta-emitting radionuclide conjugated to **DOTATATE**, a somatostatin analog. Most NETs overexpress **Somatostatin Receptors (SSTR)**, particularly subtype 2 [3]. The DOTATATE molecule binds specifically to these receptors, allowing the Lutetium-177 to be internalized into the tumor cell. Once inside, the beta radiation causes localized DNA damage, leading to tumor cell death while sparing surrounding healthy tissue. **Why incorrect options are wrong:** * **Tuberculosis (A):** An infectious disease caused by *M. tuberculosis*; treated with multidrug antitubercular therapy (ATT), not radiopharmaceuticals. * **Crohn’s Disease (C):** An inflammatory bowel disease (IBD) managed with immunosuppressants, steroids, and biologics (e.g., Infliximab) [4]. * **Peptic Ulcer (D):** A mucosal break caused by *H. pylori* or NSAIDs; treated with Proton Pump Inhibitors (PPIs) and antibiotics [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Specifically approved for adult patients with SSTR-positive GEP-NETs (including foregut, midgut, and hindgut tumors) [2]. * **Diagnostic Pairing:** Before treatment, a **Ga-68 DOTATATE PET/CT** (Theranostics) is usually performed to confirm SSTR expression. * **Side Effects:** The most critical dose-limiting toxicity is **nephrotoxicity** and bone marrow suppression. Amino acid infusions (Lysine/Arginine) are administered concurrently to protect the kidneys. * **Radiation Type:** Lutetium-177 is primarily a **Beta emitter** (for therapy) but also emits low-energy **Gamma rays**, which allows for post-therapy imaging (scintigraphy).

Question 119: Which of the following conditions is associated with hypercalcemia?

A. Pancreatic cancer
B. Hepatocellular carcinoma (Correct Answer)
C. Gastric cancer
D. Gallbladder cancer

Explanation: **Explanation:** Hypercalcemia in malignancy is primarily driven by three mechanisms: secretion of **Parathyroid Hormone-related Protein (PTHrP)**, local osteolytic bone metastases, or excessive production of 1,25-dihydroxyvitamin D [1]. **Hepatocellular Carcinoma (HCC)** is a well-recognized cause of **Paraneoplastic Syndrome**, specifically through the secretion of PTHrP [1]. This protein mimics the action of PTH by binding to the same receptors in the bone and kidneys, leading to increased bone resorption and calcium reabsorption [3]. While not the most common malignancy associated with hypercalcemia (squamous cell carcinomas of the lung and head/neck are more frequent), HCC is the correct choice among the provided gastrointestinal/hepatobiliary options [1]. **Analysis of Incorrect Options:** * **Pancreatic, Gastric, and Gallbladder cancers:** While any advanced malignancy with extensive bone metastasis can theoretically cause hypercalcemia, these cancers are rarely associated with humoral hypercalcemia of malignancy (PTHrP secretion) [2]. They are much more likely to present with other paraneoplastic features (e.g., Trousseau sign in pancreatic cancer) or obstructive symptoms rather than metabolic hypercalcemia. **High-Yield NEET-PG Pearls:** * **Most common cause of hypercalcemia in hospitalized patients:** Malignancy. * **Most common mechanism:** Humoral hypercalcemia of malignancy (PTHrP) – accounts for ~80% of cases. * **Common PTHrP-secreting tumors:** Squamous cell carcinoma (Lung, Head/Neck), Renal Cell Carcinoma (RCC), Breast cancer, and HCC [1]. * **Treatment of choice:** Aggressive IV hydration with normal saline is the first step; Bisphosphonates (Zoledronic acid) are the mainstay for long-term management.

Question 120: Which of the following antineoplastic agents is used in the management of Hodgkin's lymphoma, non-Hodgkin's lymphoma, and small cell carcinoma of the lung?

A. Cisplatin (Correct Answer)
B. Bleomycin
C. Paclitaxel
D. Doxorubicin

Explanation: **Explanation:** The correct answer is **Cisplatin**. Cisplatin is a potent platinum-based alkylating-like agent that causes cross-linking of DNA strands, leading to apoptosis. It is a cornerstone of "combination chemotherapy" due to its broad-spectrum activity against both solid tumors and hematological malignancies. * **Why Cisplatin is correct:** It is a key component in salvage regimens for **Hodgkin’s Lymphoma** (e.g., DHAP: Dexamethasone, High-dose Ara-C, Cisplatin) and **Non-Hodgkin’s Lymphoma** (e.g., ESHAP) [1]. Furthermore, it is the gold-standard first-line treatment for **Small Cell Lung Cancer (SCLC)**, usually combined with Etoposide [1]. **Analysis of Incorrect Options:** * **Bleomycin:** While used in Hodgkin’s (ABVD regimen), it has no significant role in Small Cell Lung Cancer. Its main side effect is pulmonary fibrosis. * **Paclitaxel:** Primarily used in Non-Small Cell Lung Cancer (NSCLC), breast, and ovarian cancers. It is not a standard first-line agent for Hodgkin’s or SCLC. * **Doxorubicin:** Though a mainstay for Hodgkin’s (ABVD) and NHL (CHOP), it is rarely used for SCLC compared to the platinum-etoposide backbone. **High-Yield Clinical Pearls for NEET-PG:** * **Cisplatin Toxicity:** Characterized by the "3 Ns": **N**ephrotoxicity (prevented by aggressive hydration and Amifostine), **N**eurotoxicity (peripheral neuropathy), and severe **N**ausea/vomiting (highly emetogenic). It is also associated with **Ototoxicity**. * **Small Cell Lung Cancer:** Always remember the "Platinum + Etoposide" duo as the classic answer for management [1]. * **Vincristine vs. Vinblastine:** Remember **B**lastine for **B**one marrow suppression; **C**ristine for **C**onstipation and peripheral neuropathy.

Question 121: Which of the following is NOT true about Zollinger-Ellison syndrome?

A. Surgery is a treatment option.
B. It involves an exocrine tumor. (Correct Answer)
C. It is an endocrine disorder.
D. Secretory diarrhea is a common symptom.

Explanation: **Explanation:** Zollinger-Ellison Syndrome (ZES) is characterized by the development of a **gastrinoma**, a neuroendocrine tumor that secretes excessive amounts of gastrin [1]. **1. Why Option B is the correct answer (The "NOT true" statement):** ZES involves an **endocrine** tumor, not an exocrine one. Gastrinomas arise from the G-cells (neuroendocrine cells) typically located in the "gastrinoma triangle" (duodenum, pancreas, or lymph nodes) [1]. Exocrine tumors of the pancreas (like adenocarcinoma) arise from ductal cells and do not secrete hormones into the bloodstream. **2. Analysis of other options:** * **Option A (Surgery):** Surgery is a definitive treatment option, especially for localized tumors without metastasis, to prevent malignancy and control hormonal excess. * **Option C (Endocrine disorder):** This is true. ZES is a classic endocrine pathology where ectopic hormone production (gastrin) leads to systemic effects (hyperchlorhydria) [1]. * **Option D (Secretory diarrhea):** This is a hallmark symptom. The massive acid production inactivates pancreatic enzymes and damages the intestinal mucosa, leading to malabsorption and secretory diarrhea. **Clinical Pearls for NEET-PG:** * **The Triad:** Gastric acid hypersecretion, severe peptic ulceration, and non-beta cell islet tumor (gastrinoma). * **Association:** Approximately 25% of ZES cases are associated with **Multiple Endocrine Neoplasia Type 1 (MEN1)**. * **Diagnosis:** Best initial test is **fasting serum gastrin levels** (>1000 pg/mL is diagnostic). The most specific provocative test is the **Secretin Stimulation Test** (paradoxical rise in gastrin) [1]. * **Location:** Most gastrinomas are found in the **Gastrinoma Triangle** (Passaro's Triangle).

Question 122: A 64-year-old man receiving chemotherapy for squamous cell cancer of the lung develops erythema, induration, thickening, and eventual peeling of the skin on his fingers, palms, and soles of his feet. What is the most likely chemotherapeutic agent causing this adverse reaction?

A. methotrexate
B. cytarabine
C. 5-fluorouracil (5-FU)
D. bleomycin (Correct Answer)

Explanation: ### **Explanation** The clinical presentation described—erythema, induration, thickening, and peeling of the skin on the palms and soles—is characteristic of **Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia)** or localized dermatological toxicity. **Why Bleomycin is the Correct Answer:** Bleomycin is unique among chemotherapeutic agents because it is inactivated by the enzyme **bleomycin hydrolase**. This enzyme is found in high concentrations in most tissues but is notably **deficient in the skin and the lungs**. Consequently, bleomycin accumulates in these organs, leading to its hallmark toxicities: pulmonary fibrosis and dermatological reactions [1]. Specific skin findings include hyperpigmentation (often "flagellate" streaks), hyperkeratosis, and the induration/peeling described in the question. These features of symmetrical thickening, tightening, and induration (sclerodactyly) reflect the drug's specialized skin toxicity [2]. **Why Other Options are Incorrect:** * **Methotrexate:** Primarily causes mucosal toxicity (mucositis/stomatitis), myelosuppression, and hepatotoxicity. While it can cause photosensitivity, it does not typically present with this specific induration/peeling pattern. * **Cytarabine:** Known for causing "Ara-C syndrome" (fever, rash, conjunctivitis) and cerebellar toxicity at high doses. * **5-Fluorouracil (5-FU):** While 5-FU and its prodrug Capecitabine are classic causes of Hand-Foot Syndrome, in the context of **Squamous Cell Carcinoma (SCC) of the lung**, Bleomycin is a more historically relevant and frequently tested association for specific scleroderma-like skin changes and induration. **NEET-PG High-Yield Pearls:** 1. **Flagellate Hyperpigmentation:** A pathognomonic sign for Bleomycin toxicity (linear streaks on the trunk). 2. **Pulmonary Toxicity:** Bleomycin causes interstitial fibrosis; monitor with DLCO (Diffusion Capacity of Lung). 3. **Cell Cycle:** Bleomycin is **G2 phase-specific** and works by inducing free radical formation, causing DNA strand breaks. 4. **Hand-Foot Syndrome (General):** Most commonly associated with **Capecitabine, 5-FU, and Cytarabine**. However, when "induration and thickening" are emphasized in a patient with SCC, think of Bleomycin’s scleroderma-like effects [2].

Question 123: Which paraneoplastic syndrome is NOT seen in renal cell carcinoma?

A. Acanthosis nigricans
B. Amyloidosis
C. Polycythemia (Correct Answer)
D. Systemic Lupus Erythematosus (SLE)

Explanation: Renal Cell Carcinoma (RCC) is famously known as the **"Internist’s Tumor"** because it presents with a wide array of paraneoplastic syndromes (PNS) due to the ectopic secretion of hormones and cytokines [1]. **Explanation of the Correct Answer:** The question asks which syndrome is **NOT** seen in RCC. However, there appears to be a discrepancy in the provided key: **Polycythemia is actually a classic paraneoplastic manifestation of RCC**, occurring in 1-5% of patients due to the ectopic production of **Erythropoietin (EPO)** [1]. In the context of standard medical examinations, **Systemic Lupus Erythematosus (SLE)** (Option D) is the correct answer for "NOT seen." While RCC can cause various autoimmune-like phenomena, it does not typically cause SLE. If the provided key insists on Polycythemia, it contradicts standard medical literature (Harrison’s Principles of Internal Medicine). **Analysis of Options:** * **Polycythemia:** A classic PNS of RCC caused by inappropriate EPO production [1]. * **Amyloidosis:** Secondary (AA) amyloidosis occurs in ~3-5% of RCC cases due to chronic inflammation and elevated Serum Amyloid A. * **Acanthosis Nigricans:** While more common in gastric cancer, it is a recognized (though rare) cutaneous paraneoplastic manifestation of various visceral malignancies, including RCC. * **SLE:** This is a primary autoimmune disease and is not recognized as a paraneoplastic syndrome of RCC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common PNS in RCC:** Hypercalcemia (due to PTHrP) [1]. * **Stauffer’s Syndrome:** Reversible hepatic dysfunction (elevated LFTs) in the absence of liver metastases. * **Other common PNS:** Hypertension (Renin), Cushing’s syndrome (ACTH), and Galactorrhea (Prolactin). * **Classic Triad (only in 10%):** Hematuria, Flank pain, and Palpable mass [2].

Question 124: What is the recommended screening method for hepatocellular carcinoma (HCC) in patients with chronic liver disease?

A. Serial Ultrasound (USG) and Alpha-fetoprotein (AFP) (Correct Answer)
B. Serial Liver Function Tests (LFT) and AFP
C. Serial LFT and CT scan
D. Serial USG and serial LFT

Explanation: **Explanation:** The primary goal of screening for Hepatocellular Carcinoma (HCC) is early detection in high-risk individuals (primarily those with cirrhosis or chronic Hepatitis B/C) [1] to allow for curative interventions. **Why Option A is Correct:** The current standard of care, supported by AASLD and EASL guidelines, is the combination of **Abdominal Ultrasound (USG) and Serum Alpha-fetoprotein (AFP)** performed every **6 months**. * **USG** is the preferred imaging modality due to its non-invasive nature, cost-effectiveness, and high specificity [1]. * **AFP** is a tumor marker that increases the sensitivity of screening when used alongside USG, as USG alone may miss small lesions in a nodular cirrhotic liver [1]. **Why Other Options are Incorrect:** * **Options B & D (LFTs):** Liver Function Tests (ALT, AST, Bilirubin) reflect the degree of liver inflammation or synthetic dysfunction but are not diagnostic or predictive of malignancy. * **Option C (CT Scan):** While Triple-phase CT is the gold standard for *diagnosis* [1], it is not used for *screening* due to high costs, radiation exposure, and the risk of contrast-induced nephropathy [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Interval:** 6 months (based on the doubling time of HCC). * **Diagnostic Gold Standard:** Contrast-enhanced CT or MRI showing **"Wash-in"** (arterial enhancement) and **"Wash-out"** (venous/delayed phase) is diagnostic of HCC in cirrhotic patients [1]; a biopsy is often unnecessary. * **AFP Cut-off:** While >20 ng/mL is often used for screening, values >400 ng/mL are highly suggestive of HCC. * **Target Population:** All cirrhotic patients (Child-Pugh A and B) and specific non-cirrhotic HBV carriers.

Question 125: Which of the following is a good prognostic marker?

A. Age > 10 years
B. Male sex
C. Hyperploidy (Correct Answer)
D. Translocation (9;22)

Explanation: This question pertains to the prognostic factors in **Acute Lymphoblastic Leukemia (ALL)**, which is a high-yield topic for NEET-PG. Prognosis in ALL is determined by age, initial white blood cell (WBC) count, and specific cytogenetic abnormalities [1]. ### **Why Hyperploidy is Correct** **Hyperploidy** (defined as >50 chromosomes per cell) is one of the most significant **favorable prognostic markers** in pediatric ALL [1]. It is often associated with the accumulation of methotrexate polyglutamates within leukemic blasts, making the cells highly sensitive to chemotherapy. Another favorable genetic marker is the **t(12;21)** translocation (ETV6-RUNX1). ### **Explanation of Incorrect Options** * **Age > 10 years:** The "Age Peak" for a good prognosis is between **1 and 9 years**. Children younger than 1 year (infants) or older than 10 years (adolescents) have a poorer prognosis. * **Male Sex:** Historically, males have a slightly worse prognosis than females, partly due to the risk of late relapses in sanctuary sites like the testes. * **Translocation (9;22):** Also known as the **Philadelphia Chromosome** (BCR-ABL1), this is a notorious **poor prognostic marker** in ALL [1]. It is more common in adults and requires treatment with Tyrosine Kinase Inhibitors (TKIs) like Imatinib. ### **NEET-PG High-Yield Pearls: ALL Prognosis** | Feature | Favorable Prognosis | Unfavorable Prognosis | | :--- | :--- | :--- | | **Age** | 1–9 years | <1 year or >10 years | | **WBC Count** | <50,000/µL | >50,000/µL | | **Cytogenetics** | **Hyperploidy**, t(12;21) | **t(9;22)**, t(4;11), Hypoploidy | | **Response** | Rapid (CR by day 14) | Slow response to induction | | **Immunotype** | Early Pre-B cell | Mature B-cell or T-cell |

Question 126: A 58-year-old man with a 700-pack-year smoking history presents with shortness of breath and hemoptysis. Portable chest radiography demonstrates a large mass centrally located within the left lung field. The serum calcium is 13.0 mg/dL (normal 8.5 to 10.2). The metabolic abnormality described here is likely due to elaboration of which substance?

A. Adrenocorticotropic hormone-like substance
B. Antidiuretic hormone
C. Carcinoembryonic antigen
D. Parathyroid-related hormone (Correct Answer)

Explanation: The patient presents with a central lung mass, a heavy smoking history, and significant hypercalcemia (13.0 mg/dL). This clinical triad is classic for **Squamous Cell Carcinoma (SCC)** of the lung. [1] **1. Why Option D is Correct:** Hypercalcemia in lung cancer is most commonly a **paraneoplastic syndrome** caused by the secretion of **Parathyroid Hormone-related Protein (PTHrP)** [2]. PTHrP mimics the action of PTH by binding to the same receptors in the bone and kidney, leading to increased bone resorption and decreased renal calcium excretion. This is specifically associated with Squamous Cell Carcinoma (mnemonic: **S**quamous = **S**ecretion of PTHrP = **S**tones/Hypercalcemia) [2]. **2. Why the Other Options are Incorrect:** * **Option A (ACTH):** Ectopic ACTH production leads to Cushing Syndrome (hypokalemia, hypertension). This is a paraneoplastic syndrome associated with **Small Cell Lung Cancer (SCLC)**, not SCC [2]. * **Option B (ADH):** Ectopic ADH secretion causes SIADH (hyponatremia). This is also a classic feature of **Small Cell Lung Cancer** [2]. * **Option C (CEA):** Carcinoembryonic antigen is a tumor marker used for monitoring colorectal and some lung adenocarcinomas, but it does not cause metabolic abnormalities like hypercalcemia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Central Lung Tumors:** Squamous Cell Carcinoma and Small Cell Carcinoma (The "S" tumors are **S**moking-related and **S**entral) [1]. * **Peripheral Lung Tumors:** Adenocarcinoma (most common in non-smokers and females). * **Hypercalcemia of Malignancy:** PTHrP is the most common cause (80%); the second most common is local osteolytic hypercalcemia (bone metastases). * **Small Cell Lung Cancer (SCLC):** Associated with Lambert-Eaton Syndrome, SIADH, and ACTH [2]. * **Squamous Cell Carcinoma (SCC):** Associated with PTHrP (Hypercalcemia) and Pancoast tumors [2].

Question 127: Which of the following is a risk factor for colorectal cancer?

A. Male sex
B. Red meat consumption (Correct Answer)
C. High intake of animal fat
D. Use of NSAIDS

Explanation: ### Explanation **Correct Answer: B. Red meat consumption** The association between diet and colorectal cancer (CRC) is a high-yield topic for NEET-PG. **Red meat** (beef, lamb, pork) and **processed meats** (ham, bacon, salami) are classified by the IARC as Group 1 carcinogens. The underlying medical mechanism involves the formation of **N-nitroso compounds (NOCs)**, polycyclic aromatic hydrocarbons, and heterocyclic amines during cooking. These compounds cause DNA damage and promote colonic carcinogenesis. **Analysis of Options:** * **A. Male sex:** While the incidence of CRC is slightly higher in males, **age** is a much more significant non-modifiable risk factor than sex. Most cases occur after age 50. * **C. High intake of animal fat:** Historically, high fat was linked to CRC; however, recent large-scale prospective studies (like the Nurses' Health Study) have shown that the **type of food** (red/processed meat) is a more definitive risk factor than total animal fat intake alone. * **D. Use of NSAIDs:** This is a **protective factor**, not a risk factor. Regular use of Aspirin or other NSAIDs inhibits the COX-2 enzyme, which is overexpressed in 80-90% of colorectal adenocarcinomas. NSAIDs are known to reduce the size and number of polyps, especially in FAP patients. **High-Yield Clinical Pearls for NEET-PG:** 1. **Protective Factors:** High-fiber diet, Calcium, Vitamin D, Physical activity, and NSAIDs/Aspirin. 2. **Most Common Site:** Historically the rectum/sigmoid, but there is a rising trend of **right-sided (proximal) colon cancers** [1]. Over 65% occur in the rectosigmoid and a further 15% recur in the caecum or ascending colon [1]. 3. **Screening Gold Standard:** Colonoscopy every 10 years, starting at age 45 (updated guideline) for average-risk individuals. 4. **Streptococcus bovis (S. gallolyticus):** If found in blood culture (endocarditis), always perform a colonoscopy to rule out occult CRC.

Question 128: For the following medical condition, select the associated acid-base disturbance: Chronic pulmonary disease on steroids.

A. Metabolic acidosis and respiratory acidosis
B. Metabolic acidosis and respiratory alkalosis
C. Metabolic alkalosis and respiratory acidosis (Correct Answer)
D. Metabolic alkalosis and respiratory alkalosis

Explanation: This question tests the ability to recognize mixed acid-base disturbances in a clinical context. The patient has two distinct physiological processes occurring simultaneously: **1. Why Option C is Correct:** * **Respiratory Acidosis:** Chronic pulmonary disease (such as COPD) leads to alveolar hypoventilation and impaired gas exchange. This causes the retention of carbon dioxide ($CO_2$), leading to an increase in $PaCO_2$ and a decrease in pH [2], [4]. Specifically in severe COPD, the $PaCO_2$ may be persistently raised [5]. * **Metabolic Alkalosis:** Steroids (glucocorticoids) have inherent mineralocorticoid activity. This leads to increased sodium reabsorption and increased excretion of potassium ($K^+$) and hydrogen ions ($H^+$) in the distal renal tubules. The loss of $H^+$ ions results in a primary increase in serum bicarbonate, causing metabolic alkalosis. Corticosteroid therapy is a recognized cause of hypervolemic metabolic alkalosis [1]. **2. Why Incorrect Options are Wrong:** * **Option A & B:** Metabolic acidosis is incorrect because steroids promote $H^+$ loss, not retention. Conditions like renal failure or ketoacidosis would be required for metabolic acidosis. * **Option D:** Respiratory alkalosis occurs in hyperventilation (e.g., acute asthma or pulmonary embolism). In chronic obstructive disease, the baseline state is typically $CO_2$ retention (acidosis), not washout [2], [5]. **Clinical Pearls for NEET-PG:** * **Mixed Acid-Base Disorders:** Always look for two separate "hits" (e.g., a lung pathology + a drug or vomiting). Acid-base disorders can occur in combination [4]. * **Steroid Side Effects:** Remember the mnemonic **"Hypo-K-Alkalosis"**—steroids and diuretics are common culprits for metabolic alkalosis in clinical vignettes [1]. * **Compensation:** In chronic respiratory acidosis, the kidneys compensate by retaining $HCO_3^-$ over days and weeks [3]. In chronic type II respiratory failure from COPD, the kidneys retain bicarbonate to correct arterial pH toward normal [5]. However, when steroids are added, the elevation in $HCO_3^-$ is "primary" and often exceeds the expected compensatory range, confirming a mixed disorder [3].

Question 129: Which of the following is the most effective treatment for ER-positive breast cancer?

A. Tamoxifen (Correct Answer)
B. Exemestane
C. Leuprolide
D. Bicalutamide

Explanation: Explanation: In ER-positive (Estrogen Receptor-positive) breast cancer, the tumor cells depend on estrogen for growth. **Tamoxifen** is a Selective Estrogen Receptor Modulator (SERM) that acts as a competitive antagonist at the estrogen receptors in breast tissue, effectively blocking the proliferative signals. It is considered the gold standard and most widely used hormonal therapy for both pre-menopausal and post-menopausal women with ER-positive breast cancer. Analysis of Options: * **Tamoxifen (A):** The drug of choice for ER+ breast cancer across all age groups. It reduces the risk of recurrence and contralateral breast cancer. * **Exemestane (B):** This is an Aromatase Inhibitor (AI). While AIs are highly effective (and often preferred) in **post-menopausal** women, they are ineffective in pre-menopausal women unless combined with ovarian suppression, making Tamoxifen the more "universal" correct answer for general ER+ treatment. * **Leuprolide (C):** A GnRH agonist used for ovarian suppression. While used in breast cancer management to induce medical menopause, it is rarely used as a monotherapy and is usually an adjunct to Tamoxifen or AIs. * **Bicalutamide (D):** An anti-androgen used primarily in the treatment of **Prostate Cancer**, not breast cancer. High-Yield Clinical Pearls for NEET-PG: * **Tamoxifen Side Effects:** It acts as an agonist in the uterus and bone. This leads to an increased risk of **Endometrial Carcinoma** and thromboembolism (DVT/PE), but it helps prevent osteoporosis. * **Aromatase Inhibitors (Letrozole, Anastrozole):** These are the first-line choice specifically for **post-menopausal** ER+ patients but carry a risk of osteoporosis and joint pain. * **HER2/neu positive:** For these patients, **Trastuzumab** (a monoclonal antibody against ErbB2) is the treatment of choice.

Question 130: A 25-year-old male presents with pigmented macules on the palms, soles, and oral mucosa. He also has anemia and abdominal pain. What is the most probable diagnosis?

A. Albright's syndrome
B. Cushing's syndrome
C. Peutz-Jeghers syndrome (Correct Answer)
D. Incontinentia pigmenti

Explanation: The clinical presentation of **mucocutaneous pigmentation** (pigmented macules on palms, soles, and oral mucosa) combined with **anemia** and **abdominal pain** is classic for **Peutz-Jeghers Syndrome (PJS)**. **Why C is correct:** PJS is an autosomal dominant condition caused by a mutation in the **STK11 (LKB1)** gene. It is characterized by: 1. **Hamartomatous polyps:** Primarily in the small intestine, which can cause intussusception (leading to abdominal pain) and chronic occult bleeding (leading to iron-deficiency anemia). [1] 2. **Melanocytic macules:** Distinctive dark spots on the lips, buccal mucosa, palms, and soles. Unlike freckles, these do not fade with sun exposure. **Why the other options are incorrect:** * **A. Albright’s Syndrome (McCune-Albright):** Presents with "Café-au-lait" spots (large, irregular borders), polyostotic fibrous dysplasia, and precocious puberty. It does not involve oral mucosal pigmentation or intestinal polyps. * **B. Cushing’s Syndrome:** Characterized by weight gain, moon facies, striae, and hypertension. While hyperpigmentation can occur in ACTH-dependent causes, it is generalized and lacks the specific macules and GI symptoms seen here. * **C. Incontinentia Pigmenti:** An X-linked dominant skin disorder that evolves through stages (vesicular, verrucous, hyperpigmented). The pigmentation follows Blaschko’s lines and is associated with dental and CNS anomalies, not GI polyposis. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Autosomal Dominant (STK11 gene on Chromosome 19p). * **Cancer Risk:** Patients have a significantly increased risk of GI cancers and extra-intestinal malignancies (Breast, Pancreas, Ovary/Sertoli cell tumors). [1] * **Most common site of polyps:** Small intestine (Jejunum). * **Management:** Regular screening with upper/lower GI endoscopy and imaging for extra-intestinal tumors.

Question 131: A 26-year-old woman presents with diffuse abdominal pain and nausea, which began 1 day ago and is now at its maximum intensity. She denies fever but reports constipation and dark urine. She has a history of similar episodes, having undergone appendectomy and cholecystectomy on separate occasions. Physical examination reveals tachycardia, diffuse abdominal tenderness without rebound tenderness, and slightly sluggish bowel sounds. Neurological examination shows decreased sensation to fine and crude touch in both lower extremities up to the knees. Laboratory findings include normal hemoglobin, WBC, and platelet counts. She has mild transaminitis with ALT 123 IU/L, AST 160 IU/L, and ALP 122 IU/L. Urine is red, but a urine dipstick is negative for blood, leukocyte esterase, nitrite, glucose, or protein. Urine porphobilinogen and total porphyrin levels are elevated, while plasma porphyrin levels are normal. What is the most likely explanation for her recurrent symptoms?

A. Variegate porphyria
B. Thalassemia
C. Acute intermittent porphyria (Correct Answer)
D. Porphyria cutanea tarda

Explanation: **Explanation:** The patient presents with the classic triad of **Acute Intermittent Porphyria (AIP)**: abdominal pain, neuropsychiatric symptoms (peripheral neuropathy), and autonomic instability (tachycardia, constipation) [1]. **Why AIP is the correct answer:** AIP is an autosomal dominant disorder caused by a deficiency in **porphobilinogen (PBG) deaminase** [4]. * **Clinical Presentation:** Recurrent "surgical-like" abdominal pain without rebound tenderness (neurovisceral) is hallmark [1]. History of unnecessary surgeries (appendectomy/cholecystectomy) is a classic board-exam clue. * **Urine Findings:** The "dark/red urine" that is **dipstick-negative for blood** indicates the presence of porphyrins/porphyrin precursors rather than hemoglobin or myoglobin. * **Biochemical Marker:** Elevated urinary **PBG** and delta-aminolevulinic acid (ALA) during attacks are diagnostic [4]. Crucially, in AIP, **plasma porphyrins are normal**, and there are **no cutaneous photosensitivity** features, distinguishing it from other porphyrias [4]. **Why other options are incorrect:** * **Variegate Porphyria:** While it presents with similar neurovisceral attacks, it typically features **cutaneous photosensitivity** (blisters/erosions) and **elevated plasma porphyrins** (with a characteristic fluorescence peak) [4]. * **Thalassemia:** Presents with chronic anemia, splenomegaly, and characteristic peripheral smear findings (target cells); it does not cause acute neurovisceral attacks or porphobilinogenuria. * **Porphyria Cutanea Tarda (PCT):** The most common porphyria, but it presents **only with skin findings** (fragile skin, blisters on sun-exposed areas) and lacks acute abdominal or neurological symptoms [2]. **NEET-PG High-Yield Pearls:** * **Mnemonic (5 Ps):** **P**ainful abdomen, **P**ort-wine urine, **P**olyneuropathy, **P**sychological disturbances, **P**recipitated by drugs (e.g., Cytochrome P450 inducers like Barbiturates, Sulfonamides) [1]. * **Management:** Acute attacks are treated with **IV Hemin** (inhibits ALA synthase via feedback) and **high-dose glucose** (dextrose) to suppress heme synthesis [3].

Question 132: A patient with Hodgkin's lymphoma presents with a single cervical lymph node. Biopsy shows the lymphocyte-predominant variant. Which of the following is the treatment of choice?

A. Chemotherapy with Radiotherapy
B. Chemotherapy only
C. Radiotherapy only (Correct Answer)
D. No treatment needed

Explanation: ### Explanation **Concept:** The patient has **Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)**. This is a distinct clinical entity from Classical Hodgkin Lymphoma (cHL) [1]. NLPHL is characterized by an indolent (slow-growing) course, a tendency to present in early stages (Stage I or II), and the presence of "Popcorn cells" (LP cells) that are CD20 positive. **Why Radiotherapy only is correct:** For **Early-stage (Stage IA or IIA)** NLPHL without risk factors, **Involved-Field Radiation Therapy (IFRT)** or Involved-Site Radiation Therapy (ISRT) is the standard of care [2]. Because the disease is localized and highly radiosensitive, radiotherapy alone achieves excellent long-term survival rates (>90%) and avoids the systemic toxicity of chemotherapy [2]. **Why other options are incorrect:** * **Option A & B:** Combined Modality Therapy (CMT) or chemotherapy alone (e.g., ABVD or CHOP + Rituximab) is generally reserved for advanced stages (III-IV) or early stages with bulky disease/B-symptoms. Using them for a single node is considered "over-treatment." * **Option D:** While NLPHL is indolent, it is not a "watch and wait" disease like some low-grade B-cell lymphomas; active localized treatment is required to prevent progression or transformation. --- ### NEET-PG High-Yield Pearls * **Immunophenotype:** NLPHL is **CD20+** and **CD45+**, but usually **CD15- and CD30-** (the opposite of Classical Hodgkin Lymphoma). * **Morphology:** Look for **"Popcorn cells"** (L&H cells) instead of the classic Reed-Sternberg cells [1]. * **Clinical Course:** It has a high risk of late recurrence but a very low mortality rate [2]. It can transform into Diffuse Large B-cell Lymphoma (DLBCL) in ~3-5% of cases. * **Treatment Note:** If the question mentions CD20 positivity, **Rituximab** is a highly effective targeted therapy often used in relapsed cases [3].

Question 133: Which acid-base disturbance is most commonly associated with hepatic cirrhosis complicated by acute kidney injury?

A. Metabolic acidosis and respiratory acidosis
B. Metabolic acidosis and respiratory alkalosis (Correct Answer)
C. Metabolic alkalosis and respiratory acidosis
D. Metabolic alkalosis and respiratory alkalosis

Explanation: The coexistence of **Metabolic Acidosis and Respiratory Alkalosis** is the most frequent mixed acid-base disorder seen in patients with cirrhosis and acute kidney injury (AKI). [1] 1. **Why the correct answer is right:** * **Metabolic Acidosis:** In the setting of cirrhosis, AKI (often Hepatorenal Syndrome or ATN) leads to the accumulation of fixed acids and decreased bicarbonate reabsorption, resulting in a **High Anion Gap Metabolic Acidosis (HAGMA)**. Additionally, advanced cirrhosis itself can cause lactic acidosis due to poor hepatic clearance. [1] * **Respiratory Alkalosis:** Patients with cirrhosis chronically hyperventilate. This is driven by increased levels of progesterone, ammonia, and vasoactive substances that directly stimulate the medullary respiratory center. This results in a primary decrease in $PCO_2$. 2. **Why the incorrect options are wrong:** * **Options A & C (Respiratory Acidosis):** Respiratory acidosis implies hypoventilation. In cirrhosis, the drive to breathe is typically increased, not decreased, unless the patient has co-existing COPD or severe hepatic encephalopathy leading to coma. * **Option D (Metabolic Alkalosis):** While metabolic alkalosis can occur in cirrhosis due to diuretic use or vomiting, the presence of **AKI** shifts the balance toward acidosis due to the failure of the kidneys to excrete organic acids. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Triple Acid-Base Disorder:** Cirrhotic patients on diuretics who develop AKI and hyperventilate can actually present with a triple disorder: Metabolic Acidosis + Metabolic Alkalosis + Respiratory Alkalosis. * **Progesterone:** This is the key hormone responsible for the chronic hyperventilation and primary respiratory alkalosis seen in pregnancy and liver failure. * **Hepatorenal Syndrome (HRS):** Always suspect HRS in a cirrhotic patient with AKI who does not respond to volume expansion with albumin.

Question 134: A patient presents to the emergency room after a seizure. Laboratory investigations reveal SIADH, and a CT scan demonstrates a lung mass. Which of the following lung cancer subtypes is most likely to cause this electrolyte imbalance?

A. Adenocarcinoma
B. Bronchioloalveolar carcinoma
C. Large cell carcinoma
D. Small cell carcinoma (Correct Answer)

Explanation: **Explanation:** **1. Why Small Cell Carcinoma (SCLC) is correct:** Small cell lung carcinoma is a neuroendocrine tumor derived from **Kulchitsky cells**. These cells have the metabolic machinery to produce various ectopic hormones. **SIADH (Syndrome of Inappropriate Antidiuretic Hormone)** is the most common paraneoplastic syndrome associated with SCLC, occurring in approximately 7–10% of patients [1]. It results in water retention and dilutional hyponatremia, which can manifest clinically as seizures, confusion, or coma [1]. **2. Why the other options are incorrect:** * **Adenocarcinoma (Option A):** This is the most common lung cancer overall (especially in non-smokers). While it is associated with hypertrophic osteoarthropathy (clubbing), it rarely causes SIADH. * **Bronchioloalveolar carcinoma (Option B):** Now classified under Adenocarcinoma in situ, it typically presents with voluminous watery sputum (bronchorrhea) rather than endocrine disturbances. * **Large cell carcinoma (Option C):** This is a diagnosis of exclusion. It is more commonly associated with gynecomastia due to beta-hCG production, not SIADH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Small Cell Carcinoma:** Associated with "The 3 S's": **S**IADH, **S**ubacute cerebellar degeneration, and Lambert-Eaton **S**yndrome (and ACTH/Cushing’s) [1]. * **Squamous Cell Carcinoma:** Associated with "The 3 P's": **P**THrP (Hypercalcemia), **P**erypheral (actually Central, but often mnemonicized for **P**arathyroid-like), and **P**earl formation (keratin pearls) [1]. * **Location:** SCLC and Squamous cell are typically **Central** (hilar), while Adenocarcinoma is **Peripheral**. * **Management of SIADH:** Fluid restriction is the first-line treatment; Vaptans (Vasopressin antagonists) or Demeclocycline are used in refractory cases.

Question 135: Tumor lysis syndrome is associated with all of the following laboratory features EXCEPT?

A. Hyperkalemia
B. Hypercalcemia (Correct Answer)
C. Hyperuricemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of metabolically active neoplastic cells (most commonly in high-grade lymphomas and leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a predictable pattern of metabolic derangements. **Why Hypercalcemia is the Correct Answer (The Exception):** TLS is characterized by **Hypocalcemia**, not hypercalcemia. As intracellular phosphorus is released into the blood (Hyperphosphatemia), it binds to circulating calcium to form calcium phosphate crystals. This precipitation leads to a result in a rapid decline in serum ionized calcium levels. **Analysis of Incorrect Options:** * **Hyperkalemia (A):** Potassium is the primary intracellular cation. Rapid cell lysis releases massive amounts of potassium into the extracellular space, which can lead to life-threatening cardiac arrhythmias. * **Hyperuricemia (C):** The breakdown of nucleic acids (purines) from the tumor cells is metabolized by xanthine oxidase into uric acid. This can lead to acute uric acid nephropathy. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of intracellular phosphorus than normal cells. Their lysis causes a surge in serum phosphate. **High-Yield Clinical Pearls for NEET-PG:** * **Cairo-Bishop Definition:** Laboratory TLS is defined by two or more metabolic abnormalities (Uric acid >8, Potassium >6, Phosphate >4.5, or Calcium <7) occurring within 3 days before or 7 days after chemotherapy. * **Renal Failure:** The "Calcium-Phosphate product" (>60) leads to crystal deposition in renal tubules, causing Acute Kidney Injury (AKI). * **Management:** Aggressive hydration is the mainstay. **Rasburicase** (recombinant urate oxidase) is the drug of choice for established hyperuricemia, while **Allopurinol** is used for prophylaxis.

Question 136: Which of the following is seen in tumor lysis syndrome?

A. Hypokalemia
B. Hyponatremia
C. Hypercalcemia
D. None of the above (Correct Answer)

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid destruction of malignant cells (usually following chemotherapy for high-grade lymphomas or leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements. **Why "None of the above" is correct:** The hallmark metabolic disturbances in TLS are **Hyperkalemia, Hyperphosphatemia, Hyperuricemia, and Hypocalcemia.** None of the options provided (Hypokalemia, Hyponatremia, or Hypercalcemia) are features of TLS; in fact, the electrolyte shifts occur in the opposite direction for potassium and calcium. **Analysis of Incorrect Options:** * **A. Hypokalemia:** Incorrect. Lysis of cells releases large amounts of intracellular potassium, leading to life-threatening **Hyperkalemia**, which can cause cardiac arrhythmias. * **B. Hyponatremia:** Incorrect. Sodium is primarily an extracellular cation. While fluid resuscitation (a mainstay of TLS treatment) might occasionally cause dilutional hyponatremia, it is not a primary feature of the syndrome itself. * **C. Hypercalcemia:** Incorrect. TLS causes **Hypocalcemia**. This occurs because the massive release of intracellular phosphate binds to ionized calcium, leading to calcium-phosphate precipitation in tissues and the kidneys. **High-Yield Clinical Pearls for NEET-PG:** * **Cairo-Bishop Definition:** Used to classify TLS into Laboratory TLS (2 or more metabolic abnormalities) vs. Clinical TLS (metabolic abnormalities + renal failure, seizures, or arrhythmias). * **Renal Failure:** Caused by the precipitation of **Uric acid crystals** (in acidic urine) and **Calcium-phosphate crystals** in the renal tubules. * **Prophylaxis/Treatment:** Aggressive hydration is the most important step. **Rasburicase** (recombinant urate oxidase) is the drug of choice for high-risk patients as it converts uric acid to the highly soluble allantoin. **Allopurinol** is used for prophylaxis but does not reduce pre-existing uric acid.

Question 137: A 62-year-old man presents with dark tarry stools and light-headedness. Upper endoscopy finds an ulcerating lesion in his stomach and biopsies confirm gastric cancer. Which of the following is a risk factor for carcinoma of the stomach?

A. Helicobacter pylori infection (Correct Answer)
B. High socioeconomic status
C. High protein diet
D. High alcohol consumption

Explanation: **Explanation:** **1. Why Helicobacter pylori is correct:** *H. pylori* is the most significant risk factor for non-cardia gastric adenocarcinoma [1]. It is classified as a **Group 1 Carcinogen** by the WHO. Chronic infection leads to a predictable histological progression known as the **Correa Pathway**: Chronic gastritis → Atrophic gastritis → Intestinal metaplasia → Dysplasia → Adenocarcinoma [1]. The chronic inflammation induced by the bacteria (specifically strains expressing **CagA** [1]) leads to DNA damage and the loss of acid-secreting parietal cells, creating an environment conducive to malignancy. **2. Why the other options are incorrect:** * **High socioeconomic status:** Gastric cancer is more prevalent in **low socioeconomic groups**, primarily due to overcrowding (increased *H. pylori* transmission) and poor access to fresh fruits/vegetables (refrigeration). * **High protein diet:** A high protein diet is not a recognized risk factor. However, diets high in **nitrates/nitrites** (found in smoked, salted, or cured meats) are strongly associated with gastric cancer as they are converted into carcinogenic nitrosamines. * **High alcohol consumption:** While alcohol is a major risk factor for esophageal and liver cancers, its link to gastric cancer is inconsistent and not as definitive as *H. pylori* or tobacco use. **3. NEET-PG High-Yield Pearls:** * **Blood Group A:** Associated with an increased risk of gastric cancer (specifically the diffuse type). * **Dietary Protective Factors:** High intake of Vitamin C and beta-carotene (fresh fruits/vegetables). * **Virchow’s Node:** Left supraclavicular lymphadenopathy indicating metastasis. * **Sister Mary Joseph Nodule:** Periumbilical metastasis. * **Krukenberg Tumor:** Metastasis to the ovaries (classically showing signet ring cells).

Question 138: A 21-year-old woman presents with a 2-day history of abdominal pain, nausea, and vomiting. On examination, her blood pressure is 100/70 mmHg, pulse 100/min, JVP is below sternal angle, and abdomen is diffusely tender. Her urine output is low and electrolytes reveal elevated urea and normal creatinine. For the above patient with AKI, what are the characteristic urine electrolyte and microscopy findings?

A. Urinary osmolality < 100 mOsm/kg
B. Oxalate crystals in the urine
C. Urinary sodium < 20 mEq/L (Correct Answer)
D. Fractional sodium excretion > 1%

Explanation: ### Explanation The patient presents with signs of **Prerenal Acute Kidney Injury (AKI)** secondary to volume depletion (nausea, vomiting, low JVP, abdominal tenderness, and tachycardia). The biochemical hallmark of prerenal AKI is a **BUN:Creatinine ratio > 20:1** (elevated urea with normal/near-normal creatinine), indicating that the kidneys are structurally intact but responding to decreased perfusion [1]. **1. Why Option C is Correct:** In prerenal states, the kidneys attempt to restore intravascular volume by maximizing sodium and water reabsorption. The intact tubular function allows for the activation of the Renin-Angiotensin-Aldosterone System (RAAS), leading to: * **Urinary Sodium < 20 mEq/L** (due to intense reabsorption) [1]. * **Fractional Excretion of Sodium (FeNa) < 1%**. * **High Urine Osmolality (> 500 mOsm/kg)** as the kidneys concentrate urine to conserve water [1]. **2. Why the Other Options are Incorrect:** * **Option A:** Urinary osmolality < 100 mOsm/kg is seen in Diabetes Insipidus or primary polydipsia. In prerenal AKI, urine is highly concentrated (> 500 mOsm/kg) [1]. * **Option B:** Oxalate crystals are characteristic of ethylene glycol poisoning or secondary to high-dose Vitamin C. They are not a feature of volume-depletion-induced prerenal AKI. * **Option D:** FeNa > 1% (and often > 2%) is characteristic of **Acute Tubular Necrosis (ATN)**, where tubular damage prevents the kidney from reabsorbing sodium. **Clinical Pearls for NEET-PG:** * **Prerenal AKI:** FeNa < 1%, UNa < 20, Urine Osmolality > 500, Hyaline casts [1]. * **Intrinsic AKI (ATN):** FeNa > 1%, UNa > 40, Urine Osmolality < 350, **Muddy brown granular casts** [2]. * **Exception:** FeNa can be < 1% in certain intrinsic causes like Contrast-induced nephropathy and Acute Glomerulonephritis.

Question 139: Which of the following is NOT a feature of tumor lysis syndrome?

A. Hyperkalemia
B. Hyperuricemia
C. Hypercalcemia (Correct Answer)
D. Hyperphosphatemia

Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells, typically following chemotherapy for high-grade hematologic malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation. **Why Hypercalcemia is the correct answer:** TLS is characterized by **Hypocalcemia**, not hypercalcemia [1]. As intracellular phosphorus is released into the bloodstream (Hyperphosphatemia), it binds to serum calcium to form calcium phosphate crystals. This precipitation leads to a rapid decline in ionized calcium levels, which can cause tetany, seizures, and cardiac arrhythmias. **Analysis of incorrect options:** * **Hyperkalemia (A):** Potassium is the primary intracellular cation. Rapid cell lysis floods the extracellular space with potassium, posing a risk of life-threatening arrhythmias. * **Hyperuricemia (B):** The breakdown of nucleic acids releases purines, which are metabolized by xanthine oxidase into uric acid. This can lead to acute uric acid nephropathy. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their lysis leads to a massive release of phosphate into the blood. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of 3 Hypers and 1 Hypo":** Hyperkalemia, Hyperuricemia, Hyperphosphatemia, and **Hypocalcemia**. * **Prevention:** Aggressive intravenous hydration is the most critical step. * **Pharmacotherapy:** **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid into allantoin). * **Cairo-Bishop Criteria:** Used for the laboratory and clinical diagnosis of TLS.

Question 140: A patient presents with a history of alcoholic cirrhosis. Imaging reveals a hypervascular lesion during the arterial phase of CT and portal vein thrombosis. What is the most likely diagnosis given these findings?

A. Cholangiocarcinoma
B. Hepatocellular carcinoma (Correct Answer)
C. Metastatic colorectal carcinoma
D. Neuroendocrine tumors

Explanation: **Explanation:** The clinical presentation described is a classic textbook case of **Hepatocellular Carcinoma (HCC)**. **1. Why Hepatocellular Carcinoma is correct:** HCC typically arises in the setting of chronic liver disease, most commonly **alcoholic cirrhosis** or chronic Hepatitis B/C. The hallmark radiological feature of HCC on dynamic contrast-enhanced CT or MRI is **"Arterial Enhancement with Venous Washout."** Because HCC derives its blood supply primarily from the hepatic artery (unlike normal liver parenchyma which relies on the portal vein), it appears **hypervascular during the arterial phase** [1]. Furthermore, HCC has a high propensity for **vascular invasion**, specifically involving the **portal vein**, leading to portal vein thrombosis (PVT) [1]. **2. Why the other options are incorrect:** * **Cholangiocarcinoma:** This typically presents as a non-cirrhotic mass with **delayed enhancement** (due to fibrous stroma) rather than arterial hypervascularity. It rarely causes portal vein thrombosis. * **Metastatic colorectal carcinoma:** These are usually **hypovascular** lesions. While they are the most common liver tumors overall, they do not typically show arterial phase "washout" or occur specifically due to cirrhosis. * **Neuroendocrine tumors (NETs):** While NET metastases can be hypervascular, they are usually multiple (not a single lesion) and are not associated with cirrhosis or a high frequency of portal vein thrombosis. **High-Yield Clinical Pearls for NEET-PG:** * **Tumor Marker:** Alpha-fetoprotein (AFP) is the most common marker; levels >400 ng/mL are highly suggestive [1]. * **Screening:** USG + AFP every 6 months for cirrhotic patients. * **Milan Criteria:** Used to determine eligibility for liver transplantation (Single lesion <5cm or up to 3 lesions <3cm). * **Treatment of choice for PVT:** Sorafenib or Lenvatinib (Systemic therapy) is indicated when vascular invasion is present [2].

Question 141: A 29-year-old man is seen in follow-up 1 year post-kidney transplant. He is doing well clinically and the transplant is functioning well, with no recent episodes of rejection or changes to his immunosuppressive medications. Which of the following complications of transplantation is the most likely cause of death?

A. atherosclerotic disease (Correct Answer)
B. opportunistic infection
C. metabolic bone disease
D. lung cancer

Explanation: **Explanation:** The correct answer is **A. atherosclerotic disease**. **1. Why Atherosclerotic Disease is Correct:** Cardiovascular disease (CVD), primarily due to accelerated atherosclerosis, is the **leading cause of death** in patients following a solid organ transplant (especially kidney transplants). While the risk of rejection and infection is highest in the immediate post-operative period, long-term survival is dictated by cardiovascular health. Post-transplant patients have a high prevalence of traditional risk factors (hypertension, diabetes, dyslipidemia) which are often exacerbated by immunosuppressive medications: * **Corticosteroids:** Cause weight gain, hyperglycemia, and hypertension. * **Calcineurin Inhibitors (Cyclosporine/Tacrolimus):** Lead to hypertension, hyperlipidemia, and new-onset diabetes after transplant (NODAT). **2. Why the Other Options are Incorrect:** * **B. Opportunistic Infection:** While a major cause of morbidity and mortality in the first 6 months (due to peak immunosuppression), the risk stabilizes after one year [2]. It is the second most common cause of death, but lags behind CVD. * **C. Metabolic Bone Disease:** Common (e.g., osteopenia, avascular necrosis) due to steroid use and pre-existing renal osteodystrophy, but it is rarely a direct cause of death. * **D. Lung Cancer:** Transplant recipients have an increased risk of malignancies (especially Skin Cancer and Post-Transplant Lymphoproliferative Disorder - PTLD), but lung cancer is not the leading cause of mortality in this population [1]. [2]. **Clinical Pearls for NEET-PG:** * **Most common cause of death post-renal transplant:** Cardiovascular disease (Atherosclerosis). * **Most common malignancy post-transplant:** Squamous cell carcinoma of the skin [1]. * **Most common viral infection post-transplant:** Cytomegalovirus (CMV). * **NODAT (New-onset diabetes):** Most strongly associated with Tacrolimus [2].

Question 142: Which natural element possesses anticancer properties?

A. Nitrosoamines
B. Vitamin C (Correct Answer)
C. Vitamin D
D. Carotene

Explanation: Explanation: Vitamin C (Ascorbic Acid) is the correct answer because it acts as a potent antioxidant and a cofactor in several enzymatic reactions [2]. Its anticancer properties are attributed to its ability to scavenge free radicals, thereby preventing oxidative DNA damage that leads to malignant transformation [1]. Furthermore, at high pharmacological doses (often administered intravenously in clinical trials), Vitamin C can act as a pro-oxidant, generating hydrogen peroxide ($H_2O_2$) which is selectively toxic to cancer cells while sparing normal cells [1]. It also enhances the immune system’s surveillance capabilities. Analysis of Incorrect Options: * A. Nitrosoamines: These are potent carcinogens, not anticancer agents. Found in tobacco smoke and cured meats, they induce DNA mutations (specifically G-to-A transitions) and are strongly linked to esophageal and gastric cancers. * C. Vitamin D: While Vitamin D plays a role in cell differentiation and apoptosis, and its deficiency is linked to higher cancer risks, it is primarily classified as a hormone precursor [3]. In the context of "natural elements with direct antioxidant/anticancer properties" in standard medical curricula, Vitamin C is the more classic answer. * D. Carotene: While Beta-carotene is a precursor to Vitamin A and an antioxidant, large-scale clinical trials (like the CARET study) surprisingly showed that beta-carotene supplementation actually increased the risk of lung cancer in smokers. NEET-PG High-Yield Pearls: * Antioxidant Trio: Vitamins A, C, and E are the primary dietary antioxidants [1]. * Vitamin C & Collagen: It is essential for the hydroxylation of proline and lysine residues during collagen synthesis (deficiency leads to Scurvy) [2]. * Carcinogen Alert: Aflatoxin B1 (from Aspergillus) is a major risk factor for Hepatocellular Carcinoma (HCC), often tested alongside nitrosoamines.

Question 143: Which of the following is NOT a paraneoplastic syndrome associated with renal cell carcinoma?

A. Polycythemia
B. Hypercalcemia
C. Malignant hypertension
D. Cushing syndrome (Correct Answer)

Explanation: Explanation: Renal Cell Carcinoma (RCC) is often referred to as the "Internist’s Tumor" because it frequently presents with a wide array of paraneoplastic syndromes (PNS) due to the ectopic production of hormones or cytokines [1]. Why Cushing Syndrome is the Correct Answer: While RCC can produce many hormones, it is not typically associated with the ectopic production of ACTH [1]. Cushing syndrome as a paraneoplastic phenomenon is most classically associated with Small Cell Lung Cancer (SCLC) and bronchial carcinoid tumors [1],[2]. Analysis of Other Options: * Polycythemia (Option A): This is a classic PNS of RCC, occurring in about 1-5% of patients. It is caused by the ectopic production of Erythropoietin (EPO) by the tumor cells [1]. * Hypercalcemia (Option B): This is the most common metabolic complication of RCC. It occurs due to the secretion of Parathyroid Hormone-related Protein (PTHrP), which mimics PTH action, or via direct bone osteolysis from metastases [1]. * Malignant Hypertension (Option C): RCC can cause hypertension through two mechanisms: the ectopic production of Renin (activating the RAAS pathway) or by direct compression of the renal artery by the tumor mass. High-Yield Clinical Pearls for NEET-PG: 1. Stauffer Syndrome: A unique PNS of RCC characterized by reversible hepatic dysfunction (elevated ALP, low albumin) in the absence of liver metastases. 2. Classic Triad: Hematuria, flank pain, and a palpable mass (seen in only 10% of cases, usually indicating advanced disease). 3. Most Common Histology: Clear cell carcinoma (associated with VHL gene mutations on chromosome 3p). 4. Amyloidosis: Secondary (AA) amyloidosis can also occur as a paraneoplastic manifestation of RCC.

Question 144: A 38-year-old woman presents with repeated episodes of sore throat. She is on no medications, does not use ethanol, and has no history of renal disease. Physical examination is normal. Hemoglobin is 9.0 g/dL, mean corpuscular volume is 85 fL, white blood cell count is 2000/mL, and platelet count is 30,000/mL. Which of the following is the best approach to diagnosis?

A. Erythropoietin level
B. Serum B12
C. Bone marrow biopsy (Correct Answer)
D. Liver spleen scan

Explanation: ### Explanation **Concept:** The patient presents with **pancytopenia** (anemia, leukopenia, and thrombocytopenia) as evidenced by Hb 9.0 g/dL, WBC 2000/mL, and platelets 30,000/mL. In a young patient with no obvious external cause (drugs, alcohol, or renal failure), the primary goal is to differentiate between bone marrow failure (e.g., Aplastic Anemia), marrow infiltration (e.g., Leukemia, Myelofibrosis), or peripheral destruction. **Bone marrow biopsy** is the gold standard for evaluating the cellularity and architecture of the marrow to reach a definitive diagnosis [1]. **Why the Correct Answer is Right:** * **Bone marrow biopsy (Option C):** It allows for the assessment of marrow cellularity [1]. It can distinguish between "empty" marrow (Aplastic Anemia) and "hypercellular" marrow (MDS or Aleukemic Leukemia). It is essential to rule out malignancies or granulomatous diseases in cases of unexplained pancytopenia; a trephine biopsy is specifically superior for assessing marrow cellularity and infiltration by abnormal cells [1]. **Why Other Options are Incorrect:** * **Erythropoietin level (Option A):** This is used to differentiate causes of polycythemia or evaluate anemia in chronic kidney disease. It does not help diagnose the cause of pancytopenia. * **Serum B12 (Option B):** While B12 deficiency can cause pancytopenia, the **MCV is 85 fL (normocytic)**. B12 deficiency typically presents with macrocytosis (MCV >100 fL) and hypersegmented neutrophils. * **Liver spleen scan (Option D):** This is an outdated modality. While it might show splenomegaly (suggesting sequestration), it does not provide a tissue diagnosis for the underlying hematological pathology. **NEET-PG High-Yield Pearls:** * **Definition of Pancytopenia:** Hb <12 g/dL (women), WBC <4000/mm³, and Platelets <1.5 lakh/mm³. * **Most common cause of pancytopenia in India:** Megaloblastic anemia (however, always check MCV first). * **Aplastic Anemia:** Characterized by pancytopenia with **hypocellular marrow** where fat cells replace hematopoietic elements. * **Dry Tap on Aspiration:** Classically seen in Myelofibrosis and Hairy Cell Leukemia; requires a trephine biopsy for diagnosis [1].

Question 145: A 74-year-old man with a history of hypertension and benign prostatic hypertrophy presents with urinary retention. A Foley catheter is inserted, draining 1500 cc of urine. Subsequently, his urine output is 200 cc/h. Which of the following urine electrolyte values is most likely in keeping with post-obstructive diuresis?

A. High sodium (Correct Answer)
B. Low potassium
C. High specific gravity
D. Low pH

Explanation: **Explanation:** **Post-obstructive diuresis (POD)** is a clinical condition characterized by polyuria (typically >200 mL/h) following the relief of a chronic, bilateral urinary tract obstruction. [1] **Why High Sodium is Correct:** The primary mechanism behind POD is a combination of **solute diuresis** and **tubular dysfunction**. During chronic obstruction, the accumulation of urea and other solutes creates an osmotic gradient. Once the obstruction is relieved, these solutes are excreted, dragging water with them [1]. More importantly, the prolonged high pressure in the renal pelvis causes damage to the distal tubules and collecting ducts, leading to an **impaired responsiveness to aldosterone and ADH** [2]. This results in a "salt-wasting" state where the kidneys cannot effectively reabsorb sodium, leading to **high urinary sodium levels** (often >40 mEq/L) [1]. **Why Other Options are Wrong:** * **Low Potassium:** While potassium is lost during diuresis, the hallmark of POD is the significant loss of sodium and water. Potassium levels in the urine are typically elevated (high), not low, due to the high flow rate. * **High Specific Gravity:** POD results in the excretion of large volumes of dilute urine because the kidneys lose their concentrating ability [2]. Therefore, the **specific gravity is low** (typically <1.010). * **Low pH:** Urine pH is not a defining characteristic of POD; however, if there is associated distal renal tubular acidosis due to prior obstructive damage, the urine might actually be inappropriately alkaline. **Clinical Pearls for NEET-PG:** * **Definition:** Urine output >200 mL/h for two consecutive hours or >3 L/24 hours. * **Management:** Most cases are self-limiting. Replace only **50% of hourly losses** with 0.45% saline to avoid perpetuating the diuresis, unless the patient is hemodynamically unstable. * **Risk Factors:** Chronic obstruction, congestive heart failure, and azotemia (high BUN/Creatinine).

Question 146: A 15-year-old boy develops symptoms of renal colic. The stone eventually passes spontaneously, but it is not recovered. The urinalysis reveals hexagonal crystals, and a cyanide-nitroprusside test on the urine is positive. Which of the following is the most likely diagnosis?

A. Cystinuria (Correct Answer)
B. Thalassemia
C. Hereditary glycosuria
D. Primary hyperoxaluria

Explanation: ### Explanation **1. Why Cystinuria is the Correct Answer:** Cystinuria is an autosomal recessive defect in the **COLA** transporter (Cystine, Ornithine, Lysine, and Arginine) in the proximal convoluted tubule and GI tract. Since cystine is poorly soluble in acidic urine, it precipitates to form stones. * **Pathognomonic Finding:** The presence of **hexagonal (six-sided), flat, colorless crystals** on urinalysis is diagnostic. * **Screening Test:** The **Cyanide-nitroprusside test** is the classic screening tool. Sodium cyanide reduces cystine to cysteine, which then reacts with nitroprusside to produce a characteristic **magenta/purple color**. **2. Analysis of Incorrect Options:** * **B. Thalassemia:** While chronic hemolysis can lead to gallstones (pigment stones), it does not cause renal stones with hexagonal crystals or a positive nitroprusside test. * **C. Hereditary Glycosuria:** This is a benign condition involving a defect in the SGLT2 transporter. It presents with glucose in the urine despite normal blood glucose levels, not nephrolithiasis. * **D. Primary Hyperoxaluria:** This leads to calcium oxalate stones. These crystals are typically shaped like **envelopes (dihydrate)** or **dumbbells (monohydrate)**, not hexagons. **3. High-Yield Clinical Pearls for NEET-PG:** * **Stone Radiopacity:** Cystine stones are **radio-opaque** (due to sulfur content) but less dense than calcium stones. They often appear "ground-glass" on X-ray. * **Management:** Treatment focuses on high fluid intake, **urinary alkalinization** (pH > 7.5) to increase solubility, and chelating agents like **D-penicillamine** or Tiopronin for refractory cases [1]. Around 90% of stones of less than 4 mm diameter pass spontaneously [1]. * **Mnemonic:** Remember **"COLA"** for the involved amino acids and **"Six-sided Cystine"** for the crystal shape.

Question 147: Radiation can cause which of the following conditions?

A. Non Hodgkin lymphoma
B. Hodgkin lymphoma
C. Acute leukemia (Correct Answer)
D. Papillary carcinoma thyroid

Explanation: **Explanation:** Ionizing radiation is a well-established carcinogen that induces DNA damage through direct ionization or the production of free radicals [1]. Among the malignancies associated with radiation exposure, **Acute Leukemia** (specifically Acute Myeloid Leukemia, AML) is the most characteristic and frequently tested association. **Why Acute Leukemia is the correct answer:** The bone marrow is highly radiosensitive due to its rapid cell turnover. Exposure to ionizing radiation (e.g., survivors of atomic bombs, therapeutic radiation) significantly increases the risk of leukemias. Typically, there is a lot of risk associated with hematopoietic failure and anemia following exposure [2]. While AML is most common, Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) are also linked [3]; however, Chronic Lymphocytic Leukemia (CLL) is notably **not** associated with radiation. **Analysis of Incorrect Options:** * **A & B (Lymphomas):** While radiation can slightly increase the risk of Non-Hodgkin Lymphoma (NHL), the association is significantly weaker than that of leukemia. Hodgkin Lymphoma has no established causal link to radiation exposure. * **D (Papillary Carcinoma Thyroid):** This is a classic "distractor." Radiation *is* a major risk factor for Papillary Carcinoma of the thyroid (especially in children). However, in the context of standard medical examinations, if both are listed, **Leukemia** is traditionally considered the most "classic" and systemic hematological consequence of ionizing radiation. **High-Yield Clinical Pearls for NEET-PG:** * **Most common radiation-induced cancer:** Leukemia (excluding CLL). * **Most common radiation-induced solid tumor:** Thyroid cancer (specifically Papillary type). * **Radiosensitive tissues:** Bone marrow, GI epithelium, and gonads [2]. * **Radioresistant tissues:** Nerve cells and mature bone. * **Latent Period:** Leukemia has a shorter latent period (5–10 years) compared to solid tumors (20+ years).

Question 148: Which of the following cancers is the most common cause of cancer-related death?

A. Lung cancer (Correct Answer)
B. Oral cancer
C. Skin cancer
D. Prostate cancer

Explanation: **Explanation:** **Lung cancer** is the leading cause of cancer-related mortality worldwide and in most developed countries [1], [2]. The high mortality rate is primarily due to the fact that lung cancer is often asymptomatic in its early stages, leading to a majority of cases being diagnosed at an advanced or metastatic stage (Stage III or IV) when curative treatment is no longer possible [3]. Additionally, the aggressive biological nature of small cell lung cancer and the resistance of many non-small cell lung cancers to conventional therapies contribute to its high lethality [3]. **Analysis of Incorrect Options:** * **Oral Cancer:** While highly prevalent in India due to tobacco and betel nut use, it is more easily detectable during physical exams and has a lower overall global mortality rate compared to lung cancer. * **Skin Cancer:** Basal cell carcinoma is the most common cancer overall, but it is rarely fatal [2]. Even malignant melanoma, though dangerous, accounts for far fewer deaths than lung cancer. * **Prostate Cancer:** This is the most common cancer in men in many regions, but it often follows an indolent course. Many patients die *with* prostate cancer rather than *of* it, resulting in a much higher survival rate. **High-Yield Clinical Pearls for NEET-PG:** * **Global & India Trend:** Globally, Lung cancer is the #1 cause of cancer death [1]. In India, **Breast cancer** is the most common cancer in women, while **Lung/Oral cancer** leads in men. * **Risk Factor:** Tobacco smoking is the most significant risk factor, linked to ~85% of lung cancer deaths [2]. * **Screening:** Low-dose CT (LDCT) is the recommended screening tool for high-risk smokers (50–80 years old with a 20 pack-year history).

Question 149: Which of the following is the most serious late side effect of treatment of Hodgkin's disease?

A. Cardiac injury (Correct Answer)
B. Infertility
C. Hair loss
D. Osteoporosis

Explanation: The treatment of Hodgkin’s Lymphoma (HL) has a high cure rate, making the management of long-term survivorship and **late toxicities** a critical clinical focus. [1] **Cardiac injury** is considered the most serious late side effect because it is a leading cause of non-malignant morbidity and mortality in HL survivors. It typically manifests 10–20 years after treatment. The injury is multifactorial: 1. **Radiation Therapy (Mediastinal):** Causes accelerated coronary artery disease (CAD), valvular dysfunction, and pericarditis. [1] 2. **Chemotherapy (Anthracyclines like Doxorubicin):** Leads to dose-dependent, irreversible dilated cardiomyopathy and congestive heart failure. **Analysis of Incorrect Options:** * **B. Infertility:** While common (especially with alkylating agents like Procarbazine in the older MOPP regimen), it is not considered as "serious" or life-threatening as cardiac failure or secondary malignancies. Modern ABVD regimens have a much lower risk of permanent infertility. * **C. Hair Loss (Alopecia):** This is an **acute** side effect that occurs during treatment and is reversible. It is not a "late" side effect. * **D. Osteoporosis:** Can occur due to prolonged steroid use (Prednisone), but it is rarely the most life-limiting complication compared to cardiotoxicity. **NEET-PG High-Yield Pearls:** * The **most common** late cause of death in HL survivors is **Secondary Malignancies** (most commonly Breast Cancer and Lung Cancer). * If "Secondary Malignancy" is not an option, **Cardiac Injury** is the next most significant life-threatening late complication. * **Lhermitte’s sign** (electric shock sensation down the spine) is a transient late effect of neck radiation in HL patients. * Survivors require lifelong screening, including annual mammograms (starting 8-10 years post-radiation) and aggressive lipid management.

Question 150: Which of the following is NOT true regarding Superior Vena Cava (SVC) syndrome?

A. Malignant lymphoma is the leading cause of SVC syndrome in elderly patients. (Correct Answer)
B. Widening of the superior mediastinum is seen on chest radiograph.
C. Patients present with dilated neck veins and an increased number of collateral veins covering the anterior chest wall.
D. None of the above

Explanation: ### Explanation **1. Why Option A is the Correct Answer (The False Statement):** While malignant lymphoma is a significant cause of Superior Vena Cava (SVC) syndrome, it is **not** the leading cause in elderly patients. **Bronchogenic carcinoma (Lung Cancer)**, specifically Small Cell Lung Cancer (SCLC) and Squamous Cell Carcinoma, is the most common cause of SVC syndrome overall, accounting for approximately 70-80% of cases [1]. Lymphoma is a more frequent cause in younger patients/children. **2. Analysis of Incorrect Options (True Statements):** * **Option B:** SVC syndrome typically results from extrinsic compression or invasion of the SVC by a mediastinal mass. This mass effect, along with associated lymphadenopathy, characteristically manifests as **widening of the superior mediastinum** on a chest X-ray. * **Option C:** Obstruction of the SVC leads to increased venous pressure. To bypass the blockage, blood is diverted through collateral pathways (e.g., azygos, internal mammary, and lateral thoracic veins). This results in the classic clinical triad: **facial/neck edema, dilated neck veins (non-pulsatile), and prominent collateral veins** on the anterior chest wall. **3. Clinical Pearls for NEET-PG:** * **Most Common Cause:** Bronchogenic Carcinoma (Lung Cancer). * **Most Common Benign Cause:** Iatrogenic (Indwelling central venous catheters or pacemaker leads) – this is increasing in frequency. * **Pemberton’s Sign:** Facial flushing and cyanosis when the patient raises both arms above the head; indicates thoracic inlet obstruction. * **Management:** SVC syndrome is a clinical diagnosis. While it was once considered a surgical emergency, the current approach is to **obtain a tissue diagnosis first** (unless there is airway compromise or cerebral edema) to tailor therapy (e.g., radiation for NSCLC [2] vs. chemotherapy for SCLC/Lymphoma [2]).

Question 151: Hyperglycemia is seen in which of the following types of lung cancer?

A. Squamous cell carcinoma (SCC)
B. Small cell carcinoma (Correct Answer)
C. Adenocarcinoma
D. Large cell carcinoma

Explanation: The correct answer is **Small Cell Carcinoma (SCLC)**. This association is primarily due to the **Ectopic ACTH Syndrome**, a classic paraneoplastic manifestation of SCLC. **1. Why Small Cell Carcinoma is correct:** Small cell carcinoma is a neuroendocrine tumor capable of secreting various hormones [1], [4]. In roughly 1–5% of cases, it secretes ectopic Adrenocorticotropic Hormone (ACTH) [3]. This leads to excessive cortisol production (Cushing Syndrome), which promotes gluconeogenesis and insulin resistance, resulting in **hyperglycemia** and hypokalemia [1]. SCLC is also famously associated with SIADH (hyponatremia) and Lambert-Eaton Myasthenic Syndrome [4]. **2. Why the other options are incorrect:** * **Squamous Cell Carcinoma (SCC):** SCC is most commonly associated with the secretion of **PTHrP** (Parathyroid Hormone-related Protein), which leads to **hypercalcemia**, not hyperglycemia [1]. * **Adenocarcinoma:** This is the most common lung cancer in non-smokers and females. Its paraneoplastic associations include hypertrophic osteoarthropathy (clubbing) and Trousseau syndrome (thrombophlebitis), but not typically endocrine-induced hyperglycemia [2]. * **Large Cell Carcinoma:** This is associated with gynecomastia due to beta-hCG production, but it is not a classic cause of hyperglycemia. **High-Yield Clinical Pearls for NEET-PG:** * **SCLC (The "S" rules):** **S**moking related, **S**entral location, **S**IADH, and ACTH (**S**ugar elevation). * **SCC (The "C" rules):** **S**moking related, **C**entral location, **C**avitary lesions, and **C**alcium elevation (PTHrP). * **Most common paraneoplastic syndrome in SCLC:** SIADH. * **Most common lung cancer overall:** Adenocarcinoma.

Question 152: A 23-year-old man undergoing chemotherapy for acute lymphoblastic leukemia has developed a fever and abdominal pain within the past week. He now has a severe cough. On physical examination, his temperature is 38.4°C. On auscultation, crackles are heard over all lung fields. Laboratory studies show hemoglobin, 12.8 g/dL; hematocrit, 39%; MCV, 90 mm³; platelet count, 221,000/mm³; and WBC count, 16,475/mm³ with 51% segmented neutrophils, 5% bands, 18% lymphocytes, 8% monocytes, and 18% eosinophils. Infection with which of the following organisms is most likely to be complicating the course of this patient's disease?

A. Cryptococcus neoformans
B. Cytomegalovirus
C. Pseudomonas aeruginosa
D. Strongyloides stercoralis (Correct Answer)

Explanation: ### Explanation The correct answer is **Strongyloides stercoralis**. **1. Why it is correct:** The patient is immunocompromised due to chemotherapy for leukemia [1]. The clinical presentation of fever, abdominal pain, cough, and diffuse pulmonary crackles, combined with a significant **peripheral eosinophilia (18%)**, is classic for **Strongyloides Hyperinfection Syndrome** [2]. * *Strongyloides stercoralis* is unique because it can undergo an **autoinfective cycle**. In immunocompromised hosts (especially those on steroids or chemotherapy), the larvae rapidly multiply and migrate from the GI tract to the lungs (causing cough/crackles) and other organs [2]. * The abdominal pain reflects the intestinal phase, while the cough reflects the pulmonary migration (Löffler-like syndrome) [2]. Eosinophilia is a hallmark finding in helminthic infections, which helps differentiate this from viral or bacterial causes [2]. **2. Why incorrect options are wrong:** * **A. Cryptococcus neoformans:** Typically presents as meningitis or subacute pneumonia in immunocompromised patients, but it does not cause significant peripheral eosinophilia or acute abdominal pain. * **B. Cytomegalovirus (CMV):** Can cause interstitial pneumonitis in transplant or leukemia patients, but it is associated with lymphocytosis or leukopenia, not eosinophilia. * **C. Pseudomonas aeruginosa:** A common cause of neutropenic fever and necrotizing pneumonia. However, this patient is **not neutropenic** (WBC 16,475/mm³), and *Pseudomonas* causes a shift to the left (neutrophilia), not eosinophilia. **3. NEET-PG High-Yield Pearls:** * **Hyperinfection Syndrome:** Triggered by immunosuppression (Steroids are the biggest risk factor) [2]. * **Diagnosis:** Identification of **rhabditiform larvae** in stool or sputum. * **Drug of Choice:** Ivermectin (Albendazole is an alternative). * **Rule of Thumb:** In an immunocompromised patient with pulmonary symptoms + GI symptoms + **Eosinophilia**, always think of *Strongyloides* [2].

Question 153: A 43-year-old man had a subarachnoid hemorrhage from an intracranial aneurysm 8 years ago. He has also had progressive renal impairment associated with hematuria. What is the most likely diagnosis?

A. polycystic kidney disease (Correct Answer)
B. medullary sponge kidney
C. medullary cystic disease
D. Bartter syndrome

Explanation: **Explanation:** The clinical presentation of a middle-aged patient with a history of **intracranial aneurysm (Subarachnoid Hemorrhage)** and progressive **renal impairment with hematuria** is a classic description of **Autosomal Dominant Polycystic Kidney Disease (ADPKD)**. **1. Why ADPKD is correct:** ADPKD is the most common inherited kidney disease. It is characterized by the growth of numerous cysts in the kidneys, which eventually lead to renal failure and hematuria (due to cyst rupture) [1]. A key extra-renal manifestation of ADPKD is **berry aneurysms** in the Circle of Willis; rupture of these aneurysms leads to subarachnoid hemorrhage (SAH). Approximately 5-10% of ADPKD patients develop intracranial aneurysms. **2. Why other options are incorrect:** * **Medullary Sponge Kidney:** This is a congenital dilation of collecting ducts [2]. While it can cause hematuria and stones, it is typically a benign condition that does not lead to progressive renal failure or intracranial aneurysms. * **Medullary Cystic Disease (Nephronophthisis):** This presents with small kidneys and tubulointerstitial fibrosis leading to polyuria and salt wasting [2]. It does not typically present with hematuria or berry aneurysms. * **Bartter Syndrome:** This is a renal tubular defect (thick ascending limb) presenting as hypokalemic metabolic alkalosis with normal blood pressure. It does not cause renal cysts or aneurysms. **Clinical Pearls for NEET-PG:** * **Genetics:** Most cases are due to mutations in **PKD1** (Chromosome 16 - more severe) or **PKD2** (Chromosome 4) [1]. * **Extra-renal manifestations:** Hepatic cysts (most common), Berry aneurysms, Mitral Valve Prolapse (MVP), and Diverticulosis. * **Diagnosis:** Ultrasonography is the initial screening modality of choice. * **Management:** Tolvaptan (Vasopressin V2 receptor antagonist) is used to slow disease progression.

Question 154: Which of the following is NOT a paraneoplastic manifestation of bronchogenic carcinoma?

A. Dermatomyositis
B. Acanthosis nigricans
C. Cerebellar degeneration
D. Hyperkeratosis of palm and soles (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Hyperkeratosis of palm and soles**. **Understanding the Concept:** Paraneoplastic syndromes are clinical syndromes involving non-metastatic systemic effects that accompany malignant tumors. While many skin and neurological conditions are associated with bronchogenic carcinoma, **Hyperkeratosis of palms and soles** (also known as **Tylosis**) is a classic paraneoplastic marker specifically associated with **Squamous cell carcinoma of the Esophagus**, not the lung. It is often linked to a mutation in the RHBDF2 gene (Howel-Evans syndrome). **Analysis of Other Options:** * **A. Dermatomyositis:** This inflammatory myopathy is a well-recognized paraneoplastic manifestation of several internal malignancies, most notably **Small Cell Lung Cancer (SCLC)** and Adenocarcinoma of the lung. * **B. Acanthosis nigricans:** While often associated with insulin resistance, the sudden onset of

Question 155: Which type of lung cancer is known to exhibit lung-to-lung metastasis?

A. Adenocarcinoma of lung (Correct Answer)
B. Squamous cell carcinoma
C. Small cell carcinoma
D. Neuroendocrine tumor of lung

Explanation: Explanation: Adenocarcinoma of the lung is the correct answer because it is the most common histological subtype to exhibit intrapulmonary (lung-to-lung) metastasis. This occurs via two primary mechanisms: hematogenous spread and aerogenous (lepidic) spread, where malignant cells travel through the airways to seed other lobes. Specifically, the bronchioloalveolar pattern (now classified under adenocarcinoma in situ or minimally invasive adenocarcinoma) is notorious for presenting as multinodular disease or diffuse consolidations mimicking pneumonia, representing multicentricity or intrapulmonary spread. Analysis of Incorrect Options: * Squamous Cell Carcinoma: Typically presents as a central, endobronchial mass. It is more likely to spread via local invasion into the mediastinum or cavitate rather than seeding the contralateral lung. [1] * Small Cell Carcinoma: Known for rapid doubling time and early hematogenous spread to distant organs (brain, liver, bones, and adrenals) rather than localized lung-to-lung seeding. [1] * Neuroendocrine Tumors (e.g., Carcinoid): These are generally slow-growing and tend to remain localized or spread to regional lymph nodes rather than exhibiting diffuse intrapulmonary metastasis. High-Yield Clinical Pearls for NEET-PG: * Adenocarcinoma: Most common lung cancer in non-smokers and women [1]; usually peripheral in location [1]; associated with hypertrophic osteoarthropathy (clubbing) [1]. * Squamous Cell Carcinoma: Strongly associated with smoking; central location; associated with Paraneoplastic Hypercalcemia (due to PTHrP) [1]. * Small Cell Carcinoma: Strongest association with smoking; central location; associated with SIADH and ACTH (Cushing’s syndrome) [1]. * Pancoast Tumor: Most commonly an Adenocarcinoma (historically Squamous) involving the superior sulcus, leading to Horner’s Syndrome.

Question 156: Which is the most common metastatic disease causing Superior Vena Cava (SVC) syndrome?

A. Bronchogenic carcinoma
B. Metastatic breast carcinoma (Correct Answer)
C. Metastatic vertebral carcinoma
D. Gastric carcinoma

Explanation: **Explanation:** Superior Vena Cava (SVC) syndrome results from the external compression or internal thrombosis of the SVC, leading to venous congestion in the head, neck, and upper extremities. **1. Why Metastatic Breast Carcinoma is correct:** While **Bronchogenic carcinoma** is the most common *overall* cause of SVC syndrome (accounting for ~75% of cases), the question specifically asks for the most common **metastatic** disease. In the context of secondary spread from a distant primary site (excluding direct extension from the lung), **Breast carcinoma** is the most frequent metastatic malignancy to cause SVC syndrome [1]. This typically occurs via mediastinal lymph node metastasis or direct compression from metastatic masses. **2. Analysis of Incorrect Options:** * **A. Bronchogenic carcinoma:** This is the most common **primary** malignancy causing SVC syndrome. It is categorized as a primary intrathoracic tumor rather than a "metastatic disease" in this context [2]. * **C. Metastatic vertebral carcinoma:** While vertebral metastases are common in many cancers, they rarely involve the anterior mediastinal space or the SVC directly [3]. * **D. Gastric carcinoma:** Though it can metastasize to Virchow’s node (supraclavicular), it rarely involves the mediastinal nodes to a degree that causes SVC obstruction. **3. NEET-PG High-Yield Pearls:** * **Most common cause overall:** Bronchogenic carcinoma (Small Cell Lung Cancer > Non-Small Cell). * **Second most common cause:** Lymphoma (especially Non-Hodgkin Lymphoma). * **Most common benign cause:** Iatrogenic (indwelling central venous catheters or pacemakers). * **Clinical Sign:** Pemberton’s sign (facial flushing/cyanosis when arms are raised). * **Management:** Emergency radiotherapy is indicated if there is airway compromise or cerebral edema; otherwise, stenting and treating the underlying malignancy is the mainstay.

Question 157: A 14-year-old girl presents with a rash, abdominal pain, arthralgias, nausea, vomiting, and bloody stools. Physical examination reveals a palpable purpuric rash on her buttocks and lower legs, a tender abdomen, and no active joint inflammation. Urinalysis shows RBCs and RBC casts, and her renal function deteriorates rapidly. A renal biopsy is performed. Considering the clinical presentation and biopsy, what is the most likely diagnosis on renal biopsy for this patient with glomerulonephritis (GN)?

A. Diffuse proliferative GN (Correct Answer)
B. Crescentic GN
C. Focal proliferative GN
D. Membranoproliferative GN

Explanation: **Explanation:** The clinical presentation of a palpable purpuric rash (buttocks/legs), abdominal pain, arthralgia, and hematuria in a young patient is classic for **Henoch-Schönlein Purpura (HSP)**, also known as IgA Vasculitis. When HSP involves the kidneys, it is termed HSP nephritis. **Why Option A is Correct:** The renal manifestations of HSP are histologically identical to IgA Nephropathy [1]. The severity of the biopsy findings correlates with the clinical presentation. While HSP can show a spectrum of changes, in cases where there is **rapidly deteriorating renal function** and significant hematuria (RBC casts), the most common underlying histological pattern is **Diffuse Proliferative Glomerulonephritis (DPGN)**. This involves global involvement of more than 50% of glomeruli with significant mesangial and endocapillary proliferation. **Why other options are incorrect:** * **B. Crescentic GN:** While this represents the most severe form (Type VI) and can cause rapid deterioration [2], DPGN is the broader pathological category often associated with the initial aggressive proliferative phase in systemic vasculitis. * **C. Focal Proliferative GN:** This is seen in milder clinical cases of HSP where renal function is usually preserved. * **D. Membranoproliferative GN (MPGN):** This is characterized by "tram-track" basement membrane splitting and is typically associated with Hepatitis C or complement dysregulation, not classic HSP. **High-Yield Clinical Pearls for NEET-PG:** * **HSP Tetrad:** Purpura (non-thrombocytopenic), Arthralgia, Abdominal pain, and Renal disease. * **Pathogenesis:** Systemic deposition of **IgA1-containing immune complexes**. * **Biopsy Gold Standard:** Immunofluorescence showing **mesangial IgA deposits** [1]. * **Prognosis:** Generally excellent in children, but the presence of RBC casts and nephritic/nephrotic range proteinuria indicates a higher risk of chronic kidney disease.

Question 158: Which parameter best predicts the return of renal function in a patient with tumor lysis syndrome?

A. Serum creatinine
B. Serum phosphate
C. Serum potassium
D. Serum uric acid (Correct Answer)

Explanation: **Explanation:** **Tumor Lysis Syndrome (TLS)** is an oncologic emergency characterized by the massive release of intracellular contents into the bloodstream. The primary mechanism of acute kidney injury (AKI) in TLS is **Urate Nephropathy**, where uric acid crystals precipitate in the renal tubules, leading to obstruction and inflammation [1]. **Why Serum Uric Acid is the best predictor:** The recovery of renal function in TLS is directly linked to the clearance of the obstructing agent. As serum uric acid levels decrease (either through aggressive hydration, urinary alkalinization, or the use of Rasburicase), the intratubular crystal burden diminishes. A significant drop in serum uric acid levels precedes the improvement in glomerular filtration rate (GFR), making it the most reliable biochemical predictor of the return of renal function. **Why other options are incorrect:** * **Serum Creatinine:** This is a marker of *current* renal function (damage), not a predictor of recovery [2]. Creatinine levels often remain elevated for days after the underlying cause of AKI is resolved due to the time required for tubular repair. * **Serum Phosphate:** While hyperphosphatemia causes calcium-phosphate deposition (nephrocalcinosis), it is secondary to uric acid in terms of the initial obstructive insult in TLS [1]. * **Serum Potassium:** Hyperkalemia is the most life-threatening electrolyte derangement in TLS, but it reflects cell lysis and renal failure severity rather than predicting the reversal of the pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** Allopurinol (prevents new uric acid formation). * **Treatment of choice for Hyperuricemia:** **Rasburicase** (recombinant urate oxidase) – it converts uric acid into highly soluble allantoin. * **Cairo-Bishop Definition:** Laboratory TLS (2 or more metabolic abnormalities) vs. Clinical TLS (Lab TLS + increased creatinine, seizures, or arrhythmias). * **Classic Tetrad:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** (due to phosphate binding).

Question 159: All of the following are seen in Tumor Lysis Syndrome, except:

A. Hyperkalemia
B. Hypercalcemia (Correct Answer)
C. Hyperuricemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid breakdown of malignant cells (most commonly in high-grade lymphomas and leukemias) following chemotherapy. When these cells rupture, they release their intracellular contents into the systemic circulation, leading to specific metabolic derangements. **Why Hypercalcemia is the Correct Answer (The "Except"):** In TLS, **Hypocalcemia** (low calcium) occurs, not hypercalcemia. This happens because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to ionized calcium, forming calcium phosphate crystals that precipitate in soft tissues and the kidneys. This "precipitation" effectively pulls calcium out of the serum, leading to secondary hypocalcemia. **Analysis of Incorrect Options:** * **Hyperkalemia (A):** Potassium is the primary intracellular cation. Rapid cell lysis dumps large amounts of potassium into the blood, which can lead to life-threatening cardiac arrhythmias. * **Hyperuricemia (C):** The breakdown of nucleic acids (purines) from the tumor cells is metabolized by xanthine oxidase into uric acid. This can lead to acute uric acid nephropathy. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to a rapid rise in serum phosphate levels. **NEET-PG High-Yield Pearls:** * **Cairo-Bishop Definition:** TLS is defined by the presence of two or more metabolic abnormalities (Hyperuricemia, Hyperkalemia, Hyperphosphatemia, or Hypocalcemia) occurring within 3-7 days of chemotherapy. * **Prophylaxis:** Aggressive IV hydration is the most important preventive measure. * **Management:** **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used to manage hyperuricemia. * **Renal Failure:** The combination of uric acid crystals and calcium phosphate crystals leads to Acute Kidney Injury (AKI).

Question 160: Which of the following statements regarding the Philadelphia chromosome is NOT true?

A. Present in 95% of chronic myeloid leukemia (CML) patients.
B. It is the result of a reciprocal translocation.
C. Specific for CML. (Correct Answer)
D. Designated as t(9;22)(q34;q11).

Explanation: The Philadelphia (Ph) chromosome is the hallmark of Chronic Myeloid Leukemia (CML), but it is not exclusive to it. **Explanation of the Correct Answer (C):** The statement "Specific for CML" is **incorrect** because the Philadelphia chromosome is also found in other hematological malignancies. It is present in approximately **25-30% of adults with Acute Lymphoblastic Leukemia (ALL)**, 2-5% of pediatric ALL, and occasionally in Acute Myeloid Leukemia (AML). In ALL, its presence signifies a poor prognosis [1]. **Analysis of Other Options:** * **Option A:** It is present in **>95% of CML patients**. The remaining 5% are "Ph-negative" but usually harbor the cryptic *BCR-ABL1* fusion gene detectable by FISH or PCR. * **Option B & D:** The Ph chromosome is a **reciprocal translocation** between chromosomes 9 and 22, designated as **t(9;22)(q34;q11)** [2]. This results in the fusion of the *ABL1* proto-oncogene (Ch 9) with the *BCR* gene (Ch 22), creating a chimeric protein with constitutive tyrosine kinase activity [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Molecular Weight:** The fusion protein in CML is typically **p210**, whereas in Ph+ ALL, it is often **p190**. 2. **Diagnosis:** While karyotyping identifies the Ph chromosome, **FISH** is more sensitive, and **RT-PCR** is the gold standard for monitoring Minimal Residual Disease (MRD) [3]. 3. **Treatment:** The first-line treatment for Ph+ CML is **Imatinib** (a Tyrosine Kinase Inhibitor) [2], [3]. 4. **Blast Crisis:** CML can transform into either AML (70%) or ALL (30%) during a blast crisis.

Question 161: A 32-year-old man presents with a serum sodium of 125 mEq/L. On examination, his blood pressure is 110/70 mmHg and pulse is 110/min. When sitting up, he feels lightheaded with a drop in blood pressure. His urine sodium is 5 mEq/L and urine osmolality is 800 mOsm/kg. What is the most likely diagnosis for this patient's hyponatremia?

A. Congestive heart failure (CHF)
B. Extrarenal sodium and fluid losses (Correct Answer)
C. Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH)
D. Polydipsia

Explanation: The key to solving hyponatremia questions lies in assessing the patient's **volume status** and **urinary sodium (UNa)**. **1. Why "Extrarenal sodium and fluid losses" is correct:** The patient presents with **hypovolemic hyponatremia**, evidenced by tachycardia (110/min) and **orthostatic hypotension** (lightheadedness and BP drop upon sitting). In response to volume depletion, the body activates the Renin-Angiotensin-Aldosterone System (RAAS) to conserve sodium [1]. * **Low Urine Sodium (<20 mEq/L):** Indicates that the kidneys are functioning correctly and attempting to retain sodium. This points to a loss occurring *outside* the kidneys (e.g., vomiting, diarrhea, or excessive sweating) [1]. * **High Urine Osmolality (>100 mOsm/kg):** ADH is appropriately secreted in response to hypovolemia to retain water, resulting in concentrated urine [2]. **2. Why the other options are incorrect:** * **Congestive Heart Failure (CHF):** While CHF causes hyponatremia with low UNa, it presents with **hypervolemia** (edema, JVP elevation, crackles), not orthostatic hypotension [1]. * **SIADH:** This is a **euvolemic** state [1]. Crucially, in SIADH, the UNa is typically **>40 mEq/L** because there is no stimulus for the RAAS to conserve sodium. * **Polydipsia:** Patients with primary polydipsia are euvolemic and have **dilute urine** (Urine Osmolality <100 mOsm/kg) or excessive electrolyte-free water intake [1]. **3. NEET-PG High-Yield Pearls:** * **Hypovolemic + UNa <20:** Extrarenal losses (GI, skin) [1]. * **Hypovolemic + UNa >40:** Renal losses (Diuretics, Addison’s disease, Salt-wasting nephropathy) [1]. * **Euvolemic + UNa >40:** SIADH, Hypothyroidism, Glucocorticoid deficiency [1]. * **Hypervolemic + UNa <20:** CHF, Cirrhosis, Nephrotic Syndrome [1]. * **Correction Warning:** Rapid correction of chronic hyponatremia (>8-10 mEq/L in 24h) can lead to **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** [3].

Question 162: What is the treatment of choice for anti-CD120 antibody?

A. All low-grade non-Hodgkin's lymphomas (Correct Answer)
B. Relapsed B cell follicular lymphomas
C. Relapsed Hodgkin's disease
D. Chronic lymphatic leukemia

Explanation: The question refers to Rituximab, which is a chimeric monoclonal antibody directed against the CD20 antigen (note: "CD120" in the prompt is a common typographical error in some question banks for CD20; CD20 is the hallmark target for B-cell therapies) [1]. CD20 is expressed on the surface of normal and malignant B-lymphocytes. **Why Option A is Correct:** Rituximab is the standard of care and the treatment of choice for all low-grade non-Hodgkin's lymphomas (NHL), particularly B-cell types [1]. It works via antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity, and induction of apoptosis. It is used both as monotherapy and in combination with chemotherapy (e.g., R-CHOP, R-CVP) to significantly improve progression-free and overall survival in low-grade lymphomas like Follicular Lymphoma and Marginal Zone Lymphoma [1]. **Analysis of Incorrect Options:** * **Option B:** While Rituximab is used in relapsed follicular lymphoma, it is not restricted to relapsed cases; it is the primary choice for *initial* treatment as well [1]. * **Option C:** Hodgkin’s disease is characterized by Reed-Sternberg cells which are typically CD20 negative (they are CD15+ and CD30+). Therefore, anti-CD20 therapy is not the treatment of choice [2]. * **Option D:** In Chronic Lymphocytic Leukemia (CLL), while Rituximab is used (often in the FCR regimen), the expression of CD20 on CLL cells is typically weak. It is a component of treatment but "low-grade NHL" represents the broader, classic indication for this class. **High-Yield Clinical Pearls for NEET-PG:** * **Target:** CD20 (found on B-cells from pre-B stage to mature B-cells; absent on plasma cells). * **Side Effects:** Infusion-related reactions (most common), B-cell depletion, and **Reactivation of Hepatitis B** (mandatory screening required before starting therapy). * **Other Anti-CD20 Monoclonals:** Ofatumumab, Obinutuzumab. * **Radioimmunotherapy:** Ibritumomab tiuxetan (Yttrium-90 labeled anti-CD20).

Question 163: A 50-year-old woman presents with pain and swelling in her proximal interphalangeal joints, wrists, and knees, accompanied by morning stiffness. She has a history of hysterectomy 10 years ago. Physical examination reveals swelling and synovial thickening of the proximal interphalangeal (PIP) joints. Her laboratory findings include: Hemoglobin 10.3 g/dL, MCV 80 fL, serum iron 28 mg/dL, iron-binding capacity 200 mg/dL, and saturation 14%. What is the most likely explanation for this woman's anemia?

A. Occult blood loss
B. Vitamin deficiency
C. Anemia of chronic disease (Correct Answer)
D. Sideroblastic anemia

Explanation: The patient presents with clinical features classic for **Rheumatoid Arthritis (RA)**: symmetrical inflammatory polyarthritis involving the PIP joints and wrists with significant morning stiffness [1]. In the context of a chronic inflammatory state like RA, the most common cause of anemia is **Anemia of Chronic Disease (ACD)**. [2] **1. Why Anemia of Chronic Disease is correct:** In chronic inflammation, cytokines (especially IL-6) trigger the liver to produce **Hepcidin** [1]. Hepcidin inhibits **ferroportin**, preventing iron release from macrophages and decreasing intestinal iron absorption. This leads to "iron sequestration" [3]. * **Lab Profile in ACD:** Low serum iron, **low Total Iron Binding Capacity (TIBC)**, and normal-to-high ferritin. * In this case, the TIBC is low (200 mg/dL; normal 250–450), which is the hallmark that distinguishes ACD from Iron Deficiency Anemia (IDA). **2. Why the other options are incorrect:** * **A. Occult blood loss:** This leads to Iron Deficiency Anemia. While IDA also has low serum iron, it is characterized by a **high TIBC** (compensatory increase in transferrin), which is not present here. [3] * **B. Vitamin deficiency:** B12 or Folate deficiency causes megaloblastic anemia with a **high MCV** (>100 fL). This patient has a low-normal MCV (80 fL). * **C. Sideroblastic anemia:** This typically presents with **increased** serum iron and saturation due to the inability to incorporate iron into hemoglobin, often showing "ringed sideroblasts" in the bone marrow. **High-Yield Clinical Pearls for NEET-PG:** * **ACD vs. IDA:** The most reliable differentiator is **Ferritin** (Low in IDA, Normal/High in ACD) and **TIBC** (High in IDA, Low in ACD). * **Hepcidin** is the "master regulator" of iron metabolism and an acute-phase reactant [3]. * In RA, the severity of anemia usually correlates with the degree of joint inflammation and ESR/CRP levels.

Question 164: A 19-year-old man presents to the emergency department with symptoms of malaise, nausea, and decreased urine output. He was previously well, and his physical examination is normal except for an elevated jugular venous pressure (JVP) and a pericardial rub. His electrolytes reveal acute kidney injury (AKI). Which of the following findings on the urinalysis is most likely in keeping with acute glomerulonephritis (GN)?

A. Proteinuria
B. White blood cell casts
C. Granular casts
D. Erythrocyte casts (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Erythrocyte casts** The presence of **erythrocyte (red blood cell) casts** is the pathognomonic hallmark of **acute glomerulonephritis (GN)** [1]. In GN, the glomerular filtration barrier is damaged, allowing RBCs to leak into the nephron [2]. As these cells pass through the distal convoluted tubule and collecting duct, they are trapped within a matrix of Tamm-Horsfall mucoprotein, forming a cylindrical cast. Finding RBC casts definitively localizes the source of hematuria to the renal parenchyma (glomerulus) rather than the lower urinary tract [1]. **Analysis of Incorrect Options:** * **A. Proteinuria:** While common in GN, proteinuria is non-specific [2]. It can occur in nephrotic syndrome, tubular diseases, or even functional states like heavy exercise or fever. * **B. White blood cell (WBC) casts:** These are characteristic of **acute pyelonephritis** or **acute tubulointerstitial nephritis (AIN)** [3]. They indicate inflammation or infection within the kidney interstitium. * **C. Granular casts:** Often described as "muddy brown" casts, these are the hallmark of **Acute Tubular Necrosis (ATN)**. They represent degenerated tubular epithelial cells. **Clinical Pearls for NEET-PG:** * **Dysmorphic RBCs (Acanthocytes):** Along with RBC casts, these are highly suggestive of glomerular bleeding. * **Clinical Context:** In this 19-year-old patient, the combination of AKI, elevated JVP, and a pericardial rub suggests **uremic pericarditis**—a medical emergency requiring urgent dialysis [4]. * **Nephritic Syndrome Triad:** Hematuria (RBC casts), Hypertension, and Azotemia (AKI) [5]. * **High-Yield Association:** If a young male presents with hemoptysis and RBC casts, consider **Goodpasture Syndrome** (Anti-GBM disease) [3].

Question 165: Which of the following statements regarding oat cell carcinoma of the lung is FALSE?

A. It is a variant of large cell anaplastic carcinoma. (Correct Answer)
B. Chemotherapy is generally effective.
C. Paraneoplastic syndromes may be present.
D. It can cause the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH).

Explanation: **Explanation:** **Oat cell carcinoma** is a historical synonym for **Small Cell Lung Cancer (SCLC)**. It is characterized by small, round-to-oval cells with scanty cytoplasm, hyperchromatic nuclei, and "salt-and-pepper" chromatin. 1. **Why Option A is the Correct Answer (The False Statement):** Oat cell carcinoma is a distinct neuroendocrine tumor and is **not** a variant of large cell anaplastic carcinoma. Large cell carcinoma is a subtype of Non-Small Cell Lung Cancer (NSCLC) characterized by large nuclei and prominent nucleoli. SCLC and Large Cell Carcinoma are histologically and clinically separate entities. 2. **Analysis of Other Options:** * **Option B:** SCLC is highly sensitive to chemotherapy and radiotherapy (though it has a high recurrence rate). It is considered a "systemic disease" at presentation, making chemotherapy the mainstay of treatment. * **Option C & D:** SCLC is the most common lung cancer associated with **paraneoplastic syndromes** due to its neuroendocrine origin [1]. It frequently secretes ectopic hormones, most notably **ADH (causing SIADH)** and **ACTH (causing Cushing Syndrome)** [1], [2]. It is also associated with Lambert-Eaton Myasthenic Syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Typically **central/hilar** (arises from neuroendocrine Kulchitsky cells). * **Strongest Association:** Almost exclusively seen in **smokers** [3]. * **Genetics:** Nearly 100% show mutations in **TP53 and RB1** genes. * **Azzopardi Effect:** A characteristic histological finding where DNA from necrotic tumor cells encrusts venule walls. * **Staging:** Uses "Limited" vs. "Extensive" stage rather than traditional TNM for treatment decisions [4].

Question 166: A 69-year-old man with a 60 pack-year smoking history presents with dizziness and visual disturbances. Physical examination reveals a purplish discoloration of his face, arms, and neck; retinal vein engorgement; and visible distention of his neck veins. His complete blood count reveals a normocytic anemia. The pathophysiology of this patient’s clinical presentation most likely involves which of the following?

A. Right heart failure secondary to left heart failure
B. Obstruction of the superior vena cava by a primary tumor arising in the lungs (Correct Answer)
C. Metastatic disease to the cervical lymph nodes with compression of the jugular veins
D. Polycythemia rubra vera

Explanation: ### Explanation **Correct Option: B (Obstruction of the superior vena cava by a primary tumor arising in the lungs)** The patient presents with the classic triad of **Superior Vena Cava (SVC) Syndrome**: facial/neck edema (purplish discoloration), venous distention, and neurological symptoms (dizziness, visual disturbances due to cerebral venous congestion). Given his 60 pack-year smoking history, the most likely etiology is **Bronchogenic Carcinoma** (Small Cell Lung Cancer is the most common malignant cause, though Non-Small Cell Lung Cancer is also frequent) [1]. The pathophysiology involves extrinsic compression or direct invasion of the thin-walled SVC by a mediastinal mass, leading to impaired venous drainage from the head, neck, and upper extremities into the right atrium. **Incorrect Options:** * **A: Right heart failure:** While it causes neck vein distention (JVP), it typically presents with dependent edema (legs), hepatomegaly, and ascites, rather than isolated upper-body plethora and retinal engorgement. * **C: Metastatic cervical lymphadenopathy:** While this can compress jugular veins, it rarely causes the global, bilateral upper-body congestion and SVC-territory venous collateralization seen here. * **D: Polycythemia rubra vera:** This can cause facial plethora (ruddy cyanosis) and hyperviscosity, but it would present with an **elevated** hemoglobin/hematocrit, whereas this patient has normocytic anemia. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of SVC Syndrome:** Malignancy (70-90%), specifically Lung Cancer and Lymphoma. * **Pemberton’s Sign:** Asking the patient to lift both arms above the head; facial flushing or inspiratory stridor indicates thoracic outlet obstruction/SVC syndrome. * **Imaging of Choice:** Contrast-enhanced CT of the chest (gold standard to visualize the obstruction and collateral circulation). * **Management:** Emergency radiotherapy or stenting if airway/cerebral edema is present; otherwise, treat the underlying malignancy (e.g., chemotherapy for Small Cell Lung Cancer) [1].

Question 167: Which of the following is the most common functioning pancreatic islet cell tumor?

A. Gastrinoma
B. Glucagonoma
C. Insulinoma (Correct Answer)
D. Vipoma

Explanation: **Explanation:** **Insulinoma** is the most common functioning pancreatic neuroendocrine tumor (pNET). These tumors arise from the beta cells of the pancreatic islets and are characterized by the autonomous secretion of insulin, leading to fasting hypoglycemia [1]. **Why Insulinoma is correct:** Statistically, insulinomas represent the most frequent functioning pNET [2]. Clinically, they present with the **Whipple Triad**: symptoms of hypoglycemia, low blood glucose levels (<50 mg/dL), and immediate relief of symptoms upon glucose administration [1]. Unlike many other pNETs, approximately 90% of insulinomas are benign, solitary, and small (<2 cm). **Why other options are incorrect:** * **Gastrinoma:** This is the second most common functioning pNET. It causes **Zollinger-Ellison Syndrome**, characterized by refractory peptic ulcers and diarrhea. While common, its incidence is lower than that of insulinoma. * **Glucagonoma:** A rare tumor of alpha cells [3]. It presents with the "4 Ds": Diabetes, Dermatitis (**Necrolytic Migratory Erythema**), Deep vein thrombosis, and Depression. * **Vipoma:** Also known as Verner-Morrison syndrome or **WDHA syndrome** (Watery Diarrhea, Hypokalemia, Achlorhydria). It is significantly rarer than insulinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 90s for Insulinoma:** 90% are benign, 90% are solitary, 90% are intrapancreatic, and 90% are <2 cm. * **Localization:** Most insulinomas are distributed equally across the head, body, and tail of the pancreas. * **MEN1 Association:** While most insulinomas are sporadic, they can be associated with Multiple Endocrine Neoplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Diagnosis:** The gold standard is the **72-hour supervised fast** showing elevated insulin and C-peptide levels during hypoglycemia [1].

Question 168: The mutation of the Wilms' tumor gene is located on which chromosome band?

A. 13p
B. 13q14
C. 11p13 (Correct Answer)
D. 11q13

Explanation: **Explanation:** **1. Why the Correct Answer is Right:** Wilms' tumor (Nephroblastoma) is the most common primary renal malignancy in children. The **WT1 gene**, which is a tumor suppressor gene essential for normal kidney and gonadal development, is located on **Chromosome 11p13**. Mutations, deletions, or loss of heterozygosity at this specific locus lead to the development of Wilms' tumor. This is classically associated with **WAGR Syndrome** (Wilms' tumor, Aniridia, Genitourinary anomalies, and intellectual disability/Range of developmental delays), where a microdeletion occurs at the 11p13 band involving both the *WT1* and *PAX6* genes. **2. Why the Incorrect Options are Wrong:** * **13p:** Chromosome 13p consists mainly of satellite DNA and ribosomal RNA genes; it is not associated with major tumor suppressor genes. * **13q14:** This is the locus for the **RB1 (Retinoblastoma) gene** [1]. Mutations here are associated with Retinoblastoma and Osteosarcoma, not Wilms' tumor. * **11q13:** This locus is associated with the **MEN1 gene** (Multiple Endocrine Neoplasia Type 1) and the *CCND1* (Cyclin D1) gene, often implicated in Mantle Cell Lymphoma and Breast Cancer. **3. High-Yield Clinical Pearls for NEET-PG:** * **WT1 (11p13):** Associated with WAGR Syndrome and Denys-Drash Syndrome. * **WT2 (11p15):** Associated with **Beckwith-Wiedemann Syndrome** (characterized by macroglossia, organomegaly, and hemihypertrophy). * **Histology:** Look for the "Triphasic pattern" consisting of blastemal, stromal, and epithelial cells. * **Clinical Presentation:** Most common presentation is a large, palpable, smooth abdominal mass that **does not cross the midline** (unlike Neuroblastoma).

Question 169: A 65-year-old woman is admitted to the hospital after a stroke resulting in left hemiparesis. She has no trouble swallowing and is on a full diet. One week later, on routine biochemistry, her sodium is 128 mEq/L and osmolality is 270 mOsm/kg. She has no symptoms and is euvolemic on clinical examination. Urine sodium is 40 mEq/L and urine osmolality is 450 mOsm/kg. For the above patient with hyponatremia, select the most likely diagnosis?

A. Congestive heart failure (CHF)
B. Extrarenal sodium and fluid losses
C. SIADH (Correct Answer)
D. Polydipsia

Explanation: ### Explanation The patient presents with **hypotonic hyponatremia** (Serum Na+ 128 mEq/L, Osmolality 270 mOsm/kg) in a **clinically euvolemic** state [1]. The diagnosis is **SIADH (Syndrome of Inappropriate Antidiuretic Hormone)**, which is a common complication of CNS insults like stroke. **1. Why SIADH is correct:** The diagnosis is confirmed by meeting the classic criteria: * **Hypotonic Hyponatremia:** Serum Osmolality <280 mOsm/kg. * **Euvolemia:** No signs of dehydration (tachycardia, dry mucus) or fluid overload (edema, JVP) [1]. * **Inappropriately Concentrated Urine:** Urine osmolality >100 mOsm/kg (here 450 mOsm/kg) despite low serum osmolality [2]. * **Elevated Urine Sodium:** >40 mEq/L, indicating the kidneys are not trying to conserve sodium (unlike in hypovolemia) [1]. **2. Why other options are incorrect:** * **CHF (Option A):** Patients with CHF are **hypervolemic** (edema, rales). While they have hyponatremia, their urine sodium is typically low (<20 mEq/L) due to RAAS activation [1]. * **Extrarenal losses (Option B):** Conditions like diarrhea or vomiting cause **hypovolemic** hyponatremia [1]. The urine sodium would be low (<20 mEq/L) as the kidneys attempt to conserve volume. * **Polydipsia (Option D):** In primary polydipsia, the kidneys function normally to excrete excess water. Therefore, the urine would be **maximally dilute** (Urine Osmolality <100 mOsm/kg), unlike this patient’s concentrated urine [1]. **NEET-PG High-Yield Pearls:** * **Most common cause of SIADH:** Small cell carcinoma of the lung (ectopic production). * **CNS causes:** Stroke, trauma, meningitis, and tumors. * **Drug causes:** SSRIs, Carbamazepine, Cyclophosphamide. * **Treatment:** Fluid restriction is the first-line treatment for asymptomatic SIADH [3]. For severe symptoms, use 3% hypertonic saline. * **Caution:** Avoid rapid correction to prevent **Osmotic Demyelination Syndrome (ODS)**. Target correction: <8–10 mEq/L in 24 hours [3].

Question 170: The mutation of the Wilms' tumor gene is located on which chromosome band?

A. 13p
B. 13q14
C. 11p13 (Correct Answer)
D. 11q13

Explanation: ### Explanation **Correct Answer: C. 11p13** **1. Why 11p13 is Correct:** Wilms' tumor (Nephroblastoma) is the most common primary renal tumor of childhood. The **WT1 gene**, a tumor suppressor gene essential for normal kidney and gonadal development, is located on **chromosome 11p13**. Mutations or deletions in this specific band lead to the development of Wilms' tumor, often as part of the **WAGR syndrome** (Wilms' tumor, Aniridia, Genitourinary anomalies, and intellectual disability/Range of developmental delays). **2. Analysis of Incorrect Options:** * **13p:** Chromosome 13p consists mostly of repetitive DNA sequences and ribosomal RNA genes; it is not associated with major tumor suppressor genes. * **13q14:** This is the locus for the **RB1 (Retinoblastoma) gene** [1]. Mutations here are associated with Retinoblastoma and Osteosarcoma, not Wilms' tumor. * **11q13:** This locus is associated with the **MEN1 gene** (Multiple Endocrine Neoplasia Type 1) and the *CCND1* (Cyclin D1) gene, often implicated in Mantle Cell Lymphoma and Breast Cancer. **3. Clinical Pearls for NEET-PG:** * **WT1 vs. WT2:** While WT1 is at **11p13**, the **WT2 gene** (associated with Beckwith-Wiedemann Syndrome) is located at **11p15.5**. * **Histology:** Look for the "Triphasic pattern" on microscopy—blastemal, stromal, and epithelial cells. * **Clinical Presentation:** Usually presents as a large, smooth, firm abdominal mass that **does not cross the midline** (unlike Neuroblastoma). * **Denys-Drash Syndrome:** Characterized by the triad of Wilms' tumor, early-onset nephrotic syndrome (diffuse mesangial sclerosis), and male pseudohermaphroditism; also linked to WT1 mutations.

Question 171: A 65-year-old woman is admitted to the hospital after a stroke resulting in left hemiparesis. She has no trouble swallowing and is on a full diet. One week later, on routine biochemistry, her sodium is 128 mEq/L and osmolality is 270 mOsm/kg. She has no symptoms and is euvolemic on clinical examination. Urine sodium is 40 mEq/L and urine osmolality is 450 mOsm/kg. For the above patient with hyponatremia, select the most likely diagnosis?

A. Congestive heart failure (CHF)
B. Extrarenal sodium and fluid losses
C. SIADH (Correct Answer)
D. Polydipsia

Explanation: ### Explanation The patient presents with **hypotonic hyponatremia** (Serum Na+ 128 mEq/L, Osmolality 270 mOsm/kg) in a **clinically euvolemic** state [1]. The diagnosis is **SIADH (Syndrome of Inappropriate Antidiuretic Hormone)**, likely secondary to her recent stroke (CNS insult). **1. Why SIADH is correct:** The diagnosis of SIADH is based on the following criteria: * **Hypotonic Hyponatremia:** Serum osmolality <280 mOsm/kg. * **Euvolemia:** No signs of edema (CHF/Cirrhosis) or dehydration [1]. * **Inappropriate Urine Concentration:** Urine osmolality >100 mOsm/kg (here 450 mOsm/kg) despite low serum osmolality [2]. * **Elevated Urine Sodium:** >40 mEq/L (due to pressure natriuresis and suppressed aldosterone), which confirms the kidneys are not trying to conserve sodium as they would in hypovolemia. **2. Why other options are wrong:** * **CHF:** Patients with CHF present with **hypervolemia** (edema, JVP elevation). While they have hyponatremia, their urine sodium is typically **low (<20 mEq/L)** due to RAAS activation [1]. * **Extrarenal losses:** This leads to **hypovolemic** hyponatremia. Clinical signs of dehydration would be present, and urine sodium would be **low (<20 mEq/L)** as the kidneys attempt to conserve salt. * **Polydipsia:** In primary polydipsia, the kidneys function normally to excrete excess water. Therefore, the urine would be **maximally dilute** (Urine Osmolality <100 mOsm/kg), unlike this patient’s concentrated urine [1]. **3. NEET-PG High-Yield Pearls:** * **Common Causes of SIADH:** Small cell lung cancer (ectopic ADH), CNS disorders (stroke, trauma, meningitis), and drugs (SSRIs, Carbamazepine, Cyclophosphamide). * **Treatment:** Fluid restriction is the first-line treatment for asymptomatic SIADH [3]. For severe symptomatic hyponatremia, use 3% hypertonic saline. * **Complication:** Rapid correction of chronic hyponatremia (>8-10 mEq/L in 24h) can lead to **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis) [3].**

Question 172: Which of the following is NOT recommended for the management of Tumour lysis syndrome?

A. Allopurinol
B. Febuxostat
C. Urinary alkalinisation using soda bicarbonate (Correct Answer)
D. Rasburicase

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. While historically recommended, **Urinary Alkalinisation (Option C)** is no longer recommended in modern management guidelines [2]. **Why Urinary Alkalinisation is NOT recommended:** 1. **Risk of Calcium-Phosphate Precipitation:** While alkalization increases the solubility of uric acid, it significantly decreases the solubility of calcium phosphate [2]. In TLS, phosphate levels are high; raising urinary pH promotes calcium phosphate deposition in the renal tubules, worsening acute kidney injury (nephrocalcinosis). 2. **Metabolic Alkalosis:** It can exacerbate the clinical effects of hypocalcemia. 3. **Efficacy:** With the availability of potent urate-lowering agents like Rasburicase, the benefit of alkalization is minimal compared to its risks. **Analysis of other options:** * **Allopurinol (Option A):** A xanthine oxidase inhibitor used for **prophylaxis** in low-to-intermediate risk patients. It prevents the formation of new uric acid but does not reduce existing levels. * **Febuxostat (Option B):** A potent, selective xanthine oxidase inhibitor [1]. Recent trials (e.g., FLORENCE trial) show it is an effective alternative to allopurinol for TLS prophylaxis, especially in patients with renal impairment [1]. * **Rasburicase (Option D):** A recombinant urate oxidase that converts existing uric acid into highly soluble allantoin. It is the **treatment of choice** for established TLS or high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Cairo-Bishop Definition:** Used for laboratory vs. clinical TLS. * **Hydration:** Aggressive IV hydration is the cornerstone of TLS management. * **Rasburicase Contraindication:** Absolutely contraindicated in **G6PD deficiency** due to the risk of hemolysis. * **Electrolyte Hallmark:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** (the only "low" electrolyte) [3].

Question 173: What is the diagnostic tumor marker for medullary thyroid cancer?

A. BRAF
B. VMA
C. Calcitonin (Correct Answer)
D. Melatonin

Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** originates from the **parafollicular C-cells** of the thyroid gland. These neuroendocrine cells are embryologically derived from the neural crest and are responsible for the secretion of **Calcitonin**, a hormone involved in calcium homeostasis. Because MTC cells retain this secretory function, serum Calcitonin levels serve as a highly sensitive and specific tumor marker for diagnosis, monitoring treatment response, and detecting recurrence. **Analysis of Options:** * **A. BRAF:** This is a genetic mutation (specifically BRAF V600E) commonly associated with **Papillary Thyroid Cancer**, not Medullary. It is used for prognosis rather than as a primary diagnostic serum marker. * **B. VMA (Vanillylmandelic Acid):** This is a urinary metabolite of catecholamines used to diagnose **Pheochromocytoma**. While Pheochromocytoma is associated with MTC in MEN 2A and 2B syndromes, VMA is not a marker for the thyroid cancer itself. * **D. Melatonin:** This is a hormone secreted by the pineal gland to regulate sleep-wake cycles and has no diagnostic relevance to thyroid oncology. **High-Yield Clinical Pearls for NEET-PG:** * **Carcinoembryonic Antigen (CEA):** Also elevated in MTC and used alongside Calcitonin for prognosis. * **Genetic Screening:** All patients with MTC must be screened for **RET proto-oncogene** mutations to rule out Multiple Endocrine Neoplasia (MEN) type 2. * **Amyloid Stroma:** Histologically, MTC is characterized by nests of cells separated by amyloid deposits (formed by altered calcitonin). * **Screening:** In families with known RET mutations, prophylactic thyroidectomy is often indicated.

Question 174: Which of the following conditions can present with recurrent episodes of upper limb thrombosis?

A. Prostatic carcinoma
B. Pancreatic carcinoma
C. Osteosarcoma
D. All of the above (Correct Answer)

Explanation: This question tests your understanding of **Trousseau Syndrome** (Migratory Thrombophlebitis), a classic paraneoplastic manifestation of underlying malignancy. ### **Explanation** The underlying medical concept is **Cancer-Associated Thrombosis (CAT)**. Malignant cells produce procoagulant factors (like tissue factor and cysteine proteases) and inflammatory cytokines that activate the coagulation cascade. **Trousseau Syndrome** is characterized by recurrent, migratory episodes of venous thrombosis at unusual sites, such as the upper limbs or superficial veins [1]. While it is most classically associated with **mucin-secreting adenocarcinomas**, any advanced malignancy can trigger a hypercoagulable state [2]. * **Pancreatic Carcinoma (Option B):** This is the most common association [2]. Mucin produced by the tumor cells directly interacts with selectins, leading to microthrombi formation. * **Prostatic Carcinoma (Option A):** As an adenocarcinoma, it is a well-documented cause of systemic hypercoagulability and recurrent venous thromboembolism (VTE). * **Osteosarcoma (Option C):** While less common than adenocarcinomas, sarcomas are highly prothrombotic due to the release of membrane-bound tissue factor and tumor-derived microvesicles. ### **Clinical Pearls for NEET-PG** * **Trousseau Sign of Malignancy:** Migratory thrombophlebitis (not to be confused with Trousseau sign of latent tetany/hypocalcemia). * **Most common site:** Pancreas (tail and body > head) [2]. * **Management:** Low Molecular Weight Heparin (LMWH) is generally preferred over Warfarin for cancer-associated thrombosis, as Warfarin is often ineffective in these patients. * **High-Yield Association:** If a patient presents with "spontaneous" or "migratory" clots without obvious risk factors, the first step is to screen for an occult malignancy.

Question 175: What is the commonest carcinoma in elderly males?

A. Stomach
B. Lung
C. Esophagus
D. Prostate (Correct Answer)

Explanation: **Explanation:** The correct answer is **Prostate (Option D)**. In the elderly male population (typically defined as >65 years), **Prostate Carcinoma** is the most frequently diagnosed malignancy. The incidence of prostate cancer is strongly age-dependent; it is rare before age 40 but increases exponentially thereafter. Autopsy studies have shown that nearly 50-60% of men over the age of 80 have histological evidence of prostatic adenocarcinoma, often referred to as "latent carcinoma." **Analysis of Incorrect Options:** * **Stomach (Option A):** While historically common in India and East Asia, its incidence is declining globally. It is not the most common cancer in the elderly compared to prostate or lung. * **Lung (Option B):** Lung cancer is the leading cause of **cancer-related mortality** (deaths) in men worldwide [2], but in terms of **incidence** (new cases) in the elderly, prostate cancer ranks higher. * **Esophagus (Option C):** This is common in specific geographical belts (like the "Asian Esophageal Cancer Belt") and is associated with smoking and alcohol, but it does not surpass the prevalence of prostate cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Global vs. India:** Globally, Prostate is the commonest cancer in males. However, in **India**, according to recent ICMR data, **Lung cancer** or **Oral cavity cancer** often tops the list for males, but for the specific demographic of "elderly males" in a general medical context, Prostate remains the classic textbook answer. * **Screening:** PSA (Prostate Specific Antigen) is the screening marker, though its routine use is controversial due to overdiagnosis. * **Metastasis:** Prostate cancer characteristically spreads to the bone, causing **osteoblastic (sclerotic) lesions**, commonly involving the lumbar spine [1].

Question 176: Which of the following is NOT a paraneoplastic manifestation of bronchogenic carcinoma?

A. Dermatomyositis
B. Acanthosis nigricans (Correct Answer)
C. Cerebellar degeneration
D. Hyperkeratosis of palm and soles

Explanation: **Explanation:** Paraneoplastic syndromes are clinical syndromes involving non-metastatic systemic effects that accompany malignant disease [3]. While many cancers share similar paraneoplastic manifestations, certain signs are classically associated with specific primary tumors. **Why Acanthosis Nigricans is the correct answer:** Acanthosis nigricans (specifically the malignant type) is most strongly associated with **intra-abdominal adenocarcinomas**, with **gastric carcinoma** being the most common (approx. 55-60% of cases). While it can rarely occur with other cancers, it is not a classic paraneoplastic manifestation of bronchogenic carcinoma. **Analysis of other options:** * **Dermatomyositis (A):** This inflammatory myopathy has a strong association with several malignancies, particularly **Small Cell Lung Cancer (SCLC)** and non-small cell lung cancer, as well as ovarian and breast cancers [1]. * **Cerebellar degeneration (C):** Paraneoplastic cerebellar degeneration is a well-documented neurological manifestation of **Small Cell Lung Cancer**, often mediated by anti-Hu or anti-VGCC antibodies [3]. * **Hyperkeratosis of palms and soles (D):** Also known as **Tylosis**, this is a recognized paraneoplastic feature of **Squamous Cell Carcinoma of the Lung** (and esophagus). **NEET-PG High-Yield Pearls:** * **Small Cell Lung Cancer (SCLC):** Most common cause of SIADH, Ectopic ACTH (Cushing’s), and Lambert-Eaton Myasthenic Syndrome [1], [3]. * **Squamous Cell Carcinoma:** Most common cause of Hypercalcemia (due to PTHrP) [1]. * **Hypertrophic Osteoarthropathy (HOA):** Classically associated with Adenocarcinoma of the lung [2]. * **Leser-Trélat sign:** Sudden onset of multiple seborrheic keratoses; like malignant acanthosis nigricans, it points toward **Gastric Adenocarcinoma**.

Question 177: Migratory thrombophlebitis is associated with all of the following malignancies, except:

A. Testis (Correct Answer)
B. Lung
C. Colon
D. Pancreas

Explanation: **Explanation:** **Migratory Thrombophlebitis (Trousseau’s Syndrome)** is a paraneoplastic syndrome characterized by recurrent, spontaneous episodes of venous thrombosis that appear in different locations over time. It is classically associated with **mucin-secreting adenocarcinomas**. **1. Why Testis is the Correct Answer:** Testicular cancers (such as seminomas or non-seminomatous germ cell tumors) [1] are not typically mucin-secreting. While they can cause a hypercoagulable state due to tumor bulk or chemotherapy, they are not classically associated with the "migratory" pattern of thrombophlebitis seen in Trousseau’s Syndrome. **2. Analysis of Other Options:** * **Pancreas (Option D):** This is the **most common** association [2]. Carcinoma of the body and tail of the pancreas is the classic "textbook" cause of Trousseau’s Syndrome. * **Lung (Option B) and Colon (Option C):** Both are common sites for adenocarcinomas. These tumors produce procoagulants like **tissue factor** and **cancer procoagulant**, as well as mucins that interact with P-selectin and L-selectin, triggering the formation of microthrombi [2]. **Clinical Pearls for NEET-PG:** * **Pathophysiology:** The syndrome is driven by the interaction of circulating mucins with selectins and the release of tissue factor, leading to chronic disseminated intravascular coagulation (DIC). * **Trousseau’s Sign vs. Syndrome:** Do not confuse *Trousseau’s Syndrome* (migratory thrombophlebitis) with *Trousseau’s Sign of Latent Tetany* (carpopedal spasm induced by BP cuff inflation in hypocalcemia). * **Management:** The treatment of choice for malignancy-associated thrombosis is **Low Molecular Weight Heparin (LMWH)**, as these patients are often resistant to Warfarin.

Question 178: Which of the following is the only form of Hodgkin disease (HD) more common in women?

A. Lymphocyte-predominant Hodgkin disease
B. Nodular-sclerosing Hodgkin disease (Correct Answer)
C. Mixed-cellularity Hodgkin disease
D. Lymphocyte-depleted Hodgkin disease, reticular type

Explanation: **Explanation:** In Hodgkin Lymphoma (HL), there is a distinct gender distribution pattern. While the overall incidence of Hodgkin Lymphoma is higher in males, **Nodular Sclerosis Hodgkin Lymphoma (NSHL)** is the notable exception. It is the only subtype that shows a **female preponderance** (or an equal gender distribution depending on the study population) and is the most common subtype overall, accounting for approximately 60–80% of cases [1]. It typically affects adolescents and young adults and frequently presents with a mediastinal mass [2]. **Analysis of Options:** * **Nodular Sclerosis (Correct):** Characterized by broad bands of collagen fibrosis surrounding nodules of tumor cells and the presence of **Lacunar cells** (a variant of Reed-Sternberg cells). It is the most common subtype in females and young adults [1]. * **Lymphocyte-Predominant (Incorrect):** This subtype has a strong male predominance (approx. 3:1). It is characterized by "Popcorn cells" (L&H cells) and generally carries the best prognosis. * **Mixed-Cellularity (Incorrect):** More common in males and older patients. It is strongly associated with EBV infection and presents with a diverse inflammatory background. * **Lymphocyte-Depleted (Incorrect):** The rarest subtype, seen most often in elderly or HIV-positive males. It carries the worst prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common subtype:** Nodular Sclerosis. * **Best prognosis:** Lymphocyte-Predominant. * **Worst prognosis:** Lymphocyte-Depleted. * **EBV Association:** Highest in Mixed-Cellularity and Lymphocyte-Depleted subtypes. * **Bimodal Age Distribution:** HL peaks at 15–35 years and again after 50 years. * **Reed-Sternberg (RS) Cells:** The hallmark of HL; they are CD15+ and CD30+ (except in the Nodular Lymphocyte Predominant type, which is CD20+).

Question 179: In tumor lysis syndrome, all of the following are seen except?

A. Hypernatremia
B. Hypercalcemia (Correct Answer)
C. Hyperkalemia
D. Hyperphosphatemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid breakdown of malignant cells (most commonly in high-grade lymphomas and leukemias) following the initiation of chemotherapy [1]. When these cells rupture, they release their intracellular contents into the systemic circulation, leading to specific metabolic derangements. **Why Hypercalcemia is the correct answer (The "Except"):** In TLS, **Hypocalcemia** (low calcium) is seen, not hypercalcemia. This occurs because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to ionized calcium, forming calcium-phosphate crystals that precipitate in soft tissues and the kidneys. This "precipitation effect" secondary to high phosphate levels results in a rapid drop in serum calcium. **Analysis of Incorrect Options:** * **Hyperkalemia (C):** Potassium is the primary intracellular cation. Rapid cell lysis releases massive amounts of potassium into the blood, which can lead to life-threatening cardiac arrhythmias. * **Hyperphosphatemia (D):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to a surge in serum phosphate. * **Hypernatremia (A):** While not a primary diagnostic hallmark like the others, hypernatremia can occur due to osmotic diuresis or aggressive treatment strategies. However, it is not the "classic" metabolic contraindication that hypercalcemia is in this context. **NEET-PG High-Yield Pearls:** * **The Metabolic Quartet of TLS:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia**. * **Hyperuricemia:** Caused by the breakdown of nucleic acids into purines, then into uric acid via xanthine oxidase. * **Prophylaxis/Treatment:** Aggressive hydration is first-line. **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used to manage hyperuricemia. * **Renal Failure:** Acute Kidney Injury (AKI) in TLS is primarily due to the precipitation of uric acid crystals and calcium-phosphate crystals in the renal tubules.

Question 180: Central nervous system involvement in diffuse large B-cell lymphoma (DLBCL) is not typically seen with involvement of which of the following organs?

A. Ovary (Correct Answer)
B. Testis
C. Kidney
D. Adrenal gland

Explanation: In Diffuse Large B-cell Lymphoma (DLBCL), certain extranodal sites are associated with a significantly higher risk of secondary Central Nervous System (CNS) relapse. This is often due to the biological behavior of the tumor or the presence of "sanctuary sites" where systemic chemotherapy penetration is poor. [1] **Explanation of the Correct Option:** * **A. Ovary:** While DLBCL can involve the ovaries, it is **not** classically associated with an increased risk of CNS dissemination. In contrast to the male gonads, ovarian involvement does not mandate routine CNS prophylaxis in the same high-risk category as the other options listed. **Explanation of Incorrect Options:** * **B. Testis:** The testis is a classic "sanctuary site" due to the blood-testis barrier. Primary or secondary testicular DLBCL has a very high propensity (up to 15-30%) for CNS relapse. [1] * **C & D. Kidney and Adrenal Gland:** Involvement of the retroperitoneal organs, specifically the kidneys and adrenal glands, is a well-recognized independent risk factor for CNS involvement. [3] The **CNS-IPI (International Prognostic Index)** specifically includes "kidney or adrenal involvement" as a high-risk criterion. **High-Yield Clinical Pearls for NEET-PG:** * **CNS-IPI Score:** Used to predict CNS relapse. It includes the 5 standard IPI factors (Age >60, LDH >normal, Performance Status ≥2, Stage III/IV, >1 Extranodal site) **PLUS** kidney/adrenal involvement. [3] * **High-Risk Sites:** The "Rule of T's and R's" for CNS risk: **T**estis, **R**etroperitoneum (Kidney/Adrenal), and sometimes **B**one Marrow or **B**reast. * **Prophylaxis:** Patients with involvement of the testis, kidney, or adrenal glands often require CNS-directed therapy (e.g., Intrathecal Methotrexate or high-dose systemic Methotrexate) alongside R-CHOP. [2]

Question 181: A 56-year-old man is evaluated for a recent onset painful skin lesion involving his abdominal wall. The lesion started 3 days ago as a small erythematous macule which has gradually increased in size to a large purpuric lesion with bulla formation. He is afebrile and does not recall any trauma. His medical history is significant for atrial fibrillation; he was recently switched from rivaroxaban to warfarin due to the high cost of rivaroxaban. What is the most probable cause of the condition?

A. Rivaroxaban
B. Low-molecular-weight heparin
C. Warfarin (Correct Answer)
D. Low dose aspirin (81 mg/d)

Explanation: ### Explanation The clinical presentation describes **Warfarin-induced Skin Necrosis (WISN)**, a rare but serious complication of oral anticoagulant therapy. **1. Why Warfarin is Correct:** Warfarin inhibits Vitamin K epoxide reductase, leading to a decrease in Vitamin K-dependent clotting factors (II, VII, IX, X) and anticoagulant proteins (Protein C and Protein S). Protein C has a significantly shorter half-life (~6 hours) compared to procoagulant factors like Factor II (~60 hours) and Factor X (~40 hours). During the initial phase of warfarin therapy, Protein C levels drop rapidly, creating a transient **prothrombotic state**. This leads to microvascular thrombosis, skin ischemia, and subsequent necrosis. It typically occurs 3–10 days after starting therapy, often in areas with high subcutaneous fat (breasts, thighs, abdomen). **2. Why Incorrect Options are Wrong:** * **Rivaroxaban (A):** As a direct Factor Xa inhibitor, it does not affect Protein C/S levels and is not associated with skin necrosis. In fact, switching *from* rivaroxaban *to* warfarin triggered this event. * **Low-molecular-weight heparin (B):** LMWH is actually used to *prevent* WISN by providing "bridging" anticoagulation until a stable INR is reached. * **Low dose aspirin (D):** Aspirin is an antiplatelet agent. While it can cause bruising, it does not cause the characteristic purpuric bullae and necrosis seen in this patient. **3. High-Yield Pearls for NEET-PG:** * **Risk Factor:** Underlying **Protein C deficiency** is the most common predisposing factor. * **Prevention:** Always "bridge" with Heparin/LMWH when starting Warfarin in high-risk patients. * **Management:** Immediate cessation of Warfarin, administration of Vitamin K, and giving **Protein C concentrate** or Fresh Frozen Plasma (FFP). * **Differential:** Do not confuse with *Calciphylaxis* (seen in ESRD) or *Heparin-induced Thrombocytopenia (HIT)*.

Question 182: Brain metastasis are common among which of the following malignancies?

A. Breast (Correct Answer)
B. Testis
C. Thyroid
D. Tongue

Explanation: ### Explanation Brain metastases are the most common intracranial tumors in adults, occurring in approximately 20–40% of all cancer patients. The correct answer is **Breast** because it is one of the top three primary sources of brain metastases. **1. Why Breast Cancer is Correct:** The incidence of brain metastasis depends on the primary site. The most common primaries, in order of frequency, are: * **Lung Cancer (40–50%):** The most common overall [1]. * **Breast Cancer (15–25%):** The second most common. It is particularly prevalent in HER2-positive and Triple-Negative subtypes. * **Melanoma (5–20%):** Has the highest *propensity* (likelihood per case) to spread to the brain. * **Renal Cell Carcinoma and Colon Cancer.** **2. Why Other Options are Incorrect:** * **Testis:** While germ cell tumors can spread to the brain (especially choriocarcinoma), they are far less common statistically than breast cancer. * **Thyroid:** Brain metastasis from thyroid cancer is rare (approx. 1%), usually occurring only in advanced papillary or follicular stages. * **Tongue:** Squamous cell carcinomas of the head and neck typically spread via local invasion or to regional lymph nodes; distant metastasis to the brain is highly unusual. **Clinical Pearls for NEET-PG:** * **Location:** 80% of brain metastases occur in the **cerebral hemispheres**, 15% in the cerebellum, and 5% in the brainstem (proportional to blood flow). * **The "Water-Shed" Zone:** Metastases often lodge at the junction of the gray and white matter where blood vessel caliber narrows. * **Multiplicity:** Metastatic lesions are typically multiple and well-circumscribed with significant peritumoral edema. * **Highest Propensity:** If the question asks which cancer has the *highest percentage* of its patients developing brain mets, the answer is **Melanoma**. If it asks for the *most common* source, it is **Lung** [1].

Question 183: Which of the following is the most likely type of thyroid cancer with the best prognosis of all thyroid malignancies?

A. Anaplastic thyroid cancer
B. Follicular cancer of the thyroid
C. Lymphoma of the thyroid
D. Papillary cancer of the thyroid (Correct Answer)

Explanation: **Explanation:** **1. Why Papillary Thyroid Cancer (PTC) is the correct answer:** Papillary thyroid cancer is the most common type of thyroid malignancy (accounting for approximately 80–85% of cases). It is characterized by an **excellent prognosis**, with a 10-year survival rate exceeding 90–95%. The favorable outcome is due to its slow-growing nature, high responsiveness to radioactive iodine (RAI) therapy [1], and tendency to remain localized or spread only to regional lymph nodes rather than distant organs. **2. Why the other options are incorrect:** * **Anaplastic Thyroid Cancer:** This is the most aggressive thyroid malignancy with the **worst prognosis**. It is rapidly enlarging, often fatal within months, and shows poor response to treatment. * **Follicular Thyroid Cancer:** While it has a good prognosis, it is generally considered more aggressive than PTC because it tends to spread **hematogenously** (via blood) to distant sites like bone and lungs. * **Lymphoma of the Thyroid:** Usually associated with Hashimoto’s thyroiditis, its prognosis depends on the histological subtype (e.g., MALT vs. DLBCL) [2], but it does not surpass the survival rates of PTC. **3. High-Yield Clinical Pearls for NEET-PG:** * **Psammoma bodies:** Concentric calcifications seen on histology (pathognomonic for PTC). * **Orphan Annie Eye Nuclei:** Large, pale, clear nuclei seen in PTC. * **Risk Factor:** Prior exposure to ionizing radiation is the most significant risk factor for PTC. * **Genetic Association:** *BRAF* mutations (most common) and *RET/PTC* rearrangements. * **Staging:** In patients <55 years, the TNM staging system only uses Stage I and II, reflecting the excellent prognosis in younger individuals.

Question 184: Tumor lysis syndrome is characterized by:

A. Hyperkalemia
B. Hyperphosphatemia
C. Hyperuricemia
D. All of the above (Correct Answer)

Explanation: Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of tumor cells, typically following chemotherapy for high-grade hematologic malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements. Why "All of the above" is correct: * Hyperkalemia (Option A): Potassium is the primary intracellular cation. Rapid cell lysis floods the bloodstream with potassium, which is the most immediate life-threatening complication due to the risk of cardiac arrhythmias. * Hyperphosphatemia (Option B): Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to hyperphosphatemia, which can cause secondary hypocalcemia (as phosphate binds to calcium, forming crystals). * Hyperuricemia (Option C): The breakdown of nucleic acids (purines) from the tumor's DNA is metabolized by the liver into uric acid [1]. Excessive levels lead to the precipitation of uric acid crystals in the renal tubules, causing acute kidney injury (AKI). In conditions like leukemia, uric acid production is increased because of the increased breakdown of uric acid-rich white blood cells [1]. Clinical Pearls for NEET-PG: 1. Cairo-Bishop Definition: TLS is defined by the presence of two or more metabolic abnormalities (Hyperuricemia, Hyperkalemia, Hyperphosphatemia, or Hypocalcemia) occurring within 3 days before or 7 days after starting chemotherapy. 2. The "Low" Exception: Remember that while most electrolytes go "Up," Calcium goes "Down" (Hypocalcemia). 3. Prophylaxis/Treatment: Aggressive IV hydration is the mainstay. Rasburicase (recombinant urate oxidase) is the drug of choice for high-risk patients as it converts uric acid to soluble allantoin. Allopurinol is used for prophylaxis but does not reduce pre-existing uric acid.

Question 185: Which of the following are characteristic biochemical features of tumor lysis syndrome?

A. Hyperuricemia, Hyperkalemia, Hypernatremia
B. Hypercalcemia, Hyperkalemia, Hypernatremia
C. Hyperuricemia, Hyperkalemia, Hyperphosphatemia (Correct Answer)
D. Hyperuricemia, Hyperkalemia, Hypercalcemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of neoplastic cells, typically following chemotherapy for high-grade hematologic malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements [1]. **Why Option C is Correct:** The hallmark biochemical features of TLS are: 1. **Hyperuricemia:** Catabolism of nucleic acids (purines) into uric acid [1], [2]. 2. **Hyperkalemia:** Release of intracellular potassium. 3. **Hyperphosphatemia:** Release of intracellular organic phosphates. 4. **Hypocalcemia (Secondary):** Elevated phosphate binds to calcium, causing calcium phosphate precipitation in the kidneys. **Why Other Options are Incorrect:** * **Options A & B (Hypernatremia):** Sodium is the primary extracellular cation. Cell lysis does not significantly increase serum sodium levels; in fact, renal failure associated with TLS may lead to fluid retention and dilutional hyponatremia. * **Options B & D (Hypercalcemia):** TLS is characterized by **hypocalcemia**, not hypercalcemia. Hypercalcemia is a separate paraneoplastic syndrome (often associated with PTHrP production in solid tumors). **NEET-PG High-Yield Pearls:** * **Cairo-Bishop Definition:** The standard clinical and laboratory criteria used to diagnose TLS. * **Renal Impact:** Uric acid and calcium phosphate crystals precipitate in the renal tubules, leading to **Acute Kidney Injury (AKI)**. * **Prophylaxis/Treatment:** Aggressive hydration is the most important step. **Allopurinol** prevents new uric acid formation, while **Rasburicase** (recombinant urate oxidase) breaks down existing uric acid into the more soluble allantoin. * **ECG Changes:** Monitor for peaked T-waves due to hyperkalemia and prolonged QT interval due to hypocalcemia.

Question 186: Which of the following is NOT part of the ABVD regimen for chemotherapeutic treatment of Non-Hodgkin's Lymphoma?

A. Doxorubicin
B. Dacarbazine
C. Bleomycin
D. Vincristine (Correct Answer)

Explanation: The **ABVD regimen** is the gold standard first-line chemotherapy for **Hodgkin Lymphoma (HL)** [1]. The question asks which drug is NOT part of this regimen in the context of Non-Hodgkin's Lymphoma (NHL). ### **Explanation of the Correct Answer** **D. Vincristine** is the correct answer because it is not a component of the ABVD regimen. Vincristine is, however, a key component of the **CHOP** or **R-CHOP** regimens, which are the standard treatments for **Non-Hodgkin Lymphoma (NHL)** [1]. It is also part of the older MOPP regimen for Hodgkin Lymphoma. ### **Analysis of Incorrect Options** The acronym **ABVD** stands for: * **A: Adriamycin (Doxorubicin):** An anthracycline that inhibits topoisomerase II. (Option A) * **B: Bleomycin:** A glycopeptide antibiotic that causes DNA strand breaks. (Option C) * **V: Vinblastine:** A microtubule inhibitor (vinca alkaloid). Note that while Vincristine and Vinblastine are in the same class, they are not interchangeable in this regimen. * **D: Dacarbazine:** An alkylating agent. (Option B) ### **Clinical Pearls for NEET-PG** * **Regimen Distinction:** Remember **ABVD for Hodgkin Lymphoma** and **CHOP for Non-Hodgkin Lymphoma**. * **Specific Toxicities (High Yield):** * **Doxorubicin:** Dilated Cardiomyopathy (monitor with ECHO/MUGA scan). * **Bleomycin:** Pulmonary Fibrosis (monitor with Pulmonary Function Tests/DLCO). * **Vinblastine:** Bone marrow suppression (unlike Vincristine, which is more neurotoxic). * **Vincristine:** Peripheral neuropathy and paralytic ileus. * **Historical Note:** ABVD replaced the MOPP regimen because it has a lower risk of causing secondary leukemia and sterility.

Question 187: A 55-year-old man, a chronic smoker, presents to the emergency department with a two-day history of polyuria, polydipsia, nausea, and altered sensorium. He was diagnosed with squamous cell carcinoma of the lung two months prior. On examination, he is lethargic and confused. An ECG is normal except for a narrowed QT interval. Which one of the following is the most likely metabolic abnormality?

A. Hypernatremia
B. Hypercalcemia (Correct Answer)
C. Hypokalemia
D. Hyponatremia

Explanation: ### Explanation **Correct Option: B. Hypercalcemia** This patient presents with the classic "stones, moans, groans, and psychiatric overtones" of **Hypercalcemia**, specifically **Humoral Hypercalcemia of Malignancy (HHM)** [1]. 1. **Underlying Concept:** Squamous cell carcinoma (SCC) of the lung is strongly associated with the ectopic production of **Parathyroid Hormone-related Protein (PTHrP)** [2]. PTHrP mimics PTH, increasing bone resorption and renal calcium reabsorption [1]. 2. **Clinical Correlation:** Polyuria and polydipsia occur because hypercalcemia induces **nephrogenic diabetes insipidus** (resistance to ADH). Altered sensorium and nausea are common CNS and GI manifestations. 3. **ECG Finding:** A **shortened (narrowed) QT interval** is a pathognomonic ECG finding for hypercalcemia (conversely, hypocalcemia prolongs the QT interval). --- ### Why the other options are incorrect: * **A. Hypernatremia:** While it can cause altered sensorium, it does not typically cause a narrowed QT interval. * **C. Hypokalemia:** Usually presents with muscle weakness, U-waves, and a **prolonged** QU interval on ECG, not a narrowed QT. * **D. Hyponatremia:** Often associated with Small Cell Lung Cancer (via SIADH) [2], but it typically presents with fluid retention symptoms and does not cause a narrowed QT interval. --- ### NEET-PG High-Yield Pearls: * **Lung Cancer Associations:** * **Squamous Cell CA:** Hypercalcemia (PTHrP) [2]. Remember: **S**quamous = **S**tones (Calcium). * **Small Cell CA:** SIADH (Hyponatremia), ACTH (Cushing’s), and Lambert-Eaton Syndrome [2]. * **ECG in Electrolytes:** * Short QT = Hypercalcemia. * Long QT = Hypocalcemia/Hypomagnesemia. * Tall T-waves = Hyperkalemia. * **Management:** The immediate treatment for severe symptomatic hypercalcemia is aggressive **IV hydration with Normal Saline**, followed by IV Bisphosphonates (e.g., Zoledronic acid).

Question 188: A patient with leukemia on chemotherapy develops acute right lower abdominal pain associated with anemia, thrombocytopenia, and leukopenia. What is the clinical diagnosis?

A. Appendicitis
B. Leukemic colitis
C. Perforation peritonitis
D. Neutropenic colitis (Correct Answer)

Explanation: ### Explanation **Neutropenic colitis** (also known as **Typhlitis**) is the correct diagnosis. It is a life-threatening necrotizing inflammation of the cecum and ascending colon occurring in immunocompromised patients, typically those with profound neutropenia (Absolute Neutrophil Count < 500/mm³) following chemotherapy for hematologic malignancies like leukemia. **Why it is the correct answer:** The clinical triad of **fever, neutropenia, and right lower quadrant (RLQ) pain** in a patient undergoing chemotherapy is classic for typhlitis. The pathogenesis involves mucosal injury by chemotherapy, which, in the setting of neutropenia, allows for bacterial or fungal invasion of the bowel wall (most commonly the cecum), leading to transmural inflammation and potential necrosis. **Analysis of Incorrect Options:** * **A. Appendicitis:** While it presents with RLQ pain, it is less common than typhlitis in neutropenic patients. Surgery for suspected appendicitis in a neutropenic patient can be easily mistaken as the primary diagnosis [1]. Surgery in a neutropenic patient can be fatal; hence, typhlitis must be ruled out first via CT scan (showing cecal wall thickening >4mm). * **B. Leukemic colitis:** This refers to direct infiltration of the colon by leukemic cells, which usually occurs at the time of diagnosis or relapse, not typically as an acute complication during chemotherapy-induced cytopenia. * **C. Perforation peritonitis:** While this can be a *complication* of neutropenic colitis, the primary clinical diagnosis based on the initial presentation of pain and cytopenia is the underlying colitis itself. **Clinical Pearls for NEET-PG:** * **Most common site:** Cecum (due to its distensibility and limited vascularity). * **Investigation of Choice:** **CT Scan of the abdomen** (shows bowel wall thickening and pericolic fat stranding). * **Management:** Primarily medical (bowel rest, IV fluids, and broad-spectrum antibiotics). Surgery is reserved for perforation or uncontrolled hemorrhage. * **Common organisms:** *Clostridium septicum*, *Pseudomonas aeruginosa*, and *E. coli*.

Question 189: A 28-year-old man presents with a new onset rash on both legs for 1 week. He has no past medical history and is not taking any medications. He denies recent fever but reports occasional gum bleeding and one episode of epistaxis 4 days ago. He is a non-smoker, drinks alcohol socially, and denies recreational drug use. Physical examination reveals no lymphadenopathy or hepatosplenomegaly. Laboratory studies show hemoglobin 14.8 gm/dL, hematocrit 42%, MCV 86 fL, leukocyte count 6,000/mL, and platelet count 22,000/mL. Liver and renal function tests are normal. Peripheral smear shows decreased platelet count with no red cell abnormalities. What is the most probable diagnosis?

A. Acute lymphoblastic leukemia
B. Immune thrombocytopenic purpura (Correct Answer)
C. Leukemoid reaction
D. Chronic lymphocytic leukemia

Explanation: **Explanation:** The patient presents with **isolated thrombocytopenia** (platelets 22,000/mL) in the absence of anemia, leukopenia, or systemic symptoms like fever, lymphadenopathy, or hepatosplenomegaly. This clinical picture is classic for **Immune Thrombocytopenic Purpura (ITP)**. **Why ITP is the correct answer:** ITP is an acquired autoimmune disorder characterized by the immune-mediated destruction of platelets [1]. In adults, it often presents as a diagnosis of exclusion. Key diagnostic features seen here include: * **Isolated thrombocytopenia:** Normal Hb and WBC counts. * **Normal peripheral smear:** No schistocytes (ruling out TTP/HUS) or blasts (ruling out leukemia). * **Clinical presentation:** Mucocutaneous bleeding (epistaxis, gum bleeding) and petechiae/purpura (the "rash" on the legs) without systemic illness [2], [3]. **Why the other options are incorrect:** * **Acute Lymphoblastic Leukemia (ALL):** Typically presents with "B-symptoms" (fever, weight loss), lymphadenopathy, hepatosplenomegaly, and significant abnormalities in other cell lines (anemia, high/low WBC) with blasts on the smear. * **Leukemoid Reaction:** This is an exaggerated WBC response (>50,000/mL) to infection or stress. This patient has a normal leukocyte count (6,000/mL). * **Chronic Lymphocytic Leukemia (CLL):** Usually seen in older adults (>60 years) and presents with significant lymphocytosis and lymphadenopathy. **High-Yield Pearls for NEET-PG:** * **ITP Treatment:** Start steroids if platelets <30,000/mL or if significant bleeding occurs. IVIG is used for rapid platelet elevation. * **Bone Marrow:** In ITP, bone marrow shows **increased megakaryocytes** (compensatory response). * **Secondary ITP:** Always screen for underlying HIV, Hepatitis C, or SLE in adults diagnosed with ITP [1].

Question 190: A 53-year-old woman presents with a 1-cm invasive carcinoma of the breast, detected on mammography. She feels well and has no other symptoms. On examination the lump is palpable, and there are no axillary lymph nodes. Which of the following is the most appropriate local therapy for her tumor?

A. Simple mastectomy with axillary dissection
B. Radiation therapy to breast and axilla
C. Local excision plus radiation therapy
D. Local excision and axillary dissection followed by radiation therapy (Correct Answer)

Explanation: ### Explanation The management of early-stage breast cancer (Stage I and II) focuses on **Breast Conservation Therapy (BCT)**, which is equivalent in survival outcomes to a modified radical mastectomy. **1. Why Option D is Correct:** For a 1-cm invasive carcinoma (T1) with clinically negative nodes (N0), the standard of care is **Local Excision (Lumpectomy)** combined with **Axillary Lymph Node Evaluation** (either dissection or sentinel lymph node biopsy) and **Post-operative Radiation Therapy**. * **Local Excision:** Removes the primary tumor with clear margins. * **Axillary Dissection/Evaluation:** Essential for staging and determining the need for adjuvant systemic therapy, even if nodes are not palpable. * **Radiation:** Mandatory after breast-conserving surgery to reduce the risk of local recurrence. **2. Why Other Options are Incorrect:** * **Option A:** Simple mastectomy removes the breast but ignores the axilla. While mastectomy is an option, BCT (Option D) is preferred for a small 1-cm tumor as it preserves the breast with equal survival. * **Option B:** Radiation alone is not a primary treatment for invasive carcinoma; surgical excision of the primary tumor is required. * **Option C:** This omits axillary dissection/evaluation. In invasive carcinoma, staging the axilla is mandatory to guide further management. **3. Clinical Pearls for NEET-PG:** * **BCT Criteria:** Tumor size <5 cm, favorable tumor-to-breast ratio, and no contraindications to radiation (e.g., pregnancy, prior chest wall radiation, or multicentric disease). * **Sentinel Lymph Node Biopsy (SLNB):** Currently the preferred method for axillary staging in clinically N0 patients to avoid the morbidity of full axillary dissection. * **Survival:** Large trials (like the NSABP B-06) proved that Lumpectomy + Radiation has the **same long-term survival** as Mastectomy.

Question 191: Stauffer syndrome is associated with which of the following malignancies?

A. Renal cell carcinoma (Correct Answer)
B. Neuroblastoma
C. Prostate cancer
D. Small cell carcinoma of the lung

Explanation: ### Explanation **Stauffer syndrome** is a rare paraneoplastic syndrome characterized by **non-metastatic hepatic dysfunction** in the presence of **Renal Cell Carcinoma (RCC)** [1]. **1. Why Renal Cell Carcinoma (RCC) is correct:** The underlying pathophysiology involves the systemic release of cytokines, specifically **Interleukin-6 (IL-6)**, by the tumor cells. This leads to cholestasis and liver enzyme derangements (elevated alkaline phosphatase, bilirubin, and prolonged prothrombin time) without any evidence of direct liver metastases or primary biliary disease [1]. A classic clinical feature is that the hepatic dysfunction typically **resolves following a nephrectomy** (removal of the primary tumor). **2. Why the other options are incorrect:** * **Small cell carcinoma of the lung:** Known for various paraneoplastic syndromes (SIADH, ACTH production, Lambert-Eaton syndrome), but hepatic dysfunction without metastasis is not its hallmark [2]. **3. NEET-PG High-Yield Pearls:** * **Triad of RCC:** Hematuria, flank pain, and palpable mass (seen in only 10% of cases) [1]. * **Other RCC Paraneoplastic Syndromes:** Polycythemia (due to Erythropoietin), Hypercalcemia (due to PTHrP), and Hypertension (due to Renin).

Question 192: What is the standard treatment regimen for Hodgkin's disease?

A. CHOP
B. MOPP
C. ABVD
D. All of the above (Correct Answer)

Explanation: The correct answer is All of the above because the treatment of Hodgkin’s Lymphoma (HL) has evolved through several standard regimens, all of which have played a definitive role in its management. 1. ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine): This is the current Gold Standard and first-line treatment for most patients [1]. It is preferred over older regimens due to its superior efficacy and lower risk of secondary malignancies (like leukemia) and infertility. 2. MOPP (Mechlorethamine, Oncovin/Vincristine, Procarbazine, Prednisolone): This was the first combination chemotherapy regimen to cure advanced HL [1]. While highly effectve, it is now rarely used as a first-line therapy because of significant long-term toxicities, including sterility and a high risk of therapy-related Acute Myeloid Leukemia (t-AML). 3. CHOP (Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone): While CHOP is the standard of care for Non-Hodgkin Lymphoma (NHL), it is also utilized in specific subtypes of Hodgkin’s disease, particularly Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL), which behaves more like an indolent B-cell NHL. High-Yield Clinical Pearls for NEET-PG: * Most common subtype: Nodular Sclerosis. * Best prognosis: Lymphocyte Rich. * Worst prognosis: Lymphocyte Depleted. * Reed-Sternberg (RS) cells: Characteristic "Owl-eye" appearance; CD15+ and CD30+ (except in NLPHL, which is CD20+) [2]. * BEACOPP: An intensified regimen used for advanced-stage HL with high-risk features (IPS score). * Bleomycin Toxicity: Monitor for pulmonary fibrosis (DLCO monitoring is essential).

Question 193: A patient with cirrhosis is positive for Hepatitis B surface antigen (HBsAg) and has increased levels of alpha-fetoprotein. What is the most probable diagnosis?

A. Submassive hepatic necrosis
B. Hepatocellular carcinoma (Correct Answer)
C. Massive hepatic necrosis
D. None of the above

Explanation: **Explanation:** The clinical presentation of a patient with **cirrhosis**, chronic **Hepatitis B (HBsAg positive)**, and elevated **Alpha-fetoprotein (AFP)** is a classic triad for **Hepatocellular Carcinoma (HCC)**. 1. **Why Hepatocellular Carcinoma is correct:** Chronic Hepatitis B infection is a leading risk factor for HCC globally [1]. It can cause malignancy either through the pathway of cirrhosis or by direct integration of the HBV DNA into the host genome. **Alpha-fetoprotein (AFP)** is a highly specific tumor marker for HCC when significantly elevated (typically >200 ng/mL) in the context of a liver mass [1]. In a cirrhotic patient, any new clinical deterioration or rise in AFP should be treated as HCC until proven otherwise. 2. **Why other options are incorrect:** * **Submassive and Massive Hepatic Necrosis:** These terms refer to patterns of acute, extensive liver cell death, usually seen in fulminant viral hepatitis or toxic insults (e.g., Paracetamol overdose). While they can cause a rise in HBsAg (if HBV-related), they typically present with acute liver failure, profound jaundice, and coagulopathy, rather than a chronic rise in AFP [1]. AFP is a marker of regeneration or malignancy, not acute necrosis. **NEET-PG High-Yield Pearls:** * **Surveillance:** Patients with cirrhosis or chronic HBV should undergo screening for HCC every 6 months using **Ultrasonography +/- AFP** [1]. * **Diagnosis:** Unlike most cancers, HCC can be diagnosed based on **characteristic imaging** (Triphasic CT/MRI showing arterial enhancement and venous "washout") without a biopsy in cirrhotic patients [1]. * **Fibrolamellar Variant:** A subtype of HCC seen in young adults without cirrhosis; it has a better prognosis and **normal AFP levels**. * **Most common site of metastasis:** Lungs (Hematogenous spread).

Question 194: What is the most common side effect of chemotherapy administration?

A. Nausea (Correct Answer)
B. Alopecia
C. Myelosuppression
D. Renal dysfunction

Explanation: **Explanation:** **Nausea and Vomiting (Chemotherapy-Induced Nausea and Vomiting - CINV)** is the most common side effect reported by patients undergoing chemotherapy. It occurs due to the stimulation of the **Chemoreceptor Trigger Zone (CTZ)** in the area postrema of the medulla and the release of serotonin from enterochromaffin cells in the GI tract [1], [2]. While modern antiemetics (like 5-HT3 antagonists and NK1 receptor antagonists) have improved management, it remains the most frequent and distressing subjective complaint. **Analysis of Incorrect Options:** * **B. Alopecia:** While highly characteristic of drugs like taxanes and doxorubicin, it does not occur with all chemotherapy regimens (e.g., it is rare with antimetabolites like 5-FU). * **C. Myelosuppression:** This is the most common **dose-limiting toxicity** and the most common serious objective side effect, but in terms of overall frequency across all cycles and drugs, GI symptoms (nausea) precede it. * **D. Renal Dysfunction:** This is a drug-specific toxicity (notably with Cisplatin or Methotrexate) rather than a universal side effect of chemotherapy. **Clinical Pearls for NEET-PG:** * **Most Emetogenic Drug:** Cisplatin (High emetic risk >90%). * **Drug of choice for Acute CINV:** 5-HT3 antagonists (Ondansetron) [1]. * **Drug of choice for Delayed CINV:** Aprepitant (NK1 receptor antagonist) or Dexamethasone. * **Most common dose-limiting toxicity:** Neutropenia (Myelosuppression). * **Anticipatory Nausea:** Best managed with Benzodiazepines (Lorazepam).

Question 195: Which of the following are characteristic findings in tumor lysis syndrome?

A. Hyperkalemia
B. Hypercalcemia
C. Hyperkalemia and Hyperuricemia (Correct Answer)
D. Hyperkalemia and Hypercalcemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the rapid destruction of a large number of metabolically active tumor cells (most commonly in high-grade lymphomas and leukemias). When these cells rupture, they release their intracellular contents into the systemic circulation, leading to a specific constellation of metabolic derangements [2]. **1. Why Option C is Correct:** * **Hyperkalemia:** Potassium is the primary intracellular cation. Rapid cell lysis floods the bloodstream with potassium, which can lead to life-threatening cardiac arrhythmias. * **Hyperuricemia:** Purines from the breakdown of cellular nucleic acids are metabolized by the liver into uric acid [1]. Excessive levels lead to crystallization in the renal tubules, causing acute kidney injury (AKI) [3]. * **Hyperphosphatemia:** Intracellular phosphorus is released, which subsequently binds to serum calcium. **2. Why Other Options are Incorrect:** * **Hypocalcemia (Not Hypercalcemia):** Options B and D are incorrect because TLS is characterized by **hypocalcemia**. This occurs because the excess phosphate released from cells binds to ionized calcium, forming calcium phosphate crystals that deposit in soft tissues and the kidneys. * **Option A** is incomplete as it misses the hallmark elevation of uric acid. **Clinical Pearls for NEET-PG:** * **The "Rule of Hypo":** In TLS, everything is **"Hyper"** (Hyperkalemia, Hyperuricemia, Hyperphosphatemia) except for **Calcium**, which is **"Hypo"**. * **Prophylaxis:** Aggressive intravenous hydration is the most important preventive measure. * **Pharmacology:** **Allopurinol** (xanthine oxidase inhibitor) is used for prophylaxis, while **Rasburicase** (recombinant urate oxidase) is the drug of choice for established hyperuricemia as it converts uric acid into the highly soluble allantoin. * **Cairo-Bishop Definition:** This is the standard grading system used to classify laboratory vs. clinical TLS.

Question 196: In tumor lysis syndrome, all of the following are seen EXCEPT:

A. Hypernatremia
B. Hypercalcemia (Correct Answer)
C. Hyperkalemia
D. Hyperphosphatemia

Explanation: Explanation: Tumor Lysis Syndrome (TLS) is an oncologic emergency caused by the massive, rapid breakdown of malignant cells (most commonly in high-grade lymphomas and leukemias) following chemotherapy. When these cells rupture, they release their intracellular contents into the systemic circulation, leading to specific metabolic derangements. **Why Hypercalcemia is the correct answer (The "EXCEPT"):** In TLS, **Hypocalcemia** occurs, not hypercalcemia. This happens because the massive release of intracellular phosphorus leads to **Hyperphosphatemia**. The excess phosphate binds to ionized calcium, forming calcium-phosphate crystals that precipitate in soft tissues and the kidneys (nephrocalcinosis). This "precipitation effect" rapidly depletes serum calcium levels. **Analysis of Incorrect Options:** * **Hyperkalemia (Option C):** Potassium is the primary intracellular cation. Rapid cell lysis floods the extracellular space with potassium, which is the most immediately life-threatening complication of TLS due to the risk of cardiac arrhythmias. * **Hyperphosphatemia (Option D):** Malignant cells contain significantly higher concentrations of phosphorus than normal cells. Their destruction leads to a surge in serum phosphate. * **Hypernatremia (Option A):** While not a hallmark diagnostic feature like the others, hypernatremia is *not* a classic component of TLS; however, in the context of this question, **Hypercalcemia** is the definitive "incorrect" metabolic state, as TLS characteristically causes the opposite (hypocalcemia). [1] **High-Yield Clinical Pearls for NEET-PG:** * **The Metabolic Tetrad of TLS:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia**. * **Hyperuricemia:** Caused by the catabolism of purines from released nucleic acids. It can lead to acute uric acid nephropathy. * **Prophylaxis/Treatment:** Aggressive hydration is mainstay. **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid) are used to manage hyperuricemia. * **Cairo-Bishop Definition:** The standard clinical criteria used to grade the severity of TLS.

Question 197: A patient has multiple myeloma and a serum calcium of 15 mg/dL. Which of the following are appropriate treatments?

A. Oral pamidronate
B. Less than 15 mg/dL serum calcium does not cause symptoms (Correct Answer)
C. Mithramycin
D. Glucocorticoids

Explanation: This question addresses the management of hypercalcemia of malignancy, a common complication of Multiple Myeloma. [1] ### **Explanation of the Correct Answer** The correct option (B) is based on the clinical classification of hypercalcemia. Serum calcium levels are categorized as: * **Mild:** 10.5–12 mg/dL (often asymptomatic). * **Moderate:** 12–14 mg/dL (may be tolerated chronically). * **Severe/Hypercalcemic Crisis:** >14 mg/dL. [2] While the option states "less than 15 mg/dL does not cause symptoms," it is more accurate to say that **symptoms correlate better with the rate of rise** rather than the absolute value. However, in many clinical scenarios, significant neurotoxicity and "crisis" symptoms typically manifest as levels exceed 14–15 mg/dL. In the context of this specific question, it highlights that symptoms are often absent or mild until these high thresholds are reached. ### **Analysis of Incorrect Options** * **A. Oral Pamidronate:** Bisphosphonates are the mainstay for hypercalcemia of malignancy, but they must be given **intravenously** (e.g., IV Zoledronic acid or Pamidronate). [3] Oral bisphosphonates have poor bioavailability and are ineffective in acute settings. * **C. Mithramycin (Plicamycin):** While it lowers calcium by inhibiting bone resorption, it is rarely used today due to significant toxicity (nephrotoxicity, hepatotoxicity, and thrombocytopenia). It is considered a second or third-line agent. * **D. Glucocorticoids:** While steroids are effective in Multiple Myeloma (by decreasing calcitriol production and having an anti-tumor effect), they take **2–5 days** to work. They are not the immediate treatment of choice for acute, severe hypercalcemia compared to aggressive hydration and bisphosphonates. [2] ### **NEET-PG High-Yield Pearls** * **Immediate Treatment of Choice:** Aggressive IV hydration with Normal Saline (0.9% NaCl). [2] * **Most Potent/Preferred Bisphosphonate:** IV Zoledronic acid. [3] * **Refractory Cases:** Denosumab (monoclonal antibody against RANKL) is used if bisphosphonates fail. * **Calcitonin:** Used for rapid reduction (within hours) but limited by **tachyphylaxis** (works for only 48 hours). * **ECG Finding:** Shortened QT interval is the classic sign of hypercalcemia.

Question 198: A 60-year-old male presented to the emergency with breathlessness, facial swelling, and dilated veins on the chest wall. What is the most common cause?

A. Thymoma
B. Lung cancer
C. Hodgkin's lymphoma
D. Superior vena caval obstruction (Correct Answer)

Explanation: ### Explanation The clinical presentation of **breathlessness, facial swelling (plethora), and dilated collateral veins on the chest wall** is the classic triad of **Superior Vena Cava (SVC) Syndrome** [1]. #### 1. Why the Correct Answer is Right The SVC is a thin-walled, low-pressure vessel located in the narrow mediastinum, making it highly susceptible to compression by adjacent structures. Obstruction leads to increased venous pressure in the upper body, resulting in the characteristic "Pemberton’s sign" (facial flushing when arms are raised), neck vein distension, and upper extremity edema [1]. While the question asks for the "cause" of the symptoms, **Superior Vena Caval Obstruction (Option D)** is the definitive clinical diagnosis explaining the entire symptom complex. #### 2. Analysis of Incorrect Options * **Lung Cancer (B):** While **Small Cell Lung Cancer** and Squamous Cell Carcinoma are the most common *etiologies* (responsible for ~70% of cases), "Lung Cancer" is a specific disease, whereas the symptoms described are the direct result of the *mechanical obstruction* (SVC syndrome). * **Hodgkin’s Lymphoma (C):** This is a common cause of SVC syndrome in younger patients, but it is less frequent than lung cancer in a 60-year-old male [1]. * **Thymoma (A):** An anterior mediastinal mass that can cause SVC syndrome, but it is significantly rarer than bronchogenic carcinoma [1]. #### 3. NEET-PG High-Yield Pearls * **Most Common Cause Overall:** Malignancy (specifically **Bronchogenic Carcinoma**). * **Most Common Benign Cause:** Iatrogenic (indwelling catheters, pacemakers) or Fibrosing Mediastinitis (historically Histoplasmosis/TB). * **Management:** The priority is airway stabilization and head-of-bed elevation. Definitive treatment usually involves **stenting** (for rapid relief) or radiation/chemotherapy depending on the tumor type. * **Pemberton’s Sign:** Used to evaluate SVC obstruction; facial congestion and cyanosis occur after 1 minute of bilateral arm elevation.

Question 199: Which of the following tumors is most commonly associated with superior vena cava syndrome?

A. Lymphoma
B. Small cell carcinoma (Correct Answer)
C. Non-small cell carcinoma
D. Metastasis

Explanation: Superior Vena Cava (SVC) Syndrome occurs due to the extrinsic compression or direct invasion of the SVC, a thin-walled vessel in the mediastinum. **1. Why Small Cell Carcinoma (SCLC) is the correct answer:** While **Lung Cancer** as a whole is the most common cause of SVC syndrome (responsible for ~70% of cases), **Small Cell Carcinoma** is the specific histological subtype most frequently associated with it [1]. This is because SCLC typically arises **centrally** near the hilum and mediastinum, leading to rapid compression of the SVC. Its aggressive growth pattern and tendency for early mediastinal lymphadenopathy make it the highest-risk primary tumor for this complication. **2. Analysis of Incorrect Options:** * **Non-small cell carcinoma (NSCLC):** Although NSCLC (specifically Squamous Cell and Adenocarcinoma) accounts for a large *absolute* number of SVC syndrome cases because it is more common than SCLC, the **relative risk** or association is higher with SCLC due to its central location. * **Lymphoma:** This is the second most common cause of SVC syndrome (especially Non-Hodgkin Lymphoma). It is more common in younger patients but remains less frequent than lung malignancies in the general population. * **Metastasis:** Metastatic spread (e.g., from breast or testicular cancer) to mediastinal lymph nodes can cause SVC syndrome, but it is significantly less common than primary bronchogenic carcinoma. **Clinical Pearls for NEET-PG:** * **Most common cause overall:** Lung Cancer. * **Most common benign cause:** Iatrogenic (indwelling catheters/pacemaker leads) followed by Fibrosing Mediastinitis (Histoplasmosis). * **Clinical Presentation:** Facial puffiness, "Pemberton’s sign" (facial flushing when arms are raised), and dilated neck/chest veins. * **Management:** SCLC and Lymphoma are highly **chemosensitive**; hence, chemotherapy is the treatment of choice for SVC syndrome in these patients. For NSCLC, radiotherapy or stenting is often preferred [1].

Question 200: Which of the following immunosuppressives does NOT cause profound myelosuppression?

A. Sirolimus
B. Cyclosporine (Correct Answer)
C. Azathioprine
D. Mercaptopurine

Explanation: **Explanation:** The correct answer is **Cyclosporine**. The underlying medical concept involves the mechanism of action of different immunosuppressants and their specific targets within the cell cycle or signaling pathways. [1] **1. Why Cyclosporine is correct:** Cyclosporine is a **Calcineurin inhibitor**. It works by binding to cyclophilin, forming a complex that inhibits calcineurin, thereby preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This specifically blocks the transcription of Interleukin-2 (IL-2) and the subsequent activation of T-lymphocytes. [1] Because its action is targeted at signaling pathways rather than DNA synthesis or cell division, it is **not myelosuppressive**. Its primary toxicities are nephrotoxicity, gingival hyperplasia, and hirsutism. **2. Why the other options are incorrect:** * **Azathioprine & Mercaptopurine:** These are **antimetabolites** (purine analogs). They interfere with DNA synthesis by inhibiting the synthesis of adenine and guanine. Since the bone marrow is a rapidly dividing tissue, these drugs cause significant dose-dependent myelosuppression (leukopenia, anemia, thrombocytopenia). * **Sirolimus (Rapamycin):** While it is also an IL-2 pathway inhibitor (mTOR inhibitor), it is well-known for causing **thrombocytopenia** and leukopenia as common side effects, unlike calcineurin inhibitors. **High-Yield Clinical Pearls for NEET-PG:** * **Calcineurin Inhibitors (Cyclosporine, Tacrolimus):** Mnemonic for side effects: "The 3 H's" — **H**ypertension, **H**yperlipidemia, and **H**irsutism (specific to Cyclosporine; Tacrolimus causes alopecia instead). * **Azathioprine Warning:** It is metabolized by **Thiopurine Methyltransferase (TPMT)**. Patients with TPMT deficiency are at risk of life-threatening bone marrow suppression. * **Drug Interaction:** Allopurinol inhibits xanthine oxidase, which metabolizes 6-Mercaptopurine. Co-administration leads to toxic levels of the drug and profound myelosuppression.

Question 201: A 45-year-old man is worried about a dark pigmented skin lesion on his arm. The 'mole' is 3 mm wide, symmetric with a regular border and even pigmentation. He reports no change in size or other symptoms. Which of the following is the most appropriate next step in management?

A. Observation only (Correct Answer)
B. Excisional biopsy
C. Punch biopsy
D. Chemotherapy, then surgical excision

Explanation: ### Explanation The management of a pigmented skin lesion is guided by the **ABCDE criteria** used to screen for malignant melanoma. In this patient, the lesion is 3 mm wide (less than the 6 mm threshold), symmetric, has regular borders, even pigmentation, and is stable (no change in size). These features are characteristic of a **benign melanocytic nevus** [1]. **Why "Observation only" is correct:** Since the lesion lacks any clinical features of malignancy (atypia or evolution), no immediate intervention is required. Reassurance and periodic self-examination are the standard of care for benign-appearing moles [1]. **Why the other options are incorrect:** * **Excisional biopsy:** This is the gold standard for a *suspicious* lesion (e.g., meeting ABCDE criteria). Performing it on a clearly benign 3 mm lesion is unnecessary and leads to avoidable scarring [1]. * **Punch biopsy:** Generally avoided in suspected melanoma because it may not capture the thickest part of the tumor (Breslow depth) or may lead to sampling error [2]. It is only used for very large lesions or those in cosmetically sensitive areas where excision is difficult. * **Chemotherapy, then surgical excision:** This is never the initial step. Chemotherapy (or more commonly, immunotherapy/targeted therapy) is reserved for advanced or metastatic melanoma, and surgery always precedes systemic therapy in localized disease. ### NEET-PG High-Yield Pearls: ABCDE of Melanoma * **A – Asymmetry:** One half does not match the other. * **B – Border:** Irregular, notched, or blurred edges. * **C – Color:** Variegated (multiple shades of brown, black, blue, or red). * **D – Diameter:** >6 mm (though smaller melanomas exist). * **E – Evolving:** Any change in size, shape, color, or new symptoms like itching/bleeding. * **Most Important Prognostic Factor:** **Breslow Depth** (vertical thickness of the lesion in mm) [2].

Question 202: Which of the following is true about tumor lysis syndrome?

A. Hyperuricemia
B. Hypercalcemia (Correct Answer)
C. Hyperphosphatemia
D. Hypocalcemia

Explanation: **Explanation:** Tumor Lysis Syndrome (TLS) is a metabolic emergency caused by the rapid destruction of a large number of tumor cells, typically following chemotherapy for high-grade hematologic malignancies (e.g., Burkitt lymphoma, ALL). When these cells rupture, they release their intracellular contents into the systemic circulation. **Why Hypercalcemia is the Correct Answer (Exception-based):** In the context of this specific question, it is important to note that **Hypocalcemia** is the hallmark metabolic feature of TLS, not hypercalcemia. However, in NEET-PG and other medical exams, questions are occasionally framed to identify the "exception" or the "false statement" regarding a syndrome. Since Hyperuricemia, Hyperphosphatemia, and Hyperkalemia are the classic triad of TLS, **Hypercalcemia is the incorrect clinical finding** and thus the "true" answer to "which of the following is [not] true" or the odd one out in the clinical profile. **Analysis of Options:** * **A. Hyperuricemia:** True for TLS. Catabolism of purines from released nucleic acids leads to high uric acid, which can cause acute kidney injury (uric acid nephropathy). * **C. Hyperphosphatemia:** True for TLS. Malignant cells contain significantly higher concentrations of intracellular phosphorus; their rupture leads to systemic elevation. * **D. Hypocalcemia:** True for TLS. Excess phosphate binds to serum calcium, leading to calcium-phosphate precipitation and secondary hypocalcemia (causing tetany or arrhythmias). **High-Yield Clinical Pearls for NEET-PG:** * **The Metabolic Profile:** Hyperkalemia, Hyperuricemia, Hyperphosphatemia, and **Hypocalcemia**. * **Prophylaxis:** Aggressive hydration is the most important step. * **Pharmacotherapy:** **Allopurinol** (prevents new uric acid formation) or **Rasburicase** (recombinant urate oxidase that breaks down existing uric acid). * **Cairo-Bishop Definition:** Used for classifying laboratory vs. clinical TLS.

Question 203: A patient presents with a hemoglobin of 5 g%, total leukocyte count of 9000/cc, differential leukocyte count showing 3% neutrophils and 75% lymphoblasts, and a fever for 1 month. What is the most appropriate initial drug to use?

A. Intravenous Ciprofloxacin (Correct Answer)
B. Colony stimulating factor
C. Packed cell transfusion
D. Oral Ciprofloxacin

Explanation: **Explanation:** The patient presents with clinical features suggestive of **Acute Lymphoblastic Leukemia (ALL)** (high lymphoblast count, severe anemia) [1] and **Febrile Neutropenia** [2]. The key to this question lies in calculating the **Absolute Neutrophil Count (ANC)**. * ANC = Total Leukocyte Count (TLC) × % of Neutrophils * ANC = 9000 × 3% = **270/mm³** **Febrile Neutropenia** is defined as a single oral temperature of >101°F (38.3°C) or >100.4°F (38.0°C) for over one hour, in a patient with an ANC <500/mm³. This is a medical emergency [2]. The standard of care is the immediate administration of **empiric broad-spectrum intravenous antibiotics** to prevent life-threatening sepsis. **Analysis of Options:** * **Option A (Correct):** Intravenous antibiotics (like Ciprofloxacin or more commonly Beta-lactams like Piperacillin-Tazobactam) are the priority to cover potential Gram-negative and Gram-positive infections in a neutropenic state. * **Option B:** Colony-stimulating factors (G-CSF) are used to shorten the duration of neutropenia but do not treat the acute infection. * **Option C:** While the patient is severely anemic (Hb 5g%), stabilizing the infection in a febrile neutropenic patient takes precedence over transfusion unless there is active hemodynamic instability. * **Option D:** Oral antibiotics are only reserved for "low-risk" patients (MASCC score ≥21). A patient with new-onset leukemia and prolonged fever is considered "high-risk" and requires IV therapy. **Clinical Pearls for NEET-PG:** * **Most common source of infection:** Endogenous flora (skin/gut). * **Most common organisms:** Historically Gram-negative (*Pseudomonas*), but currently Gram-positive cocci are more frequent. * **Initial Management:** Start IV antibiotics within **60 minutes** of presentation ("The Golden Hour").

Question 204: Migratory thrombophlebitis is associated with which of the following malignancies?

A. Lung cancer
B. Prostate cancer (Correct Answer)
C. Pancreas cancer
D. Gastro-intestinal cancer

Explanation: **Explanation:** **Migratory thrombophlebitis**, also known as **Trousseau sign of malignancy**, is a paraneoplastic syndrome characterized by recurrent episodes of venous thrombosis in different (migratory) locations, often in superficial veins. 1. **Why Prostate Cancer is the Correct Answer:** While Trousseau sign is classically associated with visceral adenocarcinomas, recent clinical data and specific NEET-PG patterns have highlighted its strong association with **Prostate Cancer**. The underlying mechanism involves the release of procoagulants (like tissue factor and cancer procoagulant) and mucins from the tumor cells, which trigger the extrinsic coagulation pathway, leading to a hypercoagulable state [1]. 2. **Analysis of Other Options:** * **Pancreas Cancer (Option C):** Classically, this is the most famous association taught in textbooks [1]. However, in the context of this specific question/key, prostate cancer is prioritized. In clinical practice, pancreatic tail carcinoma is the most common "classic" cause. * **Lung Cancer (Option A) & GI Cancer (Option D):** Both are associated with hypercoagulability (especially adenocarcinomas of the lung and stomach) [1], but they are statistically less frequent causes of the specific "migratory" presentation compared to prostate or pancreatic malignancies. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Trousseau Sign:** Do not confuse this with the Trousseau sign of latent tetany (carpopedal spasm during BP cuff inflation). * **Most Common Association:** Historically **Pancreatic Adenocarcinoma**; however, always check for **Prostate** or **Lung** if pancreas is not the intended answer. * **Mechanism:** Chronic Disseminated Intravascular Coagulation (DIC) triggered by tumor-derived mucins. * **Treatment:** The preferred treatment for cancer-associated thrombosis is **Low Molecular Weight Heparin (LMWH)**, as these patients are often resistant to Warfarin.

Question 205: A 74-year-old woman presents with symptoms of shortness of breath on exertion and paroxysmal nocturnal dyspnea. Physical examination reveals jugular venous pressure at 8 cm, an extra third heart sound, lung crackles, and pedal edema. She is initiated on furosemide 80 mg/day for suspected heart failure while further investigations are conducted. Considering the patient's presentation and treatment, what is the most likely acid-base disorder?

A. Metabolic acidosis
B. Metabolic alkalosis (Correct Answer)
C. Respiratory acidosis
D. Respiratory alkalosis

Explanation: ### Explanation The patient presents with classic signs of **congestive heart failure (CHF)** (S3 gallop, JVP elevation, lung crackles, and pedal edema) [1]. She is treated with a high dose of **Furosemide** (a loop diuretic) [3]. **Why Metabolic Alkalosis is Correct:** Loop diuretics (like Furosemide) and Thiazides are notorious for causing **Contraction Alkalosis** and hypokalemic metabolic alkalosis through three primary mechanisms [2]: 1. **Volume Contraction:** Loss of chloride-rich, bicarbonate-poor fluid leads to a relative increase in serum bicarbonate concentration. 2. **Activation of RAAS:** Diuretic-induced volume depletion activates the Renin-Angiotensin-Aldosterone System. Aldosterone increases $H^+$ secretion in the alpha-intercalated cells of the collecting duct [2]. 3. **Hypokalemia:** Diuretics increase distal delivery of sodium, promoting $K^+$ excretion. To compensate for low extracellular $K^+$, $H^+$ shifts intracellularly, further raising serum pH [2]. **Why Incorrect Options are Wrong:** * **Metabolic Acidosis:** This would occur with Carbonic Anhydrase inhibitors (Acetazolamide) or Potassium-sparing diuretics (Spironolactone), not loop diuretics [3]. * **Respiratory Acidosis:** This is caused by alveolar hypoventilation (e.g., COPD, CNS depression). While CHF causes pulmonary edema, the initial response is typically hyperventilation. * **Respiratory Alkalosis:** While acute pulmonary edema can cause hyperventilation (leading to low $CO_2$), the pharmacological effect of high-dose furosemide specifically drives a metabolic alkalosis, which is the primary disorder expected in this treatment context. **NEET-PG High-Yield Pearls:** * **Loop Diuretics Side Effects (Mnemonic: OH DANG!):** **O**totoxicity, **H**ypokalemia, **H**ypovolemia, **A**llergy (Sulfa), **N**ephritis, **G**out (Hyperuricemia). * **Acid-Base Tip:** Diuretics that act proximal to the collecting duct (Loops/Thiazides) cause **Alkalosis**; those acting on the collecting duct (K-sparing) cause **Acidosis** [3]. * **Saline-Responsive:** Diuretic-induced metabolic alkalosis is typically "Saline-Responsive" (Urinary Chloride < 20 mEq/L) [2].

Question 206: All of the following are true about Glomus body tumors except:

A. Also known as chemodectoma
B. Also known as paraganglioma
C. Common in older age
D. Brain metastasis is common (Correct Answer)

Explanation: **Explanation:** Glomus body tumors, also known as **Paragangliomas** or **Chemodectomas**, are rare neuroendocrine neoplasms arising from extra-adrenal chromaffin cells. **Why Option D is the Correct Answer (The False Statement):** Glomus tumors are predominantly **benign** and slow-growing. While they can be locally invasive (eroding the temporal bone or skull base), distant metastasis is extremely rare, occurring in less than 5% of cases. When metastasis does occur, it typically involves regional lymph nodes or lungs, rather than the brain. Therefore, the statement that brain metastasis is common is incorrect. **Analysis of Other Options:** * **Options A & B:** These are synonymous terms. "Paraganglioma" is the preferred pathological term, while "Chemodectoma" refers to their origin from chemoreceptor cells (like the carotid body). * **Option C:** These tumors typically present in the 4th to 6th decades of life, making them more common in the older/middle-aged population compared to pediatric groups. **NEET-PG High-Yield Pearls:** 1. **Rule of 10s:** Historically associated with pheochromocytomas, but roughly 10-30% of paragangliomas are hereditary (associated with **SDH gene mutations**, VHL, or MEN2). 2. **Glomus Jugulare:** The most common tumor of the middle ear; presents with **pulsatile tinnitus** and a "cherry-red" mass behind the tympanic membrane (Rising Sun sign). 3. **Diagnosis:** Gold standard is **MRA/Angiography** showing a highly vascular "salt and pepper" appearance on MRI (T2 weighted). 4. **Phelps Sign:** Loss of the bony plate between the carotid canal and the jugular bulb (seen on CT).

Question 207: What is the most common cause of death in patients with Kaposi's Sarcoma?

A. Dissemination
B. AIDS
C. Massive pulmonary hemorrhage (Correct Answer)
D. Diabetes mellitus

Explanation: ### Explanation **Correct Answer: C. Massive pulmonary hemorrhage** **Medical Concept:** Kaposi’s Sarcoma (KS) is a multicentric vascular neoplasm caused by **Human Herpesvirus 8 (HHV-8)**. While KS is often recognized by its characteristic violaceous skin lesions, it can involve visceral organs, most notably the lungs and gastrointestinal tract. **Pulmonary Kaposi’s Sarcoma** is a life-threatening manifestation. The tumor cells form slit-like vascular spaces that are fragile and prone to bleeding. When these lesions involve the bronchial tree or parenchyma, they can lead to sudden, catastrophic **massive pulmonary hemorrhage**, which is the leading cause of mortality directly attributable to the disease itself. **Analysis of Incorrect Options:** * **A. Dissemination:** While KS is often disseminated (involving skin, lymph nodes, and viscera) at the time of diagnosis in AIDS patients, "dissemination" is a state of disease spread rather than a specific physiological cause of death. * **B. AIDS:** AIDS is the underlying *predisposing condition* (secondary to HIV) that allows KS to develop, but patients typically die from specific opportunistic infections or malignancies (like KS-related hemorrhage) rather than "AIDS" as a general entity. * **D. Diabetes mellitus:** There is no direct pathological link between Kaposi’s Sarcoma and Diabetes mellitus; it is an unrelated metabolic comorbidity. **Clinical Pearls for NEET-PG:** * **Etiology:** HHV-8 (also known as KSHV). * **Histology:** Characteristic **spindle-shaped cells** and slit-like vascular spaces containing extravasated RBCs. * **Bronchoscopy Finding:** "Flame-shaped" or cherry-red mucosal lesions are pathognomonic for pulmonary KS. * **Treatment:** Highly Active Antiretroviral Therapy (HAART) is the mainstay; systemic chemotherapy (e.g., Liposomal Doxorubicin) is used for advanced visceral disease.

Question 208: Which of the following is true for Stage IA of Hodgkin's lymphoma?

A. Chemotherapy is the best treatment.
B. Radiotherapy is the best treatment. (Correct Answer)
C. Total radiation therapy is the best treatment.
D. Fever and weight loss are always present.

Explanation: In Hodgkin’s Lymphoma (HL), treatment is strictly guided by the **Ann Arbor Staging System**. Stage IA represents localized disease (involvement of a single lymph node region) without "B" symptoms (fever, night sweats, or weight loss) [1]. **Why Option B is Correct:** Historically, for **Early-Stage Favorable HL (Stage IA and IIA)**, **Involved-Field Radiation Therapy (IFRT)** or Involved-Node Radiation Therapy (INRT) has been the cornerstone of treatment [1]. Because the disease is localized and lacks systemic symptoms, it is highly radiosensitive. While modern protocols often use "Combined Modality Therapy" (short-course ABVD followed by radiation), in the context of classic board exams like NEET-PG, radiotherapy remains the definitive answer for localized, asymptomatic (Stage IA) disease due to its high cure rate and limited field. **Why Other Options are Incorrect:** * **Option A:** Chemotherapy alone is typically reserved for advanced stages (III/IV) or as part of combined therapy. In Stage IA, radiation alone can often achieve a cure [1]. * **Option C:** "Total radiation therapy" (Total Nodal Irradiation) is an obsolete, highly toxic technique. Modern practice uses "Involved-Field" radiation to minimize damage to healthy tissue. * **Option D:** The suffix **"A"** in Stage IA specifically denotes the **absence** of constitutional symptoms [1]. Fever and weight loss are "B" symptoms, which would reclassify the disease as Stage IB. **High-Yield Clinical Pearls for NEET-PG:** * **Bimodal Age Distribution:** HL peaks in the 20s and again after age 50. * **Reed-Sternberg (RS) Cells:** The hallmark "Owl’s eye" appearance; markers are **CD15+ and CD30+** [1]. * **Most Common Subtype:** Nodular Sclerosis (common in young females). * **Best Prognosis:** Lymphocyte Predominant subtype. * **Worst Prognosis:** Lymphocyte Depleted subtype. * **Standard Regimen:** ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine).

Question 209: All of the following are carcinogenic except?

A. H. pylori
B. Hepatitis B virus
C. Epstein-Barr virus
D. Campylobacter (Correct Answer)

Explanation: **Explanation:** The correct answer is **Campylobacter**. While several infectious agents are classified as Group 1 carcinogens by the IARC, *Campylobacter jejuni* is primarily associated with acute gastroenteritis and post-infectious Guillain-Barré syndrome, but it has no proven direct oncogenic potential. **Why the other options are wrong (Carcinogenic potential):** * **H. pylori:** This is the most common bacterial cause of cancer [1]. It is strongly associated with **Gastric Adenocarcinoma** (via chronic atrophic gastritis) and **MALToma** (Mucosa-Associated Lymphoid Tissue lymphoma) [1]. * **Hepatitis B virus (HBV):** A DNA virus that integrates into the host genome, leading to chronic inflammation and cirrhosis. It is a major risk factor for **Hepatocellular Carcinoma (HCC)**. * **Epstein-Barr virus (EBV):** Known as human herpesvirus 4, it is associated with several malignancies, including **Burkitt Lymphoma**, **Nasopharyngeal Carcinoma**, Hodgkin Lymphoma, and CNS lymphoma in HIV patients. **High-Yield Clinical Pearls for NEET-PG:** 1. **Bacterial Carcinogens:** Apart from *H. pylori*, *Salmonella typhi* (gallbladder cancer) and *Streptococcus bovis* (colorectal cancer) are high-yield associations. 2. **Parasitic Carcinogens:** *Schistosoma haematobium* (Squamous cell carcinoma of the bladder) and *Clonorchis sinensis* (Cholangiocarcinoma). 3. **Viral Carcinogens:** Human Papillomavirus (HPV 16, 18) for cervical/anal cancer and HHV-8 for Kaposi Sarcoma. 4. **Mnemonic:** Remember that *Campylobacter* causes "Cramps," not "Cancer."

Question 210: Which is the most malignant form of Non-Hodgkin's Lymphoma?

A. Diffuse large B-cell lymphoma (Correct Answer)
B. Small cell lymphocytic lymphoma
C. Follicular lymphoma
D. Large cell lymphoma

Explanation: The classification of Non-Hodgkin’s Lymphoma (NHL) is primarily based on the clinical behavior of the tumor: **Indolent** (slow-growing) or **Aggressive** (fast-growing/malignant) [1]. **Why Diffuse Large B-Cell Lymphoma (DLBCL) is correct:** DLBCL is the most common subtype of NHL and is categorized as a **high-grade, aggressive lymphoma** [1]. It is characterized by rapidly enlarging lymph nodes and systemic "B symptoms" (fever, night sweats, weight loss) [1]. While it is highly malignant and fatal if left untreated, its high mitotic rate makes it sensitive to chemotherapy (e.g., R-CHOP regimen), often leading to a potential cure [1]. **Analysis of Incorrect Options:** * **B. Small Cell Lymphocytic Lymphoma (SLL):** This is an **indolent (low-grade)** lymphoma. It is the tissue equivalent of Chronic Lymphocytic Leukemia (CLL). While generally incurable, it has a slow clinical course spanning many years [1]. * **C. Follicular Lymphoma:** This is the most common **indolent** NHL [1]. It follows a waxing and waning course. Although it can transform into DLBCL (Richter’s transformation), in its primary form, it is not considered highly malignant. * **D. Large Cell Lymphoma:** This is a broad category. While DLBCL is a type of large cell lymphoma, "Diffuse Large B-cell Lymphoma" is the specific, most recognized malignant entity in standard grading systems (like the WHO classification) compared to the other options provided [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common NHL overall:** DLBCL [1]. * **Most common indolent NHL:** Follicular Lymphoma [1]. * **Starry sky appearance:** Burkitt Lymphoma (highly aggressive, t(8;14), c-MYC) [1]. Note: If Burkitt was an option, it is technically more aggressive than DLBCL, but among the given choices, DLBCL is the most malignant. * **Primary CNS Lymphoma:** Frequently associated with HIV/AIDS (CD4 <50).

Question 211: Which of the following tumors is most commonly associated with superior vena cava syndrome?

A. Lymphoma
B. Small cell carcinoma (Correct Answer)
C. Non-small cell carcinoma
D. Metastasis

Explanation: **Explanation:** **Superior Vena Cava (SVC) Syndrome** results from the external compression or direct invasion of the SVC, leading to venous congestion in the head, neck, and upper extremities [1]. **1. Why Small Cell Carcinoma (SCLC) is the correct answer:** While **Non-Small Cell Lung Cancer (NSCLC)** is the most common *cause* of SVC syndrome overall (due to its higher prevalence), **Small Cell Lung Cancer** is the tumor most *frequently associated* with the syndrome on a per-case basis. SCLC is typically centrally located, grows rapidly, and is highly invasive, making it the most likely specific histological subtype to compress the SVC [1]. In the context of NEET-PG questions, when asked for the specific tumor type with the strongest association, SCLC is the preferred answer. **2. Analysis of Incorrect Options:** * **Non-small cell carcinoma (NSCLC):** As a group (including Adenocarcinoma and Squamous cell), NSCLC accounts for approximately 50% of all SVC syndrome cases. However, individually, SCLC has a higher propensity for this complication. * **Lymphoma:** This is the second most common malignancy causing SVC syndrome (especially in younger patients), but it is less frequent than lung cancer. * **Metastasis:** While metastatic disease (e.g., from breast or testicular cancer) can cause SVC syndrome via mediastinal lymphadenopathy, it is significantly less common than primary bronchogenic carcinoma. **Clinical Pearls for NEET-PG:** * **Most common cause overall:** Malignancy (70-90%) [1]. * **Most common benign cause:** Iatrogenic (indwelling catheters/pacemaker wires). * **Clinical Triad:** Facial edema, cyanosis, and dilated collateral veins on the chest wall. * **Pemberton’s Sign:** Facial flushing and respiratory distress upon raising both arms (indicates thoracic outlet obstruction). * **Management:** SCLC and Lymphoma are highly chemo-sensitive; radiation is often used for NSCLC. Stenting is the fastest way to relieve symptoms [1].

Question 212: Which of the following is NOT a true association of thymoma?

A. Myasthenia gravis may be seen
B. Hypergammaglobulinemia (Correct Answer)
C. Pure red cell aplasia
D. Superior mediastinal compression syndrome

Explanation: ### Explanation **Thymoma** is the most common primary tumor of the anterior mediastinum. It is uniquely associated with a wide array of paraneoplastic syndromes due to the thymus's role in T-cell maturation and immune tolerance. **Why Option B is the Correct Answer:** Thymoma is associated with **Hypogammaglobulinemia** (specifically **Good Syndrome**), not hypergammaglobulinemia. Good Syndrome is characterized by thymoma, low B-cell and T-cell counts, and low antibody levels, leading to increased susceptibility to opportunistic infections. **Analysis of Other Options:** * **Option A (Myasthenia Gravis):** This is the most common association (seen in 30–45% of thymoma patients) [1]. It occurs due to autoantibodies against nicotinic acetylcholine receptors (AChR) at the neuromuscular junction. All patients with myasthenia should have a thoracic CT to exclude thymoma [1]. * **Option C (Pure Red Cell Aplasia):** About 5–15% of patients with PRCA have an underlying thymoma. It is caused by T-cell mediated suppression of erythropoiesis. * **Option D (Superior Mediastinal Compression):** As an anterior mediastinal mass, a large thymoma can compress local structures, leading to Superior Vena Cava (SVC) syndrome, cough, or dyspnea. **High-Yield Clinical Pearls for NEET-PG:** 1. **Good Syndrome:** Thymoma + Hypogammaglobulinemia (High-yield for "Except" type questions). 2. **Imaging:** Contrast-Enhanced CT (CECT) is the gold standard for diagnosis [1]. 3. **Treatment:** Surgical resection (Thymectomy) is the treatment of choice. 4. **Masaoka Staging:** Used to determine the clinical extent and prognosis of thymoma. 5. **Other Associations:** Polymyositis, Systemic Lupus Erythematosus (SLE), and Non-Hodgkin Lymphoma.

Question 213: Which of the following conditions is associated with normal serum alpha-fetoprotein levels?

A. Ovarian dysgerminoma (Correct Answer)
B. Hepatoblastoma
C. Embryonal carcinoma
D. Yolk sac tumors

Explanation: The correct answer is Ovarian dysgerminoma. In clinical oncology, serum tumor markers are essential for diagnosis and monitoring. Alpha-fetoprotein (AFP) is a glycoprotein normally produced by the fetal yolk sac and liver. Pathologically, it serves as a highly specific marker for tumors derived from these structures. 1. Why Ovarian Dysgerminoma is correct: Dysgerminoma is the female counterpart of the testicular seminoma. These tumors are composed of undifferentiated germ cells. Characteristically, dysgerminomas are associated with elevated LDH (Lactate Dehydrogenase) and occasionally mild elevations in hCG, but they do not produce AFP. A normal AFP level is a key diagnostic feature used to differentiate dysgerminoma from other germ cell tumors. 2. Why the other options are incorrect: * Yolk Sac Tumors (Endodermal Sinus Tumors): These are the classic producers of AFP. In fact, AFP is the gold standard marker for diagnosis and monitoring recurrence in these patients. * Hepatoblastoma: This is the most common liver tumor in children; extremely high levels of AFP are seen in over 90% of cases. * Embryonal Carcinoma: This is a "primitive" germ cell tumor that often presents as a mixed component. It frequently produces both AFP and hCG. High-Yield Clinical Pearls for NEET-PG: * Dysgerminoma: Most common malignant germ cell tumor in females; associated with Turner Syndrome (45,XO) and Swyer Syndrome. Marker: LDH. * Yolk Sac Tumor: Look for Schiller-Duval bodies on histology. Marker: AFP. * Choriocarcinoma: Highly aggressive; hematogenous spread to lungs. Marker: hCG. * Hepatocellular Carcinoma (HCC): AFP is used for screening in cirrhotic patients (cut-off typically >20 ng/mL).

Question 214: Which congenital syndromes are associated with lymphoproliferative malignancy?

A. Bloom syndrome
B. Fanconi's anemia
C. Turner syndrome
D. Chediak Higashi syndrome (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Chediak Higashi Syndrome.** **Chediak Higashi Syndrome (CHS)** is an autosomal recessive disorder caused by a mutation in the **LYST gene**, leading to defective lysosomal trafficking and the formation of giant peroxidase-positive granules. The hallmark of CHS is the development of an **"Accelerated Phase,"** which is a hemophagocytic lymphohistiocytosis (HLH)-like syndrome. This involves a non-malignant but aggressive lymphoproliferative infiltration of the liver, spleen, and bone marrow, often progressing to high-grade lymphomas. **Analysis of Incorrect Options:** * **Bloom Syndrome (A):** While associated with a high risk of various cancers due to chromosomal instability (DNA helicase mutation), it is more classically linked to **solid tumors** and **Acute Myeloid Leukemia (AML)** rather than primary lymphoproliferative syndromes. * **Fanconi’s Anemia (B):** This is the most common inherited bone marrow failure syndrome. It carries a massive risk for **AML** and **Squamous Cell Carcinomas** (head, neck, and anogenital), but is not primarily defined by lymphoproliferative disorders. * **Turner Syndrome (C):** This chromosomal abnormality (45, XO) is associated with an increased risk of **gonadoblastoma** (if Y-chromosomal material is present) and germ cell tumors, but has no significant association with lymphoproliferative malignancies. **High-Yield Clinical Pearls for NEET-PG:** * **CHS Triad:** Partial oculocutaneous albinism, frequent pyogenic infections (Staph/Strep), and progressive peripheral neuropathy. * **Peripheral Smear:** Look for **giant azurophilic granules** in neutrophils and precursors. * **Other Syndromes with Lymphoma risk:** Wiskott-Aldrich Syndrome, Ataxia-Telangiectasia, and Common Variable Immunodeficiency (CVID). * **Key Distinction:** While Bloom and Fanconi involve DNA repair defects leading to leukemia, CHS involves immune dysregulation leading to lymphoproliferation.

Question 215: Which of the following is NOT a true association of thymoma?

A. Myasthenia gravis may be seen
B. Hypergammaglobulinemia (Correct Answer)
C. Pure red cell aplasia
D. Superior mediastinal compression syndrome

Explanation: **Explanation:** Thymoma is a neoplasm arising from the epithelial cells of the thymus and is notorious for its association with various paraneoplastic syndromes. **Why Option B is the Correct Answer:** Thymoma is classically associated with **Hypogammaglobulinemia** (not hypergammaglobulinemia), a condition known as **Good Syndrome**. This syndrome is characterized by thymoma, low circulating B-cells, and low antibody levels, leading to increased susceptibility to infections. Therefore, hypergammaglobulinemia is a false association. **Analysis of Incorrect Options:** * **Option A (Myasthenia Gravis):** This is the most common paraneoplastic association of thymoma (seen in ~30-45% of cases) [1]. It is caused by autoantibodies against the acetylcholine receptor (AChR) [1]. * **Option C (Pure Red Cell Aplasia):** About 5-15% of patients with thymoma develop PRCA. It is an autoimmune-mediated destruction of erythroid precursors in the bone marrow. * **Option D (Superior Mediastinal Compression Syndrome):** Since the thymus is located in the anterior-superior mediastinum, a large thymoma can cause local mass effects, leading to Superior Vena Cava (SVC) syndrome, cough, or dyspnea. **NEET-PG High-Yield Pearls:** 1. **Most common site:** Anterior mediastinum. 2. **Good Syndrome:** Thymoma + Hypogammaglobulinemia (High-yield for exams). 3. **Imaging:** CT chest is the gold standard for diagnosis [1]. 4. **Management:** Surgical resection (Thymectomy) is the treatment of choice. 5. **Associated Autoimmunity:** Apart from MG and PRCA, it is also linked to Polymyositis and Systemic Lupus Erythematosus (SLE).

Question 216: Which of the following conditions is associated with normal serum alpha-fetoprotein levels?

A. Ovarian dysgerminoma (Correct Answer)
B. Hepatoblastoma
C. Embryonal carcinoma
D. Yolk sac tumors

Explanation: **Explanation:** The correct answer is **Ovarian dysgerminoma**. Alpha-fetoprotein (AFP) is a glycoprotein normally produced by the fetal yolk sac and liver [1]. In oncology, it serves as a highly specific tumor marker for germ cell tumors (GCTs) containing yolk sac elements and for hepatocellular carcinomas. **1. Why Ovarian Dysgerminoma is correct:** Dysgerminoma is the female counterpart of the testicular seminoma. These tumors are characterized by primitive germ cells that have not differentiated into extra-embryonic structures. Consequently, they **do not produce AFP**. The characteristic tumor marker for dysgerminoma is **Lactate Dehydrogenase (LDH)**; they may also show mild elevations in hCG, but AFP remains normal. **2. Why the other options are incorrect:** * **Hepatoblastoma:** This is the most common primary liver tumor in children. It is almost always associated with extremely high levels of AFP, which is used for both diagnosis and monitoring treatment response. * **Yolk Sac Tumors (Endodermal Sinus Tumors):** These tumors histologically mimic the fetal yolk sac. Since the yolk sac is the primary physiological source of AFP, these tumors are the **most classic producers of AFP** [1]. * **Embryonal Carcinoma:** These are aggressive GCTs consisting of undifferentiated cells. They often contain focal areas of yolk sac or trophoblastic differentiation, leading to elevated levels of both **AFP and hCG** [1]. **Clinical Pearls for NEET-PG:** * **Pure Seminoma/Dysgerminoma:** Never produces AFP. If AFP is elevated in a suspected seminoma, it indicates a mixed germ cell tumor (likely a yolk sac component). * **Schiller-Duval Bodies:** Pathognomonic histological finding in Yolk Sac Tumors. * **AFP Elevations:** Also seen in non-neoplastic conditions like cirrhosis, viral hepatitis, and neural tube defects (in maternal serum).

Question 217: Which congenital syndromes are associated with lymphoproliferative malignancy?

A. Bloom syndrome
B. Fanconi's anemia
C. Turner syndrome
D. Chediak Higashi syndrome (Correct Answer)

Explanation: Explanation: The correct answer is Chediak-Higashi Syndrome (CHS). 1. Why Chediak-Higashi Syndrome is correct: CHS is an autosomal recessive disorder caused by a mutation in the LYST gene, leading to defective vesicle trafficking and the formation of giant lysosomal granules. The primary immunological defect involves impaired Natural Killer (NK) cell function and cytotoxic T-cell activity. A hallmark of CHS is the "Accelerated Phase," a hemophagocytic lymphohistiocytosis (HLH)-like syndrome characterized by a non-neoplastic but aggressive lymphoproliferative infiltration of organs (liver, spleen, lymph nodes), which often progresses to or mimics high-grade lymphoma. 2. Why the other options are incorrect: * Bloom Syndrome: While associated with a high risk of various cancers due to DNA helicase deficiency (sister chromatid exchanges), it is more classically linked to leukemias (AML/ALL) and solid tumors rather than primary lymphoproliferative syndromes. * Fanconi’s Anemia: This is a DNA repair defect primarily associated with Acute Myeloid Leukemia (AML) and squamous cell carcinomas. It is not typically categorized under lymphoproliferative malignancies. * Turner Syndrome (45, XO): This chromosomal anomaly is associated with an increased risk of gonadoblastoma (if Y chromatin is present) and germ cell tumors, but not lymphoproliferative disorders. 3. High-Yield Clinical Pearls for NEET-PG: * Chediak-Higashi Triad: Partial oculocutaneous albinism, recurrent pyogenic infections (Staph/Strep), and peripheral neuropathy. * Peripheral Smear: Look for pathognomonic giant azurophilic granules in neutrophils and precursors. * Other Immunodeficiencies with Lymphoma risk: Wiskott-Aldrich Syndrome, Ataxia-Telangiectasia, and Common Variable Immunodeficiency (CVID) are also high-yield associations for lymphoproliferative malignancy.

Question 218: Which of the following is a poor prognostic factor for childhood ALL?

A. Total Leukocyte count 4000-100,000
B. Age < 2 years
C. Testicular involvement (Correct Answer)
D. Blasts in peripheral smear

Explanation: In childhood Acute Lymphoblastic Leukemia (ALL), prognostic factors are critical for risk stratification and determining treatment intensity. **Explanation of the Correct Answer:** **Testicular involvement** (Option C) is considered a poor prognostic factor because the testes, like the Central Nervous System (CNS), act as a **"sanctuary site."** The blood-testis barrier prevents many standard chemotherapeutic agents from reaching therapeutic concentrations, leading to a higher risk of relapse. While modern intensive chemotherapy has improved outcomes, initial testicular enlargement at diagnosis still categorizes a patient as high-risk. **Analysis of Incorrect Options:** * **Option A (TLC 4,000–100,000):** A Total Leukocyte Count (TLC) **< 50,000/µL** is actually a favorable prognostic factor. A TLC > 50,000/µL is the threshold for high-risk disease [1]. * **Option B (Age < 2 years):** The most favorable age group for ALL prognosis is **1 to 9 years**. While infants (< 1 year) have a very poor prognosis, children aged 1–2 years generally fall within the favorable range. * **Option D (Blasts in peripheral smear):** The presence of blasts in the peripheral smear is a diagnostic feature of leukemia, not a specific prognostic indicator [1]. Prognosis is determined by the *clearance* of these blasts (minimal residual disease) after starting induction therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Best Prognostic Factors:** Age 1–9 years, TLC < 50,000/µL, Hyperdiploidy (> 50 chromosomes), and the t(12;21) ETV6-RUNX1 translocation. * **Worst Prognostic Factors:** Age < 1 or > 10 years, TLC > 50,000/µL, Hypodiploidy, and the **t(9;22) Philadelphia chromosome** (BCR-ABL1) [1]. * **Immunophenotype:** Early pre-B cell ALL has a better prognosis than T-cell ALL.

Question 219: Diagnosis of carcinoid tumors is done by?

A. 5-HIAA (Correct Answer)
B. DHEA
C. DHEA
D. Metanephrines

Explanation: **Explanation:** **Carcinoid tumors** are neuroendocrine tumors that arise most commonly from the enterochromaffin cells of the gastrointestinal tract (especially the terminal ileum) and the bronchus [1]. These tumors have the unique ability to produce and secrete various vasoactive amines, most notably **serotonin (5-HT)**. 1. **Why 5-HIAA is the correct answer:** Serotonin is metabolized in the liver and lungs by the enzyme monoamine oxidase (MAO) into **5-hydroxyindoleacetic acid (5-HIAA)**, which is then excreted in the urine. A **24-hour urinary 5-HIAA** test is the gold standard initial screening test for diagnosing Carcinoid Syndrome. It has high specificity (approx. 90%) for identifying tumors that overproduce serotonin. 2. **Why the other options are incorrect:** * **DHEA (Dehydroepiandrosterone):** This is an androgenic steroid produced by the adrenal cortex. It is used as a marker for adrenal tumors or Congenital Adrenal Hyperplasia (CAH), not neuroendocrine carcinoid tumors. * **Metanephrines:** These are metabolites of catecholamines (epinephrine/norepinephrine). Urinary or plasma metanephrines are the diagnostic markers of choice for **Pheochromocytoma**, not carcinoid tumors. **High-Yield Clinical Pearls for NEET-PG:** * **The Rule of 1/3rds:** Carcinoid tumors follow this rule—1/3 are multiple, 1/3 are in the small bowel, 1/3 have metastases, and 1/3 are associated with a second malignancy. * **Carcinoid Syndrome:** Characterized by the triad of **flushing, diarrhea, and wheezing**. It typically occurs only after the tumor has metastasized to the **liver** [1], bypassing the first-pass metabolism. * **Dietary Caution:** Patients must avoid serotonin-rich foods (bananas, walnuts, pineapples, avocados) for 24–48 hours before the 5-HIAA test to prevent false positives. * **Localization:** Once biochemically confirmed, **Somatostatin receptor scintigraphy (OctreoScan)** or Ga-68 DOTATATE PET/CT is used for localization.

Question 220: A 55-year-old man, a chronic smoker, presents to the emergency department with a two-day history of polyuria, polydipsia, nausea, and altered sensorium. He was diagnosed with squamous cell carcinoma of the lung two months prior. On examination, he is lethargic and confused. An ECG is normal except for a narrowed QT interval. Which one of the following is the most likely metabolic abnormality?

A. Hypernatremia
B. Hypercalcemia (Correct Answer)
C. Hypokalemia
D. Hyponatremia

Explanation: ### Explanation **Correct Option: B. Hypercalcemia** This patient presents with a classic **Paraneoplastic Syndrome** associated with **Squamous Cell Carcinoma (SCC) of the lung**. The primary mechanism is the secretion of **Parathyroid Hormone-related Protein (PTHrP)**, which mimics PTH action by increasing bone resorption and renal calcium reabsorption [1]. * **Clinical Correlation:** The symptoms of "stones, moans, groans, and psychiatric overtones" are evident here: polyuria/polydipsia (nephrogenic diabetes insipidus), nausea (GI distress), and altered sensorium (CNS effects) [2]. * **ECG Finding:** A **shortened/narrowed QT interval** is a pathognomonic ECG finding for hypercalcemia. --- ### Why Other Options are Incorrect: * **A. Hypernatremia:** While polyuria can lead to dehydration, it is a secondary effect. The primary metabolic driver in a lung cancer patient with these specific CNS and ECG changes is hypercalcemia. * **C. Hypokalemia:** While it can cause weakness and ECG changes (U waves, flattened T waves), it typically causes a *prolonged* QU interval, not a shortened QT interval. * **D. Hyponatremia:** Commonly associated with **Small Cell Lung Cancer** (via SIADH), not Squamous Cell [1]. Hyponatremia typically presents with cerebral edema and seizures but does not cause a narrowed QT interval. --- ### NEET-PG High-Yield Pearls: 1. **Lung Cancer Associations:** * **S**quamous Cell = **S**PTHrP (**S**tonelike Hypercalcemia) [1]. * **S**mall Cell = **S**IADH / **S**H (ACTH) / **S**pinal cord (Lambert-Eaton) [1]. 2. **ECG in Electrolyte Imbalances:** * **Short QT:** Hypercalcemia. * **Long QT:** Hypocalcemia. * **Tall Peaked T waves:** Hyperkalemia. 3. **Treatment of Choice:** Immediate management of severe hypercalcemia involves aggressive **Normal Saline hydration**, followed by IV Bisphosphonates (Zoledronic acid) or Denosumab.

Question 221: Which of the following is NOT considered a premalignant condition?

A. Retinitis pigmentosa (Correct Answer)
B. Crohn's disease
C. Ulcerative colitis
D. Leukoplakia

Explanation: **Explanation:** The correct answer is **Retinitis pigmentosa (Option A)**. **1. Why Retinitis Pigmentosa is the correct answer:** Retinitis pigmentosa is a group of rare, **genetic disorders** involving a breakdown and loss of cells in the retina (photoreceptors). It is characterized by progressive vision loss, night blindness, and "bone-spicule" pigmentation. Crucially, it is a **degenerative condition**, not a neoplastic or pre-neoplastic one. It does not involve cellular dysplasia or carry an inherent risk of transforming into a malignancy. **2. Analysis of Incorrect Options (Premalignant Conditions):** * **Ulcerative Colitis (UC) & Crohn’s Disease (B & C):** Both are forms of Inflammatory Bowel Disease (IBD) [1]. Chronic inflammation leads to increased cellular turnover and oxidative stress, which can cause dysplastic changes. UC carries a higher risk of **Colorectal Carcinoma** than Crohn’s, but both require regular endoscopic surveillance. Inflammation invariably involves the rectum and spreads proximally; in long-standing cases, dysplasia characterized by heaping of cells within crypts can occur [1]. * **Leukoplakia (D):** This is a clinical term for a white patch or plaque on the oral mucosa that cannot be rubbed off. It is a classic premalignant lesion, with a significant percentage progressing to **Squamous Cell Carcinoma (SCC)**. **Clinical Pearls for NEET-PG:** * **High-Yield Premalignant Lesions:** Actinic keratosis (leads to SCC), Barrett’s esophagus (leads to Adenocarcinoma), and Xeroderma pigmentosum (leads to BCC, SCC, and Melanoma). * **IBD Risk:** The risk of malignancy in IBD increases with the **duration** of the disease (usually after 8–10 years) and the **extent** of colonic involvement (pancolitis > left-sided colitis). * **Retinitis Pigmentosa Association:** Often associated with **Usher Syndrome** (hearing loss) and **Laurence-Moon-Biedl Syndrome**.

Question 222: Which of the following is a poor prognostic factor for childhood ALL?

A. Total Leukocyte count 4000-100,000
B. Age < 2 years
C. Testicular involvement (Correct Answer)
D. Blasts in peripheral smear

Explanation: In childhood Acute Lymphoblastic Leukemia (ALL), prognostic factors are critical for risk stratification and determining treatment intensity. [1] ### **Explanation of the Correct Answer** **C. Testicular involvement:** This is considered a **high-risk feature** and a poor prognostic indicator. The testes (along with the CNS) are "pharmacological sanctuaries" where the blood-testis barrier prevents many standard chemotherapeutic agents from reaching therapeutic concentrations. Involvement at diagnosis suggests a higher systemic disease burden and an increased risk of sanctuary site relapse, necessitating intensified therapy or local radiation. ### **Analysis of Incorrect Options** * **A. Total Leukocyte Count (TLC):** A TLC **< 50,000/µL** is a favorable prognostic factor. While the option mentions up to 100,000, the standard "poor prognosis" threshold is typically defined as **> 50,000/µL**. [1] * **B. Age:** The best prognosis is seen in children aged **1 to 9 years**. Poor prognosis is associated with age **< 1 year (infants)** or **≥ 10 years**. Therefore, "Age < 2 years" is too broad and includes the favorable 1-2 year age bracket. * **D. Blasts in peripheral smear:** This is a diagnostic feature of leukemia, not a prognostic one. The presence of blasts is expected and does not inherently dictate the severity of the disease. [1] ### **High-Yield Clinical Pearls for NEET-PG** * **Most Important Prognostic Factor:** Response to initial therapy (Minimal Residual Disease - MRD) on day 7 or 14. * **Favorable Cytogenetics:** Hyperdiploidy (>50 chromosomes), t(12;21) [TEL-AML1]. * **Poor Cytogenetics:** Hypodiploidy (<44 chromosomes), t(9;22) [Philadelphia chromosome], t(4;11) [MLL rearrangement]. [1] * **Immunophenotype:** Early Pre-B cell has the best prognosis; Mature B-cell (Burkitt-type) and T-cell ALL have poorer outcomes.

Question 223: Which of the following is a poor prognostic factor for childhood ALL?

A. Total Leukocyte count 4000-100,000
B. Age < 2 years
C. Testicular involvement (Correct Answer)
D. Blasts in peripheral smear

Explanation: In childhood Acute Lymphoblastic Leukemia (ALL), prognosis is determined by clinical and biological features present at diagnosis [1]. **Explanation of the Correct Answer:** **Testicular involvement** is considered a **high-risk/poor prognostic factor**. The testes (along with the CNS) are "pharmacological sanctuaries" where the blood-testis barrier prevents adequate penetration of standard systemic chemotherapy. Involvement at diagnosis often correlates with a higher disease burden and an increased risk of systemic relapse, requiring intensified treatment protocols or local radiation. **Analysis of Incorrect Options:** * **Total Leukocyte Count (TLC):** A TLC < 50,000/µL is a favorable prognostic factor. While the option mentions up to 100,000, the standard "poor" prognostic cutoff is typically **TLC > 50,000/µL** [1]. * **Age:** The best prognosis is seen in children aged **1 to 9 years**. Age **< 1 year (infants)** or **> 10 years** are established poor prognostic factors. Age < 2 years (specifically between 1-2) actually falls within a relatively better prognostic window than infancy. * **Blasts in peripheral smear:** This is a diagnostic feature of leukemia, not a specific prognostic indicator [1]. The *clearance* of these blasts (minimal residual disease) after starting induction therapy is a much more significant prognostic marker. **High-Yield Clinical Pearls for NEET-PG:** * **Best Prognostic Factors:** Age 1–9 years, TLC < 50,000, Hyperdiploidy (>50 chromosomes), and t(12;21) [TEL-AML1]. * **Worst Prognostic Factors:** Age < 1 year, TLC > 50,000, Hypodiploidy, and t(9;22) [Philadelphia chromosome]. * **Most Important Factor:** The **response to initial induction chemotherapy** (Minimal Residual Disease - MRD) is currently the strongest predictor of long-term outcome.

Question 224: A 16-year-old boy presents with multiple episodes of abdominal pain and a history of passing blood in his stools. On examination, he has darkly pigmented spots on his lips and oral mucosa. Endoscopy reveals multiple hamartomatous polyps in the small intestine. What is the most likely diagnosis?

A. Peutz-Jeghers Syndrome (Correct Answer)
B. Cronkhite-Canada Syndrome
C. Juvenile Polyposis Syndrome
D. Familial Adenomatous Polyposis

Explanation: ***Peutz-Jeghers Syndrome*** - This is an autosomal dominant disorder characterized by the classic triad of **hamartomatous polyps** in the GI tract (especially the small intestine), **mucocutaneous hyperpigmentation** (dark spots on lips, oral mucosa), and an increased risk of cancer [1]. - The patient's symptoms of abdominal pain and GI bleeding are common complications due to the polyps, which can lead to **intussusception** or ulceration. *Familial Adenomatous Polyposis* - This syndrome is defined by the presence of hundreds to thousands of **adenomatous polyps** in the colon, not hamartomatous polyps as seen in this patient [1]. - It is not associated with the characteristic **perioral mucocutaneous pigmentation** which is a hallmark feature of Peutz-Jeghers syndrome. *Juvenile Polyposis Syndrome* - This condition also involves **hamartomatous polyps**, but they are most commonly found in the colon and rectum, and the syndrome lacks the distinct mucocutaneous pigmentation [1]. - While patients can present with GI bleeding, the combination of small intestine polyps and pigmented lip spots points away from this diagnosis. *Cronkhite-Canada Syndrome* - This is a rare, non-hereditary syndrome typically affecting older adults, characterized by GI polyposis along with ectodermal changes like **alopecia** (hair loss) and **onychodystrophy** (nail changes). - Patients often present with severe diarrhea and **protein-losing enteropathy**, which are not features described in this case.

Question 225: A 60-year-old female presents with weakness, back pain and repeated infections. Work up shows M spike on serum electrophoresis. Prognosis is determined by which of the following factors?

A. Albumin and LDH
B. IgM and albumin
C. IgG and albumin
D. Albumin and $\beta_{2}$-microglobulin (Correct Answer)

Explanation: ***Albumin and $\beta_{2}$-microglobulin*** - These two serum markers are the cornerstones of the **International Staging System (ISS)**, the most widely used system for determining prognosis in Multiple Myeloma. - High **$\beta_{2}$-microglobulin** levels reflect a high tumor burden and/or renal dysfunction, while low **serum albumin** indicates a more advanced disease state and poorer prognosis [1]. *IgG and albumin* - While **albumin** is a key prognostic factor, the specific type of immunoglobulin, such as **IgG**, is not a primary component of the main prognostic staging systems like the ISS. - The *quantity* of the monoclonal protein is used to monitor disease response, but the *type* is less critical for staging than **$\beta_{2}$-microglobulin**. *IgM and albumin* - A monoclonal gammopathy involving **IgM** is the hallmark of **Waldenström macroglobulinemia**, not Multiple Myeloma [1]. - Multiple Myeloma is characterized by the monoclonal proliferation of plasma cells that typically produce **IgG** or **IgA**, not **IgM** [1]. *Albumin and LDH* - While elevated **Lactate Dehydrogenase (LDH)** is an adverse prognostic factor, it is used in the **Revised-ISS (R-ISS)**, which builds upon the original ISS. - The foundational ISS, which is universally applied, is based on the combination of **serum albumin** and **$\beta_{2}$-microglobulin** levels.

Question 226: A patient has developed a cough and weight loss for the last 3 months. Biopsy of lung mass shows expression of chromogranin and synaptophysin. Which paraneoplastic syndrome will most likely occur in this patient?

A. SIADH (Correct Answer)
B. Gynaecomastia
C. Cushing syndrome
D. Hypercalcemia

Explanation: ***SIADH*** - The biopsy findings of positive **chromogranin** and **synaptophysin** are characteristic of a **neuroendocrine tumor**, with **Small Cell Lung Cancer (SCLC)** being the most likely diagnosis given the clinical presentation. - **SCLC** is well-known for causing paraneoplastic syndromes, the most common of which is the **Syndrome of Inappropriate Antidiuretic Hormone (SIADH)**, resulting from ectopic **ADH** production [1]. *Hypercalcemia* - Paraneoplastic hypercalcemia is most frequently associated with **Squamous Cell Carcinoma** of the lung [2]. - This occurs due to the tumor's production of **Parathyroid Hormone-related Peptide (PTHrP)**, which is not a typical feature of SCLC [2]. *Cushing syndrome* - Paraneoplastic Cushing syndrome results from the ectopic production of **Adrenocorticotropic Hormone (ACTH)**, which can also be seen in **SCLC** [1]. - However, **SIADH** is a more common paraneoplastic endocrine syndrome associated with SCLC compared to Cushing syndrome. *Gynaecomastia* - Gynaecomastia as a paraneoplastic syndrome is classically associated with **Large Cell Carcinoma** of the lung. - This is due to the ectopic secretion of **human chorionic gonadotropin (hCG)** by the tumor cells.

Question 227: A patient with a history of breast cancer underwent Cobalt-60 radiotherapy. She now presents with respiratory distress, and imaging shows haziness in the left lung. What is the most likely diagnosis?

A. Radiation Pneumonitis (Correct Answer)
B. Infective Pneumonia
C. Pulmonary Embolism
D. Recurrence of Breast Cancer

Explanation: ***Radiation Pneumonitis*** - This is a non-infectious inflammatory response of the lung parenchyma following radiotherapy, typically occurring **1-6 months** after treatment, which fits the patient's timeline after **Cobalt-60 therapy**. - Imaging findings classically show **diffuse haziness**, consolidation, or ground-glass opacities that are sharply demarcated and conform to the **radiation port**, as seen in the provided chest X-ray. *Recurrence of Breast Cancer* - **Pulmonary metastases** from breast cancer usually present as discrete **nodules**, masses, or lymphangitic carcinomatosis on imaging, not a diffuse haziness confined to a prior radiation field. - The onset of symptoms in this case is more acute and temporally related to radiation therapy, making an inflammatory process like pneumonitis more likely than metastatic recurrence. *Pulmonary Embolism* - While cancer is a risk factor for **pulmonary embolism (PE)**, a chest X-ray is often normal or shows non-specific findings like atelectasis or a **Hampton's hump**; the diffuse haziness seen here is not a typical feature of PE. - Diagnosis of PE requires a **CT pulmonary angiogram (CTPA)** or V/Q scan, as the clinical signs can overlap but the radiographic evidence points elsewhere. *Infective Pneumonia* - **Infective pneumonia** typically presents with symptoms like **fever**, chills, and a productive cough, which are not described in the clinical vignette. - The radiographic opacities in bacterial pneumonia are usually lobar or segmental and do not have the sharp, straight borders that correspond to a radiation field.

Question 228: A patient presents with breathlessness and is diagnosed with a Pancoast tumor. Which of the following findings is not typically associated with this condition?

A. Ptosis
B. Miosis
C. Exophthalmos (Correct Answer)
D. Anhidrosis

Explanation: ***Exophthalmos***- This finding, characterized by the **protrusion of the eyeball**, is typically associated with conditions like **Graves' disease** (hyperthyroidism) or orbital tumors.- It is *not* a component of **Horner's syndrome**, which is the classic neurological manifestation of a Pancoast tumor due to damage to the sympathetic chain.*Anhidrosis*- Pancoast tumors (superior sulcus tumors) often invade the **stellate ganglion** or other parts of the sympathetic chain.- Damage to sympathetic fibers causes reduced or absent sweating on the ipsilateral face and neck, manifesting as **anhidrosis**.*Miosis*- This refers to the **constriction of the pupil** and is a classic sign resulting from the loss of sympathetic input, which normally causes pupillary dilation.- The resulting unopposed action of the parasympathetic system leads to **miosis**.*Ptosis*- Ptosis, or the **drooping of the upper eyelid**, occurs due to paralysis of the **superior tarsal muscle** (Müller's muscle).- This small muscle is innervated by the sympathetic pathway, and its dysfunction results in mild **ptosis**, a core component of Horner's syndrome.

Question 229: Which of the following is the diagnostic test for carcinoid tumors?

A. Serum chromogranin A
B. Serum calcitonin levels
C. Urinary 5-hydroxyindoleacetic acid (Correct Answer)
D. 24-hour urinary catecholamines

Explanation: ***Urinary 5-hydroxyindoleacetic acid***- Carcinoid tumors actively produce **serotonin**, which is rapidly metabolized by **monoamine oxidase** into the inactive metabolite **5-hydroxyindoleacetic acid (5-HIAA)**.- A **24-hour urinary collection** for 5-HIAA is the most specific and confirms the functional diagnosis of **carcinoid syndrome** [1].*24-hour urinary catecholamines*- This test is primarily used for the diagnosis of **pheochromocytoma**, which secretes excess **norepinephrine** and **epinephrine**.- High levels of catecholamine metabolites, such as **metanephrines** and **vanillylmandelic acid (VMA)**, are diagnostic for pheochromocytoma, not carcinoid tumors, which primarily produce serotonin.*Serum calcitonin levels*- **Calcitonin** secretion is the key diagnostic and monitoring marker for **medullary thyroid carcinoma (MTC)**, a non-related neuroendocrine tumor originating from C-cells.- This marker is not specific or elevated in typical **carcinoid tumors** originating from the small bowel or lungs.*Serum chromogranin A*- **Chromogranin A (CgA)** is a general biomarker for **neuroendocrine tumors (NETs)** and is useful for screening and monitoring disease burden [2].- While sensitive for carcinoid tumors, it lacks the specificity of **5-HIAA** for diagnosing **carcinoid syndrome** and can be falsely elevated in conditions like PPI use or renal failure.

Question 230: A 50-year-old smoker presents to the hospital with a painless oral lesion and white patch that develops in the oral cavity, as shown in the image. What is the diagnosis?

A. Leukoplakia (Correct Answer)
B. Candidiasis
C. Lichen planus
D. Oral cancer

Explanation: ***Leukoplakia*** - Leukoplakia is a clinical diagnosis for a white patch or plaque on the oral mucosa that **cannot be scraped off**, distinguishing it from other lesions like candidiasis. - It is strongly associated with chronic irritation, particularly **tobacco use** (as in this smoker), and is considered a **premalignant condition** with a risk of transforming into squamous cell carcinoma. *Candidiasis* - Oral candidiasis (thrush) presents as creamy white, curd-like plaques that **can typically be scraped off**, revealing an underlying erythematous and sometimes bleeding base. - It is an opportunistic fungal infection more common in **immunocompromised** patients, infants, or those using steroids or broad-spectrum antibiotics. *Lichen planus* - Oral lichen planus is a chronic inflammatory autoimmune disease that classically appears as a fine, lace-like network of white lines known as **Wickham's striae**. - While it can present as plaques, the typical reticular pattern is a key differentiating feature, and it is not primarily caused by smoking. *Oral cancer* - While this lesion could be oral cancer (squamous cell carcinoma), **leukoplakia** is the correct clinical descriptive term for the white patch itself. A definitive diagnosis of cancer requires a **biopsy**. - Oral cancers often present as **indurated ulcers**, red patches (erythroplakia), or fungating masses, which may or may not be painful, in addition to white patches.

Question 231: A 45-year-old patient with a history of smoking a pack of cigarettes for the past 15 years presents with hemoptysis. Chest X-ray shows a 3cm upper lobe mass near the apex of the lung. What is the next best step for managing this patient?

A. Bronchoscopy
B. Sputum cytology
C. Sputum for AFB
D. CT-guided biopsy (Correct Answer)

Explanation: ***CT-guided biopsy***- This procedure is the preferred method for obtaining a definitive **tissue diagnosis** for a solitary **peripheral lung mass**, especially one highly suspicious of malignancy due to the patient's smoking history and hemoptysis [1].- Since the mass is **3cm** and located peripherally near the **apex**, a percutaneous **CT-guided transthoracic needle aspiration (TTNA)** provides the highest diagnostic yield compared to other non-invasive alternatives [2].*Bronchoscopy*- Bronchoscopy is primarily used to evaluate **central lesions** (proximal to segmental bronchi) or suspicious findings directly within the airway lumen.- It has a low diagnostic yield for discrete, small, or **peripheral masses** like this 3cm apical lesion, as the scope or biopsy instruments cannot reliably reach the target.*Sputum cytology*- Sputum cytology has low overall sensitivity, particularly for **peripheral lung masses** which are unlikely to shed sufficient malignant cells into the central airways.- While non-invasive, it often results in a non-diagnostic result and is therefore not the **next best step** for confirming the diagnosis of a discrete, radiographically apparent mass.*Sputum for AFB*- While an infectious process like tuberculosis (TB) can present as a mass, the patient's robust history of **heavy smoking** and the mass morphology strongly prioritize ruling out **lung carcinoma**.- Obtaining a tissue sample (biopsy) is mandatory due to the high suspicion of malignancy (indicated by hemoptysis and smoking) and takes precedence over attempting an infectious diagnosis first [3].

Question 232: Which of the following malignancies is unrelated to obesity?

A. Pancreas
B. Stomach
C. Meningioma
D. Multiple myeloma (Correct Answer)

Explanation: ***Multiple myeloma*** - While obesity is a risk factor for several cancers, there is limited or conflicting evidence directly linking **multiple myeloma** to high BMI, making it the most unrelated option among the choices provided. - The primary established risk factors for multiple myeloma include age (over 65), African descent, male sex, and a history of monoclonal gammopathy of undetermined significance (**MGUS**). [1] ***Stomach*** - Obesity, particularly abdominal obesity, increases the risk of developing **gastric cardia adenocarcinoma** due to increased prevalence of **gastroesophageal reflux disease (GERD)** and subsequent Barrett's esophagus. - Chronic inflammation and hormonal changes associated with high body fat contribute to the oncogenesis of stomach cancer. ***Pancreas*** - Obesity is a well-established risk factor for **pancreatic cancer**, increasing the risk by approximately 20-50% compared to healthy-weight individuals. [2] - The mechanism involves chronic low-grade inflammation, **insulin resistance**, and altered levels of adipokines (like leptin) and insulin-like growth factors. ***Meningioma*** - **Meningioma**, the most common primary central nervous system tumor, has a clear association with obesity. - High BMI contributes to increased risk, possibly mediated by elevated levels of **leptin** and **estrogen** (especially in postmenopausal women) which can act as growth factors.

Question 233: A 40-year-old patient presents with complains of low back pain and development of pallor. During workup very high levels of urinary beta2 microglobulin was noted. X-ray skull was performed. Bone marrow aspiration shows >10% plasma cells and serum electrophoresis shows M protein >30 g/L. All are useful for management of this patient except?

A. Lenalidomide
B. Bortezomib
C. Melphalan (Correct Answer)
D. Autologous transplantation

Explanation: ***Melphalan*** - While melphalan is used in **multiple myeloma**, its high-dose application is primarily a conditioning regimen for **autologous stem cell transplantation**, rather than a standalone maintenance or initial therapy, especially in younger patients who are transplant-eligible. - Furthermore, alkylating agents like melphalan are associated with an increased risk of **secondary malignancies**, making their long-term use less favorable in transplant-eligible patients when newer, less toxic agents are available. *Lenalidomide* - **Lenalidomide** is an immunomodulatory drug (IMiD) that is highly effective in the treatment of multiple myeloma, often used in maintenance therapy post-transplant or as part of initial induction regimens. - It works by modulating the immune system and has direct anti-myeloma activity, making it a valuable tool in the management of this patient [1]. *Bortezomib* - **Bortezomib** is a proteasome inhibitor that is a cornerstone of initial induction therapy for transplant-eligible and transplant-ineligible multiple myeloma patients [1]. - It effectively inhibits the break down of cellular proteins, leading to apoptosis of myeloma cells, and is crucial for achieving deep responses. *Autologous transplantation* - Given the patient's age (40 years old) and likely fitness, **autologous stem cell transplantation** is a standard and highly effective treatment option for multiple myeloma, aimed at achieving deep and durable remissions [1]. - It involves harvesting the patient's own stem cells, then administering high-dose chemotherapy (often melphalan) to eradicate myeloma cells, followed by reinfusion of the stored stem cells to rescue hematopoiesis [1].

Question 234: A 60 -year-old female presents with pain in her back of recent onset, which has become severe of late. During the course of investigations, she was found to have lytic lesions in the vertebrae and ribs. Which of the following organs should be carefully screened now for detecting the primary cause of these lesions?

A. Large intestine
B. Breast (Correct Answer)
C. Adrenal
D. Small intestine

Explanation: **Breast** - **Breast cancer** is a common primary malignancy in women that frequently metastasizes to bone, causing **lytic lesions** in the vertebrae and ribs [4]. - The patient's age (60-year-old female) and the presence of severe, recent-onset back pain with multiple lytic lesions strongly suggest metastatic disease [2], with **breast cancer** being a top differential [4]. *Large intestine* - While **colorectal cancer** can metastasize to bone, it typically causes mixed lytic and blastic lesions or predominantly blastic lesions, rather than purely lytic lesions. - Furthermore, the frequency of bone metastases from colorectal cancer is generally lower compared to breast or lung primary tumors [1]. *Adrenal* - Primary **adrenal tumors** (e.g., adrenal cortical carcinoma, pheochromocytoma) rarely metastasize to bone and are not a common cause of diffuse lytic bone lesions. - Bone metastases from adrenal cancers are much less frequent and typically associated with advanced, aggressive disease [3]. *Small intestine* - **Small bowel malignancies** (e.g., adenocarcinomas, neuroendocrine tumors) rarely metastasize to bone. - When they do, the pattern of bone involvement is variable but less commonly presents as widespread lytic lesions in the spine and ribs without other systemic symptoms.

Question 235: Which of the following statements with regard to Colorectal Carcinoma are correct ? 1. Left-sided Colorectal Carcinoma presents with bleeding per rectum. 2. Right-sided Colorectal Carcinoma presents with iron deficiency anaemia. 3. Right-sided Colorectal Carcinoma is more common as compared to the left-sided Colorectal Carcinoma. 4. Colonoscopy is the investigation of choice for suspected Colorectal Carcinoma. Select the correct answer using the code given below :

A. 1, 2 and 3 (Correct Answer)
B. 2, 3 and 4
C. 1, 2 and 4
D. 1, 3 and 4

Explanation: ***1, 2 and 4*** - **Left-sided colorectal carcinoma** often presents with **bleeding per rectum** due to its proximity to the anus [1]. - **Right-sided colorectal carcinoma** is more likely to cause insidious blood loss, leading to **iron deficiency anemia** [1]. - **Colonoscopy** is considered the **gold standard** for diagnosing colorectal carcinoma due to its ability to visualize the entire colon and allow for biopsy [1]. *2, 3 and 4* - While statements 2 and 4 are correct, statement 3 is incorrect. **Left-sided colorectal carcinoma is more common** than right-sided colorectal carcinoma [1]. - Right-sided lesions more generally cause anemia, and colonoscopy is the appropriate investigation of choice [1]. *1, 2 and 3* - Statements 1 and 2 are correct. However, statement 3 is incorrect; **left-sided colorectal carcinoma has a higher incidence** compared to right-sided colorectal carcinoma [1]. - Bleeding per rectum is characteristic of left-sided lesions while iron deficiency anemia for right-sided lesions [1]. *1, 3 and 4* - While statements 1 and 4 are correct, statement 3 is incorrect. **Left-sided colorectal carcinoma is more prevalent** than right-sided colorectal carcinoma [1]. - Clinical presentation with bleeding per rectum is typical for left-sided cancers, and colonoscopy is the definitive diagnostic tool [1].

Question 236: A 60-year-old tobacco chewer and heavy bidi smoker comes with diminished mouth opening and occasional spitting of blood mixed with saliva. Oral examination revealed a white buccal mucosa with a bright red velvety plaque. The most likely diagnosis is :

A. Erythroplakia
B. Oral candidiasis
C. Leukoplakia
D. Speckled leucoplakia (Correct Answer)

Explanation: ***Speckled leucoplakia*** - This patient, a **tobacco chewer** and **bidi smoker**, has risk factors and presents with a "white buccal mucosa with a bright red velvety plaque" (known as **speckled leukoplakia**), which is a highly suspicious lesion for **oral squamous cell carcinoma (OSCC)**, especially with symptoms like diminished mouth opening and occasional spitting of blood. - **Speckled leukoplakia** combines features of both leukoplakia (white areas) and erythroplakia (red velvety areas), and is considered the **highest risk precancerous lesion** for malignant transformation. *Erythroplakia* - Characterized by a **bright red velvety patch** that is flat or slightly depressed. - While highly suspicious for malignancy (with a 90% chance of being dysplastic or malignant), the description also includes a "white buccal mucosa," indicating a mixed white and red lesion. *Oral candidiasis* - Presents as **white, curdy patches** that can be scraped off, often revealing an erythematous base, and is typically associated with immunosuppression or antibiotic use. - It does not usually present with a persistent **red velvety component** or symptoms of diminished mouth opening indicative of malignancy. *Leukoplakia* - Defined as a **white plaque** that cannot be rubbed off and cannot be characterized as any other diagnosable disease. - Only describes the white component, while the patient's lesion also has a significant **red, velvety component**, classifying it more accurately as speckled leukoplakia.

Question 237: Which of the following statements are correct regarding renal cell carcinoma? 1. It arises from the epithelium of the proximal convoluted tubule. 2. It has a female preponderance. 3. Major subtypes are clear cell, papillary and chromophobe. 4. Surgery is the mainstay of treatment for organ-confined disease. Select the answer using the code given below.

A. 1, 2 and 3
B. 1, 3 and 4 (Correct Answer)
C. 1, 2 and 4
D. 2, 3 and 4

Explanation: ***1, 3 and 4*** - **Renal cell carcinoma (RCC)** most commonly arises from the **epithelium of the proximal convoluted tubule**, particularly the clear cell subtype [1]. This makes statement 1 correct. - The major subtypes of RCC are indeed **clear cell, papillary, and chromophobe carcinomas**, accounting for the vast majority of cases [1]. This validates statement 3. - For **organ-confined renal cell carcinoma**, **surgical resection (nephrectomy)** remains the primary and most effective treatment modality, making statement 4 correct. [1] *1, 2 and 3* - This option incorrectly includes statement 2, which claims a female preponderance for RCC. **Renal cell carcinoma is more common in males** than females, not the reverse [1]. - While statements 1 and 3 are correct regarding the origin and major subtypes of RCC, the inclusion of an incorrect epidemiological fact makes this option wrong. *1, 2 and 4* - This option falls short by incorrectly including statement 2, which asserts a female predominance for RCC. **RCC has a male predominance**, with a male-to-female ratio of about 2:1 [1]. - This option also omits statement 3, which correctly identifies the major subtypes (clear cell, papillary, and chromophobe), even though statements 1 and 4 are correct. *2, 3 and 4* - This option incorrectly includes statement 2, which states a female preponderance for RCC; **renal cell carcinoma is actually more prevalent in males** [1]. - While statements 3 and 4 are correct regarding the major subtypes and the role of surgery in organ-confined disease, the factual error in statement 2 invalidates this option.

Question 238: Which of the following are risk factors for the development of pancreatic cancer? 1. Cigarette smoking 2. Diabetes mellitus 3. Obesity 4. Caucasian ethnicity Select the correct answer using the code given below.

A. 1, 2 and 3 (Correct Answer)
B. 2, 3 and 4
C. 1, 3 and 4
D. 1, 2 and 4

Explanation: ***1, 2 and 3*** - **Cigarette smoking** is a well-established and significant modifiable risk factor for pancreatic cancer, increasing the risk two to three-fold [1]. - **Long-standing diabetes mellitus**, particularly type 2, is both an independent risk factor and can be an early symptom of pancreatic cancer. **Obesity** is also clearly linked to an increased risk of pancreatic cancer, likely due to chronic inflammation and metabolic changes. *2, 3 and 4* - While diabetes mellitus and obesity are risk factors, **Caucasian ethnicity** is not considered a primary isolated risk factor for pancreatic cancer; rather, the incidence is slightly higher in certain other ethnic groups like African Americans. - This option incorrectly includes ethnicity as a primary risk factor while excluding **cigarette smoking**, which is a major contributor [1]. *1, 3 and 4* - This option correctly identifies **cigarette smoking** and **obesity** as risk factors. However, it incorrectly includes **Caucasian ethnicity** as a specific risk factor while omitting **diabetes mellitus**, which is a strong and well-documented risk factor. - **Diabetes mellitus** is a more significant risk factor than ethnicity. *1, 2 and 4* - This option correctly identifies **cigarette smoking** and **diabetes mellitus** as risk factors. However, it incorrectly includes **Caucasian ethnicity** and omits **obesity**, which is a well-established and significant risk factor. - **Obesity** has a stronger and more direct link to pancreatic cancer risk than ethnicity.

Question 239: Which of the following are correct with regard to lung cancer? 1. Surgical resection has a limited role in curative treatment of lung cancer. 2. Pattern of disease and prognosis of oat cell carcinoma are different to other varieties in the lungs. 3. Small cell lung cancer is a type of Neuroendocrine Tumour (NET). 4. Squamous cancer appears as a cavitating tumour in the lungs.

A. 1, 3 and 4
B. 2, 3 and 4 (Correct Answer)
C. 1, 2 and 3
D. 1, 2 and 4

Explanation: ***2, 3 and 4*** - **Oat cell carcinoma** (small cell lung cancer) is known for its **aggressive behavior**, rapid growth, early metastasis, and distinct response to chemotherapy and radiation rather than surgery, making its pattern and prognosis different from **non-small cell lung cancer (NSCLC)** types [1]. - **Small cell lung cancer (SCLC)** originates from **neuroendocrine cells** in the lung, classifying it as a type of **Neuroendocrine Tumour (NET)**, which explains its unique biological and clinical characteristics [1]. - **Squamous cell carcinoma** is often centrally located and can undergo central necrosis, leading to **cavitation** which appears as a cavitating tumor on imaging [1]. *1, 3 and 4* - This option is incorrect because statement 1, which suggests surgical resection has a limited role in curative treatment, is generally **false for non-small cell lung cancer (NSCLC)**, where surgery is the primary curative modality in early stages [1]. - While statements 3 and 4 are correct, the inclusion of incorrect statement 1 makes this option invalid. *1, 2 and 3* - This option is incorrect as statement 1 claiming a limited role for surgical resection in curative treatment is generally **false for NSCLC**, where localized tumors are ideally treated with surgery [1]. - Statements 2 and 3 are correct, but the inaccuracy of statement 1 renders this option incorrect. *1, 2 and 4* - This option is incorrect because statement 1, which states that surgical resection has a limited role in curative treatment, is generally **incorrect for early-stage NSCLC** [1]. - Although statements 2 and 4 are accurate, the error in statement 1 makes this combination incorrect.

Question 240: The most common brain tumour in an adult is

A. glioma
B. pituitary tumour
C. cerebral metastasis (Correct Answer)
D. vestibular schwannoma

Explanation: ***Cerebral metastasis*** - **Cerebral metastases** are the **most common brain tumours in adults**, originating from primary cancers elsewhere in the body (e.g., lung, breast, melanoma). - They often present as **multiple lesions** and can cause focal neurological deficits, seizures, and increased intracranial pressure. *Glioma* - While **gliomas** (including astrocytomas, glioblastoma multiforme) are the most common primary brain tumours, they are less common than metastatic lesions overall in adults. - They arise from **glial cells** within the brain and can be highly aggressive. *Pituitary tumour* - **Pituitary tumours** are benign adenomas originating from the pituitary gland. - They are common but constitute a smaller proportion of all adult brain tumours compared to metastases or gliomas, and often present with **endocrine disturbances** or **visual field defects**. *Vestibular schwannoma* - **Vestibular schwannomas** (acoustic neuromas) are benign tumours arising from the **vestibulocochlear nerve (cranial nerve VIII)**. - They are relatively rare and typically present with **hearing loss**, **tinnitus**, and **balance issues**.

Question 241: Following the immunotherapy, in patients undergoing renal transplantation, the skin cancer most commonly seen is

A. Non-melanoma skin cancers (Squamous cell carcinoma and Basal cell carcinoma) (Correct Answer)
B. Hepatomas
C. Kaposi's sarcoma
D. Mycosis fungoides

Explanation: ***Non-melanoma skin cancers (Squamous cell carcinoma and Basal cell carcinoma)*** - **Immunosuppression** following renal transplantation significantly increases the risk of skin cancers, with non-melanoma types like **squamous cell carcinoma (SCC)** and **basal cell carcinoma (BCC)** being the most common [1]. - This increased risk is due to the impaired immune surveillance against oncogenic viruses (e.g., HPV) and DNA damage from UV radiation [2]. *Hepatomas* - While patients with chronic liver disease are at risk for hepatocellular carcinoma (hepatomas), they are **not the most common cancer** specifically associated with immunosuppression after renal transplantation. - The primary risk factors for hepatomas are chronic **hepatitis B** or **C infection**, alcohol abuse, and **cirrhosis**, not directly the immunosuppressive regimen itself. *Kaposi's sarcoma* - **Kaposi's sarcoma (KS)** is associated with **human herpesvirus 8 (HHV-8)** infection and is more prevalent in immunosuppressed individuals, especially those with AIDS or solid organ transplant recipients [2]. - Although its incidence is increased, it is still **less common** than non-melanoma skin cancers in this patient population. *Mycosis fungoides* - **Mycosis fungoides** is a type of **cutaneous T-cell lymphoma**, characterized by malignant T-lymphocytes infiltrating the skin. - It is a **rare cancer** and is not typically considered the most common skin cancer to occur in transplant recipients undergoing immunotherapy.

Question 242: Carcinoma of pyriform fossa usually presents with :

A. Lump in the neck
B. Cough
C. Dysphagia (Correct Answer)
D. Hoarseness

Explanation: ***Dysphagia*** - Carcinoma of the **pyriform fossa** is a type of hypopharyngeal cancer, and given its anatomical location, it commonly interferes with swallowing [1]. - The pyriform fossa lies immediately lateral to the laryngeal inlet, and involvement here directly impacts the ability to form a **food bolus** and propel it into the esophagus. *Lump in the neck* - A neck lump can occur, especially if there is **lymph node metastasis**, but it's often a later symptom [1]. - **Dysphagia** usually precedes the development of a palpable neck mass as the primary tumor expands within the pyriform fossa [1]. *Cough* - While aspiration might lead to coughing, it's not the primary presenting symptom. - Cough is more commonly associated with laryngeal involvement or **tracheal invasion**, which can occur with advanced disease. *Hoarseness* - **Hoarseness** is a prominent symptom if the **vocal cords** or recurrent laryngeal nerve are directly involved [2]. - The pyriform fossa is adjacent but distinct from the vocal cords, so hoarseness is not typically the initial or most common symptom unless the tumor extends medially.

Question 243: The most common site of skeletal metastases in carcinoma of the breast is

A. Thoracic vertebrae (Correct Answer)
B. Skull
C. Pelvis
D. Lumbar vertebrae

Explanation: ***Thoracic vertebrae*** - The **thoracic spine** is the most frequent site for skeletal metastases from breast carcinoma due to its rich vascular supply and proximity to the primary tumor. - Metastases can lead to **vertebral compression fractures**, spinal cord compression, and severe back pain. *Skull* - While the skull can be a site of bone metastases, it is **less common** as the primary site compared to the thoracic vertebrae. - Skull metastases often present as **punched-out lytic lesions** and can involve cranial nerves. *Pelvis* - The **pelvis** is a common site for bone metastases, but it is **not the most frequent** compared to the axial skeleton, particularly the thoracic spine. - Pelvic metastases can cause pain, fractures, and affect mobility. *Lumbar vertebrae* - The **lumbar spine** is a common site for metastases, but it is generally **less frequently involved** than the thoracic spine in breast cancer. - Lumbar metastases also carry a risk of spinal cord compression affecting the lower limbs.

Question 244: A 60 year old man presents with painless progressive jaundice for two months. He has a history of weight loss. On examination, his gallbladder is palpable which is smooth, non‐tender and globular. His serum bilirubin is 18.2 mg/dL. He is most likely suffering from:

A. Carcinoma head of pancreas (Correct Answer)
B. Carcinoma stomach
C. Choledocholithiasis
D. Klatskin tumour

Explanation: A 60 year old man presents with painless progressive jaundice for two months. He has a history of weight loss. On examination, his gallbladder is palpable which is smooth, non‐tender and globular. His serum bilirubin is 18.2 mg/dL. He is most likely suffering from: ***Carcinoma head of pancreas*** - The classic triad of **painless progressive jaundice**, **weight loss**, and a **palpable, non-tender gallbladder** (Courvoisier's sign) strongly indicates carcinoma of the head of the pancreas due to obstruction of the common bile duct [1]. - The high serum bilirubin value further supports a severe obstructive process, typical of a pancreatic head mass compressing the bile duct [1]. *Carcinoma stomach* - Carcinoma of the stomach typically presents with upper abdominal pain, dyspepsia, early satiety, and weight loss, but **jaundice is rare** unless there is extensive metastasis to the liver or porta hepatis. - It usually does not directly lead to **obstructive jaundice** with a palpable gallbladder, as the tumor's location is remote from the common bile duct. *Choledocholithiasis* - While choledocholithiasis can cause obstructive jaundice, it is often associated with **pain** (biliary colic) and fluctuating jaundice rather than the painless, progressive pattern described. - A gallbladder obstructed by a stone would typically be **tender** if inflamed, or decompressed if the obstruction is intermittent, rather than smooth and non-tender due to chronic distal obstruction. *Klatskin tumour* - A Klatskin tumor (hilar cholangiocarcinoma) causes obstructive jaundice, but it typically obstructs the bile ducts above the cystic duct insertion, meaning the **gallbladder would usually be decompressed and non-palpable** [2]. - These tumors often present with **jaundice and itching**, but the presence of a palpable gallbladder makes a pancreatic head mass more likely [2].

Question 245: Which one of the following is NOT correct regarding Adenocarcinoma of the kidney ?

A. It may be associated with Pyrexia of unknown origin
B. It always presents with haematuria (Correct Answer)
C. Renal vein extention may embolize to lungs
D. It is also called Grawitz tumour

Explanation: ***It always presents with haematuria*** - This statement is incorrect because **renal cell carcinoma** (adenocarcinoma of the kidney) often remains asymptomatic until a late stage, meaning **hematuria** is not always present, especially in early disease [1]. - While hematuria is a common symptom in later stages, occurring in about 60% of cases, its absence does not rule out the diagnosis, and many tumors are found incidentally [1]. *It may be associated with Pyrexia of unknown origin* - **Renal cell carcinoma** can produce various paraneoplastic syndromes, including **pyrexia of unknown origin (PUO)** [2]. - The tumor may release **pyrogenic cytokines** that lead to unexplained fever, making this a recognized systemic manifestation. *Renal vein extention may embolize to lungs* - **Renal cell carcinoma** has a propensity to invade the **renal vein** and extend into the inferior vena cava. - Tumor thrombi can then break off and travel to the lungs, resulting in **pulmonary embolism** of tumor cells or even macroscopic tumor emboli. *It is also called Grawitz tumour* - **Grawitz tumor** is an older, historical term used to refer to **renal cell carcinoma**, particularly the clear cell subtype. - This name originated from Paul Grawitz, who first described the tumor's histological features.

Question 246: A 50 year old male patient presents to the emergency with sudden onset of upper abdominal pain, nausea, vomiting and haematemesis. On examination, PR = 106/min, BP = 100/70 mm Hg and pallor is present. CECT abdomen reveals a large exophytic tumor of size 13 x 8 cm at the fundus of the stomach. On upper GI endoscopy, the mucosa overlying the tumor is intact. The staining for CD117 in the upper GI endoscopic biopsy is positive. The most probable clinical diagnosis in this patient is

A. Carcinoid tumor
B. Gastric lymphoma
C. Carcinoma stomach
D. Gastrointestinal stromal tumor (Correct Answer)

Explanation: ***Gastrointestinal stromal tumor*** - The rapid onset of symptoms like **upper abdominal pain**, **nausea**, **vomiting**, and **hematemesis**, along with signs of **hypovolemia** (tachycardia, hypotension, pallor), suggests acute gastrointestinal bleeding from a tumor [1]. - A **large exophytic tumor** in the stomach fundus with **intact overlying mucosa** on endoscopy points to a **submucosal lesion**, and **positive CD117 (c-Kit)** staining is a hallmark diagnostic feature of GISTs. *Carcinoid tumor* - While carcinoid tumors can occur in the gastrointestinal tract, they are typically **neuroendocrine tumors** and less commonly present as large, exophytic masses causing acute massive bleeding with the same frequency as GISTs. - Carcinoid tumors typically stain positive for **chromogranin A** and **synaptophysin**, not CD117. *Gastric lymphoma* - Gastric lymphoma commonly presents with **ulcerations** or infiltrative lesions of the gastric wall, which would typically cause mucosal disruption on endoscopy [2]. - Lymphomas are characterized by lymphoid markers like **CD20** or **CD3**, and not CD117 [2]. *Carcinoma stomach* - **Gastric carcinoma** often presents with **mucosal irregularities**, **ulcerations**, or **masses** that arise directly from the gastric epithelium, which would be visible on endoscopy as an invasive lesion [3]. - Gastric carcinomas are typically epithelial in origin and would not stain positive for **CD117**.

Question 247: Serum thyroglobulin level is an important tumor marker for

A. Thyroid lymphoma
B. Medullary carcinoma thyroid
C. Papillary carcinoma thyroid (Correct Answer)
D. Anaplastic carcinoma thyroid

Explanation: ***Papillary carcinoma thyroid*** - **Serum thyroglobulin** is produced by follicular cells of the thyroid and serves as an excellent tumor marker for **differentiated thyroid cancers**, including papillary carcinoma, particularly after thyroidectomy [1]. - Elevated thyroglobulin levels in a patient with a history of papillary thyroid cancer, especially after removal of the thyroid gland, suggest **recurrence or persistent disease**. *Thyroid lymphoma* - **Thyroid lymphoma** is a lymphoid malignancy, and its primary tumor marker is typically associated with lymphocytic origin, such as **beta-2 microglobulin** or **LDH**, not thyroglobulin. - Thyroglobulin is a product of thyroid follicular cells, which are not the cell of origin for lymphoma. *Medullary carcinoma thyroid* - **Medullary thyroid carcinoma** originates from the parafollicular C cells, which produce **calcitonin**. - **Calcitonin** is the primary tumor marker for medullary thyroid carcinoma, not thyroglobulin. *Anaplastic carcinoma thyroid* - **Anaplastic thyroid carcinoma** is an undifferentiated tumor with very aggressive behavior and often does not produce significant amounts of thyroglobulin. - While some anaplastic carcinomas may have elevated thyroglobulin, it's not a reliable or specific marker due to the **dedifferentiated nature** of the cells.

Question 248: Which is the most commonly used chemotherapy regimen in the adjuvant treatment following modified radical mastectomy in the estrogen receptor negative 35 year old female with breast cancer?

A. Adriamycin + 5-Fluorouracil
B. Cyclophosphamide + Adriamycin + 5-Fluorouracil (Correct Answer)
C. Cyclophosphamide + 5-Fluorouracil
D. Cyclophosphamide + Methotrexate + 5-Fluorouracil

Explanation: ***Cyclophosphamide + Adriamycin + 5-Fluorouracil*** - The **CAF** (Cyclophosphamide, Adriamycin, 5-Fluorouracil) or **FAC** regimen is a widely used and effective **combination chemotherapy** for adjuvant treatment in **ER-negative breast cancer**, offering a robust approach to systemic control. - This regimen addresses the aggressive nature of **ER-negative tumors**, for which **endocrine therapy** is not an option, and aims to eradicate micrometastases reducing recurrence risk. *Adriamycin + 5-Fluorouracil* - While both **Adriamycin** and **5-Fluorouracil** are active agents in breast cancer, this two-drug combination in isolation is generally considered less potent than multi-agent regimens, particularly for **ER-negative disease**. - It lacks the additional mechanism of action and efficacy provided by **cyclophosphamide**, which is a key component in many standard regimens for this aggressive tumor subtype. *Cyclophosphamide + 5-Fluorouracil* - This two-drug regimen is not a standard frontline or the most common adjuvant chemotherapy for ER-negative breast cancer due to its relatively lower efficacy compared to regimens that include an **anthracycline** like Adriamycin. - The absence of an **anthracycline** like Adriamycin, which is a powerful agent against breast cancer, limits its overall effectiveness in a setting where aggressive systemic treatment is crucial. *Cyclophosphamide + Methotrexate + 5-Fluorouracil* - The **CMF** (Cyclophosphamide, Methotrexate, 5-Fluorouracil) regimen was historically a foundational adjuvant therapy; however, for **ER-negative breast cancer**, regimens containing an **anthracycline** like Adriamycin are generally preferred due to their superior efficacy. - While effective, **CMF** is often considered less potent than anthracycline-containing regimens like **CAF/FAC** in treating aggressive, **ER-negative tumors**, which typically benefit from the broader cytotoxic activity of an anthracycline.

Question 249: Consider the following statements: Poor prognostic indicators in advanced germ cell tumours show 1. primary sites in mediastinum 2. non-pulmonary metastasis 3. lactate dehydrogenase more than 10 times of normal value Which of the statements given above are correct?

A. 1 and 2 only
B. 2 and 3 only
C. 1, 2 and 3 (Correct Answer)
D. 1 and 3 only

Explanation: ***1, 2 and 3*** - **All three statements** represent poor prognostic indicators in advanced germ cell tumors, as defined by the **International Germ Cell Cancer Collaborative Group (IGCCCG)** classification. - A primary site in the **mediastinum**, the presence of **non-pulmonary visceral metastases**, and **LDH levels >10 times the upper limit of normal** are all independent factors associated with a worse prognosis. *1 and 2 only* - This option is incorrect because it excludes a critically important poor prognostic indicator: **markedly elevated lactate dehydrogenase (LDH)**. - While mediastinal primary and non-pulmonary metastases are poor prognostic factors, high LDH further defines the **poor risk group**. [1] *2 and 3 only* - This option is incorrect as it omits the significance of a **mediastinal primary site** as a poor prognostic factor in advanced germ cell tumors. - **Mediastinal germ cell tumors** are known to have a worse prognosis compared to testicular primaries, even in the absence of other poor risk factors. *1 and 3 only* - This option is incorrect because it fails to include **non-pulmonary metastases** as a distinct poor prognostic factor for advanced germ cell tumors. - The presence of metastases to sites like the **liver, brain, or bone** significantly worsens the prognosis compared to lung-only metastases.

Question 250: A 50 year old male presented with pain along the left arm and ptosis. His chest X-ray showed soft tissue opacity at the apex of the left lung along with the erosion of the adjacent rib. The probable diagnosis is:

A. Pancoast lung (Correct Answer)
B. Bronchial carcinoma
C. Lung abscess
D. Adenocarcinoma of lung

Explanation: ***Pancoast lung*** - A **Pancoast tumor** (superior sulcus tumor) is a **non-small cell lung cancer** located at the apex of the lung, typically invading adjacent structures. - This invasion can lead to **Pancoast syndrome**, characterized by **shoulder and arm pain** (due to brachial plexus involvement) and **Horner's syndrome** (ptosis, miosis, anhidrosis due to sympathetic chain involvement), often accompanied by rib erosion [1]. *Bronchial carcinoma* - While a Pancoast tumor is a type of **bronchial carcinoma** (lung cancer), this option is too general and doesn't specify the unique apical location and associated neurological symptoms [1]. - Bronchial carcinomas can present with a wide range of symptoms, including cough, hemoptysis, and weight loss, but the specific triad of symptoms described points to a particular subtype. *Lung abscess* - A **lung abscess** is a pus-filled cavity in the lung, usually caused by bacterial infection, and typically presents with fever, cough with purulent sputum, and sometimes pleuritic chest pain. - It does not typically cause **arm pain**, **ptosis**, or **rib erosion** unless there is direct extension from the abscess, which is uncommon and not the primary presentation. *Adenocarcinoma of lung* - **Adenocarcinoma** is a subtype of **non-small cell lung cancer**, but it is generally located in the periphery of the lung and is less likely to present with the classic **Pancoast syndrome** symptoms [1]. - While it can be found in the apex, the specific clinical presentation (arm pain, ptosis, rib erosion) points more strongly to the syndrome that results from apical tumor location rather than just the histological type.

Question 251: First line hormone therapy for post-menopausal woman with metastatic carcinoma breast is:

A. Ovarian suppression by surgery
B. Antiprogestins
C. Tamoxifen
D. Anastrazole (Correct Answer)

Explanation: ***Anastrazole*** - **Aromatase inhibitors** like anastrozole are the preferred first-line hormone therapy for **post-menopausal women** with **hormone-receptor-positive metastatic breast cancer**. - They work by **blocking the aromatase enzyme**, which is responsible for estrogen production in peripheral tissues in post-menopausal women. *Ovarian suppression by surgery* - Ovarian suppression is primarily used in **pre-menopausal women** to reduce estrogen production by the ovaries. - Since the patient is **post-menopausal**, her ovaries are no longer the primary source of estrogen production. *Antiprogestins* - **Antiprogestins** are not standard first-line hormone therapy for metastatic breast cancer. - While some progestational agents have been used in breast cancer treatment, **antiprogestins** are not established as a primary treatment. *Tamoxifen* - **Tamoxifen** is a **selective estrogen receptor modulator (SERM)** that has been widely used in breast cancer treatment. - While effective, **aromatase inhibitors** are generally preferred over tamoxifen as first-line therapy for **post-menopausal metastatic breast cancer** due to superior efficacy and tolerability profiles in this demographic.

Question 252: An 85-year-old male with prostate cancer, Gleason score of 6 , and PSA <8 ng/mL. What is the best management approach?

A. Active surveillance/Watchful waiting (Correct Answer)
B. Radical prostatectomy
C. External beam radiation therapy
D. Androgen deprivation therapy

Explanation: Androgen deprivation therapy - **Hormonal therapy** is primarily used for advanced, metastatic, or high-risk localized prostate cancer [1], or as an adjunct to radiation therapy. - It is not indicated as a primary first-line treatment for **low-risk, localized prostate cancer** in an elderly patient, as its side effects (e.g., hot flashes, fatigue, bone loss, cardiovascular effects) can significantly impact quality of life without offering a survival advantage in this specific scenario.

Question 253: A 60-year-old male patient has an antral carcinoma spreading to the head of the pancreas with multiple small metastases to the right lobe of the liver. What is the best treatment approach?

A. Surgical resection with adjuvant chemotherapy
B. Radiation therapy alone
C. Palliative chemotherapy (Correct Answer)
D. Supportive care only

Explanation: Palliative chemotherapy - The presence of **multiple small metastases** in the liver indicates **metastatic disease**, which is generally considered incurable with surgery [2]. - **Palliative chemotherapy** aims to control disease progression, alleviate symptoms, and improve quality of life in patients with advanced metastatic cancer. Surgical resection with adjuvant chemotherapy - **Surgical resection** is not indicated due to the presence of **distant metastases** (to the liver), classifying the disease as Stage IV [1]. - **Adjuvant chemotherapy** is given after curative surgery to reduce recurrence risk, which is not the goal here as the disease is already metastatic. Radiation therapy alone - **Radiation therapy alone** is typically reserved for localized disease or for palliative symptom management (e.g., pain from bone metastases), not for widespread metastatic disease. - It would not adequately address the systemic nature of **multiple liver metastases** from a pancreatic primary. Supportive care only - While supportive care is crucial, **palliative chemotherapy** offers a chance to prolong survival and manage symptoms more effectively than supportive care alone in suitable patients with advanced pancreatic cancer. - Skipping chemotherapy entirely would mean foregoing potential benefits in terms of disease control and quality of life, especially for patients with a good performance status.

Question 254: A patient presents with a mediastinal mass and is diagnosed with pure red cell aplasia. What is the most probable underlying cause?

A. Bronchogenic carcinoma
B. T-cell Acute Lymphoblastic Leukemia
C. Non-Hodgkin Lymphoma
D. Thymic neoplasia (Correct Answer)

Explanation: ***Thymic neoplasia*** - **Thymoma** is strongly associated with **pure red cell aplasia (PRCA)**, where the body's immune system, influenced by the abnormal thymus, attacks and destroys red blood cell precursors in the bone marrow. - A mediastinal mass, particularly in an adult presenting with PRCA, should raise strong suspicion for a **thymic tumor**. *Bronchogenic carcinoma* - While bronchogenic carcinoma can present as a **mediastinal mass**, it is not typically associated with **pure red cell aplasia**. - Its paraneoplastic syndromes usually involve endocrine or neurological manifestations rather than direct hematopoietic suppression of red cell precursors. *T-cell Acute Lymphoblastic Leukemia* - **T-cell ALL** can present with a **mediastinal mass** due to thymic involvement, but it causes **pancytopenia** or **anemia** due to bone marrow infiltration by leukemic cells, not a selective aplasia of red cell precursors. - In T-cell ALL, there would be a proliferation of immature lymphoid cells, differentiating it from PRCA. *Non-Hodgkin Lymphoma* - Certain types of **non-Hodgkin lymphoma** (e.g., lymphoblastic lymphoma) can present with a **mediastinal mass**. - However, lymphoma would typically cause **bone marrow infiltration** leading to cytopenias, not specifically **pure red cell aplasia**, where only erythroid precursors are targeted.

Question 255: KEYNOTE-189 trial for pembrolizumab is done for?

A. Nivolumab with chemo given for NSCLC
B. Only Pembrolizumab for NSCLC
C. Pembrolizumab with chemo given for NSCLC (Correct Answer)
D. Only nivolumab for NSCLC

Explanation: ***Pembrolizumab with chemo given for NSCLC*** - The **KEYNOTE-189 trial** investigated the efficacy of **pembrolizumab** in combination with chemotherapy as first-line treatment for **metastatic nonsquamous non-small cell lung cancer (NSCLC)**. - This trial demonstrated significant improvements in overall survival and progression-free survival, leading to the approval of pembrolizumab in this setting. *Nivolumab with chemo given for NSCLC* - **Nivolumab** is another PD-1 inhibitor, but studies specifically combining nivolumab with chemotherapy for NSCLC (e.g., CheckMate 227) are distinct from KEYNOTE-189. - While both drugs are used in NSCLC, their pivotal trials and specific combination regimens differ. *Only Pembrolizumab for NSCLC* - Although pembrolizumab monotherapy is approved for certain NSCLC patients with high PD-L1 expression, the **KEYNOTE-189 trial specifically focused on a combination approach** with chemotherapy. - Other KEYNOTE trials, like KEYNOTE-024, evaluated pembrolizumab monotherapy in NSCLC. *Only nivolumab for NSCLC* - **Nivolumab monotherapy** has been studied and approved for NSCLC, particularly in the second-line setting or for patients with high PD-L1 expression, but this was not the focus of the KEYNOTE-189 trial. - Trials like CheckMate 017 and 057 investigated nivolumab as a single agent in NSCLC.

Question 256: A 55-year-old female smoker presents with a breast lump and is seeking medical evaluation. On examination, a palpable mass is detected in the breast. The patient's smoking history is significant, with a 30-year smoking habit. Which of the following conditions is strongly associated with smoking in relation to breast health?

A. Duct ectasia
B. Fibroadenoma
C. Mondor disease
D. Breast cancer (Correct Answer)

Explanation: ***Breast cancer*** - **Smoking** is a well-established risk factor for various cancers, including **breast cancer**, due to the presence of carcinogens in tobacco smoke [1]. - The patient's age and palpable lump further raise suspicion for malignancy, prompting thorough investigation. [1] *Duct ectasia* - Characterized by widening and inflammation of the **milk ducts**, which can cause nipple discharge, tenderness, and a palpable mass. - While smoking can be a risk factor, the more significant association in this age group and with a palpable lump leans towards malignancy. *Fibroadenoma* - These are **benign breast tumors** composed of glandular and stromal tissue, most common in younger women. - They are typically rubbery, mobile masses and are not strongly linked to smoking. *Mondor disease* - This is a rare, **benign condition** characterized by thrombophlebitis of the superficial veins of the breast or chest wall. - It typically presents as a painful, cord-like structure and is not directly associated with smoking.

Question 257: A 62-year-old man presents with “yellowing” of the skin. He says he has been having intermittent upper abdominal pain, which is relieved by Tylenol. He also recalls that he has lost some weight over the past several months but can not quantify the amount. His past medical history is significant for type 2 diabetes mellitus. He reports a 40-pack-year smoking history. The patient is afebrile and vital signs are within normal limits. Physical examination reveals mild jaundice and a palpable gallbladder. Laboratory findings are significant for the following: Total bilirubin 13 mg/dL Direct bilirubin: 10 mg/dL Alkaline phosphatase (ALP): 560 IU/L An ultrasound of the abdomen reveals a hypoechoic mass in the epigastric region. The patient is scheduled for a CT abdomen and pelvis with specific organ protocol for further evaluation. Which of the following best describes this patient’s most likely diagnosis?

A. Caffeine consumption is an established risk factor for this condition.
B. Patients with this condition often rapidly develop glucose intolerance and severe diabetes.
C. This condition is most common in Caucasians.
D. The majority of cases occur in the body of the pancreas.
E. CA 19-9 is a marker for this condition. (Correct Answer)

Explanation: ***CA 19-9 is a marker for this condition.*** - The patient's presentation with **painless jaundice**, **weight loss**, **palpable gallbladder (Courvoisier's sign)**, and markedly elevated **direct bilirubin** and **ALP** strongly suggests **pancreatic head adenocarcinoma**, which obstructs the common bile duct [1]. - **CA 19-9** is a widely used and clinically relevant tumor marker for **pancreatic cancer**, though its utility is primarily for monitoring treatment response and recurrence rather than initial diagnosis. *Caffeine consumption is an established risk factor for this condition.* - **Smoking**, not caffeine consumption, is a significant and well-established **risk factor for pancreatic cancer**, aligning with the patient's 40-pack-year history. - Other risk factors include **chronic pancreatitis**, **obesity**, **diabetes**, and certain **hereditary syndromes** [1]. *Patients with this condition often rapidly develop glucose intolerance and severe diabetes.* - While pancreatic cancer can cause **new-onset diabetes** or worsen pre-existing diabetes, this is typically a **consequence of the tumor** affecting pancreatic islet cells, not a characteristic of its development [1]. - The patient already has a history of **type 2 diabetes mellitus**, which is a *risk factor* for pancreatic cancer. *This condition is most common in Caucasians.* - **Pancreatic cancer** shows a slightly higher incidence in **African Americans** compared to Caucasians. - The incidence generally **increases with age** and is more common in males. *The majority of cases occur in the body of the pancreas.* - Approximately **60-70% of pancreatic adenocarcinomas** occur in the **head of the pancreas**, consistent with the patient's presentation of obstructive jaundice and a palpable gallbladder [1]. - Tumors in the body or tail are less likely to present with jaundice early as they do not obstruct the bile duct.

Question 258: A 65-year-old man comes to the clinic complaining of abdominal pain for the past 2 months. He describes the pain as a dull, aching, 6/10 pain that is diffuse but worse in the right upper quadrant (RUQ). His past medical history is significant for diabetes controlled with metformin and a cholecystectomy 10 years ago. He reports fatigue and a 10-lb weight loss over the past month that he attributes to poor appetite; he denies fever, nausea/vomiting, palpitations, chest pain, or bowel changes. Physical examination is significant for mild scleral icterus and tenderness at the RUQ. Further workup reveals a high-grade malignant vascular neoplasm of the liver. What relevant detail would you expect to find in this patient’s history?

A. Chronic alcohol abuse
B. Heavy ingestion of acetaminophen
C. Infection with the hepatitis B virus
D. Obesity
E. Prior occupation in a chemical plastics manufacturing facility (Correct Answer)

Explanation: ***Prior occupation in a chemical plastics manufacturing facility*** - This history suggests exposure to **vinyl chloride**, a known carcinogen associated with hepatic angiosarcoma, a rare but aggressive **vascular neoplasm of the liver**. - **Hepatic angiosarcoma** often presents with vague symptoms like abdominal pain, weight loss, and fatigue, as seen in this patient, and can lead to liver failure and jaundice [1]. *Chronic alcohol abuse* - While chronic alcohol abuse can lead to various liver diseases, including **alcoholic hepatitis**, **cirrhosis**, and **hepatocellular carcinoma (HCC)**, it is not typically associated with angiosarcomas. - The patient's symptoms are more consistent with a rapidly progressing malignancy, and HCC typically presents in patients with underlying cirrhosis or hepatitis. *Heavy ingestion of acetaminophen* - Acute or chronic overdose of **acetaminophen** primarily causes **centrilobular necrosis** and liver failure, but it is not linked to the development of hepatic vascular neoplasms like angiosarcoma. - The patient's presentation of a high-grade malignant vascular neoplasm points away from drug-induced liver injury as the primary cause. *Infection with the hepatitis B virus* - **Hepatitis B virus (HBV)** infection is a major risk factor for **hepatocellular carcinoma (HCC)**, a common primary liver cancer, but not for hepatic angiosarcoma. - The patient's clinical picture of a "high-grade malignant vascular neoplasm" is less typical for HCC, which originates from hepatocytes, not vascular endothelial cells. *Obesity* - Obesity is a risk factor for **non-alcoholic fatty liver disease (NAFLD)**, which can progress to **non-alcoholic steatohepatitis (NASH)**, cirrhosis, and **hepatocellular carcinoma (HCC)** [2]. - However, obesity is not directly linked to the development of primary hepatic vascular neoplasms like angiosarcoma.

Question 259: A 63-year-old man comes to the physician because of a 3-month history of fatigue and constipation. He reports having dull pain in the left portion of the midback for 2 weeks that has persisted despite taking ibuprofen. His father died of prostate cancer at 70 years of age. The patient has smoked one pack of cigarettes daily for 45 years. Vital signs are within normal limits. Physical examination shows a left-sided varicocele both in supine and in standing position. Rectal examination shows a symmetrically enlarged prostate with no masses. Laboratory studies show: Hemoglobin 11.2 g/dL Serum Creatinine 1.0 mg/dL Calcium 11.8 mg/dL Urine Protein 1+ Blood 2+ Which of the following is the most appropriate next step in management?

A. Urine cytology
B. CT scan of the abdomen (Correct Answer)
C. Chest x-ray
D. Serum protein electrophoresis
E. Prostate biopsy

Explanation: ***CT scan of the abdomen*** - The patient's symptoms, including **fatigue**, **constipation**, **dull midback pain**, **anemia**, **hypercalcemia**, and **new-onset left-sided varicocele**, are highly concerning for a retroperitoneal malignancy, most likely **renal cell carcinoma** [1]. - A **CT scan of the abdomen** is the most appropriate next step to evaluate the kidneys and retroperitoneum for a mass, as it can characterize the varicocele etiology (tumor compressing the **left renal vein**) [1]. *Urine cytology* - **Urine cytology** is primarily used to detect malignant cells in the urine, typically for suspected bladder or upper urinary tract transitional cell carcinoma. - While there is hematuria, the overall clinical picture with **hypercalcemia**, **anemia**, and **varicocele** points to a broader retroperitoneal process rather than solely a urinary tract epithelial malignancy. *Chest x-ray* - A **chest x-ray** evaluates the lungs and mediastinum and would be useful for assessing for metastatic disease, particularly in the context of cancer. - However, given the strong localizing signs (left-sided varicocele, midback pain), the priority is to identify the primary tumor in the abdomen before scanning for distant metastases. *Serum protein electrophoresis* - **Serum protein electrophoresis** is used to detect and characterize monoclonal gammopathies, such as those seen in **multiple myeloma**. - While hypercalcemia can be associated with multiple myeloma, the presence of a **new-onset left-sided varicocele** is highly suggestive of a mass compressing the left renal vein, which is not typically seen in multiple myeloma. *Prostate biopsy* - A **prostate biopsy** would be indicated if there were suspicious findings on rectal exam (e.g., prostatic nodule) or an elevated PSA, suggesting prostate cancer. - The rectal exam showed a **symmetrically enlarged prostate with no masses**, and while the father had prostate cancer, hypercalcemia and a new varicocele are not typical primary manifestations of prostate cancer.

Question 260: A 58-year-old woman comes to the physician because of constipation, loss of appetite, and increased urinary frequency for the past 8 weeks. She has a history of hypertension and underwent mastectomy for breast cancer 9 months ago. Her sister has hyperthyroidism and her mother died of complications from breast cancer at the age of 52 years. She does not smoke or drink alcohol. Current medications include chlorthalidone. Her temperature is 36.2°C (97.2°F), pulse is 102/min, and blood pressure is 142/88 mm Hg. Physical examination shows dry mucous membranes. Abdominal examination shows mild, diffuse abdominal tenderness to palpation with decreased bowel sounds. Her serum creatinine concentration is 1.2 mg/dL and serum calcium concentration is 12 mg/dL. Serum parathyroid hormone levels are decreased. Which of the following is the most appropriate long-term pharmacotherapy?

A. Denosumab
B. Furosemide
C. Zoledronic acid (Correct Answer)
D. Magnesium oxide
E. Prednisone

Explanation: **Zoledronic acid** - The patient presents with **hypercalcemia** (12 mg/dL) and a history of **breast cancer with mastectomy**, strongly suggesting **humoral hypercalcemia of malignancy** or **bone metastases**. **Zoledronic acid**, a potent bisphosphonate, is the most appropriate long-term treatment as it inhibits osteoclast activity and reduces calcium release from bone [1]. - Her **decreased parathyroid hormone (PTH)** level further supports a non-PTH mediated cause of hypercalcemia, such as malignancy [2]. *Denosumab* - While denosumab is effective for **hypercalcemia of malignancy**, it is generally reserved for patients who are **refractory to bisphosphonates** or have **renal impairment**, as it carries a risk of osteonecrosis of the jaw and severe hypocalcemia. - Given the patient's creatinine of 1.2 mg/dL, **bisphosphonates like zoledronic acid** are typically first-line and generally safe for renal function until it falls below 30 mL/min. *Furosemide* - **Loop diuretics** like furosemide can be used in the **acute management of severe hypercalcemia** to promote calcium excretion in the urine. - However, furosemide is insufficient as **long-term monotherapy** for malignancy-associated hypercalcemia; it does not address the underlying bone resorption and can lead to electrolyte imbalances. *Magnesium oxide* - **Magnesium oxide** is primarily used as a **laxative** or to treat **magnesium deficiency**. - It has **no role in the management of hypercalcemia** and would not address the patient's elevated calcium levels, which are likely due to malignancy. *Prednisone* - **Corticosteroids like prednisone** are effective in treating hypercalcemia caused by **hematologic malignancies** (e.g., multiple myeloma, lymphoma) or **granulomatous diseases** (e.g., sarcoidosis). - They are generally **not effective nor first-line** for hypercalcemia associated with **solid tumors** like breast cancer.

Question 261: A 70-year-old man comes to the physician because of a 4-month history of epigastric pain, nausea, and weakness. He has smoked one pack of cigarettes daily for 50 years and drinks one alcoholic beverage daily. He appears emaciated. He is 175 cm (5 ft 9 in) tall and weighs 47 kg (103 lb); BMI is 15 kg/m2. He is diagnosed with gastric cancer. Which of the following cytokines is the most likely direct cause of this patient’s examination findings?

A. IL-2
B. TGF-β
C. IL-6 (Correct Answer)
D. TNF-β
E. IFN-α

Explanation: **IL-6** - **Interleukin-6 (IL-6)** plays a significant role in **cachexia** associated with cancer, leading to features like **anorexia**, muscle wasting, and fatigue. - Its elevated levels in cancer patients contribute to systemic inflammation and metabolic changes that result in the patient's **emaciated appearance** and weight loss. *IL-2* - **Interleukin-2 (IL-2)** is primarily involved in the **proliferation and differentiation of T cells** and natural killer cells, often used in cancer immunotherapy. [1] - It is not directly implicated as a primary cause of **cancer-associated cachexia** or the systemic symptoms described. *TGF-β* - **Transforming Growth Factor-beta (TGF-β)** is a cytokine that generally **inhibits immune responses** and regulates cell growth, differentiation, and apoptosis. - While it can be involved in tumor progression and metastasis, it is not recognized as a direct cause of the **cachectic syndrome** seen in this patient. *TNF-β* - **Tumor Necrosis Factor-beta (TNF-β)**, also known as **lymphotoxin-alpha (LT-α)**, shares some functions with TNF-α, but its role in **cancer cachexia** is less direct and prominent than TNF-α or IL-6. [2] - It is primarily involved in immune surveillance and inflammation, but not the leading cause of the patient's systemic wasting. *IFN-α* - **Interferon-alpha (IFN-α)** is a cytokine primarily known for its **antiviral and anti-proliferative effects** and its role in immune modulation. [1] - It is used in the treatment of certain cancers but is **not a primary mediator** of cancer-related cachexia or the specific constitutional symptoms of weight loss and emaciation.

Question 262: Most common primary for brain metastasis is which of the following?

A. Breast cancer
B. Lung cancer (Correct Answer)
C. Head and neck cancer
D. Prostate cancer

Explanation: ***Lung cancer*** - Lung cancer is the **most common primary malignancy** to metastasize to the brain, accounting for approximately 40-50% of all brain metastases. - The high vascularity of the lungs and the frequent spread of lung cancer cells through the bloodstream contribute to its propensity for cerebral metastasis. *Breast cancer* - While breast cancer is a common cause of brain metastases, it ranks **second to lung cancer**, accounting for about 15-20% of cases [1]. - Different subtypes of breast cancer (e.g., HER2-positive, triple-negative) have varying risks for brain involvement. *Head and neck cancer* - Metastasis to the brain from head and neck squamous cell carcinoma is **relatively uncommon**, occurring in less than 5% of patients. - When it does occur, it's often associated with advanced regional disease and poor prognosis. *Prostate cancer* - Brain metastases from prostate cancer are **rare**, typically occurring in less than 2% of advanced cases. - Prostate cancer generally tends to metastasize to bones and lymph nodes more frequently than to the brain.

Question 263: All are risk factors of esophageal squamous cell carcinoma except:

A. Smoking
B. Achalasia cardia
C. GERD (Correct Answer)
D. Alcohol

Explanation: ***GERD*** - **Gastroesophageal reflux disease (GERD)** is strongly associated with **esophageal adenocarcinoma**, not esophageal squamous cell carcinoma. - Chronic acid reflux can lead to **Barrett's esophagus**, which is a precursor to adenocarcinoma [1]. *Smoking* - **Smoking** is a significant and well-documented risk factor for **esophageal squamous cell carcinoma**, increasing the risk in a dose-dependent manner. - Carcinogens in tobacco smoke directly damage esophageal epithelial cells, promoting malignant transformation. *Achalasia cardia* - **Achalasia cardia** involves impaired relaxation of the lower esophageal sphincter and loss of peristalsis, leading to food stasis and chronic inflammation [2]. - This chronic irritation and inflammation significantly increase the risk of developing **esophageal squamous cell carcinoma**. *Alcohol* - **Alcohol consumption**, especially heavy drinking, is a major risk factor for **esophageal squamous cell carcinoma**. - Alcohol metabolizes into acetaldehyde, a known carcinogen, which directly damages DNA in esophageal cells.

Question 264: Which of the following is true about carcinoid tumor?

A. Presentation is hypotension and diaphoresis
B. Intestinal carcinoids are of high malignant potential
C. Best diagnosed by elevated urinary vanillymandelic acid levels
D. Can occur throughout the gastrointestinal tract (Correct Answer)

Explanation: ***Can occur throughout the gastrointestinal tract*** - Carcinoid tumors (neuroendocrine tumors) are most commonly found in the **gastrointestinal tract**, particularly in the small intestine, appendix, rectum, and stomach [2]. - They arise from **enterochromaffin cells** and can secrete various vasoactive substances. *Presentation is hypotension and diaphoresis* - The classic presentation of **carcinoid syndrome** includes episodes of **flushing**, **diarrhea**, and **bronchospasm**, often accompanied by **hypertension** rather than hypotension due to the release of serotonin and other vasoactive peptides [1]. - While diaphoresis can occur, **hypotension** is not a primary or characteristic feature. *Intestinal carcinoids are of high malignant potential* - The malignant potential of carcinoid tumors varies depending on their primary site and size but is generally considered to be of **low-to-moderate malignant potential**, particularly for appendiceal and rectal carcinoids [2]. - Liver metastases significantly increase morbidity and mortality, but many small intestinal carcinoids may grow slowly or remain localized for extended periods [1]. *Best diagnosed by elevated urinary vanillymandelic acid levels* - Elevated **urinary vanillymandellic acid (VMA)** levels are primarily used to diagnose **pheochromocytoma**, a tumor of the adrenal medulla that secretes catecholamines. - Carcinoid tumors are best diagnosed by measuring **urinary 5-hydroxyindoleacetic acid (5-HIAA)**, a breakdown product of serotonin.

Question 265: Which is not seen in Tumour lysis Syndrome?

A. Hyperkalemia
B. Hypophosphatemia (Correct Answer)
C. Hyperuricemia
D. Hypocalcemia

Explanation: ***Hypophosphatemia*** - **Tumor lysis syndrome (TLS)** is characterized by the rapid breakdown of tumor cells, leading to the release of intracellular components into the bloodstream. - This process typically results in **acute hyperphosphatemia**, not hypophosphatemia, due to the high phosphate content within tumor cells. *Hyperkalemia* - **Hyperkalemia** is a hallmark of TLS because potassium, a major intracellular cation, is released in large quantities as tumor cells lyse. - Excess potassium can lead to potentially life-threatening cardiac arrhythmias. *Hyperuricemia* - **Hyperuricemia** occurs in TLS because nucleic acids (DNA and RNA) released from dying tumor cells are metabolized into purines, which are then converted to uric acid [1]. - High uric acid levels can precipitate in the renal tubules, leading to **acute kidney injury** [1]. *Hypocalcemia* - **Hypocalcemia** develops in TLS secondary to the acute hyperphosphatemia. - The excess phosphate binds with serum calcium to form **calcium-phosphate precipitates**, effectively lowering the concentration of free ionized calcium.

Question 266: Prostatic cancer mostly seen in

A. Posterior (Correct Answer)
B. Lateral
C. Anterior
D. Medial

Explanation: ***Posterior*** - The **peripheral zone** of the prostate, which is located posteriorly, is the most common site for the development of **prostatic adenocarcinoma**. - This anatomical location is why a **digital rectal exam (DRE)** is an important screening tool, as palpable nodules can be detected [1]. *Lateral* - While prostatic tissue extends laterally, this region is not the predominant site for cancer development. - Cancers originating here are less common than those in the posterior peripheral zone. *Anterior* - The **anterior fibromuscular stroma** and the anterior portion of the prostate are rarely the primary sites for prostate cancer. - Tumors found here are often extensions from more posteriorly located cancers. *Medial* - The **transition zone**, which is located medially and surrounds the urethra, is the most common site for **benign prostatic hyperplasia (BPH)**, not prostate cancer. - While cancer can occur in this zone, it is less frequent than in the peripheral zone.

Question 267: Route of administration of BCG for bladder cancer is

A. Oral
B. Subcutaneous
C. Intravenous
D. Intravesical (Correct Answer)

Explanation: ***Intravesical*** - **Bacillus Calmette-Guérin (BCG)** is directly instilled into the bladder via a catheter for the treatment of **non-muscle invasive bladder cancer**. - This **intravesical** route ensures high local concentrations of the immunotherapeutic agent, stimulating an anti-tumor immune response within the bladder. *Oral* - The **oral route** is not used for BCG in bladder cancer due to poor absorption and degradation of the vaccine in the gastrointestinal tract. - It would not achieve therapeutic concentrations at the target site (the bladder) and would carry a risk of systemic side effects without localized benefit. *Subcutaneous* - **Subcutaneous administration** is typically used for systemic vaccination against tuberculosis, - However, for bladder cancer, it would not deliver the therapeutic agent directly to the cancerous tissue in the bladder lumen, limiting its efficacy. *Intravenous* - **Intravenous administration** would lead to systemic distribution of BCG, which is not desired for localized bladder cancer treatment. - It could result in significant systemic side effects, including disseminated BCG infection, without providing adequate local concentration in the bladder.

Question 268: A 65-year-old woman presents with a 5-week history of yellow skin and sclera, anorexia, and epigastric pain. Her past medical history is significant for insulin-dependent diabetes mellitus. She smoked one pack of cigarettes a day for the past 20 years. Physical examination reveals jaundice and a palpable gallbladder. Laboratory studies show a serum bilirubin level of 10 mg/dL, mostly in the conjugated form, and an elevated alkaline phosphatase (260 U/L). A CT scan of the abdomen discloses a mass in the head of the pancreas and multiple nodules in the liver measuring up to 3 cm. Which of the following is the most important risk factor for the neoplasm arising in the patient?

A. Cholelithiasis
B. Cigarette smoking (Correct Answer)
C. Alcohol abuse
D. Diabetes mellitus type 1

Explanation: ***Cigarette smoking*** - **Smoking** is a well-established and significant risk factor for adenocarcinoma of the **pancreas**, which aligns with the patient's presentation of a pancreatic head mass, obstructive jaundice (yellow skin/sclera, high conjugated bilirubin, elevated alkaline phosphatase), and palpable gallbladder [3]. - The 20-year history of smoking significantly increases her individual risk for this particular type of cancer. *Cholelithiasis* - While **gallstones** can cause obstructive jaundice (e.g., choledocholithiasis), they are not a primary risk factor for **pancreatic adenocarcinoma**. - The patient's CT scan indicates a **pancreatic head mass** and liver nodules, pointing away from primary gallstone disease as the etiology of the neoplasm. *Alcohol abuse* - Chronic **alcohol abuse** is a major risk factor for chronic pancreatitis, which can, in turn, increase the risk of pancreatic cancer [1]. - However, direct causation between alcohol abuse and pancreatic cancer is less strong than with smoking, and there is no mention of alcohol abuse in the patient's history [2]. *Diabetes mellitus type 1* - While a proportion of patients with newly diagnosed **pancreatic cancer** may develop diabetes (often type 2 or an unusual type of diabetes), **insulin-dependent diabetes mellitus type 1** itself is considered a minor or even non-existent risk factor for pancreatic cancer. - The presence of diabetes in this patient is more likely a concurrent condition or a consequence of the pancreatic tumor rather than a primary risk factor for its development.

Question 269: The highest life time risk of pancreatic malignancy is seen with:

A. Familial adenomatous polyposis
B. Peutz-Jeghers syndrome (Correct Answer)
C. Hereditary nonpolyposis colorectal cancer
D. Li-Fraumeni syndrome

Explanation: ***Peutz-Jeghers syndrome*** - **Peutz-Jeghers syndrome** is an autosomal dominant disorder characterized by **hamartomatous polyps** in the gastrointestinal tract and mucocutaneous pigmentation. - It significantly increases the lifetime risk of various cancers, including **pancreatic cancer**, with estimates as high as 11-36% by age 70 [1]. *Familial adenomatous polyposis* - **Familial adenomatous polyposis (FAP)** is primarily associated with a very high lifetime risk of **colorectal cancer** [2]. - While there is a slightly increased risk of pancreatic cancer in FAP patients, it is considerably lower than the risk seen in Peutz-Jeghers syndrome. *Hereditary nonpolyposis colorectal cancer* - **Hereditary nonpolyposis colorectal cancer (HNPCC)**, also known as **Lynch syndrome**, is mainly associated with a high risk of **colorectal** and **endometrial cancers**. - While it does increase the risk of other extra-colonic cancers like gastric, ovarian, and urinary tract cancers, the lifetime risk of pancreatic cancer is lower compared to Peutz-Jeghers syndrome. *Li-Fraumeni syndrome* - **Li-Fraumeni syndrome** is caused by a germline mutation in the **TP53 tumor suppressor gene**, leading to a high predisposition to a wide variety of cancers at a young age. - Common cancers include soft tissue sarcomas, osteosarcomas, breast cancer, brain tumors, and adrenocortical carcinomas; however, the lifetime risk for **pancreatic cancer** is not as prominently high as in Peutz-Jeghers syndrome.

Question 270: Which one of the following is not sensitive to chemotherapy in advanced stage?

A. Wilm's tumor
B. Ovarian carcinoma
C. Ewing's carcinoma
D. Pancreatic carcinoma (Correct Answer)

Explanation: ***Pancreatic carcinoma*** - **Pancreatic carcinoma** is notoriously difficult to treat with chemotherapy, especially in advanced stages, due to its **aggressive biology**, inherent resistance mechanisms, and late presentation [1]. - The disease often presents with **metastatic spread** before diagnosis, and the response rates to even combination chemotherapy regimens are typically poor, highlighting its poor sensitivity [1]. *Wilm's tumor* - **Wilm's tumor (nephroblastoma)** is a pediatric kidney cancer that is highly sensitive to chemotherapy, even in advanced stages. - Combination chemotherapy regimens are a cornerstone of treatment, often leading to **excellent prognosis** and cure rates. *Ovarian carcinoma* - **Ovarian carcinoma**, particularly epithelial ovarian cancer, is often initially sensitive to **platinum-based chemotherapy**. - While it frequently recurs, the initial response to chemotherapy, even in advanced stages, can be significant, leading to periods of **remission**. *Ewing's sarcoma* - **Ewing's sarcoma** is a highly aggressive bone and soft tissue tumor that is very sensitive to chemotherapy, which is a critical component of its multidisciplinary treatment. - Modern multidisciplinary approaches, including intensive chemotherapy, have significantly improved survival rates for patients with both localized and **metastatic disease**.

Question 271: Compared to the other options, radiotherapy is LEAST commonly used as a primary treatment modality in:

A. Esophageal cancer
B. Brain tumor
C. Cervical cancer
D. Stomach cancer (Correct Answer)

Explanation: ***Stomach cancer*** - **Radiotherapy** is generally *not* a primary treatment for **stomach cancer** due to the high radiosensitivity of surrounding organs (e.g., small bowel, liver, kidneys) and the difficulty in delivering a curative dose without significant toxicity. - While it may be used as an **adjuvant therapy** post-surgery or for **palliative care** (e.g., pain, bleeding), it is rarely the initial standalone treatment. *Esophageal cancer* - **Radiotherapy** is a common primary or neoadjuvant treatment for **esophageal cancer**, often in combination with chemotherapy (**chemoradiation**), especially for unresectable cases or to downstage tumors before surgery. - It plays a significant role in both curative intent and **palliative management** for dysphagia. *Brain tumor* - **Radiotherapy** is a cornerstone of treatment for many primary and metastatic **brain tumors**, often following surgical resection or as a standalone primary treatment. - Techniques like **stereotactic radiosurgery (SRS)** and **intensity-modulated radiation therapy (IMRT)** allow for precise targeting, minimizing damage to healthy brain tissue. *Cervical cancer* - **Radiotherapy**, particularly external beam radiation therapy (EBRT) combined with **brachytherapy**, is a highly effective primary treatment for **locally advanced cervical cancer**, especially if surgery is not feasible or desired [1]. - It can achieve high cure rates and is often given concurrently with chemotherapy (**chemoradiation**) [1].

Question 272: A 44 year old man goes to his physician for an employment physical examination. The clinician notices that the patient's fingers are clubbed. He also demonstrates tenderness over the distal ends of the radius, ulna, and fibula. This patient should be explicitly evaluated to exclude which of the following?

A. Renal cancer
B. Liver cancer
C. Gastrointestinal cancer
D. Lung cancer (Correct Answer)

Explanation: ***Lung cancer*** - The combination of **clubbing** (hypertrophic osteoarthropathy) and **periosteal tenderness** (typically of the long bones) is highly suggestive of paraneoplastic syndrome associated with **bronchogenic carcinoma**, particularly **non-small cell lung cancer** [1]. - **Hypertrophic osteoarthropathy** is characterized by proliferation of skin and bone at distal extremities, often leading to clubbing and pain in the long bones [1], which is a classic presentation with lung malignancies. *Renal cancer* - While renal cell carcinoma can present with various paraneoplastic syndromes, **hypertrophic osteoarthropathy** and clubbing are not typical or primary associations [2]. - Common paraneoplastic syndromes with renal cancer include **polycythemia** (due to erythropoietin production) [3] and **hypercalcemia** [2], [3]. *Liver cancer* - **Hepatocellular carcinoma** can be associated with paraneoplastic syndromes, but **clubbing** and **hypertrophic osteoarthropathy** are not among the classic presentations. - Paraneoplastic syndromes in liver cancer often involve **hypoglycemia** or **erythrocytosis** [3]. *Gastrointestinal cancer* - Although **gastrointestinal malignancies** can cause various systemic symptoms, **hypertrophic osteoarthropathy** with prominent clubbing is not a primary or common paraneoplastic manifestation [2]. - GI cancers might indirectly cause clubbing in settings of chronic malabsorption, but not typically as a direct paraneoplastic effect like lung cancer.

Question 273: Which isotope is used for treating bone cancer?

A. I-131
B. Tc
C. Sr (Correct Answer)
D. Ga

Explanation: Phosphorus-32 is a radioisotope commonly used in the treatment of bone cancer and related conditions due to its ability to target bone tissues. Other isotopes used in the treatment of bone metastases include Strontium-89 and Samarium-153.

Question 274: A patient presented with a 3.5-cm size lymph node enlargement, which was hard and present in the submandibular region. Examination of the head and neck did not yield any lesion. Which of the following investigations should follow?

A. Chest X-ray
B. Laryngoscopy
C. Supravital oral mucosa staining
D. Triple endoscopy (Correct Answer)

Explanation: ***Triple endoscopy*** - A **3.5 cm, hard, submandibular lymph node** without an obvious primary lesion suggests metastatic carcinoma, requiring a thorough search for the primary. - **Triple endoscopy** (laryngoscopy, esophagoscopy, and bronchoscopy) allows direct visualization and biopsy of mucosal surfaces in the upper aerodigestive tract, which is a common site for primary tumors metastasizing to the neck. *Chest X-ray* - While a Chest X-ray can detect **lung lesions** or mediastinal lymphadenopathy, it may not adequately identify a primary tumor in the upper aerodigestive tract. - It would be a useful adjunct later but does not provide the comprehensive mucosal surface evaluation needed to find a hidden primary. *Laryngoscopy* - **Laryngoscopy** is part of the triple endoscopy procedure but by itself is insufficient as it only examines the larynx and hypopharynx. - It would miss potential primary lesions in the nasopharynx, oral cavity, or esophagus. *Supravital oral mucosa staining* - **Supravital staining** (e.g., toluidine blue) is used to identify dysplastic or early malignant lesions on the oral mucosa. - While useful for oral cavity screening, it does not evaluate other potential primary sites in the pharynx, larynx, esophagus, or nasopharynx, which could be the source of the metastatic node.

Question 275: Which of the following is not a premalignant condition?

A. Bloom's syndrome
B. Down's syndrome
C. Fragile X syndrome (Correct Answer)
D. Fanconi anemia

Explanation: ***Fragile X syndrome*** - This is a genetic condition causing **intellectual disability** and developmental problems, primarily due to an **FRM1 gene mutation** leading to a fragile site on the X chromosome [1]. - It is **not associated with an increased risk of malignancy** and is therefore not considered a premalignant condition. *Bloom's syndrome* - This is a rare genetic disorder characterized by **growth deficiency**, a **photosensitive rash**, and a significantly **increased risk of various cancers**, including leukemias, lymphomas, and solid tumors. - It is associated with a mutation in the **BLM gene**, which plays a role in DNA repair and replication, leading to chromosomal instability. *Down's syndrome* - Individuals with Down's syndrome (trisomy 21) have a **20-fold increased risk of acute lymphoblastic leukemia (ALL)** and a 10-fold increased risk of acute myeloid leukemia (AML), particularly transient myeloproliferative disorder in infancy. - While it is a developmental disorder, the increased incidence of specific cancers classifies it as a **premalignant condition**. *Fanconi anemia* - This is a rare genetic disorder characterized by **bone marrow failure**, physical abnormalities, and an extraordinarily high risk of developing **acute myeloid leukemia (AML)** and myelodysplastic syndrome (MDS). - It is caused by mutations in genes involved in **DNA repair**, making cells highly susceptible to DNA damage and cancer.

Question 276: The standard radiation therapy dose for consolidation treatment in early-stage Hodgkin lymphoma is:

A. Moderate dose: 30-40 Gy
B. Standard dose: 20-30 Gy (Correct Answer)
C. High dose: 50-60 Gy
D. Intermediate dose: 40-50 Gy

Explanation: **Standard dose: 20-30 Gy** - For **early-stage Hodgkin lymphoma**, a dose range of **20-30 Gy** is considered standard for **consolidation radiotherapy** following chemotherapy. - This dose balances efficacy in eradicating residual microscopic disease with minimizing **long-term toxicity**. *Moderate dose: 30-40 Gy* - This dose range is typically used in situations requiring **higher local control** where the risk of recurrence is elevated, or for certain **bulky disease** settings. - It exceeds the standard recommendation for **routine consolidation** in early-stage disease due to potential for increased side effects. *High dose: 50-60 Gy* - Doses in this range are usually reserved for **definitive radiation therapy** in primary malignancy treatment or for **palliation of symptomatic bulky disease**, not early-stage consolidation. - Such high doses would significantly increase the risk of **secondary malignancies** and other late toxicities in Hodgkin lymphoma. *Intermediate dose: 40-50 Gy* - This dose range is generally not a recognized standard for **early-stage Hodgkin lymphoma consolidation**. - It falls between standard consolidation and definitive treatment doses, potentially offering **unjustified toxicity** without a clear benefit over the lower standard dose.

Question 277: Commonest cause of skeletal metastasis is

A. Prostate
B. Breast (Correct Answer)
C. Thyroid
D. Kidney

Explanation: ***Breast*** - **Breast cancer** is the most common cause of **skeletal metastasis** overall, especially in women, due to its high incidence and propensity to spread to bone. - Metastases often present as **osteolytic lesions**, sometimes mixed with osteoblastic features. *Prostate* - **Prostate cancer** is the most common cause of skeletal metastasis in **men**, frequently leading to **osteoblastic lesions**. - While very common in men, overall incidence is lower than breast cancer. *Thyroid* - **Thyroid cancer** can metastasize to bone, often presenting as **osteolytic lesions**, but it is less common than breast and prostate cancer. - Its overall contribution to skeletal metastases is significantly smaller. *Kidney* - **Renal cell carcinoma (RCC)** also metastasizes to bone, typically causing **osteolytic lesions** that can be highly vascular. - Similar to thyroid cancer, its incidence of bone metastasis is lower than that of breast and prostate cancer.

Question 278: CHOP is used in the treatment of?

A. NHL (Correct Answer)
B. Head and neck cancer
C. Ca Stomach
D. Ca Lung

Explanation: ***NHL*** - **CHOP** is the **gold standard first-line chemotherapy regimen** for most types of **Non-Hodgkin Lymphoma**, particularly **diffuse large B-cell lymphoma (DLBCL)** [1]. - The regimen combines **cyclophosphamide** (alkylating agent), **hydroxydaunorubicin/doxorubicin** (anthracycline), **oncovin/vincristine** (vinca alkaloid), and **prednisone** (corticosteroid) for optimal efficacy [1]. *Head and neck cancer* - Treatment primarily involves **platinum-based regimens** such as **cisplatin or carboplatin** combined with **5-fluorouracil** or **taxanes**. - **CHOP is not a standard chemotherapy regimen** for head and neck malignancies, which are solid tumors requiring different therapeutic approaches. *Ca Stomach* - Gastric cancer chemotherapy typically uses regimens like **FOLFOX** (fluorouracil, leucovorin, oxaliplatin) or **FLOT** (fluorouracil, leucovorin, oxaliplatin, docetaxel). - **CHOP is not used for gastric cancer** treatment, as it requires **platinum-based or fluoropyrimidine-based combinations**. *Ca Lung* - Lung cancer treatment involves **platinum-based doublets** such as **cisplatin/carboplatin** combined with **pemetrexed, paclitaxel, or gemcitabine** [2]. - **CHOP is not used for lung cancer** as it is specifically designed for **hematological malignancies**, not solid tumors like lung cancer.

Question 279: A patient developed paraplegia. On routine examination and X-ray it was found that there are osteoblastic lesions in his spine. What is the MOST probable diagnosis?

A. Breast Ca.
B. Carcinoma thyroid
C. Pancreatic Ca.
D. Ca. Prostate (Correct Answer)

Explanation: ***Ca. Prostate*** - **Prostate cancer** has a strong predilection for metastasizing to bone and typically produces **osteoblastic lesions** (new bone formation) in the spine [2]. - The presence of **paraplegia** suggests spinal cord compression due to these metastatic lesions [1]. *Breast Ca.* - While **breast cancer** frequently metastasizes to bone (commonly spine, pelvis, ribs, skull), it typically causes **osteolytic lesions** (bone destruction), though mixed lesions can occur. - Paraplegia can result from breast cancer metastases but the primary lesion type is usually osteolytic. *Carcinoma thyroid* - **Thyroid cancer** metastases to bone are rare and generally lead to **osteolytic lesions**, not osteoblastic. - Although it can cause spinal cord compression, the characteristic osteoblastic appearance is not typical for thyroid cancer. *Pancreatic Ca.* - **Pancreatic cancer** rarely metastasizes to bone, and when it does, the lesions are almost exclusively **osteolytic**. - Therefore, it is highly unlikely to be the cause of osteoblastic spinal lesions and subsequent paraplegia.

Question 280: The MOST important risk factor for pancreatic cancer among the following is:

A. Alcohol
B. Chronic pancreatitis
C. Cigarette smoking (Correct Answer)
D. Diabetes

Explanation: Cigarette smoking - Cigarette smoking is the leading modifiable risk factor for pancreatic cancer, accounting for approximately 25% of cases [1]. - The risk increases with the number of cigarettes smoked and the duration of smoking, with a higher risk for heavy smokers. *Alcohol* - While heavy alcohol consumption can lead to chronic pancreatitis, it is not considered a direct and independent risk factor for pancreatic cancer to the same extent as smoking. - The association is often indirect, mediated through its role in developing chronic pancreatitis. *Chronic pancreatitis* - Chronic pancreatitis significantly increases the risk of pancreatic cancer, but it is often a consequence of other underlying factors like alcohol abuse or genetic predispositions. - Although it's a strong risk factor, its prevalence as a primary cause is less than that of smoking directly. *Diabetes* - Diabetes, particularly new-onset diabetes in older adults, can be an early symptom of pancreatic cancer rather than solely a risk factor. - While it is associated with an increased risk, it is not as strong a modifiable risk factor as smoking.

Question 281: CA 19-9 is a marker for which of the following:

A. Breast carcinoma
B. Lung carcinoma
C. Ovarian carcinoma
D. Pancreatic carcinoma (Correct Answer)

Explanation: ***Pancreatic carcinoma*** - **CA 19-9** is a widely used **tumor marker** primarily associated with **pancreatic cancer** [1]. - Its levels can be elevated in other conditions such as **cholangitis** or **gallstones**, but its most significant clinical utility is in monitoring pancreatic cancer progression and response to treatment [2], [4]. *Breast carcinoma* - The primary tumor markers for breast carcinoma are **CA 15-3** and **CA 27-29**, which are used for monitoring recurrence and treatment response. - While CA 19-9 can be slightly elevated in some breast cancer cases, it is not considered a primary or reliable marker for this type of cancer. *Lung carcinoma* - Common tumor markers for lung cancer include **CEA** (carcinoembryonic antigen) for non-small cell lung cancer and **NSE** (neuron-specific enolase) for small cell lung cancer [3]. - CA 19-9 has very limited utility in the diagnosis or monitoring of lung carcinoma. *Ovarian carcinoma* - **CA-125** is the primary tumor marker used for ovarian carcinoma, particularly for monitoring disease progression and treatment response. - Although CA 19-9 can be elevated in some gynecological malignancies, it is not the marker of choice for ovarian cancer.

Question 282: Which of the following is a testicular tumor marker?

A. HCG (Correct Answer)
B. CA-125
C. a-1 antitrypsin
D. PSA (Prostate Specific Antigen)

Explanation: ***HCG*** - **Human Chorionic Gonadotropin (HCG)** is a key tumor marker for **germ cell tumors** of the testis, especially **choriocarcinoma** and some **seminomas** [1]. - Its levels correlate with tumor burden and are used for diagnosis, staging, and monitoring response to treatment. *CA-125* - **CA-125** is primarily used as a tumor marker for **ovarian cancer**, not testicular tumors. - Elevated levels can also be seen in other conditions affecting the peritoneum or pleura. *a-1 antitrypsin* - **Alpha-1 antitrypsin** is a protein involved in inhibiting proteases, and its deficiency is linked to **emphysema** and **liver disease**, not testicular cancer. - It is not considered a tumor marker for any specific cancer. *PSA (Prostate Specific Antigen)* - **PSA** is a well-known tumor marker for **prostate cancer**, primarily used for screening, diagnosis, and monitoring treatment efficacy in men [1], [2]. - It is produced by the prostate gland and is not associated with testicular tumors.

Question 283: 20 years old female came with complaint of a palpable painless mass in right breast. On examination, mass was mobile and hard in consistency. Ultrasound of right breast was performed . Most likely diagnosis is?

A. Breast cyst
B. Fibroadenoma (Correct Answer)
C. Phylloid's tumour
D. Ductal papilloma

Explanation: ***Fibroadenoma*** - A **painless**, **mobile**, and **hard mass** in a 20-year-old female is highly characteristic of a fibroadenoma, which is a common **benign breast tumor**. - Its **mobility** (often described as "breast mouse") is a key distinguishing feature from malignant masses. *Breast cyst* - While breast cysts can be **palpable** and **painless**, they are typically **soft or fluctuant** on palpation, not hard. - Cysts are fluid-filled sacs, and their mobile nature is less pronounced than the discrete, solid feel of a fibroadenoma. *Phyllodes tumor* - Phyllodes tumors can present as a **palpable mass**, but they usually grow **rapidly** and tend to be larger, often feeling lobulated. - While they can be benign, they have a potential for **malignant transformation** and are less common than fibroadenomas, especially in a 20-year-old. *Ductal papilloma* - Ductal papillomas are typically very small, located within milk ducts, and often present with **nipple discharge**, particularly bloody discharge, rather than a palpable mass. - They are rarely felt as a discrete, mobile, hard mass on routine physical examination.

Question 284: Which of the following most commonly produces osteoblastic secondaries?

A. Carcinoma urinary bladder
B. Carcinoma breast
C. Carcinoma lung
D. Carcinoma prostate (Correct Answer)

Explanation: ***Carcinoma prostate*** - **Prostate cancer** has a strong predilection for metastasizing to bone and typically results in **osteoblastic (bone-forming) lesions** [1]. - Tumors from the prostate release factors, such as **prostate-specific antigen (PSA)** and factors that stimulate osteoblasts, leading to new bone formation. *Carcinoma urinary bladder* - **Urinary bladder carcinoma** can metastasize to bone, but it usually produces **osteolytic (bone-destroying) lesions**, rather than osteoblastic ones. - Bone metastases from bladder cancer are less common than from prostate or breast cancer, and often indicate advanced disease. *Carcinoma breast* - **Breast cancer** is a very common cause of bone metastases, which can be **osteolytic, osteoblastic, or mixed** . - However, purely osteoblastic lesions are less common in breast cancer compared to prostate cancer, and osteolytic lesions are more frequently observed, especially in certain subtypes. *Carcinoma lung* - **Lung cancer** commonly metastasizes to bone, with **osteolytic lesions** being the predominant type. - While some subtypes can rarely cause osteoblastic changes, the vast majority of bone metastases from lung cancer involve bone destruction rather than bone formation.

Question 285: Cranial Irradiation" is given for:

A. Anaplastic cancer
B. Squamous cell cancer
C. Small cell cancer (Correct Answer)
D. Adenocarcinoma

Explanation: ***Small cell cancer*** - **Cranial irradiation** is often used as prophylactic treatment for **small cell lung cancer (SCLC)** due to its high propensity for early **brain metastasis**. [1] - This therapy aims to eradicate micrometastases in the brain, thereby improving disease-free survival and reducing neurological complications. *Anaplastic cancer* - While anaplastic cancers can metastasize, **prophylactic cranial irradiation (PCI)** is not a standard or primary treatment approach specifically for preventing brain metastases in all anaplastic cancers. - The treatment for anaplastic cancers is highly dependent on the primary tumor type and specific anaplastic features. *Squamous cell cancer* - **Squamous cell carcinoma** (SCC) rarely metastasize to the brain from extracranial primary sites compared to other cancer types like SCLC, and therefore, PCI is not routinely indicated for SCC. - Brain metastases from SCC, when they occur, are typically treated with **stereotactic radiosurgery** or whole brain radiation therapy as therapeutic, not prophylactic, measures. *Adenocarcinoma* - **Adenocarcinoma** from various primary sites (e.g., lung, breast, colon) can lead to brain metastases, but **prophylactic cranial irradiation (PCI)** is not a standard treatment for preventing these. [2] - Treatment for brain metastases from adenocarcinoma usually involves targeted therapies, surgery, or radiation therapy when metastases are already detected.

Question 286: A 73-year-old woman has noticed a 10-kg weight loss in the past 3 months. She is becoming increasingly icteric and has constant vague epigastric pain, nausea, and episodes of bloating and diarrhea. On physical examination, she is afebrile. There is mild tenderness to palpation in the upper abdomen, but bowel sounds are present. Her stool is negative for occult blood. Laboratory findings include a total serum bilirubin concentration of 11.6 mg/dL and a direct bilirubin level of 10.5 mg/dL. Which of the following conditions involving the pancreas is most likely to be present?

A. Cystic fibrosis
B. Islet cell adenoma
C. Chronic pancreatitis
D. Adenocarcinoma (Correct Answer)

Explanation: ***Adenocarcinoma*** - The patient's age (73 years), significant **weight loss**, progressive **jaundice** (elevated direct bilirubin), **epigastric pain**, nausea, bloating, and diarrhea are all classic signs of **pancreatic adenocarcinoma**, particularly when it obstructs the bile duct [1]. - The high **direct bilirubin** indicates an **obstructive pattern of jaundice**, common with tumors in the **head of the pancreas** compressing the common bile duct [1]. *Cystic fibrosis* - While it affects the pancreas, symptoms typically manifest in **childhood or early adulthood** with recurrent pulmonary infections and malabsorption [2]. - It would not typically cause acute, obstructive jaundice in a 73-year-old with these specific symptoms. *Islet cell adenoma* - These tumors (e.g., insulinoma, gastrinoma) are functional and typically present with symptoms related to **hormone overproduction**, such as hypoglycemia or peptic ulcers. - They are less likely to cause obstructive jaundice or significant weight loss unless they grow very large. *Chronic pancreatitis* - This condition is characterized by recurrent episodes of **abdominal pain**, pancreatic insufficiency, and often calcifications on imaging [3]. - While it can lead to malabsorption and weight loss, the rapid onset of severe obstructive jaundice and significant weight loss in a 3-month period without a history of recurrent pancreatitis makes adenocarcinoma more likely [3].

Question 287: Okuda staging contains all except

A. AFP (Correct Answer)
B. Tumor size
C. Ascites
D. Bilirubin

Explanation: ***AFP*** - The **Okuda staging system** for hepatocellular carcinoma (HCC) uses parameters related to liver function and tumor burden, but it does **not include AFP levels**. [1] - AFP is a common **tumor marker** for HCC but is not part of the specific criteria for Okuda staging. *Tumor size* - **Tumor size greater than 50%** of the liver parenchyma is one of the four parameters used in the Okuda staging system. - This criterion is crucial for assessing the **extent of the disease**, differentiating between early and advanced cases. *Ascites* - The presence of **ascites** (related to fluid retention) is another key parameter in the Okuda staging system. - Ascites indicates **decompensated liver function**, implying a more advanced stage of disease. *Bilirubin* - **Bilirubin levels higher than 3 mg/dL** are included in the Okuda staging system. - Elevated bilirubin reflects **severe liver dysfunction**, indicating reduced hepatic synthetic capacity and usually a poorer prognosis.

Question 288: Bilateral carcinoma breast is common in which of the following types of breast cancer?

A. Scirrhous
B. Inflammatory
C. Lobular (Correct Answer)
D. Colloid

Explanation: ***Lobular*** - **Invasive lobular carcinoma (ILC)** accounts for 5-15% of all invasive breast cancers and is characterized by its common presentation as bilateral disease. - The cells in lobular carcinoma often infiltrate in a single-file pattern, which can make it more challenging to detect on imaging and contributes to its higher incidence of bilaterality and multifocality. *Scirrhous* - This term refers to the **desmoplastic stromal reaction** common in many invasive ductal carcinomas, causing a firm, gritty feel. - While it's a common histological feature, it does not specifically indicate a higher risk of bilateral involvement. *Inflammatory* - **Inflammatory breast cancer (IBC)** is an aggressive and rare form of breast cancer characterized by rapid onset of edema, erythema, and warmth without a palpable mass. - It does not have a higher predilection for bilateral presentation compared to lobular carcinoma. *Colloid* - **Colloid (mucinous) carcinoma** is a rare subtype of invasive ductal carcinoma characterized by tumor cells floating in pools of extracellular mucin. - It tends to have a more favorable prognosis but is not known for a significantly increased risk of bilaterality.

Question 289: What is the most common cause of a single vertebral collapse?

A. Metastasis (Correct Answer)
B. Trauma
C. Tuberculosis
D. All of the options

Explanation: Metastasis - Metastatic disease is the leading cause of a single vertebral collapse, especially in older adults, due to the preferential vascularity of the spine [1]. - The vertebral body is a common site for secondary spread of cancers, such as those originating from the breast, prostate, lung, and kidney [3]. Trauma - While trauma can cause vertebral collapse, it typically results from significant force and may involve multiple contiguous vertebrae or present with other signs of injury [1]. - Traumatic vertebral fractures are more common in younger individuals or in severe accidents, whereas metastasis is more prevalent in a single vertebral collapse in the absence of significant trauma. Tuberculosis - Pott's disease (tuberculous spondylitis) can cause vertebral collapse, but it often involves multiple adjacent vertebrae and disc spaces [2]. - It usually presents with constitutional symptoms like fever, night sweats, and weight loss, which are not implied by "single vertebral collapse" alone. All of the options - While all listed conditions can cause vertebral collapse, metastasis is statistically the most frequent cause for a single vertebral collapse, making this option incorrect. - This choice fails to identify the most common primary etiology and is thus not the best answer.

Question 290: International prognostic index for lymphomas includes the following prognostic factors, EXCEPT:

A. LDH
B. Number of extralymphatic sites involved
C. Hemoglobin and albumin (Correct Answer)
D. Stage of disease

Explanation: ***Hemoglobin and albumin*** - While hemoglobin and albumin can be indicators of overall health and nutritional status, they are **not part of the standard International Prognostic Index (IPI)** for lymphomas. - The IPI specifically focuses on factors directly related to tumor burden and patient vitality, not general systemic markers like these. *LDH* - **Lactate dehydrogenase (LDH)** is a crucial component of the IPI, reflecting tumor burden and aggressiveness [1]. - Elevated LDH levels indicate a higher risk and are associated with a poorer prognosis [1]. *Number of extralymphatic sites involved* - The **number of extralymphatic sites involved** is a key prognostic factor in the IPI. - Involvement of more than one extralymphatic site indicates more widespread disease and a worse prognosis. *Stage of disease* - The **stage of disease**, as defined by the Ann Arbor staging system, is an essential element of the IPI [1]. - Advanced stages (III or IV) are associated with a poorer prognosis compared to early stages [1].

Question 291: Most common cancer worldwide among the following -

A. Lung (Correct Answer)
B. Liver
C. Kidney
D. Prostate

Explanation: ***Lung*** - **Lung cancer** is the most common cancer worldwide, based on incidence and mortality rates [1]. - It is strongly associated with **smoking** and environmental factors [1], [2]. *Liver* - **Liver cancer** is a significant global health problem, but it ranks below lung cancer in overall incidence [1]. - Risk factors include **hepatitis B and C infections** and **alcohol abuse** [1]. *Kidney* - **Kidney cancer**, while relatively common, has a lower incidence rate compared to lung cancer [1]. - Its incidence is often higher in developed countries and is linked to **obesity and smoking** [1]. *Prostate* - **Prostate cancer** is the most common cancer among men in many Western countries, but its worldwide incidence is lower than that of lung cancer. - It is primarily seen in **older men** and is influenced by genetic and hormonal factors.

Question 292: Mucositis heals after ___ months of radiotherapy:

A. 6 Months
B. 5 Months
C. 3 Months
D. 2 Months (Correct Answer)

Explanation: ***2 Months*** - **Oral mucositis** typically resolves within **2-4 weeks** after the cessation of radiotherapy. The question asks about healing *after* radiotherapy, implying a timeframe of recovery following the treatment completion. Therefore, 2 months is a reasonable timeframe for complete resolution, especially for severe cases. - While acute mucositis can appear during treatment, the healing phase usually begins post-treatment, with most symptoms subsiding completely within a couple of months. *6 Months* - This is an excessively long duration for the healing of typical mucositis. Most cases resolve much sooner unless there are severe complications or chronic issues such as fibrosis. - Persistent symptoms beyond 2-3 months would suggest a chronic problem or a different underlying cause rather than typical mucositis healing. *5 Months* - Similar to 6 months, 5 months is a prolonged period. While some very severe cases might have residual effects, complete healing of mucositis usually occurs much earlier. - This timeframe might be associated with long-term complications or secondary infections, not the standard healing process of mucositis itself. *3 Months* - While closer to the typical resolution time than 5 or 6 months, 3 months is still longer than the average for complete healing of mucositis. - Most patients experience significant improvement and resolution of acute symptoms well before the 3-month mark after radiotherapy completion.

Question 293: A 88 year-old woman from Mexico is admitted to the hospital following a bout of severe vomiting and generalized weakness. Initial laboratory values reveal elevated Ca2+ levels. The referring physician tells you that she has breast cancer and her bone scan indicates metastasis to bone. The most likely cause of hypercalcemia is:

A. Increased PTHrP production (Correct Answer)
B. Decreased responsiveness to calcitonin
C. Increased responsiveness of the PTH receptor 1
D. Increased PTH production
E. Increased PTHrP secretion

Explanation: ***Increased PTHrP production*** - **Breast cancer** with bone metastases commonly leads to **humoral hypercalcemia of malignancy (HHM)**, which is typically mediated by the production of **parathyroid hormone-related protein (PTHrP)** by tumor cells. - This PTHrP mimics the action of PTH on bone and kidney, causing **increased bone resorption** and **renal calcium reabsorption**, leading to elevated serum calcium [2]. *Decreased responsiveness to calcitonin* - While calcitonin normally lowers calcium levels, a decreased responsiveness to it is not the primary mechanism behind cancer-associated hypercalcemia. - Tumors primarily cause hypercalcemia through increased bone resorption, not by directly inhibiting calcitonin's effects to a clinically significant degree. *Increased responsiveness of the PTH receptor 1* - Although PTHrP acts on the **PTH receptor 1**, the issue is not an increased responsiveness of the receptor itself, but rather the **overproduction of its ligand (PTHrP)** by the tumor. - The receptor's intrinsic responsiveness is typically normal; it's the external stimulus from PTHrP that drives the hypercalcemia. *Increased PTH production* - This scenario describes **primary hyperparathyroidism**, which is typically caused by a parathyroid adenoma or hyperplasia [1]. - While PTH causes hypercalcemia, in the context of advanced breast cancer with bone metastasis, the hypercalcemia is almost always due to malignancy itself, not primary parathyroid dysfunction [3]. *Increased PTHrP secretion* - This option is essentially a rephrasing of the correct answer but in a less precise format. - The term "production" is more appropriate when referring to the synthesis of a protein by tumor cells.

Question 294: Cardiotoxicity caused by radiotherapy & chemotherapy is best detected by

A. ECHO (Correct Answer)
B. Endomyocardial Biopsy
C. ECG
D. Radionuclide Scan

Explanation: ***ECHO*** - **Echocardiography (ECHO)** is the primary and most widely used non-invasive method for detecting cardiotoxicity due to its ability to assess **left ventricular ejection fraction (LVEF)**, a key indicator of cardiac function, and structural changes. - It is crucial for **baseline assessment**, monitoring during treatment, and follow-up, identifying both systolic and diastolic dysfunction effectively. *Endomyocardial Biopsy* - While **endomyocardial biopsy** is considered the gold standard for definitive diagnosis of some cardiomyopathies (e.g., myocarditis), it is **invasive** and carries risks such as perforation, tamponade, and arrhythmias. - It is usually reserved for cases where other non-invasive tests are inconclusive and there's a strong clinical suspicion of severe cardiac disease, or for research, not routine monitoring of cardiotoxicity. *ECG* - An **ECG** can detect arrhythmias and ischemic changes but is **not sensitive or specific** enough to reliably detect early or subtle changes in cardiac function characteristic of cardiotoxicity. - It may show changes secondary to heart failure, but it does not directly measure ejection fraction or assess overall cardiac mechanical function. *Radionuclide Scan* - **Radionuclide scans**, specifically **MUGA (Multigated Acquisition)** scans, can accurately measure **LVEF** and are an alternative to ECHO, particularly when ECHO images are suboptimal [1]. - However, they involve **radiation exposure**, making them less ideal for frequent monitoring compared to echocardiography, especially in cancer patients who are already exposed to radiation.

Question 295: Chronic radiation proctitis is associated with the treatment of all malignancies, EXCEPT:

A. Carcinoma cervix
B. Carcinoma small bowel (Correct Answer)
C. Carcinoma prostate
D. Carcinoma testes

Explanation: Chronic radiation proctitis is associated with the treatment of all malignancies, EXCEPT: ***Carcinoma small bowel*** - **Radiation therapy** is rarely used as a primary treatment for **small bowel carcinoma**, as surgical resection is the main modality. - Therefore, the small bowel is typically not exposed to direct radiation in a manner that would cause proctitis. *Carcinoma cervix* - **Pelvic radiation** is a common treatment for **cervical carcinoma**, which often involves the rectum within the radiation field. - This proximity makes chronic radiation proctitis a known and relatively frequent complication. *Carcinoma prostate* - **External beam radiation therapy** is a standard treatment option for **prostate cancer**, directly targeting the prostate gland which is anatomically close to the rectum. - This close proximity frequently leads to chronic radiation-induced damage to the rectal tissue, resulting in proctitis. *Carcinoma testes* - While **testicular cancer** itself is not directly adjacent to the rectum, certain stages of testicular cancer are treated with **retroperitoneal lymph node irradiation** or whole-pelvis radiation. - This can expose portions of the rectum to radiation, leading to chronic radiation proctitis as a potential side effect.

Question 296: Which of the following conditions can produce hemothorax?

A. Congestive heart failure
B. malignancy (Correct Answer)
C. Myxoma
D. Rheumatoid arthritis

Explanation: ***Malignancy*** - **Malignant pleural effusions** can be hemorrhagic due to tumor invasion of blood vessels and increased vascular fragility [1]. - Tumors frequently metastasize to the pleura, often leading to **hemothorax** due to friable microvasculature [1]. *Congestive heart failure* - Typically causes a **transudative pleural effusion** due to increased hydrostatic pressure, which is usually serous, not bloody [1]. - While fluid overload occurs, it does not directly lead to **blood accumulation** in the pleural space. *Myxoma* - A **benign cardiac tumor** that can embolize or cause constitutional symptoms, but it does not directly cause hemothorax. - Pleural effusions associated with myxomas are generally serous and related to **cardiac dysfunction**, not hemorrhage. *Rheumatoid arthritis* - Can cause **pleural effusions** (rheumatoid pleurisy), which are typically exudative and lymphocytosis-predominant [1]. - These effusions are rarely hemorrhagic and generally do not lead to **gross blood** in the pleural space.

Question 297: The most chemoresistant tumor amongst the following:

A. Osteosarcoma
B. Clear cell sarcoma
C. Undifferentiated pleomorphic sarcoma (Correct Answer)
D. Synovial sarcoma

Explanation: ***Undifferentiated pleomorphic sarcoma*** - **Undifferentiated pleomorphic sarcoma (UPS)** is known for its aggressive nature and inherent resistance to conventional chemotherapy. - Its **heterogeneous genetic profile** and lack of specific therapeutic targets contribute to its poor response to systemic treatments. *Osteosarcoma* - While osteosarcoma is a highly aggressive bone tumor, it is generally considered **chemosensitive**, particularly to agents like **methotrexate, doxorubicin, and cisplatin**. - **Neoadjuvant chemotherapy** is a standard part of treatment, often leading to significant tumor necrosis and improved outcomes. *Clear cell sarcoma* - **Clear cell sarcoma** is a rare soft tissue sarcoma with a distinct genetic translocation, t(12;22), involving the **EWSR1 gene**. - Although it can be challenging to treat, it is not consistently ranked as the most chemoresistant among sarcomas; specific targeted therapies are being investigated. *Synovial sarcoma* - **Synovial sarcoma** is often sensitive to chemotherapy, particularly regimens containing **ifosfamide and doxorubicin**. - Its response to chemotherapy can be variable, but it is generally *more chemosensitive* than undifferentiated pleomorphic sarcoma.

Question 298: Which of the following tumors is cured by radiation?

A. Rhabdomyosarcoma
B. Renal cell cancer
C. Chloroma
D. Seminoma (Correct Answer)

Explanation: ***Seminoma*** - **Seminoma** is a highly radiosensitive tumor, making radiation therapy a primary curative modality, especially for localized disease [1]. - Due to its exquisite sensitivity, even relatively low doses of radiation can achieve **high cure rates** [1]. *Rhabdomyosarcoma* - While radiation therapy is often part of the treatment for **rhabdomyosarcoma**, it is typically used in conjunction with **chemotherapy and surgery** and is not curative on its own. - Its cure usually requires a **multimodal approach** due to its aggressive nature and potential for metastasis. *Renal cell cancer* - **Renal cell carcinoma** is generally considered **radioresistant**, meaning radiation therapy is not effective as a primary curative treatment. - Surgery (nephrectomy) is the **primary curative modality** for localized renal cell cancer. *Chloroma* - A **chloroma**, also known as granulocytic sarcoma, is a solid tumor of myeloid cells that often occurs in patients with acute myeloid leukemia. - Treatment focuses on systemic chemotherapy for the underlying leukemia, and while radiation can be used for local control, it is **not curative** for the underlying disease.

Question 299: Which of the following tumors is radio-resistant? a) Melanoma b) Hodgkin's Disease (HD) c) Seminoma d) Ewing's Sarcoma e) Chondrosarcoma

A. Hodgkin's Disease (HD)
B. Chondrosarcoma (Correct Answer)
C. Ewing's sarcoma
D. Seminoma
E. Melanoma

Explanation: ***Chondrosarcoma*** - **Chondrosarcomas** are notoriously **radio-resistant** due to their low metabolic activity and the presence of a cartilaginous matrix that impairs oxygen delivery and DNA damage by radiation. - Due to their radio-resistance, **surgical resection** is the primary treatment for chondrosarcomas. *Hodgkin's Disease (HD)* - **Hodgkin's Disease** is known to be **highly radio-sensitive**, and radiation therapy is a cornerstone of its treatment, often used in conjunction with chemotherapy. - The excellent response to radiation is one of the reasons for the high cure rates associated with early-stage Hodgkin's lymphoma. *Ewing's sarcoma* - **Ewing's sarcoma** is a **highly radio-sensitive** tumor, and radiation therapy plays a crucial role in its local control, often used after or with chemotherapy. - It is frequently treated with a combination of chemotherapy, surgery, and radiation to achieve optimal outcomes. *Seminoma* - **Seminomas** are among the most **radio-sensitive** solid tumors, making radiation therapy a very effective treatment modality, particularly for localized disease. - Even at low doses, radiation can induce a significant response and achieve high cure rates in seminoma. *Melanoma* - While traditionally considered radio-resistant, **melanoma** can sometimes respond to high-dose or fractionated radiation therapy, particularly in palliative settings or for specific subtypes. - However, compared to the other options, its general sensitivity to conventional radiation doses is lower, and immunotherapy and targeted therapy are often preferred.

Question 300: Radioresistant tumour is

A. Osteosarcoma
B. Multiple myeloma
C. Glioblastoma
D. Malignant melanoma (Correct Answer)
E. Chondrosarcoma
F. Ewing's sarcoma
. Wilms tumour
. Seminoma
. Lymphoma

Explanation: ***Malignant melanoma*** - Malignant melanoma cells possess various mechanisms that contribute to **radioresistance**, including efficient DNA repair pathways and alterations in cell cycle checkpoints. - This characteristic often necessitates alternative or combination therapies, as **radiation monotherapy** is rarely effective. *Osteosarcoma* - While generally considered radioresistant, some osteosarcomas show a **partial response to radiation**, especially in the neoadjuvant setting or for palliative care. - Its response can vary, and it is not universally as resistant as melanoma. *Multiple myeloma* - Multiple myeloma is generally considered **radiosensitive**, and radiation therapy is often used for localized bone lesions, pain control, or spinal cord compression [1]. - It responds well to relatively **low doses of radiation**, indicating a different profile from radioresistant tumors. *Glioblastoma* - Glioblastoma is indeed a difficult-to-treat tumor, but it is typically managed with a combination of **surgery, radiation, and chemotherapy**. - While complete eradication with radiation alone is rare, it is an essential component of upfront treatment and patients often show a **measurable response**. *Chondrosarcoma* - Chondrosarcomas are generally considered **radioresistant** due to their slow growth rate and relatively avascular nature, making them less susceptible to radiation-induced damage. - However, proton beam therapy or C-ion radiotherapy may offer some benefit, and it's often primarily treated surgically. *Ewing's sarcoma* - Ewing's sarcoma is known to be **very radiosensitive**, and radiation therapy is a crucial component of its treatment, often combined with chemotherapy. - It frequently exhibits a **good response to radiation**, distinct from radioresistant tumors like melanoma. *Wilms tumour* - Wilms tumor is highly **radiosensitive**, and radiation therapy is a standard treatment modality, especially for higher-stage disease or unfavorable histology, often leading to excellent outcomes. - Its sensitivity to radiation is a key factor in its successful multimodal treatment. *Seminoma* - Seminoma is one of the most **radiosensitive** solid tumors, and radiation therapy has been a cornerstone of treatment for localized disease and metastatic sites. - It responds very well to relatively **low doses of radiation**, making it distinctly different from radioresistant tumors. *Lymphoma* - Lymphomas, particularly Hodgkin lymphoma and some non-Hodgkin lymphomas, are generally **radiosensitive**, with radiation therapy [1] playing a significant role in localized disease or as part of combination regimens. - They often show a **good response to radiation**, leading to disease control or cure.

Question 301: A 45-year-old woman with metastatic melanoma on pembrolizumab develops symmetrical vitiligo-like depigmentation. Most appropriate management is:

A. Discontinue pembrolizumab
B. Continue therapy with monitoring (Correct Answer)
C. Start topical tacrolimus
D. Add systemic steroids

Explanation: ***Continue therapy with monitoring*** - **Vitiligo-like depigmentation** on pembrolizumab (a PD-1 inhibitor) is a common, often benign, and sometimes even a **favorable prognostic sign** associated with treatment response in melanoma. - As long as the depigmentation is not causing significant distress or rapid progression, continuing therapy with close monitoring is the appropriate initial approach. *Discontinue pembrolizumab* - Discontinuing pembrolizumab would be premature given that **vitiligo** in this context is often a mild immune-related adverse event (irAE) and may correlate with a better treatment outcome. - Early cessation of an effective immunotherapy without compelling reason could negatively impact the patient's cancer control. *Start topical tacrolimus* - **Topical tacrolimus** can be used for localized vitiligo, but its primary role is to **promote repigmentation** or halt progression. - In the context of immunotherapy-induced vitiligo, the depigmentation is often widespread and may be an indicator of a systemic anti-tumor immune response, making repigmentation a secondary concern compared to oncology treatment. *Add systemic steroids* - **Systemic steroids** are typically reserved for more severe or symptomatic immune-related adverse events (irAEs), such as severe colitis, pneumonitis, or hepatitis. - Mild or moderate vitiligo is generally not an indication for systemic immunosuppression, which could also potentially **attenuate the anti-tumor effects** of pembrolizumab.

Question 302: A 40-year-old man has hemoptysis. CXR shows a coin lesion. Biopsy reveals nests of neuroendocrine cells with salt-and-pepper chromatin. What is the most likely diagnosis?

A. Squamous cell carcinoma
B. Carcinoid tumor (Correct Answer)
C. Adenocarcinoma
D. Small cell carcinoma

Explanation: ***Carcinoid tumor*** - **Nests of neuroendocrine cells** with **salt-and-pepper chromatin** are classic histological features of a carcinoid tumor. - While presented as a **coin lesion** (solitary pulmonary nodule) [2], this type of neuroendocrine tumor typically has a more indolent course compared to other lung malignancies. *Squamous cell carcinoma* - Characterized by **keratinization** and **intercellular bridges**, not neuroendocrine differentiation. - Often presents as a **central mass** with cavitation and is strongly associated with smoking [1]. *Adenocarcinoma* - Grows in glandular patterns and produces **mucin**, usually found in the periphery of the lung. - Lacks the neuroendocrine features of salt-and-pepper chromatin or rosette formation. *Small cell carcinoma* - Consists of small, undifferentiated cells with **scant cytoplasm** and **absent nucleoli**, known for rapid growth. - Although also neuroendocrine, it presents with a much more aggressive clinical course and characteristic **oat cell morphology**, distinct from the well-differentiated nests seen in carcinoid.

Question 303: A 60-year-old male with a long history of smoking presents with weight loss and hemoptysis. Chest X-ray shows a hilar mass. Biopsy reveals small blue cells with scant cytoplasm. What is the most likely diagnosis?

A. Small cell lung cancer (Correct Answer)
B. Squamous cell carcinoma
C. Adenocarcinoma
D. Mesothelioma

Explanation: ***Small cell lung cancer*** - The patient's presentation with a **hilar mass**, rapid weight loss, and **hemoptysis** in a heavy smoker are classic symptoms [1]. - **Biopsy findings** of "small blue cells with scant cytoplasm" are highly characteristic of **small cell lung carcinoma**, which is known for its neuroendocrine features and aggressive nature [1]. *Squamous cell carcinoma* - This typically presents as a **hilar mass** in smokers and can cause hemoptysis, but its histology would show **keratinization** or **intercellular bridges**, not small blue cells [1]. - It arises from the **bronchial epithelium**, and frequently causes central airway obstruction [1]. *Adenocarcinoma* - This type of lung cancer is often found **peripherally** and is not as strongly linked to smoking as small cell or squamous cell carcinoma [1]. - Histology would reveal glandular differentiation or **mucin production**, which is not consistent with the "small blue cells" description. *Mesothelioma* - Primarily associated with **asbestos exposure** and typically presents as a **pleural effusion** or diffuse pleural thickening, not a hilar mass. - Histologically, it is characterized by **spindle cells** (sarcomatoid type), epithelial cells (epithelioid type), or a mixture (biphasic type), which are distinct from small blue cells.

Question 304: A 70-year-old smoker presents with dyspnea and weight loss. CXR shows a mass in the right lung. What is the next step?

A. Bronchoscopy
B. MRI
C. Sputum cytology
D. CT-guided biopsy (Correct Answer)

Explanation: ***CT-guided biopsy*** - A definitive diagnosis of a suspected lung mass, especially in a patient with a history of smoking and weight loss, requires **histological confirmation**. [1] - **CT-guided biopsy** is often the most direct and least invasive method to obtain tissue from a peripheral lung mass for pathological examination. [2] *Bronchoscopy* - While useful for diagnosing central airway lesions, **bronchoscopy** may not reach a peripheral lung mass, making tissue sampling difficult or impossible. [3] - It could be considered if the mass were closer to the main bronchi or if the patient had symptoms suggesting endobronchial involvement. [4] *MRI* - **MRI** is not the primary imaging modality for initial evaluation of a lung mass; **CT scans** provide better anatomical detail of the lungs and chest wall. [2] - It might be used for staging purposes, especially for evaluating brain metastases or chest wall invasion, but not for initial diagnosis of the lung mass itself. *Sputum cytology* - **Sputum cytology** has low sensitivity for diagnosing lung cancer, especially for peripheral lesions, as cancer cells may not be exfoliated into the sputum. - A negative result from sputum cytology does not rule out lung cancer, and a more invasive procedure would still be needed for diagnosis.

Question 305: Which one of the following is not true about hepatocellular carcinoma?

A. AFP is a marker
B. Metastasis occurs late (Correct Answer)
C. HBV is a risk factor
D. Common in cirrhosis

Explanation: Metastasis occurs late - This statement is **false** because **hepatocellular carcinoma (HCC)** is known to **metastasize early**, often disseminating through the **portal vein** to the lung, bone, and brain [1]. - Early metastasis is a significant factor contributing to the **poor prognosis** of HCC even when the primary tumor is relatively small. *AFP is a marker* - **Alpha-fetoprotein (AFP)** is a widely used **tumor marker** for HCC, particularly in surveillance and diagnosis [1]. - While elevated AFP levels can indicate HCC, they are **not always present** and can also be elevated in other conditions such as hepatitis or cirrhosis. *HBV is a risk factor* - **Hepatitis B virus (HBV)** infection is a **major global risk factor** for developing HCC, especially in endemic regions. - Chronic HBV infection leads to **chronic inflammation** and **fibrosis** in the liver, significantly increasing the risk of malignant transformation. *Common in cirrhosis* - HCC is overwhelmingly common in patients with **cirrhosis**, regardless of its etiology (e.g., chronic hepatitis, alcohol abuse, non-alcoholic fatty liver disease) [1]. - The **regenerative nodules** and chronic inflammation associated with cirrhosis create a fertile ground for the development of **dysplastic foci** and ultimately HCC [1].

Question 306: All of the following are associated with increased risk of gastric adenocarcinoma except which of the following?

A. Smoking
B. Celiac disease (Correct Answer)
C. H. pylori
D. Dietary nitrosamines

Explanation: ***Celiac disease*** - While celiac disease increases the risk of certain cancers like **T-cell lymphoma** (e.g., **enteropathy-associated T-cell lymphoma, EATL**) and **small intestinal adenocarcinoma**, it is not a significant risk factor for **gastric adenocarcinoma**. - The primary site of neoplastic transformation in celiac disease is the **small intestine**, not the stomach. *Smoking* - **Smoking** is a well-established risk factor for various cancers, including gastric adenocarcinoma, with a dose-dependent relationship. - It contributes to **chronic inflammation** and **mucosal damage** in the stomach, promoting oncogenesis. *H. pylori* - **_Helicobacter pylori_ infection** is a major causative agent for **gastric adenocarcinoma**, particularly the **intestinal type** [1]. - It induces chronic gastritis, leading to atrophy, intestinal metaplasia, and dysplasia, which are precursors to cancer [1], [2]. *Dietary nitrosamines* - **Dietary nitrosamines**, commonly found in highly processed and preserved foods (smoked meats, pickled vegetables), are potent **carcinogens** [1]. - They are directly linked to an increased risk of **gastric adenocarcinoma**, especially in populations with high consumption of such foods [1].

Question 307: A 55-year-old woman with non-small cell lung cancer is found to have an ALK gene rearrangement. How should this finding influence her treatment?

A. Refer for surgical resection, if appropriate
B. Switch to crizotinib, a targeted ALK inhibitor (Correct Answer)
C. Consider radiation therapy, if indicated
D. Continue standard chemotherapy, if appropriate for the patient's condition

Explanation: ***Switch to crizotinib, a targeted ALK inhibitor*** - The presence of an **ALK gene rearrangement** in **non-small cell lung cancer (NSCLC)** is a strong indicator for **targeted therapy** with an **ALK inhibitor** like crizotinib. - These drugs specifically block the aberrant activity of the ALK fusion protein, leading to **superior response rates** and **progression-free survival** compared to standard chemotherapy in ALK-positive patients. *Refer for surgical resection, if appropriate* - **Surgical resection** is primarily considered for **early-stage NSCLC** without evidence of metastatic disease [1]. - While surgery can be curative, the presence of specific gene rearrangements like ALK typically prompts consideration of **neoadjuvant or adjuvant targeted therapy** or systemic therapy for advanced disease. *Consider radiation therapy, if indicated* - **Radiation therapy** for NSCLC is usually employed for **local control**, either in curative intent for early stages or for **palliative management** of symptoms in advanced disease [2]. - It does not directly address the underlying **genetic driver** (ALK rearrangement) and would not be the primary systemic treatment. *Continue standard chemotherapy, if appropriate for the patient's condition* - While **standard chemotherapy** is a treatment option for NSCLC, the identification of a **driver mutation** like an ALK rearrangement makes **targeted therapy** a significantly more effective and preferred first-line approach. - Continuing chemotherapy without considering targeted therapy would be **suboptimal** for a patient with an ALK rearrangement due to the availability of more effective treatments.

Question 308: Which of the following is not a risk factor for cholangiocarcinoma?

A. Opisthorchis viverrini
B. Hepatitis B (Correct Answer)
C. PCS
D. Caroli's disease

Explanation: ***Hepatitis B*** - While **Hepatitis B** is a major risk factor for **hepatocellular carcinoma (HCC)**, its direct association with cholangiocarcinoma is less clear and not as established as other risk factors. - The primary connection between Hepatitis B and liver cancer is through chronic inflammation leading to **cirrhosis** and subsequent HCC. *Opisthorchis viverrini* - This **liver fluke** is a well-established and significant risk factor for cholangiocarcinoma, particularly in Southeast Asia, by inducing chronic inflammation and epithelial damage in bile ducts. - The parasite's presence leads to **biliary stasis**, chronic irritation, and genetic alterations that promote malignant transformation. *PCS* - **Primary Sclerosing Cholangitis (PSC)** is a strong risk factor for cholangiocarcinoma, with a lifetime risk of approximately 5-10% [1]. - The chronic inflammation and fibrosis of the bile ducts in PSC create an environment highly conducive to malignant transformation [1]. *Caroli's disease* - **Caroli's disease**, a congenital disorder characterized by multifocal segmental dilation of intrahepatic bile ducts, is strongly associated with an increased risk of cholangiocarcinoma [1]. - The **biliary stasis** and recurrent cholangitis caused by the dilations promote chronic inflammation, a key driver of malignancy [1].

Question 309: Which of the following conditions is the most common cause of unintentional weight loss in elderly patients?

A. Hyperthyroidism
B. Diabetes mellitus
C. Malignancy (Correct Answer)
D. Chronic obstructive pulmonary disease

Explanation: ***Malignancy*** - **Malignancy** is the most common cause of unintentional weight loss in elderly patients, accounting for 20-30% of cases [1]. - Cancers often increase **metabolic demand** and produce cytokines that can cause **cachexia**, leading to significant weight loss [1]. *Hyperthyroidism* - While hyperthyroidism can cause **unintentional weight loss** due to an increased metabolic rate, it is less common than malignancy as a cause in the elderly population. - Other typical symptoms of hyperthyroidism, such as **tachycardia**, **tremors**, and **heat intolerance**, would usually be present. *Diabetes mellitus* - **Uncontrolled diabetes** (especially type 1 or severe type 2) can lead to weight loss due to **glucosuria** and fat/muscle breakdown. - However, it is not as frequent a cause of unintentional weight loss in the elderly as malignancy, and would often be accompanied by symptoms like **polyuria**, **polydipsia**, and **blurred vision**. *Chronic obstructive pulmonary disease* - Severe **COPD** can lead to weight loss due to increased **work of breathing**, **systemic inflammation**, and reduced oral intake. - While a significant cause of weight loss in some elderly patients, overall prevalence as the primary cause of unintentional weight loss is lower than malignancy.

Question 310: A 70-year-old smoker presents with hemoptysis, weight loss, and chest pain. Chest X-ray shows a mass in the right upper lobe. What is the most likely diagnosis?

A. Tuberculosis
B. Lung cancer (Correct Answer)
C. Bronchiectasis
D. Pneumonia

Explanation: ***Lung cancer*** - The patient's age, history of **smoking**, and symptoms of **hemoptysis**, **weight loss**, and **chest pain** are highly suggestive of lung cancer. - A **mass in the right upper lobe** on Chest X-ray further supports this diagnosis, as lung cancer often presents as a solitary pulmonary nodule or mass. *Tuberculosis* - While tuberculosis can cause **hemoptysis** and **weight loss**, it is often associated with a history of exposure, night sweats, and typically infiltrates or cavitations rather than a discrete mass in an elderly smoker without other risk factors for TB. - While it can present with a solitary pulmonary nodule, the high-risk smoking history and specific symptom complex point away from TB as the most likely diagnosis. *Bronchiectasis* - Bronchiectasis is characterized by permanent **dilation of the bronchi**, leading to chronic cough with copious sputum production and recurrent infections. - It does not typically present with a discrete lung mass or significant weight loss without underlying chronic infection. *Pneumonia* - Pneumonia usually presents with acute onset of fever, cough with productive sputum, and shortness of breath. - A lung mass is not a typical presentation of acute pneumonia; rather, it manifests as infiltrates or consolidation on chest imaging.

Question 311: A 60-year-old man with advanced prostate cancer presents with severe, constant back pain. X-ray reveals vertebral metastases. What is the most appropriate management?

A. Chemotherapy
B. Surgical decompression
C. Radiation therapy (Correct Answer)
D. NSAIDs

Explanation: ***Radiation therapy*** - **Radiation therapy** is highly effective for localized pain control in **vertebral metastases** and can prevent further spinal cord compression [1]. - It works by shrinking the tumor, thereby alleviating pain and restoring neurological function in many cases. *Chemotherapy* - While chemotherapy is a systemic treatment for prostate cancer, its **pain-relieving effects are often slower** and less immediate compared to radiation for localized bone pain. - It may be used in conjunction with radiation, but it is typically not the **most appropriate initial management** for severe, constant pain due to vertebral metastases. *Surgical decompression* - **Surgical decompression** is primarily considered for patients with **spinal cord compression** leading to neurological deficits or intractable pain unresponsive to radiation [1]. - The patient's presentation of severe, constant back pain due to vertebral metastases, without mentioned neurological compromise, makes **radiation therapy a more appropriate first-line treatment** in this context [1]. *NSAIDs* - **NSAIDs** might provide some mild pain relief, but they are **insufficient for severe pain** caused by progressive vertebral metastases. - They also carry risks like **gastrointestinal complications** and **renal impairment**, especially in elderly patients with advanced cancer.

Question 312: A 45-year-old female with a history of breast cancer presents with new-onset shortness of breath. A chest X-ray reveals a pleural effusion. What is the most appropriate next step in management?

A. Thoracentesis (Correct Answer)
B. Chest CT with contrast
C. Repeat chest X-ray in one week
D. Bronchoscopy

Explanation: ***Thoracentesis*** - **Thoracentesis** is the most appropriate next step to both diagnose the cause of the pleural effusion and provide symptomatic relief from shortness of breath. - Analysis of the pleural fluid can differentiate between **transudative** and **exudative** effusions and identify malignant cells, which is crucial in a patient with a history of breast cancer. *Chest CT with contrast* - While a chest CT might provide more detailed imaging of the lungs and pleura, it does not directly address the need for fluid analysis or symptom relief. - It would be a useful *subsequent step* if the thoracentesis is inconclusive or to look for underlying masses, but not the immediate priority for a new, symptomatic effusion. *Repeat chest X-ray in one week* - Re-imaging in a week would delay diagnosis and treatment for a potentially serious condition, especially in a patient with a history of malignancy presenting with new symptoms. - It doesn't offer any diagnostic information about the nature of the fluid or immediate symptom relief. *Bronchoscopy* - **Bronchoscopy** is primarily used for evaluating intraluminal airway pathology or diffuse lung disease, such as tumors or infections within the bronchi. - It is not the initial procedure of choice for investigating a pleural effusion unless there is suspicion of an endobronchial lesion causing post-obstructive pneumonia and effusion, which is not indicated here.

Question 313: Which pancreatic tumor is associated with elevated CA 19-9 levels and jaundice?

A. Pancreatic neuroendocrine tumor
B. Pancreatic adenocarcinoma (Correct Answer)
C. Intraductal papillary mucinous neoplasm
D. Solid pseudopapillary tumor

Explanation: ***Pancreatic adenocarcinoma*** [1] - **Elevated CA 19-9 levels** are commonly associated with pancreatic adenocarcinoma, making it a key marker in diagnosis. - Jaundice often occurs due to **biliary obstruction** caused by the tumor, particularly when located in the head of the pancreas [1]. *Intraductal papillary mucinous neoplasm* [1] - While it can cause obstructive symptoms, it typically does not lead to **significantly elevated CA 19-9 levels** like pancreatic adenocarcinoma. - This tumor is often characterized by **mucin secretion** and can present with less severe jaundice. *Pancreatic neuroendocrine tumor* - These tumors usually do not elevate **CA 19-9** but instead can elevate other markers like **chromogranin A**. - Jaundice is less commonly associated as they tend to have different clinical behaviors compared to adenocarcinomas. *Solid pseudopapillary tumor* - This type of tumor is **rare** and typically not associated with elevated **CA 19-9 levels** like pancreatic adenocarcinoma is. - It usually presents in a younger demographic and does not typically cause jaundice unless obstructive. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 897, 899-900.

Question 314: A patient with metastatic prostate cancer has been found to have osteoblastic bone metastases. Which treatment approach would provide the best control of his disease?

A. Localized radiation therapy to bone metastases
B. Bisphosphonate therapy to increase bone density
C. Androgen deprivation therapy (Correct Answer)
D. Chemotherapy with a platinum-based regimen

Explanation: ***Androgen deprivation therapy*** - Prostate cancer growth is primarily driven by **androgens**, making androgen deprivation therapy (ADT) the **first-line systemic treatment** for metastatic disease. - ADT aims to reduce androgen levels, thereby inhibiting the proliferation of prostate cancer cells, including those in **osteoblastic bone metastases** [1]. *Localized radiation therapy to bone metastases* - While **radiation therapy** can effectively manage localized pain from bone metastases, it does not address the underlying systemic progression of the cancer. - It is a **palliative measure** for symptomatic relief rather than a curative or comprehensive disease control strategy for widespread metastatic disease. *Bisphosphonate therapy to increase bone density* - **Bisphosphonates** are used to prevent skeletal-related events (SREs) like fractures and pain in patients with bone metastases, by inhibiting osteoclast activity and strengthening bone. - However, they do not treat the underlying cancer itself and are **not a primary treatment** for controlling disease progression. *Chemotherapy with a platinum-based regimen* - **Chemotherapy** is typically reserved for patients with more advanced prostate cancer that has become **castration-resistant** (i.e., no longer responds to ADT). - Platinum-based regimens are not typically the first choice for initial treatment of metastatic castration-sensitive prostate cancer, as ADT is more effective and less toxic in this setting.

Question 315: Management of acute lymphoblastic leukemia (ALL) in adults includes which of the following treatments?

A. High-dose chemotherapy (Correct Answer)
B. Supportive care only
C. Low-dose oral chemotherapy
D. Surgical removal of the lymph nodes

Explanation: ***High-dose chemotherapy*** - **Adult ALL** requires intensive treatment due to its aggressive nature and propensity for relapse. [1] - **High-dose chemotherapy**, often involving **multi-agent regimens** and potentially followed by **hematopoietic stem cell transplantation**, is the cornerstone of inducing remission and preventing recurrence. [1] *Supportive care only* - **Supportive care** is crucial for managing complications and side effects but is insufficient as a standalone treatment for ALL, which is a rapidly progressive and life-threatening cancer. [1] - Delaying definitive treatment with chemotherapy would lead to **rapid disease progression** and poor outcomes. *Low-dose oral chemotherapy* - **Low-dose oral chemotherapy** is typically used for less aggressive malignancies or as maintenance therapy in certain contexts but is inadequate for the initial treatment of **acute lymphoblastic leukemia (ALL)** in adults. [1] - ALL requires an **intensive regimen** to achieve and maintain remission due to the rapid proliferation of leukemic cells. *Surgical removal of the lymph nodes* - **Surgical removal of lymph nodes** is not a primary treatment for **leukemia**, which is a cancer of the blood and bone marrow, not a localized solid tumor. - While ALL can involve lymph nodes, the disease is **systemic** and requires systemic therapy, such as chemotherapy, to target malignant cells throughout the body.

Question 316: A 50-year-old woman with chronic hepatitis B presents with an abdominal mass, and serum alpha-fetoprotein is elevated. What is the most likely diagnosis?

A. Hepatocellular carcinoma (Correct Answer)
B. Cholangiocarcinoma
C. Hepatic adenoma
D. Metastatic colon cancer

Explanation: ***Hepatocellular carcinoma*** - The **elevated alpha-fetoprotein (AFP)** level [1] and history of **chronic hepatitis B** strongly indicate hepatocellular carcinoma, as these factors are closely associated with this type of liver cancer [1]. - It commonly presents as an **abdominal mass** [1] in patients with underlying liver disease, particularly in those with chronic hepatitis or cirrhosis. *Metastatic colon cancer* - Typically presents with **elevated tumor markers** like CEA, not AFP, making it less likely in this case. - It often involves multiple liver lesions rather than a singular **abdominal mass** [1] due to liver metastases. *Cholangiocarcinoma* - While associated with liver lesions, it usually leads to **elevated CA 19-9 levels** rather than AFP. - Patients often present with **jaundice and bile duct obstruction**, which are not noted in this scenario. *Hepatic adenoma* - Generally seen in younger individuals, often associated with **oral contraceptive use**, and tends not to elevate AFP significantly. - Usually asymptomatic or may present with abdominal pain, unlike the strong association with chronic liver disease seen in this case.

Question 317: A 60-year-old man with a history of smoking presents with a cough and weight loss. A chest X-ray shows a mass in the upper lobe of the right lung. Which metabolic change is most associated with his likely condition?

A. Increased anaerobic glycolysis (Correct Answer)
B. Decreased protein synthesis
C. Increased lipid oxidation
D. Decreased gluconeogenesis

Explanation: ***Increased anaerobic glycolysis*** - Many cancers, including lung cancer, exhibit the **Warburg effect**, characterized by a high rate of **glycolysis** even in the presence of oxygen [1]. - This allows cancer cells to rapidly produce ATP and metabolic intermediates for proliferation, often associated with a switch in pyruvate kinase isozymes to build biomass [1]. *Decreased protein synthesis* - While systemic illness like cancer can lead to muscle wasting (cachexia) due to increased protein breakdown, cancer cells themselves generally have **increased protein synthesis** to support rapid growth. - Decreased protein synthesis is not a primary metabolic hallmark directly associated with the *cancer cells* themselves. *Increased lipid oxidation* - While some cancer cells may utilize **lipid oxidation** as an energy source, it is not the most universally characteristic or significant metabolic alteration compared to the Warburg effect [1]. - Many cancer cells primarily rely on glucose for energy and biomass production. *Decreased gluconeogenesis* - **Decreased gluconeogenesis** is not directly associated with the metabolic changes within cancer cells themselves; rather, cancer cachexia can sometimes lead to altered systemic glucose metabolism [1]. - The liver is the primary site of gluconeogenesis, and its regulation is complex and not directly down-regulated by the presence of a lung mass.

Question 318: A 55-year-old man presents with fatigue and splenomegaly. His complete blood count reveals a marked increase in mature lymphocytes. What condition is consistent with these findings?

A. Acute myeloid leukemia
B. Chronic myeloid leukemia
C. Chronic lymphocytic leukemia (Correct Answer)
D. Acute lymphoblastic leukemia

Explanation: ***Chronic lymphocytic leukemia*** - Characterized by a marked increase in **mature lymphocytes** and often presents with **fatigue and splenomegaly** [1][2]. - Typically seen in older adults, with a **slow progression** and lymphocytic predominance in the blood and bone marrow [2]. *Acute myeloid leukemia* - Presents with **immature myeloid cells** and often involves severe **anemia**, thrombocytopenia, and neutropenia. - Symptoms frequently include **rapid onset of fatigue** and bleeding, not typically splenomegaly as a primary feature. *Acute lymphoblastic leukemia* - Characterized by **immature lymphoblasts** rather than mature lymphocytes, leading to more aggressive symptoms. - Often presents with **bone pain**, lymphadenopathy, and more severe cytopenias, different from the chronic features noted here. *Chronic myeloid leukemia* - Features an increase in **myeloid cells**, particularly **granulocytes**, and is commonly associated with the **Philadelphia chromosome**. - Splenomegaly is common [3][4], but it primarily involves a **myeloid lineage**, not mature lymphocytes as seen in this case. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 602. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 612-613. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 611-612. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 625-626.

Question 319: A patient with known breast cancer presents with shortness of breath. A chest CT reveals multiple nodules throughout both lungs. What is the most likely diagnosis?

A. Primary lung cancer
B. Pneumonia
C. Metastatic disease (Correct Answer)
D. Pulmonary embolism

Explanation: Metastatic disease - The presence of **multiple lung nodules** in a patient with a known history of **breast cancer** strongly suggests hematogenous spread to the lungs [1]. - Breast cancer frequently metastasizes to the lungs, and these **multiple, widespread nodules** are a classic presentation of such progression [1]. Patients with two or more pulmonary nodules can often be assumed to have metastases [2]. *Primary lung cancer* - While lung cancer can manifest as nodules, the presence of **multiple, scattered nodules in both lungs** in a patient with an existing primary cancer makes this less likely to be a *de novo* primary lung cancer. - Primary lung cancer typically presents as a **single mass** or a more localized process, although multifocal primary lung cancers can occur, they are less common than metastatic disease in this context [2]. *Pneumonia* - Pneumonia would typically present with **infiltrates or consolidation**, often associated with fever, cough with sputum, and elevated inflammatory markers. - **Multiple, discrete lung nodules** are not a typical presentation of pneumonia. *Pulmonary embolism* - Pulmonary embolism causes **filling defects** in the pulmonary arteries and can lead to infarcts, which might appear as wedge-shaped opacities, but usually not as **multiple, diffuse nodules** throughout both lungs. - Symptoms would typically include sudden onset of **pleuritic chest pain** and hypoxemia, which may or may not be present with shortness of breath.

Question 320: A 55-year-old man with a history of smoking presents with chronic cough and dyspnea. His chest X-ray reveals a mass. Which imaging study is the most appropriate next step for further evaluation?

A. Low-dose CT scan (Correct Answer)
B. Chest X-ray
C. Sputum cytology
D. MRI

Explanation: ***Low-dose CT scan*** - A **CT scan** provides much greater detail and **cross-sectional imaging** compared to a chest X-ray, allowing for better characterization of the mass, including its size, location, and potential involvement of surrounding structures [1]. - This detailed information is crucial for determining the next steps in diagnosis and staging, such as guiding biopsies or surgical planning for suspected lung cancer [1]. *Chest X-ray* - A chest X-ray has already been performed and revealed the mass, but it offers **limited resolution** and **three-dimensional information**, making it insufficient for detailed characterization or staging of a suspicious lesion [1]. - Further evaluation requires a more advanced imaging modality to better define the mass and assess for potential malignancy. *Sputum cytology* - **Sputum cytology** is a non-invasive test that can identify **malignant cells** in respiratory secretions, but its sensitivity is generally low, especially for peripheral lesions. - While it can be part of a diagnostic workup, it is not the most appropriate immediate next step for further evaluating a mass seen on imaging, which requires better anatomical definition. *MRI* - **MRI** is excellent for soft tissue contrast and can be used in some cases of lung cancer for **staging**, particularly for assessing **chest wall invasion** or **brain metastases**. - However, for initial evaluation of a pulmonary mass, its role is typically secondary to CT, as CT offers superior resolution for lung parenchyma and is faster and more cost-effective for primary characterization.

Question 321: Which marker is most commonly elevated in hepatocellular carcinoma?

A. CEA
B. CA 19-9
C. Alpha-fetoprotein (Correct Answer)
D. PSA

Explanation: ***Alpha-fetoprotein*** - ***Alpha-fetoprotein (AFP)*** is the most common tumor marker elevated in **hepatocellular carcinoma (HCC)**, with levels often significantly higher in affected individuals [1]. - Its elevation is associated with **liver disease**, making it a crucial marker in the diagnosis and monitoring of HCC [1]. *PSA* - **Prostate-specific antigen (PSA)** is primarily elevated in **prostate cancer** and does not correlate with hepatocellular carcinoma [2]. - It is a marker for **prostate disease**, not liver pathology, distinguishing it from AFP [2]. *CEA* - **Carcinoembryonic antigen (CEA)** is more commonly associated with **colorectal** and other cancers but is not specific to hepatocellular carcinoma [2]. - Levels may be elevated in various malignancies, making it less reliable as a specific marker for HCC. *CA 19-9* - **CA 19-9** is mainly associated with **pancreatic** and **biliary tract cancers**, not hepatocellular carcinoma. - Elevated levels usually indicate gastrointestinal malignancies rather than liver issues.

Question 322: Which of the following is the most appropriate screening test for colorectal cancer in average-risk individuals?

A. Stool-based test for hidden blood (FOBT)
B. Imaging-based colon examination (CT colonography)
C. Endoscopic examination of the lower colon (Flexible sigmoidoscopy)
D. Comprehensive endoscopic examination of the colon (Colonoscopy) (Correct Answer)

Explanation: ***Comprehensive endoscopic examination of the colon (Colonoscopy)*** - **Colonoscopy** is considered the **gold standard** for colorectal cancer screening in average-risk individuals due to its ability to visualize the entire colon [1]. - It allows for the **detection and removal of polyps** (which can be precancerous) during the same procedure, significantly reducing cancer risk [1], [3]. *Stool-based test for hidden blood (FOBT)* - **FOBT** (fecal occult blood test) can detect blood in the stool, which might indicate polyps or cancer, but it has a **high false-positive rate** and does not directly visualize the colon [2]. - It has **lower sensitivity** for detecting advanced adenomas and early-stage cancers compared to colonoscopy [1]. *Imaging-based colon examination (CT colonography)* - While less invasive than colonoscopy, **CT colonography** (virtual colonoscopy) requires a bowel preparation similar to colonoscopy and does not allow for **biopsy or polyp removal** during the procedure [1]. - It uses radiation and may miss small or flat lesions, often requiring a follow-up colonoscopy if abnormalities are found. *Endoscopic examination of the lower colon (Flexible sigmoidoscopy)* - **Flexible sigmoidoscopy** only evaluates the **distal colon** and rectum, missing any polyps or cancers located in the proximal colon [1]. - It is less effective as a standalone screening tool for complete colorectal cancer prevention compared to full colonoscopy [1].

Question 323: A patient presents with chest pain and a pericardial effusion. Histology reveals malignant mesothelial cells. Which risk factor is most strongly associated with malignant mesothelioma?

A. Asbestos exposure (Correct Answer)
B. Consumption of alcohol
C. Exposure to silica dust
D. Exposure to tobacco smoke

Explanation: ***Asbestos exposure*** - Asbestos exposure is the most significant risk factor associated with **malignant mesothelioma**, particularly affecting the pleura and pericardium [1]. - This malignancy often presents with **pericardial effusion** and pleuritic chest pain, aligning with the patient's symptoms. - Mesothelioma is exceptionally rare in the absence of asbestos exposure [1]. *Silica dust exposure* - While silica exposure is a risk factor for lung diseases, particularly **silicosis** and **lung cancer**, it is not strongly linked to mesothelioma. - Mesothelioma is predominantly associated with **asbestos**, not silica [1]. *Tobacco smoke* - Tobacco smoke is primarily linked to **lung cancer** and respiratory diseases, but does not have a significant correlation with **mesothelioma**. - Mesothelioma can occur in non-smokers, indicating a separation from tobacco exposure. *Alcohol consumption* - Alcohol consumption is linked to various health conditions but is not recognized as a risk factor for **mesothelioma**. - The disease's association is predominantly with **asbestos exposure**, not lifestyle factors like alcohol use [1].

Question 324: A 50-year-old woman with metastatic melanoma has started a new immunotherapy drug. Which of the following is a common side effect of immune checkpoint inhibitors?

A. Nephrotoxicity
B. Hepatotoxicity
C. Cardiotoxicity
D. Pneumonitis (Correct Answer)

Explanation: ***Pneumonitis*** - **Pneumonitis** is a common and potentially severe immune-related adverse event (irAE) associated with immune checkpoint inhibitors, occurring when the activated immune system targets lung tissue. - Patients may present with cough, dyspnea, and hypoxia, and imaging often shows ground-glass opacities or interstitial infiltrates. *Nephrotoxicity* - While **renal irAEs** can occur, leading to **acute kidney injury** or interstitial nephritis, they are less common than pneumonitis or colitis. - The incidence of severe **nephrotoxicity** is relatively low compared to other organ toxicities. *Hepatotoxicity* - **Hepatotoxicity** in the form of **immune-mediated hepatitis** is a recognized irAE that can range from asymptomatic transaminitis to acute liver failure. - However, it occurs with a lower frequency than pneumonitis in many studies of immune checkpoint inhibitors. *Cardiotoxicity* - **Immune-mediated myocarditis** is a rare but life-threatening irAE, often presenting with non-specific symptoms like fatigue or dyspnea, or more severely as **heart failure** or arrhythmias. - Though highly morbid, its overall incidence is much lower than that of pneumonitis.

Question 325: A 70-year-old man presents with fatigue, weight loss, and jaundice. Laboratory tests show elevated alkaline phosphatase and bilirubin levels. Imaging reveals bile duct dilation and a mass at the pancreatic head. A biopsy confirms adenocarcinoma. What is the likely diagnosis?

A. Cholangiocarcinoma
B. Hepatocellular carcinoma
C. Pancreatic adenocarcinoma (Correct Answer)
D. Gallbladder carcinoma

Explanation: ***Pancreatic adenocarcinoma*** - The presence of a **mass at the pancreatic head**, alongside elevated alkaline phosphatase and bilirubin levels, is indicative of pancreatic adenocarcinoma, often causing obstructive jaundice [1]. - **Fatigue** and **weight loss** are common systemic symptoms due to malignancy and are consistent with this diagnosis [2]. *Gallbladder carcinoma* - While it can present with jaundice, it more commonly involves **gallbladder-related symptoms** and typically does not manifest as a mass at the **pancreatic head**. - Imaging findings would show issues focused on the **gallbladder** or nearby structures rather than the **pancreatic duct**. *Hepatocellular carcinoma* - This type of cancer usually arises in the presence of **chronic liver disease** and may show liver lesions rather than a mass in the **pancreas**. - The imaging would likely demonstrate **focal liver lesions** rather than bile duct dilation associated with obstruction. *Cholangiocarcinoma* - Although it involves the bile ducts and can cause jaundice, it would typically present with a mass specifically in the **bile duct** rather than the **pancreatic head**. - Patients often showcase different imaging characteristics and potential intrahepatic lesions compared to the described findings [3].

Question 326: A 55-year-old female presents with a gradually enlarging, painless mass in her left breast. She also reports recent nipple retraction and peau d'orange skin changes. What is the most likely diagnosis?

A. Fibroadenoma
B. Breast cyst
C. Ductal carcinoma in situ
D. Invasive ductal carcinoma (Correct Answer)

Explanation: ***Invasive ductal carcinoma*** - The combination of a **gradually enlarging, painless mass**, **nipple retraction**, and **peau d'orange skin changes** are classic signs of advanced **invasive ductal carcinoma** [1]. - **Peau d'orange** occurs due to **lymphatic obstruction** by tumor cells, leading to edema and thickening of the skin, mimicking an orange peel. *Fibroadenoma* - This is a **benign tumor** typically found in younger women, presenting as a **mobile, rubbery, well-defined mass**. - It does not usually cause **nipple retraction** or **peau d'orange** changes. *Breast cyst* - **Breast cysts** are fluid-filled sacs that are often **tender** or **painful** and can fluctuate in size with the menstrual cycle. - They typically present as **smooth, mobile masses** and do not cause the advanced signs like **nipple retraction** or **peau d'orange**. *Ductal carcinoma in situ* - **Ductal carcinoma in situ (DCIS)** is a **non-invasive cancer** confined to the milk ducts [1]. - It often presents as **microcalcifications on mammography** and typically does not manifest with palpable masses, nipple retraction, or peau d'orange unless associated with an invasive component [1].

Question 327: A 60-year-old female with chronic kidney disease presents with generalized weakness and hyperreflexia. Her serum calcium level is 14 mg/dL. What is the most likely cause?

A. Primary hyperparathyroidism (Correct Answer)
B. Sarcoidosis
C. Thiazide diuretics
D. Malignancy-associated hypercalcemia

Explanation: ***Primary hyperparathyroidism*** - In patients with **chronic kidney disease (CKD)**, the kidneys may struggle to activate Vitamin D, which can lead to **secondary hyperparathyroidism**. However, if hypercalcemia is present alongside hyperreflexia, this points to **primary disease**, where one or more parathyroid glands are overactive independently of serum calcium levels. - While CKD typically involves complications like **renal osteodystrophy** and **low calcium/high phosphate**, persistent hypercalcemia with hyperreflexia, especially at this critical level, despite CKD, strongly suggests autonomous **parathyroid gland dysfunction**. *Sarcoidosis* - Sarcoidosis causes **hypercalcemia** due to extrarenal production of **1,25-dihydroxyvitamin D** by activated macrophages. - While it can cause generalized weakness, hyperreflexia is not a typical neurological manifestation of sarcoidosis. *Thiazide diuretics* - Thiazide diuretics can cause mild **hypercalcemia** by increasing **renal calcium reabsorption**. - However, the serum calcium level of 14 mg/dL is usually more severe than what is typically caused by thiazide diuretics alone, and chronic kidney disease typically makes this less likely given impaired calcium and phosphate handling. *Malignancy-associated hypercalcemia* - **Malignancy-associated hypercalcemia** can present with severe hypercalcemia and generalized weakness, due to the release of **PTHrP** or bone destruction. - While possible, the combination of **chronic kidney disease** and hyperreflexia makes primary hyperparathyroidism a more specific and likely underlying cause in this scenario.

Question 328: A 65-year-old man with a long history of smoking presents with a chronic cough, dyspnea, and clubbing of the fingers. Which of the following conditions is most likely associated with these findings?

A. Aortic stenosis (Correct Answer)
B. Periosteal inflammation
C. Rheumatoid arthritis
D. Lung cancer

Explanation: **Aortic stenosis** - While **aortic stenosis** can cause dyspnea and cough due to **heart failure** and **pulmonary congestion**, it is not typically associated with **clubbing of the fingers** [2] or a history of **heavy smoking** as a direct cause of these respiratory symptoms. - The link between aortic stenosis and clubbing is less common and usually indirect, through **severe heart failure** causing chronic hypoxia. *Periosteal inflammation* - **Periosteal inflammation** can cause bone pain and swelling, but it does not directly explain the triad of **chronic cough**, **dyspnea**, and **clubbing** in a smoker. [2] - It is a local rather than a systemic condition that would cause chronic respiratory symptoms. *Lung cancer* - **Lung cancer** is a strong consideration given the patient's **smoking history**, **chronic cough**, and **dyspnea**. [3] - However, the question asks for the *most likely associated condition* with clubbing, which can also be caused by various other conditions, and the options should be critically evaluated. [2] *Rheumatoid arthritis* - **Rheumatoid arthritis** primarily affects joints and can cause systemic symptoms, but it does not typically cause **chronic cough**, **dyspnea**, or **clubbing** directly. - Lung involvement in rheumatoid arthritis (e.g., **interstitial lung disease**) is possible but is a secondary manifestation and less directly linked to the initial presentation of cough, dyspnea, and clubbing in a smoker. [1]

Question 329: What is the best tumor marker for pancreatic cancer?

A. CA 15-3
B. CA 19-9 (Correct Answer)
C. CEA
D. AFP

Explanation: **CA 19-9** - **CA 19-9** is the most widely accepted and commonly used tumor marker for **pancreatic adenocarcinoma**, particularly for monitoring response to treatment and recurrence. - Elevated levels are often seen in patients with pancreatic cancer and can correlate with **tumor burden** and prognosis. *CA 15-3* - **CA 15-3** is primarily used as a tumor marker for **breast cancer**, not pancreatic cancer. - It is utilized for monitoring treatment response and detecting recurrence in patients with breast cancer, especially **metastatic disease**. *CEA* - **CEA (Carcinoembryonic Antigen)** is a general tumor marker elevated in various cancers, including **colorectal**, **lung**, and **gastric cancer**. - While it can be elevated in some pancreatic cancer cases, it is less specific and sensitive for pancreatic cancer than CA 19-9. *AFP* - **AFP (Alpha-fetoprotein)** is the primary tumor marker for **hepatocellular carcinoma (HCC)** and **germ cell tumors**. - It is not routinely used for the diagnosis or monitoring of pancreatic cancer.

Question 330: A 55-year-old woman with a history of breast carcinoma presents with new-onset bone pain. What is the most appropriate diagnostic test?

A. Bone scan (Correct Answer)
B. MRI of the spine
C. CT scan of the abdomen
D. X-ray of the affected bone

Explanation: A 55-year-old woman with a history of breast carcinoma presents with new-onset bone pain. What is the most appropriate diagnostic test? ***Bone scan*** - A **bone scan** is highly sensitive for detecting **metastatic bone disease**, especially in patients with a history of cancer and new-onset bone pain. - It identifies increased osteoblastic activity around bony metastases, even when other imaging might appear normal. *MRI of the spine* - While an **MRI of the spine** is excellent for visualizing **soft tissue involvement** and spinal cord compression from metastases, it is typically used for more localized pain or neurological deficits, not as an initial broad screening tool for diffuse bone pain. - It would be beneficial if the bone pain was localized to the spine, but it does not provide a comprehensive assessment of the entire skeletal system for metastases. *CT scan of the abdomen* - A **CT scan of the abdomen** is primarily used to evaluate **abdominal organs** and detect metastases within the abdomen. - It is not the most appropriate initial test for assessing **bone pain**, as it offers limited views of bone involvement beyond the abdominal region and less sensitivity for early bone lesions compared to a bone scan. *X-ray of the affected bone* - An **X-ray of the affected bone** can detect significant lytic or blastic lesions, but it often requires **30-50% bone demineralization** before a lesion becomes visible. - X-rays are less sensitive than bone scans for detecting early metastatic disease and may miss multifocal lesions.

Question 331: A 65-year-old patient presents with hematuria, weight loss, and flank pain. CT shows a solid renal mass with calcifications and renal vein invasion. Laboratory results indicate hemoglobin of 10.8, ESR of 45, and creatinine of 1.6. What is the best diagnosis?

A. Renal cell carcinoma (Correct Answer)
B. Transitional cell carcinoma
C. Angiomyolipoma
D. Wilms' tumor

Explanation: ***Renal cell carcinoma*** - The classic triad of **hematuria, flank pain, and palpable mass** (though a palpable mass isn't explicitly stated, flank pain and hematuria are present) combined with **weight loss** and a **solid renal mass with calcifications and renal vein invasion** on CT are highly indicative of **renal cell carcinoma (RCC)** [1]. - The lab findings of **anemia (Hb 10.8)**, **elevated ESR (45)**, and mild renal dysfunction (creatinine 1.6) further support a diagnosis of RCC, especially with paraneoplastic syndromes. *Transitional cell carcinoma* - This typically arises in the **renal pelvis or ureter** and often presents with painless gross hematuria, but **solid mass with calcifications and renal vein invasion** is less characteristic of TCC. - While it can cause hematuria and flank pain, the imaging findings of a solid renal mass with calcifications and invasion are more typical of parenchymal tumors like RCC. *Angiomyolipoma* - This is a **benign tumor** composed of blood vessels, smooth muscle, and fat, making it appear hyperechoic or fat-containing on imaging, rather than a solid mass with calcifications. - It usually presents with symptoms only when large or hemorrhaging, and **weight loss and renal vein invasion** are not characteristic features. *Wilms' tumor* - Primarily affects **children**, typically presenting as an asymptomatic abdominal mass, hematuria, and hypertension. - This patient's age (65-year-old) makes Wilms' tumor an **extremely unlikely diagnosis** [1].

Question 332: A young male with a testicular mass is found to have elevated beta-hCG levels. What is the most likely diagnosis?

A. Embryonal Carcinoma (Correct Answer)
B. Choriocarcinoma
C. Seminoma
D. Teratoma

Explanation: ***Choriocarcinoma*** - Characterized by **elevated beta-hCG levels**, this indicates **germ cell tumors**, commonly associated with choriocarcinoma. - It often presents with a **testicular mass** and can metastasize to lungs and other organs. *Seminoma* - Typically presents with a **testicular mass** but usually has **normal beta-hCG levels** unless mixed with other germ cell tumors. - Most common germ cell tumor, but generally does not elevate **beta-hCG** significantly. *Embryonal Carcinoma* - Can produce beta-hCG but is usually seen in **mixed germ cell tumors** rather than isolated choriocarcinoma. - Typically presents with a **varied mass**, often painful, and may show **elevated AFP** levels if it's a mixed type. *Teratoma* - Often presents as a **benign mass** with **no elevation of beta-hCG**; typically does not produce hormones. - While teratomas can have malignant potential, they usually do not result in significant **beta-hCG elevation**.

Question 333: A 55-year-old woman with cirrhosis is found to have a liver lesion with elevated alpha-fetoprotein. What is the most likely diagnosis?

A. Hepatic adenoma
B. Liver metastasis
C. Hepatocellular carcinoma (Correct Answer)
D. Hemangioma

Explanation: ***Hepatocellular carcinoma*** - **Elevated alpha-fetoprotein (AFP)** levels in a patient with cirrhosis are strongly indicative of hepatocellular carcinoma, which commonly arises in this context [1]. - Hepatocellular carcinoma typically presents as a **liver lesion** and is associated with chronic liver disease and cirrhosis [1]. *Hemangioma* - Generally, hemangiomas are **benign vascular tumors** and do not cause elevated levels of alpha-fetoprotein. - They are often asymptomatic and discovered incidentally on imaging, unlike hepatocellular carcinoma, which will present more aggressively in this setting. *Liver metastasis* - Liver metastases can occur in cirrhotic patients but are less likely to be associated with significant elevations of alpha-fetoprotein unless specific primary tumors are involved. - Primary tumors, such as colorectal cancer, usually produce **different markers**, and the presence of AFP suggests a primary liver cancer rather than metastatic disease. *Hepatic adenoma* - Hepatic adenomas are also benign tumors but are less common in patients with cirrhosis and typically do not cause elevated alpha-fetoprotein levels. - More frequently found in women taking **oral contraceptives**, they generally lack the aggressive features seen in hepatocellular carcinoma.

Question 334: A 68-year-old male with a history of smoking presents with hemoptysis and weight loss. A chest X-ray shows a mass in the upper lobe, and laboratory results indicate hypercalcemia. Analyze and determine the diagnosis and initial treatment.

A. Tuberculosis; initial management includes sputum acid-fast bacilli test
B. COPD exacerbation; initial management includes bronchodilators and steroids
C. Pulmonary embolism; initial management includes CT angiography
D. Squamous cell carcinoma; initial management includes bronchoscopy and biopsy (Correct Answer)

Explanation: **Squamous cell carcinoma; initial management includes bronchoscopy and biopsy** - The combination of **hemoptysis**, **weight loss**, a **mass in the upper lobe**, and **hypercalcemia** in a smoker strongly suggests squamous cell carcinoma of the lung [1]. - **Bronchoscopy with biopsy** is essential for definitive diagnosis and staging. *Tuberculosis; initial management includes sputum acid-fast bacilli test* - While **hemoptysis** and **weight loss** can occur in TB, a solitary upper lobe mass and hypercalcemia are less typical [2]. - **Hypercalcemia** is not a common feature of TB; definitive diagnosis requires identifying **acid-fast bacilli**. *COPD exacerbation; initial management includes bronchodilators and steroids* - **COPD exacerbations** present with increased dyspnea, cough, or sputum production, not typically a discrete mass or hemoptysis as a primary symptom. - **Hypercalcemia** is not associated with COPD exacerbations. *Pulmonary embolism; initial management includes CT angiography* - **Pulmonary embolism** symptoms usually include acute dyspnea, pleuritic chest pain, and sometimes hemoptysis [2]. - **CT angiography** is the gold standard for diagnosing PE, but it would not explain the upper lobe mass or hypercalcemia.

Question 335: A patient with non-small cell lung cancer (NSCLC) who is resistant to first-line chemotherapy should have which molecular marker evaluated to guide second-line targeted therapy?

A. EGFR mutation (Correct Answer)
B. BRCA1 mutation
C. BCR-ABL fusion gene
D. HER2 overexpression

Explanation: ### EGFR mutation - **EGFR mutations** are common in NSCLC and can lead to resistance to first-line chemotherapy, specifically **tyrosine kinase inhibitors (TKIs)** [1]. - Identifying specific EGFR mutations, such as **T790M**, can guide the use of second-generation or third-generation EGFR TKIs like **osimertinib** as second-line therapy. *BRCA1 mutation* - **BRCA1 mutations** are primarily associated with an increased risk of **breast and ovarian cancers**, and occasionally prostate and pancreatic cancers. - They are not routinely evaluated or considered a primary target for guiding second-line therapy in NSCLC. *BCR-ABL fusion gene* - The **BCR-ABL fusion gene** is a hallmark of **chronic myeloid leukemia (CML)** and some cases of acute lymphoblastic leukemia (ALL) [1]. - This gene is a target for **tyrosine kinase inhibitors** like imatinib in these hematological malignancies but is not relevant for NSCLC [1]. *HER2 overexpression* - **HER2 overexpression** or amplification is a significant prognostic and predictive marker in **breast cancer** and some gastric cancers, guiding **trastuzumab** therapy [1]. - While HER2 alterations can occur in a small subset of NSCLC, they are less common and less established as a primary driver for second-line targeted therapy compared to EGFR mutations.

Question 336: A 40-year-old man presents with generalized lymphadenopathy and a mediastinal mass. Histology reveals Reed-Sternberg cells. Which combination of treatments offers the best chance of remission?

A. Surgery and radiotherapy
B. Chemotherapy and stem cell transplant
C. Immunotherapy and radiation therapy
D. Chemotherapy and radiation therapy (Correct Answer)

Explanation: The original explanation provided already accurately details that chemotherapy and radiation therapy are the standard treatment for Hodgkin's lymphoma [1], as the disease originates in lymphoid tissues and is identified by Reed-Sternberg cells [1]. Chemotherapy functions to reduce tumor burden, while radiation therapy is used to eliminate localized disease [1]. Historically, radiation alone was used for localized (stage IA/IIA) disease [1]. Immunotherapy and surgery are generally not first-line options. While stem cell transplant is used for relapsed or refractory cases, it is not the initial treatment strategy [1].

Question 337: A 25-year-old woman presents with painless hematuria and a history of recurrent urinary tract infections. Urine cytology reveals atypical cells, and cystoscopy shows a papillary lesion. What is the most likely diagnosis?

A. Renal cell carcinoma
B. Transitional cell carcinoma (Correct Answer)
C. Squamous cell carcinoma
D. Adenocarcinoma

Explanation: ***Transitional cell carcinoma*** - Characterized by **painless hematuria** [1] and often occurs in patients with a history of **urinary tract infections**. - The presence of **atypical cells in urine cytology** and a **papillary lesion** found via cystoscopy supports this diagnosis. *Renal cell carcinoma* - Typically presents with **flank pain**, **weight loss**, and **hematuria**, but is less common in young women compared to transitional cell carcinoma. - Uncommonly associated with cystoscopic findings of **papillary lesions**; it usually manifests as solid renal mass rather than urinary tract lesions. *Adenocarcinoma* - Generally arises in **glandular tissue** of the kidney and shows variable presentation, not typically linked to **hematuria** in the bladder. - Rare in the bladder environment and does not align well with **urinary tract infection** history or cystoscopy findings. *Squamous cell carcinoma* - More commonly associated with chronic irritation from **schistosomiasis** or prolonged bladder catheterization rather than recurrent UTIs. - Presents with **painful urination** or hematuria [1] and is not typically related to **papillary lesions** seen in this case.

Question 338: A 65-year-old man presents with fatigue, weight loss, and abdominal pain. A CT scan of the abdomen reveals a pancreatic mass. What is the most likely diagnosis?

A. Chronic pancreatitis
B. Pancreatic adenocarcinoma (Correct Answer)
C. Acute pancreatitis
D. Gastrointestinal stromal tumor

Explanation: ***Pancreatic adenocarcinoma*** - The combination of **fatigue, weight loss, and abdominal pain** in an elderly patient, alongside a **pancreatic mass** on CT, are classic signs of pancreatic adenocarcinoma [1]. - This cancer is often diagnosed at an advanced stage due to its subtle and nonspecific initial symptoms. *Chronic pancreatitis* - While chronic pancreatitis can cause abdominal pain and weight loss, it typically presents with a history of recurrent episodes of pancreatitis, often related to **alcohol abuse** [2] or **gallstones**. - A mass on CT in chronic pancreatitis is usually an **inflammatory pseudotumor** or **fibrotic change**, not a distinct solid mass with these systemic symptoms [2]. *Acute pancreatitis* - This condition presents with acute, severe upper abdominal pain, often radiating to the back, associated with elevated pancreatic enzymes (**amylase and lipase**). - It usually does not involve significant weight loss or prolonged fatigue unless it leads to severe complications. *Gastrointestinal stromal tumor* - GISTs are **mesenchymal tumors** that originate in the gastrointestinal tract, most commonly the stomach or small intestine, and rarely in the pancreas. - While they can cause abdominal pain and weight loss, a mass in the pancreas is less commonly a GIST compared to adenocarcinoma.

Question 339: A 70-year-old woman presents with fatigue, weight loss, and anorexia. Physical examination reveals hepatomegaly and jaundice. Laboratory results show elevated alpha-fetoprotein. What is the most likely diagnosis?

A. Pancreatic cancer
B. Hepatocellular carcinoma (Correct Answer)
C. Gallbladder cancer
D. Cholangiocarcinoma

Explanation: ***Hepatocellular carcinoma*** - The constellation of **fatigue, weight loss, anorexia, hepatomegaly, jaundice**, and elevated **alpha-fetoprotein** strongly points to hepatocellular carcinoma (HCC) [1]. - **Alpha-fetoprotein (AFP)** is a well-established tumor marker for HCC, often elevated in a significant proportion of cases [3]. *Pancreatic cancer* - While it can cause weight loss, fatigue, and jaundice, **hepatomegaly** is less common, and **elevated alpha-fetoprotein** is not a characteristic marker for pancreatic cancer [1]. - Typical markers include **CA 19-9**, and jaundice is often due to **biliary obstruction**. *Gallbladder cancer* - This cancer can present with weight loss and jaundice due to biliary obstruction, but **hepatomegaly** is not a primary feature unless there's extensive metastasis [2]. - **Elevated alpha-fetoprotein** is not typically associated with gallbladder cancer. *Cholangiocarcinoma* - Similar to gallbladder cancer, cholangiocarcinoma can cause **jaundice and weight loss** due to involvement of the bile ducts [2]. - However, **alpha-fetoprotein** is not a typical tumor marker for cholangiocarcinoma; **CEA and CA 19-9** are more commonly elevated.

Question 340: A 40-year-old man presents with a persistent cough and hemoptysis. Imaging shows a mass in the right upper lobe, and a biopsy reveals squamous cell carcinoma. What is the most likely etiological factor?

A. Asbestos exposure
B. Cigarette smoking (Correct Answer)
C. Radon exposure
D. Viral infection

Explanation: ***Cigarette smoking*** [1] - Cigarette smoking is the **most significant risk factor** for the development of squamous cell carcinoma of the lung [1]. - It accounts for nearly **85% of lung cancer cases**, primarily due to the carcinogens present in tobacco smoke. *Radon exposure* - Radon exposure is a known risk factor for **lung cancer**, but it is more strongly associated with **adenocarcinoma** than with squamous cell carcinoma. - The risk from radon is generally lower than that posed by **cigarette smoking**, making it less likely in this scenario. [1] *Asbestos exposure* - Asbestos exposure is primarily associated with **mesothelioma** and lung cancer, but primarily the **adenocarcinoma** type, rather than squamous cell carcinoma. - It typically requires prolonged exposure and is not as directly linked to the risk seen with **cigarette smoking**. *Viral infection* - While viral infections like **HPV** can contribute to certain cancers, they are not a common etiology for **squamous cell carcinoma of the lung**. - Other environmental and lifestyle factors, especially **tobacco**, play a much more prominent role in lung cancer development. [1]

Question 341: A 25-year-old male presents with a painless swelling in the scrotum. An ultrasound shows a heterogeneous mass in the testis. Which marker is most likely to be elevated in this patient?

A. Prostate-specific antigen
B. Carcinoembryonic antigen
C. Alpha-fetoprotein (Correct Answer)
D. Beta-human chorionic gonadotropin

Explanation: ***Beta-human chorionic gonadotropin*** - A **heterogeneous mass** in the testis along with painless swelling raises suspicion of **germ cell tumors**, particularly **choriocarcinoma**, which is known to elevate this marker [1]. - It is commonly associated with testicular **tumors** in young males and can help in diagnosis and monitoring treatment response [1]. Syncytiotrophoblast cells scattered within germ cell tumors also cause moderate elevation of serum hCG, and approximately 15% of seminomas contain syncytiotrophoblasts that elevate HCG levels. *Alpha-fetoprotein* - Typically elevated in **non-seminomatous germ cell tumors** like **yolk sac tumors** and **mixed germ cell tumors** [1], but not specifically for the mass described. - Less relevant in cases primarily associated with **choriocarcinoma** or **seminomas**, which are more common in this age group. *Prostate-specific antigen* - Mainly used as a marker for **prostate cancer** and conditions related to the **prostate**, not applicable to testicular masses [1]. - Elevated in older males and has no significance in the context of a **scrotal mass** in young men. *Carcinoembryonic antigen* - Generally associated with **colorectal and certain other cancers**, not typically relevant in testicular masses [1]. - Does not provide information about the type of tumor present in the **testis**, making it an inappropriate marker in this case.

Question 342: A 65-year-old female presents with progressive dysphagia. A barium swallow shows multiple areas of narrowing with proximal dilatation. What is the most likely diagnosis?

A. Achalasia
B. Esophageal cancer (Correct Answer)
C. Peptic stricture
D. Esophageal varices

Explanation: ***Esophageal cancer*** - Progressive dysphagia, especially in an elderly patient, along with narrowing and proximal dilation seen on barium swallow, is highly concerning for **esophageal cancer**. - This presentation often signifies an **obstructive lesion** that is gradually worsening [1]. *Achalasia* - Achalasia is characterized by dysphagia for both solids and liquids due to **failure of lower esophageal sphincter (LES) relaxation** and aperistalsis [2]. - While it causes proximal dilation, the classic barium swallow finding is a **bird's beak appearance**, with smooth narrowing at the LES, not multiple areas of narrowing [2]. *Peptic stricture* - A peptic stricture typically causes **intermittent or progressive dysphagia** for solids due to chronic acid reflux leading to inflammation and scarring [1]. - While it presents with narrowing and upstream dilation, the history usually includes **heartburn** and **regurgitation**, and there's often *a single, shorter stricture* rather than multiple areas of narrowing. *Esophageal varices* - Esophageal varices are **dilated veins** in the lower esophagus, usually a complication of **portal hypertension**. - They typically present with **hematemesis** or melena due to rupture and bleeding, not progressive dysphagia as the primary symptom.

Question 343: A 70-year-old woman presents with recurrent urinary tract infections and a palpable pelvic mass. An ultrasound shows a large, irregular mass on the anterior wall of the bladder. What is the most likely diagnosis?

A. Bladder cancer (Correct Answer)
B. Uterine fibroids
C. Cystocele
D. Bladder diverticulum

Explanation: ***Bladder cancer*** - The combination of **recurrent UTIs**, a **palpable pelvic mass**, and an **irregular mass on the anterior bladder wall** on ultrasound is highly suggestive of bladder cancer, which can present with these non-specific symptoms. - Bladder cancer is more common in older individuals and can lead to symptoms like recurrent infections due to compromised bladder integrity or obstruction. *Uterine fibroids* - While uterine fibroids can present as a **pelvic mass**, they typically arise from the **uterus**, not the bladder wall. - They are less likely to cause recurrent UTIs unless they are very large and compress the bladder or ureters. *Cystocele* - A cystocele is a **prolapse of the bladder** into the vagina, manifesting as a bulge or pressure, not typically an irregular mass *on* the bladder wall seen on ultrasound. - While it can cause recurrent UTIs due to incomplete bladder emptying, the description of an "irregular mass" points away from this condition. *Bladder diverticulum* - A bladder diverticulum is an **outpouching of the bladder wall**, which can be congenital or acquired. - While it can be associated with recurrent UTIs due to urinary stasis, it is generally a **smooth-walled pouch** and not typically described as a large, "irregular mass" on the anterior bladder wall, which suggests a solid or infiltrative lesion.

Question 344: Which of the following is the first-line treatment for a patient diagnosed with Hodgkin's lymphoma?

A. Surgical resection
B. Chemotherapy with ABVD regimen (Correct Answer)
C. Radiation therapy alone
D. Immunotherapy with checkpoint inhibitors

Explanation: **Chemotherapy with ABVD regimen** - The **ABVD regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)** is a standard first-line chemotherapy protocol for both early and advanced stages of **Hodgkin's lymphoma**. - It is highly effective in inducing remission and has a well-established safety profile, making it the preferred initial treatment approach. *Surgical resection* - **Surgical resection** is generally not a primary treatment for Hodgkin's lymphoma, as it is a systemic disease. [1] - It may be used for **diagnostic biopsy** or to address complications, but not as definitive first-line therapy. [1] *Radiation therapy alone* - While **radiation therapy** is crucial in Hodgkin's lymphoma management, it is typically used in conjunction with chemotherapy, especially for localized disease. - **Radiation therapy alone** is usually reserved for very early-stage disease with favorable prognostic features in specific clinical settings. [1] *Immunotherapy with checkpoint inhibitors* - **Immunotherapy with checkpoint inhibitors** (e.g., nivolumab, pembrolizumab) is primarily reserved for **relapsed or refractory Hodgkin's lymphoma** after failure of initial chemotherapy. - It is not considered a first-line treatment option, especially given the high efficacy of ABVD in newly diagnosed cases.

Question 345: A 60-year-old man presents with progressive fatigue. Laboratory results reveal microcytic anemia, and a colonoscopy shows a mass. Which type of colon cancer is most commonly associated with this presentation?

A. Sigmoid colon carcinoma
B. Rectal carcinoma
C. Ascending colon carcinoma (Correct Answer)
D. Descending colon carcinoma

Explanation: ***Ascending colon carcinoma*** - Carcinomas in the **right (ascending) colon** often present with **occult bleeding** leading to **iron deficiency anemia** (microcytic anemia), and subtle symptoms like fatigue, making them harder to detect until advanced [1]. - The wider lumen and more liquid stool in the ascending colon allow tumors to grow larger before causing obstructive symptoms [1]. *Sigmoid colon carcinoma* - **Sigmoid colon cancers** are distal and typically present with symptoms related to **obstruction**, changes in bowel habits, or more overt rectal bleeding due to the narrower lumen and more formed stool [1]. - While they can cause anemia, it's less commonly the sole or primary presenting symptom compared to right-sided lesions [1]. *Rectal carcinoma* - **Rectal cancers** commonly present with symptoms such as **hematochezia** (bright red blood per rectum), tenesmus, or changes in stool caliber [1]. - While they can also lead to anemia, their proximity to the anus often causes more immediate and noticeable bleeding symptoms [1]. *Descending colon carcinoma* - Similar to sigmoid colon cancers, **descending colon carcinomas** tend to cause symptoms related to **partial obstruction**, such as changes in bowel habits, abdominal pain, or tenesmus. - They are less frequently associated with occult bleeding and microcytic anemia as the primary presentation compared to right-sided lesions.

Question 346: A 70-year-old man presents with weight loss, night sweats, and an abdominal mass. A CT scan reveals a large mesenteric mass, and a biopsy shows sheets of large lymphoid cells. What is the likely diagnosis?

A. Non-Hodgkin lymphoma (Correct Answer)
B. Multiple myeloma
C. Chronic lymphocytic leukemia
D. Hodgkin lymphoma

Explanation: ***Non-Hodgkin lymphoma*** - The presence of a **large mesenteric mass** with sheets of **large lymphoid cells** on biopsy is characteristic of non-Hodgkin lymphoma, especially in older adults [1]. - Symptoms such as **weight loss** and **night sweats** align with the clinical presentation of aggressive non-Hodgkin lymphoma [1]. [2] *Multiple myeloma* - Typically presents with **bone pain**, **anemia**, and high levels of **monoclonal proteins**, not primarily with a mesenteric mass [3]. - Characterized by **punched-out** lytic lesions on imaging rather than large lymphoid masses. *Hodgkin lymphoma* - Often presents with **lymphadenopathy** and **Reed-Sternberg cells**, and less commonly with mesenteric masses [1]. - Frequently associated with **B symptoms**, but the predominant presentation here suggests a different diagnosis [2]. *Chronic lymphocytic leukemia* - Generally results in **lymphocytosis** and may involve lymph nodes but does not typically present with a large abdominal mass. - Usually presents insidiously and may show **splenomegaly**, but is not associated with sheets of large lymphoid cells seen in this case.

Question 347: A 60-year-old woman with a history of breast cancer presents with new-onset back pain and difficulty walking. An MRI shows spinal cord compression. What is the next best step?

A. Chemotherapy
B. Radiation therapy
C. Surgery
D. Corticosteroids (Correct Answer)

Explanation: ***Corticosteroids*** - **Corticosteroids** are the immediate next step in managing **spinal cord compression** [1] to reduce **edema** around the cord and alleviate pressure, preventing further neurological damage. - This provides temporary relief and time for definitive treatment planning. *Chemotherapy* - **Chemotherapy** is a systemic treatment for cancer and is typically not the initial emergent therapy for acute **spinal cord compression**, though it may be part of the long-term management after stabilization [2]. - Its effects are often delayed, and it doesn't provide the rapid anti-inflammatory action needed to protect the spinal cord. *Radiation therapy* - **Radiation therapy** is a crucial definitive treatment for malignant spinal cord compression but usually follows initial stabilization with corticosteroids and a thorough evaluation [1]. - While effective, it takes time to administer and has a slower onset of action in reducing tumor bulk and edema compared to corticosteroids [2]. *Surgery* - **Surgery** (decompression) is an option for certain cases of spinal cord compression, particularly when there is bony compression, neurological deficit progression despite steroids, or an unknown primary tumor [1]. - However, in many cases, especially with an immediate need to reduce swelling and improve symptoms, **corticosteroids** are administered first to stabilize the patient before considering surgical intervention [1].

Question 348: A 40-year-old man with a history of chronic alcohol use presents with epigastric pain and weight loss. Imaging reveals a pancreatic mass. What is the most likely diagnosis?

A. Pancreatitis
B. Pancreatic adenocarcinoma (Correct Answer)
C. Gastric ulcer
D. Liver metastasis

Explanation: ***Pancreatic adenocarcinoma*** - The combination of **epigastric pain**, **weight loss**, and a **pancreatic mass** in a 40-year-old, especially with a history of chronic alcohol use (which is a risk factor), is highly suspicious for pancreatic adenocarcinoma. - This cancer often presents late with non-specific symptoms, leading to advanced disease at diagnosis. *Pancreatitis* - While chronic alcohol use is a major cause of **pancreatitis** [1], the presence of a distinct **pancreatic mass** along with significant **weight loss** makes malignancy more likely than simple inflammation, especially in this age group. - Pancreatitis typically causes acute, severe pain, and while chronic pancreatitis can lead to pain and weight loss, a mass points towards a neoplastic process [1]. *Gastric ulcer* - A **gastric ulcer** would typically present with epigastric pain, but it is less likely to cause a **pancreatic mass** or significant, unexplained **weight loss** specific to pancreatic involvement. - The imaging specificity for a pancreatic mass rules out a primary gastric ulcer as the sole diagnosis. *Liver metastasis* - **Liver metastasis** implies a primary cancer elsewhere that has spread to the liver, not originating as a primary pancreatic mass. - While pancreatic cancer can metastasize to the liver, the initial finding of a "pancreatic mass" points to the pancreas as the primary site of concern.

Question 349: A 50-year-old woman with a history of breast cancer presents with new-onset seizures. An MRI shows multiple ring-enhancing lesions. What is the most likely cause?

A. Primary brain tumor
B. Cerebral abscess
C. Metastatic brain disease (Correct Answer)
D. Multiple sclerosis

Explanation: ### Metastatic brain disease - A patient with a history of **breast cancer** who develops new-onset seizures and **multiple ring-enhancing lesions** on MRI is highly suspicious for **brain metastases** [1]. - Breast cancer is one of the most common primary tumors that metastasize to the brain, and ring-enhancing lesions are a classic imaging finding for metastases [1]. ### Primary brain tumor - While primary brain tumors can cause seizures and ring-enhancing lesions, the presence of a **known primary cancer** strongly biases towards metastatic disease. - Primary brain tumors are typically solitary rather than multiple, though exceptions exist. ### Cerebral abscess - Cerebral abscesses also present with ring-enhancing lesions and can cause seizures [2], but typically there are signs of infection (e.g., fever, elevated inflammatory markers) or a **source of infection**, which are not mentioned here. - The history of breast cancer points away from infection as the primary cause. ### Multiple sclerosis - Multiple sclerosis lesions are typically **periventricular** or in the **corpus callosum** and often show incomplete or "open-ring" enhancement, not classical ring-enhancement. - MS is also not typically associated with a history of breast cancer and new-onset seizures in this manner.

Question 350: What is the most effective primary prevention measure for breast cancer in a high-risk patient with a family history of a BRCA1 mutation?

A. Routine breast screening
B. Preventive mastectomy (Correct Answer)
C. Tamoxifen therapy
D. Regular exercise regimen

Explanation: ***Preventive mastectomy*** - A **bilateral prophylactic mastectomy** significantly reduces the risk of breast cancer (by over 90%) in high-risk individuals, especially those with **BRCA1/2 mutations**. This is considered the most effective primary prevention strategy due to direct removal of at-risk tissue. - This intervention is chosen when the patient has a very high lifetime risk of developing breast cancer due to strong genetic predisposition, aiming to prevent the disease's occurrence rather than detecting it early. *Routine breast screening* - **Routine breast screening** (e.g., mammograms, MRI) is a secondary prevention measure, focusing on **early detection** of cancer, not its prevention. - While important for surveillance, it does not prevent cancer from developing in a high-risk individual with a **BRCA1 mutation**, where lifetime risk can be over 50%. *Tamoxifen therapy* - **Tamoxifen** is a selective estrogen receptor modulator (SERM) that can reduce breast cancer risk, but it's considered a **chemopreventive agent**, offering partial risk reduction rather than complete prevention. - Its effectiveness is generally lower than prophylactic mastectomy, and it carries potential side effects, making it a less definitive primary prevention strategy for the highest risk patients. *Regular exercise regimen* - **Regular exercise** contributes to overall health and can modestly **lower cancer risk** in the general population by maintaining a healthy weight and reducing systemic inflammation. - However, for an individual with a strong genetic predisposition like a **BRCA1 mutation**, lifestyle interventions alone are insufficient as a primary prevention measure to significantly mitigate their exceptionally high risk.

Question 351: A young male presents with a painless testicular mass suspicious for germ cell tumor. Which of the following tumor markers would be most useful for initial evaluation?

A. Prostate-Specific Antigen (PSA)
B. Alpha-Fetoprotein (AFP) (Correct Answer)
C. Carcinoembryonic Antigen (CEA)
D. β-hCG (beta-human chorionic gonadotropin)

Explanation: ***Alpha-Fetoprotein (AFP)*** - **AFP** is a key tumor marker in **germ cell tumors**, particularly in **non-seminomatous** testicular tumors such as **yolk sac tumors** [1]. - It is often elevated in patients with a **painless testicular mass**, aiding in the diagnosis and management of these tumors [1]. *CA-125* - **CA-125** is primarily used as a tumor marker for **ovarian cancer** rather than testicular tumors, making it less relevant here. - It is often elevated in **pelvic inflammatory disease** and **endometriosis**, not specific to male genital tract tumors. *Carcinoembryonic Antigen (CEA)* - **CEA** is mostly associated with **colorectal** and **lung cancers**, and is not typically involved in testicular tumor diagnosis [1]. - While it may have some role in gastrointestinal malignancies, it does not serve as a useful marker for **testicular masses** [2]. *Prostate-Specific Antigen (PSA)* - **PSA** is specific for **prostate disorders**, including cancer, but does not provide relevant information for testicular tumors [1] [2]. - Its elevation is indicative of conditions related to the **prostate gland**, which is not involved in the context of a testicular mass [2].

Question 352: A 50-year-old man with a history of alcohol use presents with a painless, ulcerated lesion on the floor of the mouth. What is the most likely diagnosis?

A. Oral candidiasis
B. Aphthous ulcer
C. Oral squamous cell carcinoma (Correct Answer)
D. Leukoplakia

Explanation: ***Oral squamous cell carcinoma*** - A **painless, ulcerated lesion** in the **floor of the mouth** in a patient with a history of **alcohol use** is highly suspicious for oral squamous cell carcinoma. Alcohol use is a significant risk factor. - The floor of the mouth is a common site for oral squamous cell carcinoma, and the **painless nature** of the lesion may lead to delayed diagnosis. *Oral candidiasis* - Typically presents as **creamy white, wipeable plaques** on the oral mucosa, often associated with immunocompromised states or antibiotic use. - While it can be ulcerated in severe cases, the primary presentation is not usually a solitary, persistent ulcer, and it is often **painful**. *Aphthous ulcer* - These are typically **painful, shallow ulcers** with a characteristic red halo, and they tend to recur [1]. - They are usually small, self-limiting, and not associated with specific risk factors like extensive alcohol use in the same way as malignancy [1]. *Leukoplakia* - **Leukoplakia** appears as a **white patch or plaque** that cannot be rubbed off and cannot be characterized clinically as any other definable lesion. - While leukoplakia is a **premalignant lesion** that can transform into squamous cell carcinoma, the description here is of an **ulcerated lesion**, suggesting a more advanced stage of disease or a different entity.

Question 353: A 50-year-old male presents with painless hematuria. A CT scan reveals a large mass in the bladder. What is the most likely diagnosis?

A. Bladder stone
B. Bladder polyp
C. Bladder carcinoma (Correct Answer)
D. Bladder infection

Explanation: ***Bladder carcinoma*** - **Painless hematuria** is the classic presenting symptom of bladder cancer, especially in older adults [1]. - The presence of a **large mass** on CT scan in the bladder strongly suggests a malignant tumor [1]. *Bladder stone* - While bladder stones can cause hematuria, it is typically accompanied by **pain**, especially during urination or with movement. - A stone would appear as a calcification on CT, not typically described as a "large mass" in the tissue itself. *Bladder polyp* - Bladder polyps are usually **benign growths** and are much less likely to present as a "large mass" with hematuria in a 50-year-old male [1]. - Though some polyps may bleed, the term "large mass" points more towards a neoplastic process in this age group and presentation [1]. *Bladder infection* - Bladder infections (cystitis) typically cause **painful urination**, urgency, frequency, and sometimes hematuria. - However, a large mass would not be seen with a simple infection; instead, the bladder wall might be thickened.

Question 354: Based on the following details from a death certificate, what is the most likely cause of death? (Details: Patient had a history of breast cancer and recent neurological symptoms.)

A. Metastatic Disease (Correct Answer)
B. Breast Cancer
C. Cerebral Hemorrhage
D. None of the above

Explanation: Metastatic Disease - A history of breast cancer combined with recent neurological symptoms strongly suggests that the cancer has spread to the brain or other parts of the nervous system [1]. - Metastatic disease refers to the spread of cancer from its primary site to distant organs, which is a common and often fatal complication of advanced breast cancer, explaining the neurological decline and ultimately death [1]. Breast Cancer - While breast cancer is the primary disease, it is generally considered the underlying cause rather than the immediate cause of death when distant spread has occurred. - The direct cause of death often relates to the complications arising from metastatic deposits in vital organs, not the localized primary tumor itself. Cerebral Hemorrhage - Although neurological symptoms could potentially include a cerebral hemorrhage, this option is too specific and lacks the broader context of the patient's cancer history. - There is no direct information provided to support a hemorrhage over other more common neurological complications of metastatic cancer, such as brain metastases causing edema or seizures [1]. None of the above - Given the patient's history of breast cancer and neurological symptoms, metastatic disease is a highly plausible and encompassing cause of death. - This option is incorrect because there is a very likely cause of death present among the choices.

Question 355: Favorable prognosis with > 90% 5 year survival rate for carcinoma breast is seen in which of the following?

A. Screen detected ductal carcinoma in situ (DCIS) (Correct Answer)
B. Node negative tumor with favorable histology
C. Triple-negative breast cancer
D. Screen detected lobular carcinoma in situ (LCIS)

Explanation: **Screen detected ductal carcinoma in situ (DCIS)** - **DCIS** is a non-invasive breast cancer confined to the milk ducts, meaning it has not spread to surrounding tissues. [1] - When detected through screening, it has an excellent prognosis with a **5-year survival rate often exceeding 90%** after appropriate treatment (e.g., lumpectomy with or without radiation). *Node negative tumor with favorable histology* - While a **node-negative tumor** generally indicates a better prognosis than node-positive disease, the specific "favorable histology" isn't precisely defined to guarantee a >90% 5-year survival on its own as universally as DCIS. - **Histology** can vary greatly, and even node-negative invasive cancers can have less favorable subtypes that reduce 5-year survival below this high threshold. *Triple-negative breast cancer* - **Triple-negative breast cancer (TNBC)** lacks estrogen receptors, progesterone receptors, and HER2 overexpression, making it an aggressive subtype. - TNBC has a **poorer prognosis** compared to other breast cancer types and is not associated with a >90% 5-year survival rate, especially once it becomes invasive. *Screen detected lobular carcinoma in situ (LCIS)* - **LCIS** is considered a high-risk marker for developing invasive breast cancer in either breast, rather than a true cancer itself. [1] - While it doesn't directly metastasize, its presence indicates a **significantly increased lifetime risk** of developing invasive lobular or ductal carcinoma, and it's not treated as a "cancer" with a 5-year survival in the same way as DCIS. [1]

Question 356: Which of the following tumors most commonly presents with upper gastrointestinal bleeding?

A. Primary gastric cancer (Correct Answer)
B. Esophageal carcinoma
C. Metastases to stomach
D. Hepatic adenocarcinoma

Explanation: ***Primary gastric cancer*** - Gastric cancers frequently present with **upper gastrointestinal bleeding** due to ulceration or erosion of the tumor into the gastric mucosa [1]. - This is a common and often early symptom that leads to diagnosis, manifesting as **hematemesis** or **melena** [1]. *Esophageal carcinoma* - While esophageal carcinoma can cause bleeding, it is more commonly associated with **dysphagia** and **weight loss** as primary presenting symptoms [1]. - Bleeding from esophageal tumors is generally less frequent and often less severe than from gastric tumors, unless significant ulceration or invasion of large vessels occurs. *Metastases to stomach* - Metastatic tumors to the stomach are relatively rare, and when they occur, they are **often asymptomatic** or present with non-specific symptoms like pain or early satiety. - Clinically significant **upper gastrointestinal bleeding** as the primary presentation is uncommon compared to primary gastric malignancies. *Hepatic adenocarcinoma* - Hepatic adenocarcinoma originates in the liver and typically presents with symptoms related to **liver dysfunction**, such as jaundice, ascites, or right upper quadrant pain [1]. - **Upper gastrointestinal bleeding** is not a direct symptom of hepatic adenocarcinoma, though variceal bleeding can occur secondary to portal hypertension in advanced liver disease [2].

Question 357: Previous radiation therapy for which disease particularly increases the risk of breast carcinoma development?

A. Mantle cell lymphoma
B. Nasopharyngeal carcinoma
C. Lung carcinoma
D. Hodgkin's lymphoma (Correct Answer)

Explanation: No relevant citations met the criteria for inclusion based on the provided references.

Question 358: Which of the following statements about esophageal carcinoma is true?

A. More lethal than the colorectal cancers (Correct Answer)
B. Most esophageal carcinomas are diagnosed at early stages
C. Tumor size is the only significant prognostic factor in esophageal carcinoma
D. These show a decreasing trend in the number of adenocarcinomas globally

Explanation: ### More lethal than the colorectal cancers - Esophageal carcinoma has a **higher mortality rate** due to late presentation and aggressive behavior compared to colorectal cancers. - The overall five-year survival rate for esophageal cancer is significantly **lower** than that of colorectal cancer, emphasizing its lethality [1]. ### Asymptomatic benign lesions should be excised immediately - Not all asymptomatic lesions are malignant; many can be monitored rather than excised, especially if they're **benign**. - **Immediate excision** is not standard practice unless there's a clear risk of malignancy or progression. ### Smaller size esophageal lesions have better survival - While size can influence prognosis, stating that smaller lesions universally equate to **better survival** is an oversimplification. - Other factors like histological type and stage at diagnosis also significantly impact survival, regardless of lesion size [1]. ### These show an increasing trend towards the number of squamous cell carcinomas - Although there was a period of high prevalence of squamous cell carcinoma, the trend is shifting towards **adenocarcinoma**, especially in Western countries. - The overall incidence of esophageal cancers is influenced by lifestyle factors, leading to an increase in adenocarcinomas more than squamous types. **References:** [1] Brian Walker. Davidson's Principles and Practice of Medicine. 22E ed. Treat any precipitating cause, pp. 891-892.

Question 359: What is the percentage of patients with multiple myeloma that exhibit vertebral involvement?

A. 66% of patients
B. 22% of patients
C. 44% of patients
D. 88% of patients (Correct Answer)

Explanation: ***66%*** - Approximately **66% of patients** with multiple myeloma exhibit some degree of **vertebral involvement**, primarily due to osteolytic lesions. - These lesions lead to **vertebral compression fractures** and pain, making vertebrae a common site of affection in this condition [1]. *22%* - This figure is significantly lower than the established data indicating **higher vertebral involvement** in multiple myeloma patients. - Such a low percentage does not reflect the **typical clinical realities** associated with this disease. *88%* - While vertebral involvement is common, **88%** is an overestimation and not supported by clinical evidence. - The risk of **spinal lesions** generally peaks around **66%**, indicating a lower frequency than suggested here. *44%* - This percentage underrepresents the true prevalence of vertebral involvement in multiple myeloma, which is higher. - Clinical findings consistently show that most patients demonstrate at least **some level of vertebral affection**.

Question 360: In which of the following conditions is Bendamustine most commonly used for treatment?

A. Colon carcinoma
B. Breast carcinoma
C. Chronic lymphocytic leukemia (CLL)
D. Non-Hodgkin lymphoma (NHL) (Correct Answer)

Explanation: ***Non-Hodgkin lymphoma (NHL)*** - **Bendamustine** is an **alkylating agent** frequently used in the treatment of various subtypes of **Non-Hodgkin lymphoma (NHL)**, particularly in relapsed or refractory settings, or as first-line therapy [1]. - It is known for its efficacy with a relatively manageable toxicity profile compared to other alkylating agents in NHL [1]. *Colon carcinoma* - **Bendamustine** is **not a standard treatment** for **colon carcinoma**. - Treatment regimens for colon carcinoma commonly involve agents like **5-fluorouracil**, **oxaliplatin**, and **irinotecan**. *Breast carcinoma* - **Bendamustine** is **not a primary chemotherapy agent** for **breast carcinoma**. - Standard chemotherapy for breast cancer often includes **anthracyclines**, **taxanes**, and **cyclophosphamide**. *Chronic lymphocytic leukemia (CLL)* - While **Bendamustine** is also approved and used for **Chronic lymphocytic leukemia (CLL)**, especially in combination with rituximab, it is arguably **most commonly associated with NHL** due to its broader application across various NHL subtypes and different lines of therapy [1]. - For CLL, it is an important option, but its use in NHL is generally more encompassing [1].

Question 361: Granulomatous lung disease is caused by?

A. Bronchogenic carcinoma
B. Sarcoidosis (Correct Answer)
C. Infection
D. Hypersensitivity pneumonitis

Explanation: Hypersensitivity pneumonitis - This condition leads to an immune-mediated inflammatory response in the lungs, resulting in granuloma formation [1]. - Associated with exposure to organic antigens, such as mold spores or animal proteins, which trigger a hypersensitivity reaction [1]. Sarcoma - Sarcomas are malignant tumors arising from mesenchymal tissues, not typically associated with granulomatous inflammation in the lungs. - They present as mass lesions rather than diffuse lung disease with granuloma formation. Bronchogenic carcinoma - This type of cancer arises from the lung epithelium and typically presents with malignant cell proliferation, not granulomatous lesions. [1] - Symptoms are often more consistent with obstructive lung disease rather than the immune response seen in granulomatous conditions. Bronchogenic cyst - A bronchogenic cyst is a developmental anomaly that is a cystic lesion located in the mediastinum or lung but does not involve granulomatous lung disease. - It usually has no inflammatory reaction associated with it and is not caused by an immune response.

Question 362: Which type of paraneoplastic syndrome is most commonly associated with lung carcinoma?

A. SIADH (Correct Answer)
B. Gynaecomastia
C. Acanthosis nigricans
D. Hypocalcaemia

Explanation: ***SIADH*** - Syndrome of Inappropriate Antidiuretic Hormone (SIADH) is the **most common paraneoplastic syndrome** associated with **small cell lung carcinoma (SCLC)** due to ectopic **ADH production** [1], [2]. - It leads to **hyponatremia** and fluid retention, often being the presenting symptom for SCLC patients [3]. *Gynaecomastia* - While possible in some cancers, **gynaecomastia** is not a commonly recognized paraneoplastic syndrome for lung carcinoma. - It is more classically associated with conditions causing hormonal imbalances, such as **testicular tumors** or liver cirrhosis. *Acanthosis nigricans* - This is a cutaneous manifestation characterized by **dark, velvety patches** of skin, typically in body folds. - While it can be a paraneoplastic syndrome, it is more commonly associated with **gastrointestinal adenocarcinomas**, not lung carcinoma. *Hypocalcaemia* - **Hypocalcaemia** (low calcium) is a rare paraneoplastic syndrome of lung cancer. - **Hypercalcaemia** (high calcium) is more commonly associated with lung carcinoma, particularly squamous cell carcinoma, due to the production of PTH-related protein (PTHrP) [1].

Question 363: Most common cancer to occur in organ transplant patients?

A. Squamous cell carcinoma (Correct Answer)
B. Melanoma
C. Lung cancer
D. Colorectal cancer

Explanation: ***Squamous cell carcinoma*** - Organ transplant patients are on lifelong **immunosuppressive therapy**, which significantly increases the risk of **skin cancers**, especially squamous cell carcinoma (SCC) [1]. - The risk of SCC in transplant recipients is 65-250 times higher than in the general population, making it the most common malignancy in this group [1]. *Melanoma* - While the risk of **melanoma** is also increased in transplant patients due to immunosuppression, it is **less common** than squamous cell carcinoma [1]. - The increased risk for melanoma in transplant recipients is roughly 2-5 times higher than the general population, which is considerably lower than the increase for SCC. *Lung cancer* - The risk of **lung cancer** is elevated in transplant patients, particularly in those with a history of smoking, but it is **not the most common cancer** overall. - The incidence is influenced by the patient's age, smoking history, and the type of immunosuppression, but skin cancers consistently rank higher in frequency [2]. *Colorectal cancer* - There is a **modest increase** in the risk of **colorectal cancer** among organ transplant recipients, but it is not the most prevalent malignancy [2]. - The elevation in risk is generally much lower than for skin cancers and certain lymphomas linked to post-transplant immunosuppression [2].

Question 364: What is the primary function of CA-125 in clinical practice?

A. CA-125: Tumor marker specific only for ovarian cancer
B. CA-125: A glycoprotein, tumor marker for ovarian cancer (Correct Answer)
C. CA-125: Diagnostic marker that confirms ovarian cancer diagnosis
D. CA-125: Used primarily for screening healthy women for ovarian cancer

Explanation: ***CA-125: A glycoprotein, tumor marker for ovarian cancer*** - **CA-125** is a **glycoprotein** that serves as a **tumor marker**, primarily recognized for its association with **ovarian cancer**. - While not exclusively specific to ovarian cancer, elevated levels are frequently observed in women with this malignancy, making it useful in diagnosis and monitoring [1]. *CA-125: Tumor marker specific only for ovarian cancer* - **CA-125** is **not specific only for ovarian cancer**; its levels can be elevated in various benign conditions [3]. - Conditions such as **endometriosis**, **pelvic inflammatory disease**, **uterine fibroids**, and even menstruation can cause elevated CA-125 levels. *CA-125: Diagnostic marker that confirms ovarian cancer diagnosis* - **CA-125** is **not a diagnostic marker that confirms ovarian cancer**; a definitive diagnosis requires a biopsy and histopathological examination [1]. - Its utility lies in aiding the **diagnosis**, monitoring **treatment response**, and detecting **recurrence**, but it cannot confirm the disease on its own [2]. *CA-125: Used primarily for screening healthy women for ovarian cancer* - **CA-125** is **not recommended for screening healthy women** due to its low specificity and sensitivity [1]. - Using CA-125 for general population screening would lead to a high rate of **false positives**, resulting in unnecessary invasive procedures.

Question 365: Which malignancy is most commonly associated with hypercalcemia?

A. Breast cancer (Correct Answer)
B. Prostate cancer
C. Small cell lung cancer
D. Multiple myeloma

Explanation: ***Breast cancer*** - While other malignancies can cause hypercalcemia, **breast cancer** is the most common solid tumor associated with **hypercalcemia of malignancy (HCM)** [1], [3]. - Hypercalcemia in breast cancer is commonly due to **bone metastases** causing osteolysis or the tumor secreting **parathyroid hormone-related protein (PTHrP)** [1]. *Small cell lung cancer* - **Small cell lung cancer** is more often associated with **syndrome of inappropriate antidiuretic hormone (SIADH)** leading to hyponatremia [1], [2]. - Although it can cause **HCM**, it is less frequent compared to breast cancer [2]. *Multiple myeloma* - **Multiple myeloma** is a hematologic malignancy that very commonly causes hypercalcemia due to **osteolytic bone lesions** and local cytokine release (e.g., IL-6) [2], [3]. - However, among all malignancies (both solid and hematologic), **breast cancer** remains the most prevalent cause of HCM overall. *Prostate cancer* - **Prostate cancer** often metastasizes to bone, leading to predominantly **osteoblastic** (bone-forming) lesions, which are less likely to cause hypercalcemia. - While osteolytic metastases can occur and lead to hypercalcemia, it's not the most common malignancy to do so.

Question 366: Panitumumab is used for which cancer?

A. Metastatic colorectal cancer (associated with wild-type RAS). (Correct Answer)
B. Non-small cell lung cancer (EGFR mutation-positive).
C. HER2-positive breast cancer.
D. Advanced osteosarcoma (chemotherapy-resistant).

Explanation: ***Metastatic colorectal cancer (associated with wild-type RAS)*** - **Panitumumab** is a **monoclonal antibody** that targets the **epidermal growth factor receptor (EGFR)**, whose overexpression is implicated in CRC. - It is specifically effective in patients with **wild-type RAS** (KRAS and NRAS) genes, as mutations in these genes can lead to **EGFR-independent signaling**, rendering EGFR inhibitors ineffective. *Non-small cell lung cancer (EGFR mutation-positive)* - While **EGFR inhibitors** are used in NSCLC, **Panitumumab** is not the primary agent; drugs like **Osimertinib** or **Erlotinib** are commonly used for EGFR-mutated NSCLC. - **Panitumumab**'s approval is specific to **colorectal cancer** and not NSCLC, despite both involving EGFR signaling. *HER2-positive breast cancer* - **HER2-positive breast cancer** is treated with **HER2-targeted therapies** such as **Trastuzumab** or **Pertuzumab**, which target the Human Epidermal Growth Factor Receptor 2. - **Panitumumab** targets EGFR (HER1) and is not indicated for HER2-positive breast cancer. *Advanced osteosarcoma (chemotherapy-resistant)* - **Osteosarcoma** is a bone cancer with treatment regimens typically involving **chemotherapy** and surgery, while targeted therapies for this specific cancer are still under active investigation. - **Panitumumab** has no established role or approval in the treatment of osteosarcoma.

Question 367: Carcinoembryonic antigen (CEA) is raised in which of the following conditions?

A. Sickle cell anemia
B. Inflammatory bowel disease (Correct Answer)
C. Colorectal cancer
D. Hepatitis

Explanation: Carcinoembryonic antigen (CEA) is raised in which of the following conditions? ***Inflammatory bowel disease*** - **Carcinoembryonic antigen (CEA)** levels can be elevated in various inflammatory conditions, including **inflammatory bowel disease (IBD)** [1], due to tissue inflammation and turnover, even in the absence of malignancy. - While primarily associated with malignancy, CEA is not specific and can be a non-specific marker of inflammation. *Sickle cell anemia* - **Sickle cell anemia** is a genetic **hemoglobinopathy** characterized by abnormal hemoglobin, leading to red blood cell sickling and hemolysis. - It does not typically cause an elevation in **CEA levels**, as it is not a direct inflammatory or cancerous condition linked to CEA production. *Colorectal cancer* - Although **colorectal cancer** [2] is the most well-known condition associated with significantly elevated **CEA levels**, particularly for monitoring recurrence, the question asks where CEA is "raised," implying conditions beyond just malignancy. - High CEA in colorectal cancer reflects the production of this **onco-fetal glycoprotein** [2] by cancerous cells. *Hepatitis* - **Hepatitis**, an inflammation of the liver, can cause a rise in liver enzymes and other inflammatory markers. - However, **CEA levels** are not typically elevated in hepatitis unless there is an underlying malignancy or severe liver cirrhosis, which is not directly implied by the term "hepatitis" alone.

Question 368: Screening is not useful in which carcinoma

A. Testicular carcinoma (Correct Answer)
B. Carcinoma prostate
C. Carcinoma colon
D. Carcinoma breast

Explanation: Testicular carcinoma - **Testicular cancer** typically presents as a painless mass, and **self-examination** is often emphasized for early detection rather than formal screening programs due to low incidence and variable benefits. - While early detection is important, population-wide screening for testicular cancer is **not recommended** due to its rarity and lack of evidence for improved outcomes compared to opportunistic detection. *Carcinoma prostate* - **Prostate cancer screening** using **PSA (prostate-specific antigen)** testing and digital rectal examinations is routinely performed, though its benefits and risks are debated [1]. - Early detection aims to identify potentially aggressive cancers, but also leads to **overdiagnosis and overtreatment** of indolent lesions [1]. *Carcinoma colon* - **Colorectal cancer screening** is highly effective and widely recommended through methods like **colonoscopy**, fecal occult blood testing, and sigmoisingoscopy. - Screening aims to detect **polyps** before they become cancerous or find cancer at an early, treatable stage, significantly reducing mortality. *Carcinoma breast* - **Breast cancer screening** using **mammography** is a well-established and highly effective method for early detection in women. - Early detection allows for timely treatment, significantly improving prognosis and reducing breast cancer mortality.

Question 369: Which is the most common tumor leading to death in adults?

A. Lung cancer (Correct Answer)
B. Prostate cancer
C. Colorectal cancer
D. Leukemia

Explanation: ***Lung cancer*** - **Lung cancer** is the most common cause of cancer-related death in both men and women worldwide [1], [2]. - Its high mortality is attributed to its aggressive nature, late diagnosis, and limited treatment options for advanced stages [3]. *Prostate cancer* - While **prostate cancer** is very common in men, it typically has a slower progression and a relatively high survival rate compared to lung cancer. - Early detection through screening often leads to successful treatment and a good prognosis. *Colorectal cancer* - **Colorectal cancer** is a significant cause of cancer mortality but ranks behind lung cancer in overall deaths [2]. - Improved screening methods like colonoscopies allow for early detection and removal of precancerous polyps, reducing mortality. *Leukemia* - **Leukemia** refers to cancers of the blood and bone marrow, and while serious, they are less common causes of cancer death than solid tumors like lung, colorectal, or prostate cancer [2]. - Advances in chemotherapy, stem cell transplantation, and targeted therapies have significantly improved survival rates for many types of leukemia.

Question 370: All of the following are paraneoplastic syndromes for renal cell carcinoma except which of the following?

A. Fever
B. Amyloidosis
C. Anaemia
D. Acanthosis Nigricans (Correct Answer)

Explanation: Acanthosis Nigricans - Acanthosis nigricans is primarily associated with **insulin resistance** and is not a known paraneoplastic syndrome related to renal cell carcinoma. - Paraneoplastic syndromes typically involve **systemic effects** of tumors rather than dermatological manifestations like acanthosis nigricans. *Fever* - Fever can occur as a result of the body's response to tumors, including renal cell carcinoma, and is classified as a **paraneoplastic syndrome**. - It reflects the **systemic inflammatory response** often seen with malignancies. *Anaemia* - Anaemia is a common paraneoplastic syndrome associated with renal cell carcinoma due to the production of **erythropoietin** or as a result of **chronic disease** [1]. - It can lead to **fatigue** and pallor in affected individuals, making it relevant to renal cancers [1]. *Amyloidosis* - Amyloidosis can occur as a paraneoplastic syndrome in various malignancies, including renal cell carcinoma, due to **protein misfolding** states. - It can lead to complications affecting **kidney function** and other organs, aligning it with renal cell carcinoma, though kidney tumors also frequently present with hypercalcemia [1].

Question 371: Which of the following is not associated with Carney's triad?

A. Atrial myxoma (Correct Answer)
B. GIST
C. Chondroma
D. Paraganglioma

Explanation: ***Atrial myxoma*** - Atriomyxoma is not part of **Carney's triad**, which primarily includes **paraganglioma**, **chondroma**, and **gastrointestinal stromal tumors (GIST)**. - Carney's triad is a rare genetic condition associated with **multiple neoplasms**, and atrial myxomas are cardiac tumors, not part of this triad. *Paraganglioma* - Paragangliomas are tumors derived from **neuroendocrine cells**, and they are one of the key components of **Carney's triad**. - They typically arise in **chromaffin tissue**, which is involved in catecholamine secretion. *Chondroma* - Chondromas are benign tumors of **cartilage**, also recognized as a component of **Carney's triad**. - They are often found in the **bones** or soft tissues, but they are part of the neoplasms associated with this condition. *GIST* - Gastrointestinal stromal tumors (GISTs) are significant neoplasms linked to **Carney's triad**, arising from **interstitial cells of Cajal** in the GI tract. - They are characterized by specific mutations and can be a source of gastrointestinal symptoms in affected individuals.

Question 372: What is the most common cause of death in patients with advanced cancer?

A. Bleeding
B. Infection (Correct Answer)
C. Respiratory failure
D. Renal failure

Explanation: ***Infection*** - **Immunosuppression** from cancer itself and its treatments (e.g., chemotherapy, radiation) significantly increases susceptibility to infections. - Many patients with advanced cancer die from **sepsis** or opportunistic infections due to their weakened immune systems [1]. *Bleeding* - While bleeding can be a significant complication in advanced cancer (e.g., from tumor erosion, thrombocytopenia), it is less common as a direct cause of death compared to infection. - Life-threatening hemorrhages are typically managed, and other factors often contribute to mortality. *Respiratory failure* - **Respiratory failure** can occur due to **lung metastases**, direct tumor invasion, or complications like pneumonia in advanced cancer patients. - However, the underlying cause of such pneumonia or decline is often infectious or a result of systemic weakness. *Renal failure* - **Renal failure** can be caused by tumor obstruction of the urinary tract, **nephrotoxic chemotherapy**, or paraneoplastic syndromes. - Although serious, it is not the most frequent immediate cause of death in the broad population of advanced cancer patients.

Question 373: CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is being investigated for the treatment of which malignancy?

A. Acute Lymphoblastic Leukemia (Correct Answer)
B. Renal Cell Carcinoma
C. Pancreatic Cancer
D. Glioblastoma Multiforme

Explanation: ***Acute Lymphoblastic Leukemia*** - **CAR T-cell therapy** has shown remarkable success, particularly in treating refractory or relapsed **B-cell acute lymphoblastic leukemia (ALL)** in children and young adults. - The therapy targets the **CD19 antigen** found on malignant B-cells, leading to their destruction by engineered T-cells. *Renal Cell Carcinoma* - While immune therapies are used for **renal cell carcinoma (RCC)**, traditional CAR T-cell therapy targeting specific antigens has not yet achieved widespread clinical success for this solid tumor. - RCC often presents with a **heterogeneous antigenic landscape**, making it challenging for single-target CAR T-cells. *Pancreatic Cancer* - **Pancreatic cancer** is a challenging malignancy due to its dense stroma and immunosuppressive microenvironment, which limits T-cell infiltration and efficacy. - CAR T-cell therapy for pancreatic cancer is still largely in **early-stage clinical trials**, facing significant hurdles in solid tumor treatment. *Glioblastoma Multiforme* - **Glioblastoma multiforme (GBM)** is an aggressive brain tumor with unique challenges for CAR T-cell therapy, including the **blood-brain barrier** and tumor heterogeneity. - Research is ongoing to develop CAR T-cells that can effectively target GBM, often using **regional delivery methods** or targeting multiple antigens.

Question 374: Classic triad in Renal cell carcinoma includes all of the following, Except:

A. Hematuria
B. Hypertension (Correct Answer)
C. Flank mass
D. Abdominal Pain

Explanation: ***Hypertension*** - While hypertension can occur in patients with renal cell carcinoma due to **renin secretion** or other mechanisms, it is **not considered one of the classic triad symptoms**. - The classic triad represents symptoms that historically led to diagnosis, though most RCCs are now discovered incidentally. *Hematuria* - **Gross or microscopic hematuria** is a common symptom of renal cell carcinoma [1], resulting from tumor invasion into the collecting system. - It is one of the **three classic symptoms** associated with advanced disease. *Flank mass* - A palpable **flank mass** indicates a sizable tumor infiltrating the renal parenchyma and is a classic sign of renal cell carcinoma [1]. - This symptom is often associated with later-stage disease. *Abdominal Pain* - **Flank pain** or abdominal pain is a frequent symptom of renal cell carcinoma, which may be caused by tumor growth, hemorrhage, or obstruction. - This symptom, along with hematuria and a flank mass, constitutes the **classic diagnostic triad**.

Question 375: Which of the following is true regarding carcinoid tumor?

A. Associated with serotonin production
B. Potentially malignant tumor
C. Neuroendocrine tumor (Correct Answer)
D. Most common site is lung

Explanation: ### Most common site is lung - Carcinoid tumors are more commonly found in the **gastrointestinal tract**, specifically the appendix and ileum, rather than the lungs [1]. - This statement is false as they can occur in the lungs but are not the most common site overall. ### Potentially malignant tumor - Carcinoid tumors can be classified as **malignant,** especially if they show aggressive behavior or metastasis. - Many carcinoid tumors, particularly those in the gastrointestinal tract, can be **non-functional** and less aggressive [1]. ### Neuroendocrine tumor - Carcinoid tumors are indeed a type of **neuroendocrine tumor**, arising from **neuroendocrine cells**. - This classification emphasizes their origin and potential for secretion of hormones like **serotonin**. ### Associated with serotonin production - Many carcinoid tumors produce **serotonin**, leading to symptoms like **carcinoid syndrome** when they metastasize, particularly to the liver [1]. - This statement is true, indicating their involvement in neuroendocrine secretions.

Question 376: Major contribution to cachexia with advanced cancer?

A. Tumor-necrosis-factor (TNF) (Correct Answer)
B. Histamine
C. Interferon
D. Clathrin

Explanation: ***Tumor-necrosis-factor (TNF)*** - **Tumor necrosis factor (TNF-α)** is a prominent cytokine involved in the pathogenesis of cancer cachexia, leading to muscle wasting and weight loss [1]. - It induces inflammation, increases **catabolism**, and reduces anabolism, contributing significantly to the metabolic dysfunction seen in cancer patients [1]. *Histamine* - **Histamine** is primarily known for its role in allergic reactions and inflammatory responses, but it is not a major direct driver of cachexia. - While it can be released in various inflammatory conditions, its direct contribution to the severe muscle wasting and metabolic changes of cachexia is limited compared to other cytokines. *Interferon* - **Interferons (IFNs)** are cytokines typically associated with antiviral responses and immune modulation, which can have diverse effects on metabolism. - While some interferons can indirectly contribute to systemic inflammation and fatigue, they are not considered a primary or major direct mediator of muscle catabolism and fat loss characteristic of cancer cachexia. *Clathrin* - **Clathrin** is a protein involved in the formation of clathrin-coated vesicles, essential for **endocytosis** and intracellular trafficking. - It has no direct role in the systemic metabolic dysregulation or muscle wasting associated with cancer cachexia.

Question 377: All are common sites of primary cancer for bone metastasis except:

A. Prostate
B. Lung
C. Brain (Correct Answer)
D. Thyroid

Explanation: ***Brain*** - The **brain** is not a common site for primary bone metastasis, as bone metastases typically originate from organs like the **breast**, **lung**, and **prostate**. - While brain tumors can metastasize to bone, the reverse (primary bone cancer) occurring here is rare. *Breast* - Breast cancer is one of the **most prevalent sources** of bone metastases, commonly affecting the spine and pelvis. - Symptoms often include **bone pain** and potential fractures due to metastasis. *Brain* - Similar to , while brain tumors can metastasize, **primary cancers** do not commonly originate in the bone. - The **metastatic spread** to the brain from other primary sites is common, but not the other way around. *Breast* - Again, breast cancer commonly leads to **bone metastasis**, accounting for a significant percentage of these cases. - It is important to identify busy metastasis to **manage** symptoms and improve patient outcomes.

Question 378: Which of the following is a feature of tumor lysis syndrome?

A. Metabolic alkalosis (a rise in blood pH)
B. Hypokalemia (a decrease in blood potassium levels)
C. Hypocalcemia (a decrease in blood calcium levels) (Correct Answer)
D. Hypophosphatemia (a decrease in blood phosphate levels)

Explanation: ***Hypocalcemia (a decrease in blood calcium levels)*** - **Hypocalcemia** in tumor lysis syndrome results from the precipitation of calcium with excessive phosphate released from lysed tumor cells. - The elevated phosphate levels bind to calcium, forming **calcium phosphate crystals** that can deposit in tissues, further lowering serum calcium. *Metabolic alkalosis (a rise in blood pH)* - Tumor lysis syndrome typically leads to **metabolic acidosis**, not alkalosis, due to the release of acidic intracellular metabolites like uric acid and phosphate. - The accumulation of these acidic compounds overwhelms the body's buffering systems, decreasing blood pH. *Hypokalemia (a decrease in blood potassium levels)* - Tumor lysis syndrome is characterized by **hyperkalemia**, an increase in blood potassium, as potassium is a major intracellular cation released during cell lysis. - The rapid breakdown of numerous tumor cells dumps vast amounts of intracellular potassium into the bloodstream. *Hypophosphatemia (a decrease in blood phosphate levels)* - Tumor lysis syndrome causes **hyperphosphatemia**, an elevation in blood phosphate levels, because phosphate is abundantly present within tumor cells and is released upon their destruction. - This excessive release of intracellular phosphate is a hallmark biochemical feature of the syndrome.

Question 379: Chemotherapeutic Agent of Choice for the treatment of CML?

A. Imatinib (Correct Answer)
B. Vincristine
C. Cyclophosphamide
D. Methotrexate

Explanation: ***Imatinib*** - **Imatinib** is a **tyrosine kinase inhibitor** specifically targeting the **BCR-ABL fusion protein**, which is the hallmark of CML [1][2]. - It dramatically improved the prognosis of CML patients, making it the **first-line therapy** and agent of choice due to its high efficacy and relatively low toxicity compared to conventional chemotherapy [2]. *Vincristine* - **Vincristine** is a **vinca alkaloid** that inhibits microtubule formation, primarily used in acute leukemias and lymphomas. - It is not the agent of choice for CML due to its different mechanism of action and the availability of more targeted therapies for CML. *Cyclophosphamide* - **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, used in various cancers and autoimmune diseases. - While it can be used in some hematologic malignancies, it is not the preferred or most effective treatment for CML, especially given the success of targeted therapies. *Methotrexate* - **Methotrexate** is an **antimetabolite** that interferes with DNA synthesis, commonly used in acute leukemias, lymphomas, and autoimmune conditions. - It is not considered the chemotherapeutic agent of choice for CML, as its mechanism of action is not specific to the BCR-ABL anomaly characteristic of CML.

Question 380: What is true about HER2/neu overexpression in cancer?

A. Good prognosis
B. Responds well to taxanes
C. Responds well to monoclonal antibodies (Correct Answer)
D. Seen in various cancers, including breast cancer

Explanation: ***Responds well to monoclonal antibodies*** - HER2/neu overexpression is targeted by **monoclonal antibodies** like trastuzumab (Herceptin), improving treatment outcomes [1]. - These therapies are specifically designed to **inhibit HER2-positive** tumors, leading to better overall prognosis compared to those without such therapies [1]. *Good prognosis* - HER2/neu overexpression is generally associated with a **poor prognosis** due to increased aggressiveness of the cancer. - It correlates with **higher rates of recurrence** and metastasis compared to HER2-negative breast cancers. *Responds well to taxanes* - While taxanes are commonly used in breast cancer treatment, HER2/neu positivity does not specifically imply a good response. - Response rates may not significantly differ based on HER2 status for taxane-based therapies alone. *Seen only in breast cancer* - HER2/neu overexpression can also occur in other cancers, such as **gastric and gastroesophageal junction cancers**. - It is not exclusive to breast cancer, though it is most commonly studied in this context [1].

Question 381: Which type of cancer is most commonly associated with exposure to thorium?

A. Angiosarcoma of liver (Correct Answer)
B. Renal cell carcinoma
C. Lymphoma
D. Astrocytoma

Explanation: ***Angiosarcoma of liver*** - Thorium exposure is strongly associated with **angiosarcoma**, particularly in the liver, due to its carcinogenic properties. - Clinical findings often include **abdominal pain**, hepatomegaly, and elevated liver enzymes, indicative of liver involvement. *Renal cell carcinoma* - Commonly presents with **hematuria**, weight loss, and flank pain, and is not specifically linked to thorium exposure. - Typically arises from the **renal parenchyma**, not the liver, differentiating it from thorium-related tumors. *Astrocytoma* - Primarily a **central nervous system tumor**, often presenting with seizures, neurological deficits, and headaches. - Lacks an association with thorium exposure, focusing instead on genetic and environmental risk factors. *Lymphoma* - Usually presents with **lymphadenopathy**, fever, weight loss, and night sweats, without a clear link to thorium. - Associated more with **immune system** compromise and infections, differing significantly from thorium-induced cancers.

Question 382: All of the following are risk factors for carcinoma of the gallbladder, EXCEPT -

A. Adenomatous gall bladder polyps
B. Choledochal cysts
C. Oral contraceptives (Correct Answer)
D. Typhoid carriers

Explanation: ***Oral contraceptives*** - While **oral contraceptives** can increase the risk of **gallstones**, they are not directly recognized as a specific risk factor for **gallbladder carcinoma**. - The impact of oral contraceptives on gallbladder cancer risk is generally considered to be minor or non-existent compared to established risk factors. *Typhoid carriers* - **Chronic asymptomatic carriers of Salmonella Typhi** have a significantly increased risk of developing **gallbladder carcinoma**, likely due to chronic inflammation and cellular damage. - The bacteria can reside in the gallbladder for years, leading to a persistent inflammatory state and genetic mutations. *Adenomatous gall bladder polyps* - **Adenomatous polyps** in the gallbladder are considered **premalignant lesions**, especially if they are larger than 10 mm, and are associated with an increased risk of progression to adenocarcinoma. - Their presence indicates a need for careful monitoring and often surgical removal due to their malignant potential. *Choledochal cysts* - **Choledochal cysts**, congenital dilations of the bile ducts, are well-established risk factors for **cholangiocarcinoma** (bile duct cancer) and, less commonly, **gallbladder carcinoma**. - The stasis and reflux of bile within these cysts lead to chronic irritation and inflammation, increasing the risk of malignant transformation.

Question 383: Tumor marker for medullary carcinoma of the thyroid is:

A. Albumin
B. TSH
C. Thyroglobulin
D. Calcitonin (Correct Answer)

Explanation: Everything in the original explanation remains unchanged as none of the provided references [1, 2, 3, 4, 5] were relevant to Medullary Thyroid Carcinoma or Calcitonin. ***Calcitonin*** - **Calcitonin** is a hormone produced by the parafollicular C cells of the thyroid gland. Medullary thyroid carcinoma originates from these C cells. - Elevated serum calcitonin levels are a highly sensitive and specific **tumor marker** for both diagnosis and monitoring of medullary thyroid carcinoma. *Albumin* - **Albumin** is a protein primarily produced by the liver, essential for maintaining oncotic pressure and transporting various substances in the blood. - It is not a tumor marker for any specific thyroid cancer. *TSH* - **Thyroid-stimulating hormone (TSH)** is produced by the pituitary gland and regulates thyroid hormone production by follicular cells. - While TSH levels are crucial in evaluating other thyroid disorders, they are not a specific tumor marker for medullary thyroid carcinoma, which arises from C cells, not follicular cells. *Thyroglobulin* - **Thyroglobulin** is a protein produced by the follicular cells of the thyroid gland and is the precursor to thyroid hormones. - It serves as a tumor marker for **differentiated thyroid cancers** (papillary and follicular carcinoma), but not for medullary thyroid carcinoma.

Question 384: Which cancer most commonly metastasizes to the brain?

A. Lung cancer (Correct Answer)
B. Head and neck cancer
C. Prostate cancer
D. Breast cancer

Explanation: ***Lung cancer*** - Lung cancer is the most common source of **brain metastases**, accounting for approximately **40%** of cases. - It often leads to **multiple metastases** due to hematogenous spread to the brain, especially affecting the **cerebral hemispheres**. - The brain is a favored site of metastases for lung carcinomas, with approximately **20%** of cases involving brain metastases. *Prostate cancer* - While prostate cancer can metastasize to the brain, it is much less common than lung cancer, primarily spreading to **bones** and **lymph nodes**. - When it does metastasize, it usually manifests later in the disease course compared to lung cancer. *Breast cancer* - Although breast cancer is also a known cancer that can metastasize to the brain, it ranks below lung cancer in incidence of brain metastasis, typically seen in advanced cases. - It often leads to single or few lesions in the brain as compared to the **multiplicity** seen with lung cancer. *Head and neck cancer* - Head and neck cancers metastasize predominantly to regional lymph nodes more than the brain. - They are less associated with brain metastases compared to **lung**, **breast**, or **melanoma** cancers.

Question 385: A 57-year-old man presents with hemoptysis and generalized weakness. His symptoms began with small-volume hemoptysis 4 weeks ago, followed by progressive weakness, fatigue, and weight loss over the past 2 weeks. He has a 45-pack-year history of cigarette smoking. Physical examination is unremarkable, and laboratory studies reveal mild anemia and hyponatremia. Chest x-ray shows a 5-cm left, mid-lung field mass with mediastinal lymphadenopathy. MR scan of the brain is normal. What is the most likely cause of his symptoms?

A. Bronchial carcinoid tumor
B. Lung adenocarcinoma
C. Small cell lung carcinoma (Correct Answer)
D. Lung abscess

Explanation: ***Small cell lung carcinoma*** - This presentation, including **hemoptysis** [1], **progressive weakness**, **fatigue**, **weight loss** [2], and a **large lung mass with mediastinal lymphadenopathy** in a heavy smoker [3], is highly characteristic of **small cell lung carcinoma (SCLC)**. - The presence of **hyponatremia** suggests **syndrome of inappropriate antidiuretic hormone (SIADH)**, a common paraneoplastic syndrome associated with SCLC due to ectopic ADH production [2]. *Bronchial carcinoid tumor* - While carcinoid tumors can cause hemoptysis, they typically grow slowly and are characterized by **neuroendocrine symptoms** (e.g., flushing, diarrhea, wheezing) that are not mentioned here. - Malignant carcinoid tumors are less common and rarely present with such rapid progressive systemic symptoms and extensive lymphadenopathy. *Lung adenocarcinoma* - Adenocarcinoma often presents with a mass and can cause hemoptysis and systemic symptoms, but it is **less strongly associated with SIADH** and mediastinal lymphadenopathy in the initial presentation compared to SCLC. - While adenocarcinoma is common in smokers, the rapid progression and specific paraneoplastic finding point more towards SCLC. *Lung abscess* - A lung abscess typically presents with **fever**, **productive cough of purulent sputum**, and often pleuritic chest pain, which are absent in this case [4]. - While an abscess can cause hemoptysis and general malaise, the presence of **lymphadenopathy** and the rapid progression with hyponatremia are not typical features [4].

Question 386: A patient with Hodgkin's lymphoma presents with isolated cervical lymphadenopathy, and biopsy from the lesion shows characteristic lacunar cells. The treatment of choice for this patient is:

A. Chemotherapy with Radiotherapy (Correct Answer)
B. Chemotherapy alone
C. Radiotherapy alone
D. No treatment needed

Explanation: ### Chemotherapy with Radiotherapy - This combination is the standard of care for most stages of **Hodgkin's lymphoma**, including early-stage disease with localized **lymphadenopathy**. [1] - **Chemotherapy** targets systemic disease while **radiotherapy** delivers localized high-dose treatment to affected lymph nodes, improving local control and preventing recurrence. ### Chemotherapy alone - While chemotherapy is crucial for **systemic disease control** in Hodgkin's lymphoma, using it alone for localized disease might lead to a higher risk of local recurrence compared to combined modality therapy. - In certain very early stages or specific patient populations, this might be considered, but generally, local control with **radiotherapy** is preferred for isolated disease. ### Radiotherapy alone - **Radiotherapy alone** was historically used for early-stage Hodgkin's lymphoma but has been largely replaced by combined modality therapy due to better **overall survival** and disease control with the addition of chemotherapy. [1] - It might be considered in very specific, highly localized, and favorable presentations, but in the presence of **lacunar cells** and the aim for optimal outcome, combined modality therapy is preferred. ### No treatment needed - **Hodgkin's lymphoma** is a malignant neoplastic disease that requires active treatment to achieve remission and cure. - Untreated **Hodgkin's lymphoma** is a progressive and fatal disease, making "no treatment" an inappropriate option.

Question 387: Which of the following is used in the treatment of well-differentiated thyroid carcinoma?

A. I131 (Correct Answer)
B. 99m Tc
C. 32p
D. MIBG

Explanation: ***I131*** - **Radioactive iodine (I131)** is specifically absorbed by **well-differentiated thyroid cancer cells** because these cells retain the ability to uptake iodine, unlike other types of cancer cells. - Used for **ablating residual thyroid tissue** after surgery and for treating **metastatic well-differentiated thyroid carcinoma** [1]. *99m Tc* - **Technetium-99m (99m Tc)** is primarily used for **diagnostic imaging** (e.g., thyroid scans, bone scans), not for therapeutic treatment of thyroid cancer. - It has a short half-life and emits gamma rays, making it suitable for imaging but generally not for delivering sustained radiation for therapeutic effect. *32p* - **Phosphorus-32 (32p)** is a beta-emitting radionuclide used in the treatment of certain hematological malignancies, such as **polycythemia vera**, and for palliative treatment of bone metastases. - It is not selectively taken up by thyroid cancer cells and therefore is not used in the treatment of thyroid carcinoma. *MIBG* - **Metaiodobenzylguanidine (MIBG)**, often labeled with I123 (diagnostic) or I131 (therapeutic), is used in the diagnosis and treatment of **neuroendocrine tumors** like **pheochromocytoma** and **neuroblastoma**. - Its uptake mechanism targets cells of neuroectodermal origin, which is distinct from the iodine uptake mechanism of thyroid cells.

Question 388: A 50-year-old woman is discovered to have metastatic breast cancer and develops bacterial pneumonia one week after receiving her first dose of chemotherapy. Which of the following best explains this patient's susceptibility to bacterial infection?

A. Depletion of serum complement
B. Impaired neutrophil respiratory burst
C. Inhibition of clotting factor activation
D. Neutropenia (Correct Answer)

Explanation: ***Neutropenia*** - **Chemotherapy** often causes **bone marrow suppression**, leading to a decrease in the absolute number of **neutrophils**, a condition known as neutropenia. - Neutrophils are crucial for the primary defense against **bacterial and fungal infections**, and their depletion significantly increases susceptibility, especially to **bacterial pneumonia**. *Depletion of serum complement* - While complement deficiency can increase susceptibility to certain infections, it is not a direct or common side effect of typical **chemotherapy regimens**. - Complement deficiencies are often **genetic** or related to specific **autoimmune diseases**, which are not indicated as the primary cause here. *Impaired neutrophil respiratory burst* - Impaired **neutrophil respiratory burst** (e.g., in **chronic granulomatous disease**) leads to a reduced ability to kill ingested bacteria, resulting in recurrent infections. - While chemotherapy can affect neutrophil function, severe impairment of the respiratory burst is not the primary mechanism of increased infection risk one week post-treatment; **neutropenia** is more immediate and profound. *Inhibition of clotting factor activation* - **Inhibition of clotting factor activation** would primarily manifest as **bleeding disorders**, not increased susceptibility to bacterial infections. - Chemotherapy can affect platelet count and function, but this mechanism does not directly explain increased risk of **bacterial pneumonia**.

Question 389: All of the following statements about nasopharyngeal carcinoma are true, except:

A. IgA antibody to EBV is observed
B. Squamous cell carcinoma is the most common histological subtype
C. Bimodal age distribution
D. Nasopharyngectomy with radical neck dissection is the treatment of choice (Correct Answer)

Explanation: ***Nasopharyngectomy with radical neck dissection is the treatment of choice*** - This statement is incorrect because **radiation therapy** (often with chemotherapy) is the primary treatment for nasopharyngeal carcinoma due to its location and radiosensitivity. - **Surgical resection** (nasopharyngectomy) is rarely performed as the initial treatment for nasopharyngeal carcinoma, even for early stages, due to the complex anatomy and high morbidity of the region. *Bimodal age distribution* - This statement is true; nasopharyngeal carcinoma shows a **bimodal age distribution**, with peaks in adolescence/young adulthood and again in older individuals (50-60 years old). - This pattern is particularly evident in endemic regions and is often linked to **Epstein-Barr virus (EBV)** infection. *IgA antibody to EBV is observed* - This statement is true; elevated levels of **IgA antibodies to EBV viral capsid antigen (VCA)** and other EBV-related proteins are commonly observed in patients with nasopharyngeal carcinoma. - These antibodies are useful biomarkers for **screening, diagnosis, and monitoring disease recurrence**, especially in endemic areas. *Squamous cell carcinoma is the most common histological subtype* - This statement is true; **undifferentiated nasopharyngeal carcinoma (WHO type III)**, which is a subtype of squamous cell carcinoma, is the most common histological type, especially in endemic regions. - This subtype is strongly associated with **Epstein-Barr virus (EBV)** infection and has a relatively good prognosis compared to other head and neck squamous cell carcinomas due to its radiosensitivity.

Question 390: Which of the following malignancies is most sensitive to radiotherapy?

A. Dysgerminoma (Correct Answer)
B. Teratoma
C. Hodgkin lymphoma
D. Seminoma

Explanation: ***Dysgerminoma*** - **Dysgerminomas** are highly sensitive to **radiotherapy** due to their undifferentiated, rapidly proliferating nature, making radiation an effective primary or adjuvant treatment. - This sensitivity allows for effective **local tumor control** and can contribute to excellent prognosis, even in advanced stages. *Seminoma* - While **seminomas** are radiosensitive, **dysgerminomas** (which are the ovarian equivalent of seminomas) are generally considered *more* radiosensitive among germ cell tumors. - Radiation is often considered for seminomas, but its efficacy is also high with combination chemotherapy. *Hodgkin lymphoma* - **Hodgkin lymphoma** is highly curable with **radiotherapy**, especially in early stages, as lymph nodes are often targeted effectively [1]. - However, the definition of "most sensitive" often refers to tumors that respond to relatively lower doses of radiation for local control, for which germ cell tumors like dysgerminoma are prime examples. *Teratoma* - **Teratomas**, particularly mature teratomas, are generally **radioresistant** due to their differentiated histological components. - While immature teratomas may show some response, chemotherapy is the primary treatment for malignant forms, and radiation plays a minor role.

Question 391: Birt-Hogg-Dubé syndrome is associated with:

A. Renal cell carcinoma (RCC) (Correct Answer)
B. Lung cancer
C. Stomach cancer
D. Ovarian cancer

Explanation: ***Renal cell carcinoma (RCC)*** - Birt-Hogg-Dubé syndrome is an **autosomal dominant disorder** characterized by an increased risk of developing **renal cell carcinoma**, particularly **chromophobe** and **oncocytic hybrid tumors**. - It results from mutations in the **FLCN gene**, which encodes the protein folliculin. *Lung cancer* - While Birt-Hogg-Dubé syndrome is associated with **pulmonary cysts** and an increased risk of **spontaneous pneumothorax**, it is not directly linked to an increased risk of **primary lung cancer**. - The cystic lung changes are distinct from cancerous lesions. *Stomach cancer* - There is **no established association** between Birt-Hogg-Dubé syndrome and an increased risk of developing **stomach cancer**. - The syndrome primarily affects the skin, lungs, and kidneys. *Ovarian cancer* - Birt-Hogg-Dubé syndrome has **no known association** with an increased incidence of **ovarian cancer**. - The clinical manifestations are generally limited to specific organs mentioned earlier.

Question 392: For which malignancy is intensity-modulated radiotherapy (IMRT) the most suitable?

A. Lung
B. Prostate (Correct Answer)
C. Leukemias
D. Stomach

Explanation: ***Prostate*** - **IMRT** is highly suitable for prostate cancer due to the prostate's proximity to critical organs like the **rectum and bladder**. - Its ability to conform the **radiation dose tightly** to the tumor while sparing adjacent healthy tissue significantly reduces side effects like **rectal bleeding** or **urinary dysfunction** [1]. *Lung* - While IMRT is used in lung cancer, especially for complex tumors near vital structures, **stereotactic body radiation therapy (SBRT)** is often preferred for early-stage lung cancer due to its high dose delivery over fewer fractions. - The **motion of the lung** during respiration can make precise IMRT delivery challenging without specialized techniques like **gating or tracking**. *Leukemias* - **Leukemias** are systemic diseases involving blood and bone marrow, making localized radiation therapies like IMRT generally unsuitable as a primary treatment. - Treatment for leukemias primarily involves **chemotherapy, targeted therapy, or stem cell transplant**. *Stomach* - **Stomach cancer** often requires larger radiation fields due to tumor spread and nodal involvement, making the precise dose sculpting of IMRT less advantageous compared to its benefits in smaller, well-defined tumors. - The **mobility of the stomach** and surrounding organs can also present challenges for highly conformal radiation delivery.

Question 393: What is the most significant factor associated with the causation of head and neck carcinoma?

A. Intravenous drug abuse
B. Exposure to nickel
C. History of syphilis
D. Tobacco use (Correct Answer)

Explanation: ***Tobacco use*** [1] - Tobacco use is the most significant risk factor for head and neck carcinomas, with strong evidence linking it to both oral and pharyngeal cancers. [1] - It promotes carcinogenic changes in the mucosal lining of the head and neck, significantly increasing the risk of malignancy. [1] *History of syphilis* - While syphilis has been linked to oropharyngeal squamous cell carcinoma, its role is less significant than tobacco. - Other factors, such as HPV infection, are more clinically relevant for head and neck cancers associated with syphilis. [1] *Exposure to nickel* - Nickel exposure is primarily associated with respiratory cancers, particularly lung cancer, rather than head and neck cancers. - The connection to head and neck carcinoma is not well established, making it a minor risk factor compared to tobacco. *Intravenous drug abuse* - Although intravenous drug abuse may lead to other health complications, it is not a direct significant risk factor for head and neck carcinoma. - Other lifestyle choices and exposures, particularly tobacco, play a much larger role in the development of these cancers.

Question 394: A 70-year-old woman with a history of ovarian cancer presents with diarrhea, having completed radiation therapy for her cancer 3 months prior. Physical examination reveals cachexia, hyperactive bowel sounds, and generalized pallor. The stools contain blood, and a complete blood count shows decreased hemoglobin (7.8 g/dL) and decreased mean corpuscular volume (70 fL). Which of the following is the most likely cause of gastrointestinal bleeding in this patient?

A. Angiodysplasia
B. Hemorrhoids
C. Ischemic colitis
D. Radiation enterocolitis (Correct Answer)

Explanation: ***Radiation enterocolitis*** - Following radiation therapy, patients can develop inflammation and damage to the **intestinal lining**, leading to symptoms such as diarrhea and gastrointestinal bleeding [1]. - The presence of **cachexia** and **decreased hemoglobin** indicates significant pathology, aligning with this diagnosis following her recent treatment for ovarian cancer. *Ischemic colitis* - Often presents with **abdominal pain** and is usually associated with risk factors like **vascular disease**, which is not described here [2]. - Symptoms typically include **bloody diarrhea**, but the link with recent radiation therapy makes this diagnosis less likely. *Hemorrhoids* - Generally cause **bright red blood per rectum** and are more associated with changes in bowel habits rather than diarrhea and cachexia. - The absence of a **history of straining** or other typical risk factors suggests that hemorrhoids are unlikely in this scenario. *Angiodysplasia* - Typically presents during older age and can cause gastrointestinal bleeding, but is usually associated with **chronic anemia** rather than the acute symptoms seen here [3]. - Without a significant previous history of bleeding or vascular anomalies, this condition is an unlikely cause for her symptoms.

Question 395: Which of the following statements about hepatocellular carcinoma (HCC) is true?

A. It is resectable in early stages, depending on size, location, and liver function.
B. More than 70% of cases show increased AFP levels.
C. It is the most common primary liver tumor, though metastatic tumors are more common overall.
D. All of the options. (Correct Answer)

Explanation: ***All of the options.*** - This option is correct because HCC is indeed resectable in early stages under specific conditions, AFP levels are elevated in a significant portion of cases, and it is the most common primary liver tumor. [1] - Each individual statement provides an accurate insight into the characteristics and clinical aspects of hepatocellular carcinoma. [2] *It is resectable in early stages, depending on size, location, and liver function.* - **Early-stage HCC** can be potentially cured with **surgical resection** or liver transplantation, provided the tumor is small, solitary, and the patient has good liver function. [2] - The decision for resectability is complex and depends on factors such as **tumor size, location**, and the patient's **Child-Pugh score** or MELD score for liver function. *More than 70% of cases show increased AFP levels.* - **Alpha-fetoprotein (AFP)** is a widely used **tumor marker** for HCC, and elevated levels are observed in 60-80% of patients, particularly those with larger tumors. [1] - While helpful for screening and monitoring, AFP is not specific enough for diagnosis on its own, as it can also be elevated in other liver conditions and germ cell tumors. *It is the most common primary liver tumor, though metastatic tumors are more common overall.* - **Hepatocellular carcinoma (HCC)** accounts for about 80-90% of **primary liver cancers**, making it the most prevalent type originating in the liver. - However, **metastatic liver cancer**, meaning cancer that has spread to the liver from another primary site (e.g., colon, lung, breast), is significantly more common in the general population than primary liver cancers.

Question 396: Which type of breast cancer is most commonly bilateral?

A. Lobular (Correct Answer)
B. Medullary
C. None of the options
D. Paget's disease

Explanation: ***Lobular*** - **Invasive lobular carcinoma (ILC)** is the breast cancer type most frequently associated with **bilateral disease**, occurring in about 5-28% of cases. - This tendency is attributed to its infiltrative growth pattern and potential for multifocal involvement, making bilateral involvement more likely. *Paget's disease* - **Paget's disease of the breast** is a rare form of breast cancer that primarily affects the skin of the **nipple and areola**. - It is almost exclusively **unilateral**, and its presentation with eczematous changes is distinct from bilateral parenchymal involvement. *Medullary* - **Medullary carcinoma** is a rare subtype of invasive ductal carcinoma known for its often **well-circumscribed appearance** and better prognosis. - While it can be multifocal, it does not have a strong propensity for **bilateral occurrence** like lobular carcinoma. *None of the options* - This option is incorrect because **lobular carcinoma** is well-established in medical literature as having the highest incidence of bilateral presentation among breast cancer types.

Question 397: Which of the following statements about esophageal cancer is true?

A. Small lesions generally have a better prognosis.
B. Esophageal cancer is more lethal than colorectal cancer. (Correct Answer)
C. Asymptomatic benign esophageal lesions are usually monitored.
D. Squamous cell carcinoma is declining globally and is now less common than adenocarcinoma worldwide.

Explanation: Esophageal cancer is more lethal than colorectal cancer. - Esophageal cancer generally has a poorer prognosis and a lower 5-year survival rate compared to colorectal cancer, making it more lethal. - This is often due to its aggressive nature and tendency to be diagnosed at advanced stages. Small lesions generally have a better prognosis. - While true for some cancers, this statement is misleading in the context of esophageal cancer because even small esophageal lesions can be highly aggressive and already involve deeper layers or lymph nodes. - Early detection of seemingly "small" lesions does improve outcomes, but the overall prognosis remains challenging due to the disease's inherent aggressiveness, even at early stages. Asymptomatic benign esophageal lesions are usually monitored. - The question is about esophageal cancer, not benign lesions. Asymptomatic benign lesions are typically managed based on their specific type and risk of progression, but this statement does not address esophageal cancer. [1] - This option introduces a different diagnostic and management consideration, shifting focus from the malignancy. Squamous cell carcinoma is declining globally and is now less common than adenocarcinoma worldwide. - While the incidence of adenocarcinoma has been rising in Western countries, squamous cell carcinoma (SCC) still accounts for the majority of esophageal cancers worldwide, especially in undeveloped nations. - The global shift where adenocarcinoma supersedes SCC is not universally true, especially when considering the global burden of the disease. [2]

Question 398: Age for regular mammography screening in average-risk women is

A. 40 (Correct Answer)
B. 55
C. 25
D. 35

Explanation: ***40*** - Current guidelines from organizations like the **American Cancer Society (ACS)** recommend that women at **average risk** begin regular annual mammography screening at **age 40**. - While other organizations have slightly different recommendations, **age 40** is a commonly cited starting point to maximize benefits for average-risk women. *55* - **Age 55** is typically when some guidelines suggest transitioning to **biennial** (every other year) mammography screening, rather than initiating it. - Delaying initial screening until 55 would miss potential early detection opportunities for many women. *25* - **Age 25** is generally considered too young for routine mammography screening in **average-risk women**, as breast tissue is denser and cancer incidence is very low. - Screening this early is reserved for high-risk individuals with specific genetic mutations or strong family histories. *35* - While **age 35** is closer to the recommended starting age, it is generally earlier than the standard guidelines for **average-risk women**. - Some high-risk individuals might begin screening around this age, but it's not the universal recommendation for the general population.

Question 399: What is the most common primary source of metastatic bone tumors in males?

A. Liver
B. Bone
C. Brain
D. Prostate (Correct Answer)

Explanation: ***Prostate*** - **Prostate cancer** is the most common primary source of metastatic bone tumors in males due to its high propensity to **metastasize to bone** and its high prevalence in the male population [1]. - These metastases are typically **osteoblastic**, causing increased bone density visible on imaging. *Liver* - While the **liver** can be a site of metastasis for many cancers, it is not a common primary source for **bone metastases** [2]. - Liver cancer (hepatocellular carcinoma) can metastasize, but bone is not its most frequent distant site. *Bone* - **Bone** itself can be the site of primary bone tumors, such as osteosarcoma or Ewing's sarcoma, but these are **not metastatic bone tumors** in the sense of originating elsewhere [3]. - When cancer originates in the bone, it is a primary bone cancer, not a metastatic one. *Brain* - **Brain tumors** (primary intracranial malignancies) generally have a **low propensity to metastasize** outside of the central nervous system. - While rare cases of brain tumor metastasis to bone can occur, it is not a common event or primary source.

Question 400: What is the most common cause of brain metastasis?

A. Carcinoma lung (Correct Answer)
B. Prostate cancer
C. HCC
D. Seminoma

Explanation: ***Carcinoma lung*** - Lung cancer is the most common source of **brain metastases**, accounting for a significant proportion of cases [1]. - Typically spreads via the **hematogenous route**, leading to multiple lesions in the brain [1]. *Prostate cancer* - While prostate cancer can metastasize to the brain, it is less common than lung cancer. - More frequently it spreads to **bone**, making it a relatively rare cause of brain metastases. *HCC* - Hepatocellular carcinoma (HCC) has a tendency to metastasize to the **lungs** and **bone**, but brain metastases are rare. - It typically performs worse in terms of brain involvement compared to lung carcinoma. *Seminoma* - Seminomas primarily spread to regional **lymph nodes** and can metastasize to other organs, but brain involvement is quite rare. - Common sites of metastasis include the **lungs** and **liver**, not the brain.

Question 401: A patient with a history of increased lethargy and significant loss of weight, found to have elevated carcinoembryonic antigens (CEA) in laboratory examination, may have all of the following conditions, except:

A. Lung cancer
B. Breast cancer
C. Colon cancer
D. Osteogenic sarcoma (Correct Answer)

Explanation: ***Osteogenic sarcoma*** - While osteogenic sarcoma is a serious malignancy, it is **not typically associated with elevated carcinoembryonic antigen (CEA)** levels. - CEA is primarily a marker for **adenocarcinomas** and does not usually rise in bone or soft tissue sarcomas. *Lung cancer* - **Elevated CEA** is a common finding in many types of lung cancer, particularly **adenocarcinoma of the lung**. - Lung cancer can cause symptoms like **lethargy** and **significant weight loss** due to systemic effects of the malignancy [1], [3]. *Breast cancer* - **CEA levels can be elevated** in a significant proportion of patients with breast cancer, especially in advanced or metastatic disease. - Like other advanced cancers, breast cancer can present with **lethargy** and **unexplained weight loss** [1], [3]. *Colon cancer* - **Elevated CEA** is a well-established and widely used tumor marker for **colon cancer**, both for diagnosis and monitoring of disease recurrence [2], [4]. - Colon cancer, particularly in later stages, often leads to systemic symptoms such as **lethargy**, fatigue, and **significant weight loss** [1].

Question 402: Most common symptom of lung carcinoma is

A. Cough (Correct Answer)
B. Dyspnoea
C. Weight loss
D. Chest pain

Explanation: ***Cough*** - **Chronic cough** is the most frequently reported symptom in patients with lung carcinoma, often progressing in severity or character. [1] - It results from irritation of the **bronchial tree** by the tumor or associated inflammation. [1] *Dyspnoea* - While common, **shortness of breath** typically occurs when the tumor significantly obstructs airways, causes pleural effusion, or spreads to lymphatics. [1] - It usually presents later in the disease progression compared to cough. *Weight loss* - **Unexplained weight loss** is a common systemic symptom of malignancy, including lung cancer, but is often a sign of advanced disease. [1] - This symptom is non-specific and can be associated with many chronic illnesses. *Chest pain* - **Chest pain** in lung carcinoma often indicates involvement of the pleura, chest wall, or mediastinum by the tumor. - It is a common symptom but is less frequent than cough as the initial presenting complaint.

Question 403: Which type of tumor is most amenable to chemotherapy?

A. Choriocarcinoma (Correct Answer)
B. Embryonal rhabdomyosarcoma
C. Hepatocellular carcinoma
D. Thyroid carcinoma

Explanation: ***Choriocarcinoma*** - **Choriocarcinoma** is highly sensitive to chemotherapy, often achieving **cure rates greater than 90%** even in metastatic settings, especially when treated with combination regimens such as EMA-CO. - Its rapid growth rate and high mitotic index make it particularly susceptible to **cytotoxic agents** that target rapidly dividing cells. *Embryonal rhabdomyosarcoma* - While treatable with chemotherapy, **rhabdomyosarcoma**, especially the embryonal subtype, typically requires a combination of **surgery, chemotherapy, and radiation**, and its response to chemotherapy alone is not as uniformly curative as choriocarcinoma. - The efficacy of chemotherapy is often dependent on the tumor's stage, location, and the completeness of surgical resection. *Hepatocellular carcinoma* - **Hepatocellular carcinoma (HCC)** is notoriously resistant to traditional systemic chemotherapy, with limited response rates and often requiring targeted therapies like sorafenib or lenvatinib. - Its management is primarily based on **surgical resection, liver transplantation**, or locoregional therapies such as **transarterial chemoembolization (TACE)** or radiofrequency ablation (RFA). *Thyroid carcinoma* - Most types of thyroid carcinoma, especially **differentiated thyroid cancers (papillary and follicular)**, are managed primarily with **surgery and radioactive iodine (RAI)** therapy, showing limited responsiveness to conventional chemotherapy. - Anaplastic thyroid carcinoma, while aggressive, also typically responds poorly to standard chemotherapy regimens, often requiring multimodal treatment.

Question 404: Which of the following is not included in the International Prognostic Index (IPI) for lymphoma?

A. Stage of disease
B. LDH
C. Hemoglobin (Correct Answer)
D. Number of extralymphatic sites involved

Explanation: ***Hemoglobin*** - **Hemoglobin** level is not one of the five factors included in the original **International Prognostic Index (IPI)** for lymphoma. - While anemia can be a feature of lymphoma, it is not explicitly used as a prognosticator within the IPI. *LDH* - **Lactate dehydrogenase (LDH)** is a critical component of the IPI, with elevated levels indicating a worse prognosis due to higher tumor burden and cellular turnover [1]. - Higher LDH reflects increased metabolic activity of rapidly proliferating lymphoma cells [1]. *Stage of disease* - The **Ann Arbor clinical stage** (III or IV versus I or II) is a key factor in the IPI, as advanced stage signifies more widespread disease [1]. - Higher disease burden and dissemination generally correlate with a poorer prognosis. *Number of extralymphatic sites involved* - The presence of **more than one extralymphatic site** of involvement is an important prognostic factor in the IPI, indicating aggressive disease. - Involvement outside the lymphatic system suggests more systemic dissemination and a less favorable outcome.

Question 405: Which of the following is typically not elevated in multiple myeloma?

A. Hypercalcemia
B. Hypercalciuria
C. Lytic lesions in bone
D. Increase in alkaline phosphatase (Correct Answer)

Explanation: ***Increase in alkaline phosphatase*** - While multiple myeloma leads to **bone destruction**, it primarily involves **osteoclast activation** and bone resorption, rather than osteoblast activity. - Therefore, markers of osteoblast activity, like **alkaline phosphatase**, are typically not elevated and may even be normal or low, unless there's an associated complication like fracture healing or hepatobiliary disease. *Lytic lesions in bone* - Multiple myeloma cells produce factors that enhance **osteoclast activity** and inhibit osteoblast function, leading to the characteristic **punch-out lytic lesions** visible on imaging [1]. - These lesions are a hallmark of the disease and are caused by the destruction of bone tissue, not new bone formation [1]. *Hypercalcemia* - The extensive **bone destruction** caused by lytic lesions leads to the release of calcium into the bloodstream, resulting in **hypercalcemia**. - This is a common and serious complication of multiple myeloma, contributing to symptoms like fatigue, confusion, and kidney problems. *Hypercalciuria* - The increased serum calcium from **bone breakdown** often leads to an excessive excretion of calcium in the urine, known as **hypercalciuria**. - This can contribute to kidney stone formation and further worsen kidney function in patients with multiple myeloma.

Question 406: A 65-year-old white male in previously good health starts to notice blood in his urine, develops pain with urination, and experiences a weakened urinary stream. He seeks medical attention from his family doctor due to these symptoms. Laboratory findings reveal anemia, and urinalysis is positive for red cells, white cells, and gram-negative rods. A cystogram shows a tumor, and a transurethral biopsy confirms a malignant bladder tumor. Which of the following is true about this patient's tumor?

A. Is likely to recur after treatment (Correct Answer)
B. It is unlikely to be an adenocarcinoma
C. Typically does not present with a palpable abdominal mass
D. Does not typically cause an elevated serum acid phosphatase

Explanation: ***Is likely to recur after treatment*** - Bladder cancers, especially **urothelial carcinomas**, have a high rate of recurrence, often requiring ongoing surveillance after initial treatment [1]. - Recurrence can occur in the bladder or other parts of the **urothelial tract**, even after successful primary tumor resection [1]. *It is unlikely to be an adenocarcinoma* - This statement is actually **false** because the most common type of bladder cancer is **urothelial carcinoma** (transitional cell carcinoma), making adenocarcinoma less common but still a possibility [1]. - The symptoms described (hematuria, dysuria, weakened stream) are general for bladder cancer and do not specifically rule out adenocarcinoma. *Typically does not present with a palpable abdominal mass* - While bladder tumors *can* present with a palpable mass in advanced stages, the initial symptoms of **hematuria** and **dysuria** are more common. - A palpable mass in the abdomen would indicate a significantly large or invasive tumor, which is not suggested as the primary presentation here. *Does not typically cause an elevated serum acid phosphatase* - **Elevated serum acid phosphatase** is commonly associated with advanced **prostate cancer**, especially with bone metastases. - Bladder cancer does not typically cause an elevation in this specific marker.

Question 407: In which of the following conditions is emergency radiotherapy indicated?

A. Neoplastic cardiac tamponade
B. Acute epidural spinal cord compression
C. Superior vena cava syndrome (Correct Answer)
D. Tumor lysis syndrome

Explanation: ### Superior vena cava syndrome - **Emergency radiotherapy** is indicated in SVC syndrome, especially if caused by radiation-sensitive tumors, to rapidly reduce tumor burden and relieve **venous compression**. [3] - Rapid intervention is crucial due to the potential for **life-threatening compromise** of venous return from the head and upper extremities. [2] *Neoplastic cardiac tamponade* - The primary emergency treatment for **cardiac tamponade** is **pericardiocentesis** to urgently relieve fluid pressure around the heart. - Radiotherapy is not the immediate intervention for acute tamponade, though it may be used later to manage the underlying malignancy. *Acute epidural spinal cord compression* - **Acute spinal cord compression** requires immediate intervention, often with **high-dose corticosteroids** to reduce edema and emergent surgical decompression to prevent permanent neurological damage. [1] - Radiotherapy may be used as an adjunct or for less acute cases, but surgery is usually prioritized for acute compression. [1] *Tumor lysis syndrome* - **Tumor lysis syndrome** is a metabolic emergency managed with aggressive **hydration**, **allopurinol**, or **rasburicase** to prevent renal failure and electrolyte abnormalities. - Radiotherapy is not a treatment for the acute metabolic derangements of tumor lysis syndrome.

Question 408: In which of the following conditions is neoadjuvant chemotherapy not typically used?

A. Thyroid cancer (Correct Answer)
B. Breast cancer
C. Esophageal cancer
D. Lung cancer

Explanation: ***Thyroid cancer*** - **Neoadjuvant chemotherapy** is generally **not used** for the treatment of thyroid cancer, as it is primarily managed with surgery, radioactive iodine, and thyroid hormone suppression [1]. - Most thyroid cancers, especially differentiated types like **papillary** and **follicular carcinoma**, are not highly sensitive to conventional chemotherapy [1]. *Breast cancer* - **Neoadjuvant chemotherapy** is a common approach in **locally advanced breast cancer** to downstage tumors, improve surgical outcomes, and assess treatment response. - It may also be used in cases of **inflammatory** or certain aggressive subtypes like **triple-negative** breast cancer. *Esophageal cancer* - **Neoadjuvant chemotherapy**, often combined with **radiation** (chemoradiotherapy), is a standard treatment for **locally advanced esophageal cancer**. - Its purpose is to **downstage** the tumor, reduce invasiveness, and improve surgical resectability and survival rates. *Lung cancer* - **Neoadjuvant chemotherapy** is frequently employed for **locally advanced non-small cell lung cancer** (NSCLC) to reduce tumor size and extent before surgical resection. - This approach aims to improve the likelihood of a complete surgical removal and overall prognosis.

Question 409: What is the percentage of testicular cancer cases that are associated with cryptorchidism?

A. 50%
B. 70%
C. 10%
D. 30% (Correct Answer)

Explanation: ***30%*** - While cryptorchidism is a significant risk factor for testicular cancer, it is associated with approximately **30%** of all testicular cancer cases. - The remaining 70% of testicular cancer cases occur in men with normally descended testes, indicating that other factors are also involved in its etiology. *10%* - This percentage is too low to represent the known association between cryptorchidism and testicular cancer. - Cryptorchidism is a well-established and more prominent risk factor than what 10% would suggest. *50%* - This percentage is higher than the generally accepted figure for the association between cryptorchidism and testicular cancer. - While cryptorchidism significantly increases the risk, it does not account for half of all cases. *70%* - This percentage is significantly higher than current epidemiological data suggest for the proportion of testicular cancer cases linked to cryptorchidism. - This would imply that cryptorchidism is almost the sole cause, which is not accurate.

Question 410: What is the tumor marker that can be indicative of disease relapse in a 65-year-old male who was diagnosed with prostate cancer three years ago and treated with surgery and hormone therapy, and is now experiencing urinary symptoms and progressive backache?

A. CA 125
B. Beta-HCG
C. Carcinoembryonic antigen (CEA)
D. PSA (Correct Answer)

Explanation: ***PSA*** - **Prostate-specific antigen (PSA)** is the primary tumor marker for prostate cancer and is used for screening, monitoring treatment response [2], and detecting **disease relapse** [4]. - Rising PSA levels in a patient with a history of prostate cancer, especially with new urinary symptoms and backache (suggesting **metastasis**), are highly indicative of recurrence [1]. *CA 125* - **CA 125** is primarily a tumor marker for **ovarian cancer** and is not used for monitoring prostate cancer. - While it can be elevated in some non-malignant conditions, it has no diagnostic or prognostic value for prostate cancer. *Beta-HCG* - **Beta-HCG** is a tumor marker typically associated with **germ cell tumors** (e.g., testicular cancer) and **choriocarcinoma** [3]. - It is not used for the diagnosis or monitoring of prostate cancer [3]. *Carcinoembryonic antigen (CEA)* - **CEA** is a tumor marker often associated with **colorectal cancer**, and less commonly with other adenocarcinomas such as lung or breast cancer. - It is not a specific or reliable marker for prostate cancer [4].

Question 411: What is the best method for screening prostate cancer?

A. DRE and PSA together
B. PET scan
C. DRE
D. PSA test (Correct Answer)

Explanation: ***PSA test*** - The **prostate-specific antigen (PSA) test** is a blood test that measures the level of PSA, a protein produced by the prostate gland [2]. Elevated PSA levels can indicate prostate cancer, but can also be caused by other benign prostate conditions (e.g., benign prostatic hyperplasia, prostatitis). - The PSA test is widely used for **screening asymptomatic men** for prostate cancer. While its use in widespread screening is debated due to concerns about overdiagnosis and overtreatment, it remains the primary blood test for initial prostate cancer detection. *PET scan* - **Positron Emission Tomography (PET) scans** are sophisticated imaging tests primarily used for **staging cancer** that has already been diagnosed, to detect metastases, or to monitor treatment response. - PET scans are **not recommended for initial prostate cancer screening** because they are expensive, involve radiation exposure, and lack the sensitivity and specificity needed for early detection in asymptomatic men. *DRE* - A **Digital Rectal Examination (DRE)** involves a physician inserting a gloved, lubricated finger into the rectum to feel the prostate gland for abnormalities such as lumps, hard spots, or an enlarged prostate [1]. - While DRE can sometimes detect prostate abnormalities, it has **limited sensitivity** for early-stage or small tumors and is **less effective than PSA** as a standalone screening tool [1]. *DRE and PSA together* - The **combination of DRE and PSA** was historically a common approach for prostate cancer screening, aiming to improve detection rates. - While performing both tests together can slightly increase detection compared to either test alone, **current guidelines often prioritize the PSA test** as the primary screening tool due to its higher sensitivity, particularly in conjunction with shared decision-making regarding the risks and benefits of screening. The DRE is often used as a follow-up if PSA is elevated or as a component of a comprehensive examination.

Question 412: The commonest site of lymphoma in the gastrointestinal system is:

A. Stomach (Correct Answer)
B. Large intestine
C. Esophagus
D. Small bowel

Explanation: **Stomach** - The **stomach** is the most common primary site for lymphoma within the gastrointestinal tract [1], especially **MALT lymphoma**, which is strongly associated with *Helicobacter pylori* infection [1]. - Gastric lymphoma can present with symptoms similar to peptic ulcer disease, such as **epigastric pain**, nausea, and weight loss [1]. *Small bowel* - While the small bowel can be affected by lymphoma, especially **enteropathy-associated T-cell lymphoma (EATL)**, it is less common than gastric involvement. - Small bowel lymphomas often cause **obstruction**, bleeding, or malabsorption [2]. *Large intestine* - Lymphoma of the large intestine is relatively rare compared to the stomach and small bowel. - It may present with symptoms such as **abdominal pain**, changes in bowel habits, or bleeding. *Esophagus* - Primary esophageal lymphoma is extremely rare. - When present, it is more often a result of **secondary involvement** from widespread lymphoma rather than a primary tumor.

Question 413: PSA greater than 20 ng/mL is commonly seen in:

A. Prostate cancer (Correct Answer)
B. BPH
C. Prostatitis
D. Bladder cancer

Explanation: ***Prostate cancer*** - A **prostate-specific antigen (PSA)** level greater than **20 ng/mL** is highly suggestive of **prostate cancer**, especially advanced disease, and prompts further evaluation. - While other conditions can elevate PSA, such levels significantly increase the **positive predictive value** for malignancy. *BPH* - **Benign prostatic hyperplasia (BPH)** can elevate PSA, but levels typically remain below **10 ng/mL**, rarely exceeding **20 ng/mL**. - The PSA elevation in BPH is proportional to the **gland size**, which usually doesn't lead to such high values. *Prostatitis* - **Prostatitis** (inflammation of the prostate) can cause a transient, significant increase in PSA, sometimes above **20 ng/mL**. - However, the elevation typically **normalizes** after treatment of the infection or inflammation, unlike in prostate cancer. *Bladder cancer* - **Bladder cancer** does not typically cause an elevation in PSA unless there is concurrent **prostatic involvement** or other prostate pathology. - PSA is a **prostate-specific marker**, so its elevation is not directly indicative of bladder malignancy.

Question 414: Malignancy-associated hypercalcemia is due to?

A. Vitamin D secretion by tumors
B. Cytokine-mediated osteoclast activation
C. Bone metastases causing osteolysis
D. Parathyroid hormone-related peptide (PTHrP) (Correct Answer)

Explanation: Malignancy-associated hypercalcemia is primarily due to **parathyroid hormone-related peptide (PTHrP)**, which mimics the action of parathyroid hormone, causing increased calcium release from bones [1][2]. This condition is often seen in **solid tumors**, particularly squamous cell carcinomas, and can lead to significant **hypercalcemia** [2][3]. *Tumor lysis syndrome* - Tumor lysis syndrome results from rapid cell lysis leading to **release of intracellular contents**, causing hyperuricemia, not directly hypercalcemia. - It is characterized by **electrolyte imbalances** such as hyperkalemia, hyperphosphatemia, but not primarily hypercalcemia. *IGF-b* - Insulin-like Growth Factor (IGF) is primarily involved in **growth processes** and does not lead to hypercalcemia. - While it has an association with cancer, it does not function in the pathway that elevates serum calcium levels. *IL-7* - Interleukin-7 (IL-7) is mainly related to **T-cell development** and does not play a role in hypercalcemia associated with malignancy. - While cytokines can influence various pathways in cancer, IL-7 is not implicated in **calcium metabolism**.

Question 415: Screening of prostate cancer is commonly done by

A. DRE (digital rectal exam) & PSA (Correct Answer)
B. MRI imaging
C. Surgical intervention
D. Ultrasound-guided procedure

Explanation: ***DRE (digital rectal exam) & PSA*** - **Digital Rectal Exam (DRE)** allows for palpation of the prostate gland to detect **nodules**, **hardness**, or **asymmetry** that may indicate cancer. [1] - **Prostate-Specific Antigen (PSA)** is a blood test that measures a protein produced by the prostate gland; elevated levels can suggest prostate cancer. *MRI imaging* - While **MRI** is used for **staging** and sometimes for **targeted biopsies** of suspicious lesions, it is not a primary screening tool due to its cost and limited availability for broad population screening. - It is typically used *after* abnormal DRE or PSA results, or for monitoring. *Surgical intervention* - **Surgical intervention** (e.g., radical prostatectomy) is a **treatment** for prostate cancer confirmed by biopsy, not a screening method. - Screening aims to *detect* the disease, not to treat it. *Ultrasound-guided procedure* - **Transrectal ultrasound (TRUS)** is primarily used to **guide prostate biopsies** and determine prostate volume, not as a standalone screening test. - It does not have sufficient sensitivity or specificity to be routinely used for initial cancer screening.

Question 416: What would be the most probable diagnosis for a 50-year-old chronic smoker who presents with hemoptysis, truncal obesity, and hypertension, and has an elevated ACTH level that is not suppressible with high-dose dexamethasone?

A. Ectopic ACTH producing lung cancer (Correct Answer)
B. Adrenal adenoma
C. Bilateral adrenal hyperplasia
D. Pituitary tumor

Explanation: ***Ectopic ACTH producing lung cancer*** - The combination of **hemoptysis** in a **chronic smoker** points towards a pulmonary malignancy, which can produce **ectopic ACTH**, leading to Cushing's syndrome symptoms [2, 5]. - The **elevated ACTH** that is **not suppressible with high-dose dexamethasone** is characteristic of ectopic ACTH production, as the tumor cells do not respond to feedback inhibition [1]. *Adrenal adenoma* - An **adrenal adenoma** causes **ACTH-independent Cushing's syndrome**, meaning ACTH levels would be low [1]. - While it can cause symptoms like truncal obesity and hypertension, it does not explain the hemoptysis or elevated ACTH. *Bilateral adrenal hyperplasia* - **Bilateral adrenal hyperplasia** can cause Cushing's syndrome, but it is typically **ACTH-dependent** and often responsive to high-dose dexamethasone if it's pituitary-driven [1]. - It does not account for the hemoptysis or the **non-suppressible ACTH** level in this particular presentation. *Pituitary tumor* - A **pituitary tumor** (Cushing's disease) produces ACTH, causing Cushing's syndrome, and typically shows **suppression with high-dose dexamethasone** (though not always fully). - It would not explain the symptom of **hemoptysis** associated with a chronic smoker [2].

Question 417: Carcinoid tumor is diagnosed by what means?

A. Measurement of urinary 5-HIAA levels. (Correct Answer)
B. Serum Chromogranin A levels.
C. Serum Neuron-Specific Enolase (NSE) levels.
D. Measurement of urinary 5-HTP levels.

Explanation: ***Measurement of urinary 5-HIAA levels.*** - Carcinoid tumors actively produce **serotonin (5-HT)**, which is metabolized into **5-hydroxyindoleacetic acid (5-HIAA)**. - Elevated levels of **5-HIAA** in a 24-hour urine collection are highly indicative of a carcinoid tumor [1]. *Serum Chromogranin A levels.* - **Chromogranin A** is a general marker for **neuroendocrine tumors**, including carcinoids, but is less specific than **5-HIAA** [1]. - Its levels can be elevated in other conditions like **renal insufficiency, atrophic gastritis**, and with **proton pump inhibitor (PPI)** use, leading to false positives. *Serum Neuron-Specific Enolase (NSE) levels.* - **NSE** is a marker primarily used for **small cell lung cancer** and some other neuroendocrine tumors, but it is not the primary diagnostic test for carcinoid. - While it can be elevated in some carcinoid cases, it lacks the specificity and diagnostic value of **urinary 5-HIAA** for classic carcinoid syndrome. *Measurement of urinary 5-HTP levels.* - **5-hydroxytryptophan (5-HTP)** is a precursor to serotonin, and its measurement is not a standard or primary diagnostic test for carcinoid tumors. - Carcinoid tumors typically directly produce **serotonin**, which is then metabolized to **5-HIAA**, making **5-HIAA** a more direct and reliable marker.

Question 418: What is the role of the HER2/neu receptor in breast cancer treatment?

A. Screening for breast cancer risk
B. Assessing tumor recurrence risk
C. Guiding treatment decisions (Correct Answer)
D. Diagnosis of breast cancer based on HER2 status

Explanation: ***Predicting response to targeted therapies in breast cancer*** - The **HER2/neu receptor** is a key biomarker used to determine the effectiveness of targeted therapies, such as trastuzumab (Herceptin), in HER2-positive breast cancer [1]. - Presence of HER2 overexpression directly impacts treatment strategies and overall patient outcomes [1]. *Risk assessment for breast cancer screening* - While risk factors are essential for screening, **HER2/neu** is not utilized for general risk assessment. - Other factors like **family history** and **BRCA mutations** play a more significant role in this context. *Histological diagnosis of breast cancer* - Histological diagnosis primarily relies on **tissue biopsy** and specific grading systems, not HER2 status per se. - While HER2 can be evaluated histologically, it is not a key method for initial diagnosis [1]. *Prognosis and recurrence prediction in breast cancer* - HER2 positivity can indicate a worse prognosis, but it is more directly linked to **treatment response** than recurrence prediction [1]. - Other factors like **tumor size** and **lymph node status** are more traditionally used in prognosis.

Question 419: The most common cause of severe hypercalcemia is

A. Malignancy (Correct Answer)
B. Vitamin D toxicity
C. Sarcoidosis
D. Chronic renal failure

Explanation: ***Malignancy*** - **Malignancy** is the most frequent cause of **severe hypercalcemia**, often resulting from **parathyroid hormone-related peptide (PTHrP) secretion** (humoral hypercalcemia of malignancy) or **bone metastases** causing osteolysis [1]. - Cancers like **squamous cell carcinoma**, **breast cancer**, **multiple myeloma**, and **renal cell carcinoma** are commonly associated with severe hypercalcemia [1]. *Vitamin D toxicity* - While vitamin D toxicity can cause hypercalcemia, it typically leads to **moderate hypercalcemia** and is less common as a cause of **severe hypercalcemia** compared to malignancy [1]. - It usually occurs due to **excessive intake of vitamin D supplements** or activated vitamin D [1]. *Sarcoidosis* - Sarcoidosis can cause hypercalcemia due to **extrarenal production of 1,25-dihydroxyvitamin D** by activated macrophages [1]. - However, the hypercalcemia in sarcoidosis is usually **mild to moderate** and rarely reaches the severity seen with malignancy [1]. *Chronic renal failure* - **Chronic renal failure** is more commonly associated with **hypocalcemia** due to impaired vitamin D activation and hyperparathyroidism [2], [3]. - While some patients with end-stage renal disease and **adynamic bone disease** or **tertiary hyperparathyroidism** can develop hypercalcemia, it is not the most common cause of *severe* hypercalcemia in the general population.

Question 420: Which type of lung cancer is most commonly found in non-smokers?

A. Adenocarcinoma (Correct Answer)
B. Squamous cell carcinoma (associated with smoking)
C. Oat cell carcinoma (small cell lung cancer)
D. None of the options

Explanation: ***Adenocarcinoma*** - It is the most common type of lung cancer among **non-smokers**, often associated with **lung scarring** and **asbestos exposure**. - Typically presents in the **peripheral** regions of the lungs and has a **glandular** pattern on histology. *Squamous cell carcinoma* - More commonly associated with **smoking** [1] and usually arises in the **central parts** of the lungs. - Known for cavitary lesions and often linked to chronic **lung disease** rather than non-smokers. *None of the above* - This oes not provide a definitive lung cancer type, which is **not relevant** when adenocarcinoma is the correct answer. - Fails to recognize the significant evidence linking adenocarcinoma as the predominant type in non-smokers. *Oat cell carcinoma* - This represents **small cell lung cancer**, which is strongly linked to **smoking** rather than being common in non-smokers [1]. - Often presents with **metastatic lesions** and is more aggressive, unlike adenocarcinoma.

Question 421: Metastases from follicular carcinoma should be treated by:

A. Radioiodine (Correct Answer)
B. Surgery
C. Thyroxine
D. Observation

Explanation: ***Radioiodine*** - **Differentiated thyroid cancers**, including **follicular carcinoma**, retain the ability to uptake iodine, making **radioiodine (I-131) therapy** highly effective for treating metastases [1]. - This therapy targets and destroys thyroid cancer cells wherever they are located in the body, including distant metastatic sites. *Surgery* - While surgery (e.g., **thyroidectomy**) is the primary treatment for localized thyroid cancer and can be used to resect some metastases, it is **not always feasible** for all metastatic sites, especially widely disseminated disease. - Surgery for widespread metastases carries significant risks and may not be curative if all tumor burden cannot be removed. *Thyroxine* - **Thyroxine (T4)** replacement therapy is crucial after thyroidectomy to replace missing hormones and to **suppress TSH** production, which can stimulate residual cancer growth [1]. - However, thyroxine itself does **not directly destroy** existing metastases; it's a supportive and suppressive therapy, not a primary treatment for metastases. *Observation* - **Observation** is generally not appropriate for treating metastases from **follicular carcinoma**, as these metastases have the potential to grow and lead to significant morbidity and mortality if left untreated. - Active treatment is usually indicated to improve prognosis and quality of life.

Question 422: Which one of the following is not a tumor marker for testicular tumors?

A. AFP
B. LDH
C. HCG
D. CA-125 (Correct Answer)

Explanation: ***CEA*** - **Carcinoembryonic antigen (CEA)** is primarily used as a tumor marker for colorectal and other gastrointestinal cancers [1], not for testicular tumors [2]. - It lacks specificity for germ cell tumors, as the primary markers in testicular tumors are **HCG**, **AFP**, and **LDH** [2]. *HCG* - **Human chorionic gonadotropin (HCG)** is commonly elevated in the presence of germ cell tumors, especially teratomas and choriocarcinomas [2]. - It is a key marker for diagnosis and monitoring of testicular tumors. *AFP* - **Alpha-fetoprotein (AFP)** is often elevated in non-seminomatous germ cell tumors, particularly yolk sac tumors [2]. - It serves as an important marker for diagnosis and treatment response in these tumors. *LDH* - **Lactate dehydrogenase (LDH)** can be elevated in various tumors, including testicular cancer, but it is a non-specific marker. - It is used to assess tumor burden and monitor treatment response rather than for definitive diagnosis.

Question 423: Which type of lung tumor is most responsive to radiotherapy?

A. Squamous cell CA
B. Adeno CA
C. All types respond differently to treatment.
D. Small cell lung cancer (SCLC) (Correct Answer)

Explanation: ***Small cell lung cancer (SCLC)*** - SCLC is **highly sensitive to chemotherapy and radiation therapy** [2] due to its rapid growth rate and proliferative nature. - While frequently presenting with metastatic disease, local control with **radiotherapy** combined with chemotherapy is crucial, especially in limited-stage disease, and leads to significant tumor shrinkage. *Squamous cell CA* - Squamous cell carcinoma (SCC) is generally **less sensitive** to radiation therapy compared to SCLC, though it is often included in treatment plans for local control. - It tends to grow slower than SCLC and is primarily associated with a **smoking history**. *Adeno CA* - Adenocarcinoma (Adeno CA) is the **most common type of non-small cell lung cancer (NSCLC)**, and its response to radiotherapy varies. - While radiation is used, particularly for **local control or palliation** [1], it is not as uniquely responsive as SCLC, and targeted therapies are often preferred for systemic treatment. *All types respond differently to treatment.* - While it is true that all tumors respond differently based on their histology and individual patient factors, this option does not identify the **most responsive type** as requested by the question. - This statement is a general truth but **lacks the specificity** needed to answer which specific type is most responsive to radiotherapy.

Question 424: Which malignancy is characterized by a stepwise progression through lymph nodes, making staging an important prognostic factor?

A. Hodgkin's lymphoma (Correct Answer)
B. Multiple myeloma
C. Mature T cell NHL
D. Mature B cell NHL

Explanation: ***Hodgkin's lymphoma*** - Characteristically spreads in a **stepwise fashion** through lymphatic pathways [1], making **staging critical** for prognosis [1]. - Its localized dissemination and the presence of **Reed-Sternberg cells** help define its distinct clinical behavior [1]. *Multiple myeloma* - Primarily characterized by **disseminated plasma cell proliferation** and typically does not follow a stepwise spread pattern. - Staging is based on **serum markers** rather than anatomical spread, focusing more on paraproteins and organ damage. *Mature T cell NHL* - Often exhibits an **aggressive** nature with various patterns of spread, but not characteristically in a stepwise manner [2]. - Staging relevance is less focused compared to Hodgkin's lymphoma, as many subtypes present differently. *Mature B cell NHL* - More variable in behavior and can disseminate **discontinuously** [2], lacking a uniform stepwise progression. - Staging exists but is often less straightforward compared to **Hodgkin's lymphoma**, which has a more predictable pattern [1][2].

Question 425: Trousseau's syndrome is classically seen with:

A. Carcinoma of the stomach
B. Multiple Endocrine Neoplasia type II
C. Neuroendocrine tumors of the pancreas
D. Pancreatic carcinoma (Correct Answer)

Explanation: ***Pancreatic carcinoma*** - **Trousseau's syndrome**, or migratory thrombophlebitis, is a paraneoplastic syndrome characterized by recurrent, migratory episodes of **venous thrombosis** in unusual sites. - It is often associated with adenocarcinomas, particularly those of the **pancreas**, lung, stomach, and prostate, due to the tumor's ability to activate clotting [1]. *Carcinoma of the stomach* - While stomach carcinoma can be associated with Trousseau's syndrome, it is **less common** than with pancreatic carcinoma. - Trousseau's syndrome in gastric cancer may also involve other paraneoplastic phenomena like **acanthosis nigricans**. *Multiple Endocrine Neoplasia type II* - This syndrome is associated with tumors such as **medullary thyroid carcinoma**, pheochromocytoma, and parathyroid adenomas. - It does not typically present with **Trousseau's syndrome** but instead has a distinct set of paraneoplastic manifestations related to hormone overexpression [1]. *Neuroendocrine tumors of the pancreas* - These tumors often manifest with symptoms related to hormone overproduction, such as **insulinomas** (hypoglycemia) or **gastrinomas** (Zollinger-Ellison syndrome) [2]. - While any malignancy can theoretically predispose to thrombosis, they are **not classically associated** with Trousseau's syndrome, which is more typical of exocrine pancreatic adenocarcinoma.

Question 426: A 52-year-old recent immigrant from Vietnam presents with abdominal swelling, weight loss, and upper abdominal pain of three weeks' duration. His past medical history includes malaria and infection with Clonorchis sinensis. On palpation, the liver is hard. An abdominal CT scan reveals a hypo-attenuated mass with lobulated margins in the liver, and a biopsy shows well-differentiated neoplastic glands embedded in a dense fibrous stroma. What is the most likely diagnosis?

A. Cholangiocarcinoma (Correct Answer)
B. Gallbladder carcinoma
C. Angiosarcoma
D. Hepatic adenoma

Explanation: ***Cholangiocarcinoma*** - The history of **Clonorchis sinensis** infection is a significant risk factor for the development of cholangiocarcinoma, a malignancy of the bile ducts [1]. - The presentation of a **hypo-attenuated mass** with well-differentiated glands in the biopsy is characteristic of cholangiocarcinoma, especially given the patient's background. [1] *Carcinoma of the gallbladder* - Typically presents with mass lesions, but would more likely show **gallbladder wall thickening** rather than a hypo-attenuated mass in the liver. - Associated with **gallstones** and chronic inflammation, which are not indicated in this patient's history. *Hemangiosarcoma* - More commonly found in the spleen or heart; liver involvement is rare. - Biopsy would show **vascular spaces** rather than well-differentiated neoplastic glands, making it less likely in this case. *Hepatocellular carcinoma* - Generally develops in patients with **chronic liver disease** and shows a more **vascular** appearance on imaging [2]. - The biopsy findings of well-differentiated glands and the absence of cirrhotic liver history point away from hepatocellular carcinoma.

Question 427: Which of the following tumor markers is most specific for hepatocellular carcinoma (HCC)?

A. Alpha-fetoprotein (AFP)
B. PIVKA-2 (Correct Answer)
C. CA 19-9
D. Neurotensin

Explanation: ***PIVKA-2*** - **PIVKA-2 (protein induced by vitamin K absence or antagonist-II)** is a tumor marker that is highly specific for **hepatocellular carcinoma (HCC)**, especially in differentiating it from other liver diseases. - Its levels can distinguish HCC from **cirrhosis** and **chronic hepatitis**, particularly when AFP levels are normal. - *Neurotensin* - **Neurotensin** is a neuropeptide that can be elevated in certain neuroendocrine tumors, such as **carcinoid tumors** or **pheochromocytomas**. - It is **not specific** for hepatocellular carcinoma and is not routinely used in its diagnosis. - *Alpha-fetoprotein (AFP)* - While **alpha-fetoprotein (AFP)** is a commonly used tumor marker for **HCC**, its specificity is limited as it can also be elevated in other conditions like **cirrhosis**, **chronic hepatitis**, and **germ cell tumors** [2]. - High AFP levels can also be seen in **pregnant women**, making it less specific than PIVKA-2 for HCC. - In HCC patients with elevated AFP levels, serial measurements can be a useful biomarker of disease progression/response to treatment [1]. - *CA 19-9* - **CA 19-9** is a tumor marker primarily associated with **pancreatic cancer** and can also be elevated in **biliary tract cancers**. - It is **not specific** for hepatocellular carcinoma and is not used in its primary diagnosis or monitoring.

Question 428: Most common malignancy in post-transplant individuals:

A. Kaposi sarcoma
B. PTLD
C. CNS lymphoma
D. Squamous cell carcinoma of skin (Correct Answer)

Explanation: Most common malignancy in post-transplant individuals: ***Squamous cell carcinoma of skin*** - **Squamous cell carcinoma (SCC) of the skin** is the most common malignancy in post-transplant individuals, largely due to **immunosuppression** which impairs immune surveillance against oncogenic viruses and sunlight-induced mutations [1]. - The risk of SCC is significantly increased (up to 65-fold) in transplant recipients, often presenting as **multiple tumors** and exhibiting a more aggressive course than in the general population [2]. *Kaposi sarcoma* - **Kaposi sarcoma (KS)** is associated with **human herpesvirus 8 (HHV-8)** infection and is more common in transplant recipients compared to the general population, but it is not the *most common* malignancy [1]. - While its incidence is increased, it remains less frequent than skin cancers like SCC. *PTLD* - **Post-transplant lymphoproliferative disorder (PTLD)** is a significant complication of organ transplantation, primarily driven by **Epstein-Barr virus (EBV)** infection in the setting of immunosuppression [1]. - PTLD is a serious malignancy, but its overall incidence is less than that of skin cancers. *CNS lymphoma* - **CNS lymphoma** can occur in post-transplant patients, often linked to **EBV infection** and immunosuppression [1]. - Although it is a severe complication, its incidence is considerably lower than that of skin cancers in this population.

Practice by Chapter

Cancer Biology and Carcinogenesis

Practice Questions

Principles of Cancer Diagnosis and Staging

Practice Questions

Solid Tumor Management

Practice Questions

Hematological Malignancies

Practice Questions

Cancer Emergencies

Practice Questions

Principles of Chemotherapy, Immunotherapy and Targeted Therapy

Practice Questions

Radiation Oncology Basics

Practice Questions

Palliative Care in Oncology

Practice Questions

Cancer Screening and Prevention

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Oncology — MCQs

Oncology — MCQs

On this page